'en:renal failure'
(id=6795500 ; fe=en:renal failure ; type=1 ; niveau=200 ;
luminosité=25 ;
somme entrante=66200 creation date=2017-06-25 touchdate=2025-09-11 21:14:57.000) ≈ 1686 relations sortantes
- en:renal failure --
r_associated #0: 223 / 1 ->
médecine
n1=en:renal failure | n2=médecine | rel=r_associated | relid=0 | w=223
- en:renal failure --
r_associated #0: 173 / 0.776 ->
défaillance rénale
n1=en:renal failure | n2=défaillance rénale | rel=r_associated | relid=0 | w=173
- en:renal failure --
r_associated #0: 172 / 0.771 ->
non précisée, insuffisance rénale
n1=en:renal failure | n2=non précisée, insuffisance rénale | rel=r_associated | relid=0 | w=172
- en:renal failure --
r_associated #0: 153 / 0.686 ->
insuffisance rénale non précisée
n1=en:renal failure | n2=insuffisance rénale non précisée | rel=r_associated | relid=0 | w=153
- en:renal failure --
r_associated #0: 152 / 0.682 ->
syndrome d'insuffisance rénale
n1=en:renal failure | n2=syndrome d'insuffisance rénale | rel=r_associated | relid=0 | w=152
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:3 ml testosterone undecanoate 250 mg/ml injection
n1=en:renal failure | n2=en:3 ml testosterone undecanoate 250 mg/ml injection | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:5000 mg testosterone 0.01 mg/mg topical gel
n1=en:renal failure | n2=en:5000 mg testosterone 0.01 mg/mg topical gel | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:abnormal glomeruli seen on biopsy
n1=en:renal failure | n2=en:abnormal glomeruli seen on biopsy | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:abnormal nephrogenesis
n1=en:renal failure | n2=en:abnormal nephrogenesis | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:abnormal renal calyces
n1=en:renal failure | n2=en:abnormal renal calyces | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:acitretin 10 mg oral capsule [soriatane]
n1=en:renal failure | n2=en:acitretin 10 mg oral capsule [soriatane] | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:ammonium chloride 500 mg oral tablet
n1=en:renal failure | n2=en:ammonium chloride 500 mg oral tablet | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:amyloid nephropathy
n1=en:renal failure | n2=en:amyloid nephropathy | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:anomalous renal pelvis (rare)
n1=en:renal failure | n2=en:anomalous renal pelvis (rare) | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:breast disorder
n1=en:renal failure | n2=en:breast disorder | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:calcifediol, anhydrous 20micrograms capsule
n1=en:renal failure | n2=en:calcifediol, anhydrous 20micrograms capsule | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:calcium oxalate urolithiasis
n1=en:renal failure | n2=en:calcium oxalate urolithiasis | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:carnitine palmitoyltransferase ii deficiency, late-onset
n1=en:renal failure | n2=en:carnitine palmitoyltransferase ii deficiency, late-onset | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:chloral hydrate
n1=en:renal failure | n2=en:chloral hydrate | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:chronic kidney disease, stage 5
n1=en:renal failure | n2=en:chronic kidney disease, stage 5 | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:cisplatin pwdr
n1=en:renal failure | n2=en:cisplatin pwdr | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:clofibrate 500 mg oral capsule
n1=en:renal failure | n2=en:clofibrate 500 mg oral capsule | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:complication of external stoma of urinary tract
n1=en:renal failure | n2=en:complication of external stoma of urinary tract | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:cyclosporine 100 mg oral capsule
n1=en:renal failure | n2=en:cyclosporine 100 mg oral capsule | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:cyclosporine 100 mg oral capsule [sandimmune]
n1=en:renal failure | n2=en:cyclosporine 100 mg oral capsule [sandimmune] | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:cyclosporine 100 mg/ml oral solution
n1=en:renal failure | n2=en:cyclosporine 100 mg/ml oral solution | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:cyclosporine 100 mg/ml oral solution [sandimmune]
n1=en:renal failure | n2=en:cyclosporine 100 mg/ml oral solution [sandimmune] | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:cyclosporine 50 mg oral capsule
n1=en:renal failure | n2=en:cyclosporine 50 mg oral capsule | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:diabetic end stage renal disease
n1=en:renal failure | n2=en:diabetic end stage renal disease | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:diatrizoate meglumine 180mg + iodine 85mg/ml (18%) injection solution 300ml bottle
n1=en:renal failure | n2=en:diatrizoate meglumine 180mg + iodine 85mg/ml (18%) injection solution 300ml bottle | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:diatrizoate meglumine 300mg + iodine 141mg/ml (30%) injection solution 300ml bottle
n1=en:renal failure | n2=en:diatrizoate meglumine 300mg + iodine 141mg/ml (30%) injection solution 300ml bottle | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:diatrizoate meglumine 50%/diatrizoate na 25% inj
n1=en:renal failure | n2=en:diatrizoate meglumine 50%/diatrizoate na 25% inj | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:diatrizoate meglumine 66%/diatrizoate na 10% soln,oral
n1=en:renal failure | n2=en:diatrizoate meglumine 66%/diatrizoate na 10% soln,oral | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:diphenidol
n1=en:renal failure | n2=en:diphenidol | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:discrete dilatation of the right kidney pelvis (rare)
n1=en:renal failure | n2=en:discrete dilatation of the right kidney pelvis (rare) | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:edetate disodium
n1=en:renal failure | n2=en:edetate disodium | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:end stage renal disease (20-40 years)(28% of patients)
n1=en:renal failure | n2=en:end stage renal disease (20-40 years)(28% of patients) | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:enlarged kidney
n1=en:renal failure | n2=en:enlarged kidney | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:familial mediterranean fever
n1=en:renal failure | n2=en:familial mediterranean fever | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:fenofibrate 120mg tablet
n1=en:renal failure | n2=en:fenofibrate 120mg tablet | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:fenofibrate micronized 67mg capsule
n1=en:renal failure | n2=en:fenofibrate micronized 67mg capsule | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:fentanyl 0.4 mg/actuat nasal spray
n1=en:renal failure | n2=en:fentanyl 0.4 mg/actuat nasal spray | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:fentanyl 600micrograms buccal tablet
n1=en:renal failure | n2=en:fentanyl 600micrograms buccal tablet | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:fentanyl citrate 600mg lozenge
n1=en:renal failure | n2=en:fentanyl citrate 600mg lozenge | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:frasier syndrome
n1=en:renal failure | n2=en:frasier syndrome | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:glomerular c3 deposits, subendothelial and mesangial
n1=en:renal failure | n2=en:glomerular c3 deposits, subendothelial and mesangial | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:glomerulonephritis, autoimmune
n1=en:renal failure | n2=en:glomerulonephritis, autoimmune | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:glomerulonephritis, postinfectious (1 patient)
n1=en:renal failure | n2=en:glomerulonephritis, postinfectious (1 patient) | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:hemorrhagic fever with renal syndrome
n1=en:renal failure | n2=en:hemorrhagic fever with renal syndrome | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:heterotopic kidney
n1=en:renal failure | n2=en:heterotopic kidney | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:hypertension
n1=en:renal failure | n2=en:hypertension | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:hypertrophic podocytes
n1=en:renal failure | n2=en:hypertrophic podocytes | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:hypomagnesemia 2, renal
n1=en:renal failure | n2=en:hypomagnesemia 2, renal | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:iga nephropathy
n1=en:renal failure | n2=en:iga nephropathy | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:immune complex nephritis
n1=en:renal failure | n2=en:immune complex nephritis | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:increased echogenicity of entire parenchyma
n1=en:renal failure | n2=en:increased echogenicity of entire parenchyma | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:increased mesangial matrix
n1=en:renal failure | n2=en:increased mesangial matrix | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:increased renal tubular phosphate reabsorption
n1=en:renal failure | n2=en:increased renal tubular phosphate reabsorption | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:infundibular stenosis
n1=en:renal failure | n2=en:infundibular stenosis | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:joubert syndrome type 4
n1=en:renal failure | n2=en:joubert syndrome type 4 | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:juxtaglomerular hyperplasia due to activation of the renin-aldosterone axis
n1=en:renal failure | n2=en:juxtaglomerular hyperplasia due to activation of the renin-aldosterone axis | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:ketorolac tromethamine 0.45% ophthalmic solution
n1=en:renal failure | n2=en:ketorolac tromethamine 0.45% ophthalmic solution | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:kidney necrosis
n1=en:renal failure | n2=en:kidney necrosis | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:magnesium 84mg tab,sa
n1=en:renal failure | n2=en:magnesium 84mg tab,sa | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:magnesium gluconate 500 mg oral tablet
n1=en:renal failure | n2=en:magnesium gluconate 500 mg oral tablet | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:magnesium gluconate,dihydrate
n1=en:renal failure | n2=en:magnesium gluconate,dihydrate | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:magnesium so4 2meq/ml inj
n1=en:renal failure | n2=en:magnesium so4 2meq/ml inj | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:magnesium sulfate 500 mg/ml injection
n1=en:renal failure | n2=en:magnesium sulfate 500 mg/ml injection | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:magnesium sulfate anhydrous
n1=en:renal failure | n2=en:magnesium sulfate anhydrous | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:malignant kidney neoplasm
n1=en:renal failure | n2=en:malignant kidney neoplasm | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:metaxalone
n1=en:renal failure | n2=en:metaxalone | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:metaxalone 800mg tablet
n1=en:renal failure | n2=en:metaxalone 800mg tablet | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:metformin hydrochloride 750mg m/r tablet
n1=en:renal failure | n2=en:metformin hydrochloride 750mg m/r tablet | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:methocarbamol
n1=en:renal failure | n2=en:methocarbamol | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:methotrexate
n1=en:renal failure | n2=en:methotrexate | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:microscopic hematuria
n1=en:renal failure | n2=en:microscopic hematuria | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:nephritis, tubulointerstitial
n1=en:renal failure | n2=en:nephritis, tubulointerstitial | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:nephrolithiasis
n1=en:renal failure | n2=en:nephrolithiasis | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:nephrotic syndrome (1 patient)
n1=en:renal failure | n2=en:nephrotic syndrome (1 patient) | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:normal glomerular function
n1=en:renal failure | n2=en:normal glomerular function | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:oliguria
n1=en:renal failure | n2=en:oliguria | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:overactive bladder
n1=en:renal failure | n2=en:overactive bladder | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:patient problem codes fda cdrh
n1=en:renal failure | n2=en:patient problem codes fda cdrh | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:phenolsulfonphthalein
n1=en:renal failure | n2=en:phenolsulfonphthalein | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:plasma cell myeloma post-transplant lymphoproliferative disorder
n1=en:renal failure | n2=en:plasma cell myeloma post-transplant lymphoproliferative disorder | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:polycystic kidney disease
n1=en:renal failure | n2=en:polycystic kidney disease | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:potassium bicarbonate 6.5 meq oral tablet
n1=en:renal failure | n2=en:potassium bicarbonate 6.5 meq oral tablet | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:potassium chloride 0.4 meq/ml injectable solution
n1=en:renal failure | n2=en:potassium chloride 0.4 meq/ml injectable solution | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:potassium chloride 10 meq extended release oral tablet
n1=en:renal failure | n2=en:potassium chloride 10 meq extended release oral tablet | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:potassium chloride 3.2 meq/ml injectable solution
n1=en:renal failure | n2=en:potassium chloride 3.2 meq/ml injectable solution | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:potassium chloride 8 meq extended release oral tablet
n1=en:renal failure | n2=en:potassium chloride 8 meq extended release oral tablet | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:potassium chloride strong 15% injection solution 10ml ampule
n1=en:renal failure | n2=en:potassium chloride strong 15% injection solution 10ml ampule | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:potassium phosphate monobase 500mg tablet
n1=en:renal failure | n2=en:potassium phosphate monobase 500mg tablet | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:pyelonephritis (in some patients)
n1=en:renal failure | n2=en:pyelonephritis (in some patients) | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:pyuria
n1=en:renal failure | n2=en:pyuria | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:quinethazone
n1=en:renal failure | n2=en:quinethazone | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:renal agenesis, unilateral (1 patient)
n1=en:renal failure | n2=en:renal agenesis, unilateral (1 patient) | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:renal biopsy shows tubular atrophy
n1=en:renal failure | n2=en:renal biopsy shows tubular atrophy | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:renal calcification (in some patients)
n1=en:renal failure | n2=en:renal calcification (in some patients) | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:renal calculi (urate and calcium oxalate)
n1=en:renal failure | n2=en:renal calculi (urate and calcium oxalate) | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:renal dysplasia due to fetal exposure to angiotensin converting enzyme inhibitor
n1=en:renal failure | n2=en:renal dysplasia due to fetal exposure to angiotensin converting enzyme inhibitor | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:renal failure may occur
n1=en:renal failure | n2=en:renal failure may occur | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:renal phosphate wasting (in some patients)
n1=en:renal failure | n2=en:renal phosphate wasting (in some patients) | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:ribavirin 600 mg oral tablet
n1=en:renal failure | n2=en:ribavirin 600 mg oral tablet | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:salcedo syndrome
n1=en:renal failure | n2=en:salcedo syndrome | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:small echogenic kidneys
n1=en:renal failure | n2=en:small echogenic kidneys | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:sodium phosphate, dibasic, heptahydrate
n1=en:renal failure | n2=en:sodium phosphate, dibasic, heptahydrate | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:sodium phosphate, tribasic
n1=en:renal failure | n2=en:sodium phosphate, tribasic | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:structure of inferior pole of kidney
n1=en:renal failure | n2=en:structure of inferior pole of kidney | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:testosterone 2.5mg/24hours transdermal patch
n1=en:renal failure | n2=en:testosterone 2.5mg/24hours transdermal patch | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:testosterone 30mg buccal system
n1=en:renal failure | n2=en:testosterone 30mg buccal system | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:testosterone enanthate 100 mg/ml injectable solution
n1=en:renal failure | n2=en:testosterone enanthate 100 mg/ml injectable solution | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:thickening of renal arterial walls
n1=en:renal failure | n2=en:thickening of renal arterial walls | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:toxoplasma tubulointerstitial nephropathy
n1=en:renal failure | n2=en:toxoplasma tubulointerstitial nephropathy | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:turp syndrome
n1=en:renal failure | n2=en:turp syndrome | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:urinary fistula complication
n1=en:renal failure | n2=en:urinary fistula complication | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:vesicoureteral reflux
n1=en:renal failure | n2=en:vesicoureteral reflux | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 149 / 0.668 ->
en:vesicoureteral reflux (rare)
n1=en:renal failure | n2=en:vesicoureteral reflux (rare) | rel=r_associated | relid=0 | w=149
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:{14 (ribavirin 400 mg oral tablet) } pack
n1=en:renal failure | n2=en:{14 (ribavirin 400 mg oral tablet) } pack | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:0.4 ml methotrexate 62.5 mg/ml auto-injector
n1=en:renal failure | n2=en:0.4 ml methotrexate 62.5 mg/ml auto-injector | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:0.6 ml fondaparinux sodium 12.5 mg/ml prefilled syringe
n1=en:renal failure | n2=en:0.6 ml fondaparinux sodium 12.5 mg/ml prefilled syringe | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:60 actuat testosterone 12.5 mg/actuat topical gel
n1=en:renal failure | n2=en:60 actuat testosterone 12.5 mg/actuat topical gel | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:8 ml methotrexate 25 mg/ml injection
n1=en:renal failure | n2=en:8 ml methotrexate 25 mg/ml injection | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:abnormality of the renal collecting system
n1=en:renal failure | n2=en:abnormality of the renal collecting system | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:absence of renal corticomedullary differentiation
n1=en:renal failure | n2=en:absence of renal corticomedullary differentiation | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:adrenal cortex atrophy (42%)
n1=en:renal failure | n2=en:adrenal cortex atrophy (42%) | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:adult fanconi syndrome
n1=en:renal failure | n2=en:adult fanconi syndrome | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:alteration in patterns of urinary elimination
n1=en:renal failure | n2=en:alteration in patterns of urinary elimination | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:amprenavir 150mg capsule
n1=en:renal failure | n2=en:amprenavir 150mg capsule | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:amprenavir 15mg/ml oral solution
n1=en:renal failure | n2=en:amprenavir 15mg/ml oral solution | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:bilateral hydronephrosis
n1=en:renal failure | n2=en:bilateral hydronephrosis | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:cardiorenal syndrome
n1=en:renal failure | n2=en:cardiorenal syndrome | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:chronic glomerulonephritis
n1=en:renal failure | n2=en:chronic glomerulonephritis | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:chronic kidney insufficiency
n1=en:renal failure | n2=en:chronic kidney insufficiency | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:cyclosporine, modified 100 mg oral capsule
n1=en:renal failure | n2=en:cyclosporine, modified 100 mg oral capsule | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:cystic nephroma
n1=en:renal failure | n2=en:cystic nephroma | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:cystic renal dysplasia (less common)
n1=en:renal failure | n2=en:cystic renal dysplasia (less common) | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:cystinosis
n1=en:renal failure | n2=en:cystinosis | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:dahlberg borer newcomer syndrome
n1=en:renal failure | n2=en:dahlberg borer newcomer syndrome | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:dark urine following exercise
n1=en:renal failure | n2=en:dark urine following exercise | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:decreased kidney volume (1 patient)
n1=en:renal failure | n2=en:decreased kidney volume (1 patient) | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:dedifferentiated atrophic tubules with thick basement membrane seen on renal biopsy
n1=en:renal failure | n2=en:dedifferentiated atrophic tubules with thick basement membrane seen on renal biopsy | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:deposition of complement component c3 in glomerular basement membrane
n1=en:renal failure | n2=en:deposition of complement component c3 in glomerular basement membrane | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:dextrothyroxine 1 mg oral tablet
n1=en:renal failure | n2=en:dextrothyroxine 1 mg oral tablet | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:diatrizoate 76% injection solution 100ml vial
n1=en:renal failure | n2=en:diatrizoate 76% injection solution 100ml vial | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:diatrizoate meglumine 60%/diatrizoate na 30% inj
n1=en:renal failure | n2=en:diatrizoate meglumine 60%/diatrizoate na 30% inj | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:diatrizoate sodium
n1=en:renal failure | n2=en:diatrizoate sodium | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:dilated calyces (rare)
n1=en:renal failure | n2=en:dilated calyces (rare) | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:discoloration of kidney
n1=en:renal failure | n2=en:discoloration of kidney | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:diseases of male genital organs (n40-n53)
n1=en:renal failure | n2=en:diseases of male genital organs (n40-n53) | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:dofetilide 125micrograms capsule
n1=en:renal failure | n2=en:dofetilide 125micrograms capsule | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:drug-induced nephropathy
n1=en:renal failure | n2=en:drug-induced nephropathy | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:duplicated calyx
n1=en:renal failure | n2=en:duplicated calyx | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:effacement of epithelial foot processes
n1=en:renal failure | n2=en:effacement of epithelial foot processes | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:end-stage renal disease (in some)
n1=en:renal failure | n2=en:end-stage renal disease (in some) | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:end-stage renal disease by third decade of life
n1=en:renal failure | n2=en:end-stage renal disease by third decade of life | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:enlarged, hyperechogenic kidneys (ultrasound)
n1=en:renal failure | n2=en:enlarged, hyperechogenic kidneys (ultrasound) | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:fenofibrate 54 mg oral tablet
n1=en:renal failure | n2=en:fenofibrate 54 mg oral tablet | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:fentanyl 0.1 mg/actuat nasal spray
n1=en:renal failure | n2=en:fentanyl 0.1 mg/actuat nasal spray | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:fentanyl 0.6 mg/actuat mucosal spray
n1=en:renal failure | n2=en:fentanyl 0.6 mg/actuat mucosal spray | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:fentanyl 400microgram buccal soluble film
n1=en:renal failure | n2=en:fentanyl 400microgram buccal soluble film | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:fentanyl 400micrograms buccal tablet
n1=en:renal failure | n2=en:fentanyl 400micrograms buccal tablet | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:fentanyl 800micrograms lozenge
n1=en:renal failure | n2=en:fentanyl 800micrograms lozenge | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:fentanyl citrate 20 ug in 1 ml intravenous injection, solution
n1=en:renal failure | n2=en:fentanyl citrate 20 ug in 1 ml intravenous injection, solution | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:foot process fusion
n1=en:renal failure | n2=en:foot process fusion | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:gemfibrozil
n1=en:renal failure | n2=en:gemfibrozil | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:glomerular and renal tubular cysts
n1=en:renal failure | n2=en:glomerular and renal tubular cysts | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:granular material in cortical tubules
n1=en:renal failure | n2=en:granular material in cortical tubules | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:high fractional excretion of magnesium
n1=en:renal failure | n2=en:high fractional excretion of magnesium | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:hydronephrosis (male)
n1=en:renal failure | n2=en:hydronephrosis (male) | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:hypoaldosteronism, hyporeninemic
n1=en:renal failure | n2=en:hypoaldosteronism, hyporeninemic | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:immature podocytes
n1=en:renal failure | n2=en:immature podocytes | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:impaired reabsorption of chloride
n1=en:renal failure | n2=en:impaired reabsorption of chloride | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:ketorolac trometamol 0.5% ophthalmic solution
n1=en:renal failure | n2=en:ketorolac trometamol 0.5% ophthalmic solution | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:ketorolac trometamol 15.75mg nasal spray
n1=en:renal failure | n2=en:ketorolac trometamol 15.75mg nasal spray | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:kidney circulation disorder
n1=en:renal failure | n2=en:kidney circulation disorder | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:kidney morphologic
n1=en:renal failure | n2=en:kidney morphologic | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:kidney vascular disorder
n1=en:renal failure | n2=en:kidney vascular disorder | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:lipomatosis renis
n1=en:renal failure | n2=en:lipomatosis renis | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:magnesium acetate tetrahydrate
n1=en:renal failure | n2=en:magnesium acetate tetrahydrate | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:magnesium aspartate 615 mg delayed release oral tablet
n1=en:renal failure | n2=en:magnesium aspartate 615 mg delayed release oral tablet | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:magnesium citrate
n1=en:renal failure | n2=en:magnesium citrate | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:magnesium gluconate 200 mg/ml oral solution
n1=en:renal failure | n2=en:magnesium gluconate 200 mg/ml oral solution | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:magnesium oxide 200 mg oral tablet
n1=en:renal failure | n2=en:magnesium oxide 200 mg oral tablet | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:magnesium oxide 500 mg oral tablet
n1=en:renal failure | n2=en:magnesium oxide 500 mg oral tablet | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:malakoplakia of kidney
n1=en:renal failure | n2=en:malakoplakia of kidney | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:medullary cystic renal disease
n1=en:renal failure | n2=en:medullary cystic renal disease | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:metformin hydrochloride
n1=en:renal failure | n2=en:metformin hydrochloride | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:methotrexate 12.5mg/ml infusion solution 30ml vial
n1=en:renal failure | n2=en:methotrexate 12.5mg/ml infusion solution 30ml vial | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:mild proteinuria (in some patients)
n1=en:renal failure | n2=en:mild proteinuria (in some patients) | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:mild subclinical decrease in renal function
n1=en:renal failure | n2=en:mild subclinical decrease in renal function | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:mitomycin 0.2 mg/ml ophthalmic solution
n1=en:renal failure | n2=en:mitomycin 0.2 mg/ml ophthalmic solution | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:neonatal renal disorder
n1=en:renal failure | n2=en:neonatal renal disorder | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:nephroblastomatosis
n1=en:renal failure | n2=en:nephroblastomatosis | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:nephrogenic diabetes insipidus
n1=en:renal failure | n2=en:nephrogenic diabetes insipidus | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:no renal disease
n1=en:renal failure | n2=en:no renal disease | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:non-neoplastic kidney disorder
n1=en:renal failure | n2=en:non-neoplastic kidney disorder | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:oculocerebrorenal syndrome
n1=en:renal failure | n2=en:oculocerebrorenal syndrome | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:osteolysis, hereditary, of carpal bones with or without nephropathy
n1=en:renal failure | n2=en:osteolysis, hereditary, of carpal bones with or without nephropathy | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:other disorders of female genital tract
n1=en:renal failure | n2=en:other disorders of female genital tract | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:other disorders of the genitourinary system
n1=en:renal failure | n2=en:other disorders of the genitourinary system | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:other specified disorders of urinary system
n1=en:renal failure | n2=en:other specified disorders of urinary system | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:other specified disorders resulting from impaired renal function
n1=en:renal failure | n2=en:other specified disorders resulting from impaired renal function | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:polycystic kidney - body part
n1=en:renal failure | n2=en:polycystic kidney - body part | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:polythiazide 2mg tablet
n1=en:renal failure | n2=en:polythiazide 2mg tablet | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:potassium bicarbonate 25 meq effervescent oral tablet
n1=en:renal failure | n2=en:potassium bicarbonate 25 meq effervescent oral tablet | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:potassium chloride 0.67 meq/ml injectable solution
n1=en:renal failure | n2=en:potassium chloride 0.67 meq/ml injectable solution | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:potassium chloride 13 meq delayed release oral tablet
n1=en:renal failure | n2=en:potassium chloride 13 meq delayed release oral tablet | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:potassium chloride 15 meq extended release oral tablet
n1=en:renal failure | n2=en:potassium chloride 15 meq extended release oral tablet | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:potassium chloride 6.7 meq extended release oral tablet
n1=en:renal failure | n2=en:potassium chloride 6.7 meq extended release oral tablet | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:potassium citrate 260 mg oral tablet
n1=en:renal failure | n2=en:potassium citrate 260 mg oral tablet | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:potassium gluconate 2.35 meq oral tablet
n1=en:renal failure | n2=en:potassium gluconate 2.35 meq oral tablet | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:potassium phosphate 1450 mg oral capsule
n1=en:renal failure | n2=en:potassium phosphate 1450 mg oral capsule | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:proteinuria (rare)
n1=en:renal failure | n2=en:proteinuria (rare) | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:pyelitis
n1=en:renal failure | n2=en:pyelitis | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:pyelonephrosis
n1=en:renal failure | n2=en:pyelonephrosis | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:renal abscess
n1=en:renal failure | n2=en:renal abscess | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:renal anomalies (major)
n1=en:renal failure | n2=en:renal anomalies (major) | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:renal biopsy showed interstitial fibrosis
n1=en:renal failure | n2=en:renal biopsy showed interstitial fibrosis | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:renal complication of procedure
n1=en:renal failure | n2=en:renal complication of procedure | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:renal duplication
n1=en:renal failure | n2=en:renal duplication | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:renal failure and impairment
n1=en:renal failure | n2=en:renal failure and impairment | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:renal failure, mild
n1=en:renal failure | n2=en:renal failure, mild | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:renal function abnormal glomer
n1=en:renal failure | n2=en:renal function abnormal glomer | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:renal hamartoma
n1=en:renal failure | n2=en:renal hamartoma | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:renal impairment
n1=en:renal failure | n2=en:renal impairment | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:renal malformation (in some patients)
n1=en:renal failure | n2=en:renal malformation (in some patients) | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:renal phosphate wasting
n1=en:renal failure | n2=en:renal phosphate wasting | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:renal sodium wasting
n1=en:renal failure | n2=en:renal sodium wasting | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:renal tubular acidosis (in some patients)
n1=en:renal failure | n2=en:renal tubular acidosis (in some patients) | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:ribavirin 400 mg oral tablet
n1=en:renal failure | n2=en:ribavirin 400 mg oral tablet | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:single kidney
n1=en:renal failure | n2=en:single kidney | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:sodium phosphate
n1=en:renal failure | n2=en:sodium phosphate | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:sodium phosphate dihydrate
n1=en:renal failure | n2=en:sodium phosphate dihydrate | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:structural urinary tract
n1=en:renal failure | n2=en:structural urinary tract | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:tabular atrophy
n1=en:renal failure | n2=en:tabular atrophy | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:tegaserod maleate
n1=en:renal failure | n2=en:tegaserod maleate | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:testosterone 20.25 mg/actuat topical gel
n1=en:renal failure | n2=en:testosterone 20.25 mg/actuat topical gel | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:testosterone 6mg/24hours transdermal patch
n1=en:renal failure | n2=en:testosterone 6mg/24hours transdermal patch | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:testosterone cypionate 50 mg/ml injectable solution
n1=en:renal failure | n2=en:testosterone cypionate 50 mg/ml injectable solution | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:testosterone enanthate 200 mg/ml injectable solution
n1=en:renal failure | n2=en:testosterone enanthate 200 mg/ml injectable solution | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:testosterone enanthate 200mg/testosterone propionate 25mg inj
n1=en:renal failure | n2=en:testosterone enanthate 200mg/testosterone propionate 25mg inj | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:thickening of glomerular basement membrane
n1=en:renal failure | n2=en:thickening of glomerular basement membrane | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:transplanted kidney complication
n1=en:renal failure | n2=en:transplanted kidney complication | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:tubular basement membrane disintegration
n1=en:renal failure | n2=en:tubular basement membrane disintegration | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:tumors of the kidney (may progress to malignancy in less than 2%)
n1=en:renal failure | n2=en:tumors of the kidney (may progress to malignancy in less than 2%) | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:ultrasound shows hyperechoic kidneys
n1=en:renal failure | n2=en:ultrasound shows hyperechoic kidneys | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:uriniferous tubule
n1=en:renal failure | n2=en:uriniferous tubule | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:urogenital injury
n1=en:renal failure | n2=en:urogenital injury | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 148 / 0.664 ->
en:volume depletion, renal, due to effector loss (hormonal deficit)
n1=en:renal failure | n2=en:volume depletion, renal, due to effector loss (hormonal deficit) | rel=r_associated | relid=0 | w=148
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:{12 (methotrexate 2.5 mg oral tablet) } pack
n1=en:renal failure | n2=en:{12 (methotrexate 2.5 mg oral tablet) } pack | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:1250 mg testosterone 0.0162 mg/mg topical gel [androgel]
n1=en:renal failure | n2=en:1250 mg testosterone 0.0162 mg/mg topical gel [androgel] | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:abnormal corticomedullary differentiation
n1=en:renal failure | n2=en:abnormal corticomedullary differentiation | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:acitretin
n1=en:renal failure | n2=en:acitretin | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:acitretin 25 mg oral capsule [soriatane]
n1=en:renal failure | n2=en:acitretin 25 mg oral capsule [soriatane] | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:acute genitourinary disorder
n1=en:renal failure | n2=en:acute genitourinary disorder | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:acute kidney insufficiency
n1=en:renal failure | n2=en:acute kidney insufficiency | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:acute tubular necrosis
n1=en:renal failure | n2=en:acute tubular necrosis | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:adrenal hyperplasia
n1=en:renal failure | n2=en:adrenal hyperplasia | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:allanson pantzar mcleod syndrome
n1=en:renal failure | n2=en:allanson pantzar mcleod syndrome | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:anatomic structures
n1=en:renal failure | n2=en:anatomic structures | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:aneurysm of renal artery
n1=en:renal failure | n2=en:aneurysm of renal artery | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:anhydrous citric acid
n1=en:renal failure | n2=en:anhydrous citric acid | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:bardet-biedl syndrome 10
n1=en:renal failure | n2=en:bardet-biedl syndrome 10 | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:basement membrane thickening
n1=en:renal failure | n2=en:basement membrane thickening | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:bendroflumethiazide 5 mg extended release oral tablet
n1=en:renal failure | n2=en:bendroflumethiazide 5 mg extended release oral tablet | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:bicarbonate-wasting renal tubular acidosis
n1=en:renal failure | n2=en:bicarbonate-wasting renal tubular acidosis | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:bilateral ureteropelvic junction stenosis
n1=en:renal failure | n2=en:bilateral ureteropelvic junction stenosis | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:biopsy shows dilated proximal tubules
n1=en:renal failure | n2=en:biopsy shows dilated proximal tubules | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:calcium oxalate/carbonate urolithiasis
n1=en:renal failure | n2=en:calcium oxalate/carbonate urolithiasis | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:caliectasis
n1=en:renal failure | n2=en:caliectasis | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:chlorothiazide 250mg tablet
n1=en:renal failure | n2=en:chlorothiazide 250mg tablet | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:chronic disease of genitourinary system
n1=en:renal failure | n2=en:chronic disease of genitourinary system | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:chronic kidney disease
n1=en:renal failure | n2=en:chronic kidney disease | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:cisapride 20mg tablet
n1=en:renal failure | n2=en:cisapride 20mg tablet | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:citric acid,hydrous
n1=en:renal failure | n2=en:citric acid,hydrous | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:citrus naringinine
n1=en:renal failure | n2=en:citrus naringinine | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:coach syndrome
n1=en:renal failure | n2=en:coach syndrome | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:congenital single renal cyst
n1=en:renal failure | n2=en:congenital single renal cyst | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:cortical calcifications (in some patients)
n1=en:renal failure | n2=en:cortical calcifications (in some patients) | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:crush syndrome
n1=en:renal failure | n2=en:crush syndrome | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:cyclosporine, modified 100 mg oral capsule [gengraf]
n1=en:renal failure | n2=en:cyclosporine, modified 100 mg oral capsule [gengraf] | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:cyclosporine, modified 25 mg oral capsule [gengraf]
n1=en:renal failure | n2=en:cyclosporine, modified 25 mg oral capsule [gengraf] | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:cyclothiazide
n1=en:renal failure | n2=en:cyclothiazide | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:defective urinary concentrating ability
n1=en:renal failure | n2=en:defective urinary concentrating ability | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:dextrothyroxine
n1=en:renal failure | n2=en:dextrothyroxine | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:dextrothyroxine 6 mg oral tablet
n1=en:renal failure | n2=en:dextrothyroxine 6 mg oral tablet | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:diatrizoate na pwdr,oral
n1=en:renal failure | n2=en:diatrizoate na pwdr,oral | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:dilated collecting tubules
n1=en:renal failure | n2=en:dilated collecting tubules | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:disorder of kidney co-occurrent with human immunodeficiency virus infection
n1=en:renal failure | n2=en:disorder of kidney co-occurrent with human immunodeficiency virus infection | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:duplex kidney
n1=en:renal failure | n2=en:duplex kidney | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:duplicated collecting system (1 patient)
n1=en:renal failure | n2=en:duplicated collecting system (1 patient) | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:duplicated kidneys (rare)
n1=en:renal failure | n2=en:duplicated kidneys (rare) | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:dysplastic renal parenchyma
n1=en:renal failure | n2=en:dysplastic renal parenchyma | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:ergocalciferol
n1=en:renal failure | n2=en:ergocalciferol | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:ergocalciferol 1.25mg capsule
n1=en:renal failure | n2=en:ergocalciferol 1.25mg capsule | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:fanconi syndrome
n1=en:renal failure | n2=en:fanconi syndrome | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:fenofibrate 48mg tablet
n1=en:renal failure | n2=en:fenofibrate 48mg tablet | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:fenofibrate micronized 50mg tablet
n1=en:renal failure | n2=en:fenofibrate micronized 50mg tablet | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:fentanyl 200micrograms buccal tablet
n1=en:renal failure | n2=en:fentanyl 200micrograms buccal tablet | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:fentanyl 200micrograms lozenge
n1=en:renal failure | n2=en:fentanyl 200micrograms lozenge | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:fentanyl 800microgram buccal soluble film
n1=en:renal failure | n2=en:fentanyl 800microgram buccal soluble film | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:fentanyl citrate pwdr
n1=en:renal failure | n2=en:fentanyl citrate pwdr | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:focal segmental glomerulosclerosis
n1=en:renal failure | n2=en:focal segmental glomerulosclerosis | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:fondaparinux sodium 2.5mg/0.5ml prefilled syringe
n1=en:renal failure | n2=en:fondaparinux sodium 2.5mg/0.5ml prefilled syringe | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:genitourinary tract hemorrhage
n1=en:renal failure | n2=en:genitourinary tract hemorrhage | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:glomerular epithelial cytoplasmic vacuolization
n1=en:renal failure | n2=en:glomerular epithelial cytoplasmic vacuolization | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:glomerulopathy with giant fibrillar deposits
n1=en:renal failure | n2=en:glomerulopathy with giant fibrillar deposits | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:healed glomerulonephritis
n1=en:renal failure | n2=en:healed glomerulonephritis | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:hepatorenal syndrome
n1=en:renal failure | n2=en:hepatorenal syndrome | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:hereditary nephropathy
n1=en:renal failure | n2=en:hereditary nephropathy | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:horseshoe kidney (1 patient)
n1=en:renal failure | n2=en:horseshoe kidney (1 patient) | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:hyperplasia of kidney
n1=en:renal failure | n2=en:hyperplasia of kidney | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:hyperplasia of zona fasciculata of adrenal gland
n1=en:renal failure | n2=en:hyperplasia of zona fasciculata of adrenal gland | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:hypertension, moderate
n1=en:renal failure | n2=en:hypertension, moderate | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:hypertensive nephropathy
n1=en:renal failure | n2=en:hypertensive nephropathy | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:inflammatory disorder of genitourinary system
n1=en:renal failure | n2=en:inflammatory disorder of genitourinary system | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:interstitial cell infiltrate
n1=en:renal failure | n2=en:interstitial cell infiltrate | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:intralobular nephrogenic rests
n1=en:renal failure | n2=en:intralobular nephrogenic rests | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:iron deposition in renal tubular cells
n1=en:renal failure | n2=en:iron deposition in renal tubular cells | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:left kidney
n1=en:renal failure | n2=en:left kidney | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:magnesium
n1=en:renal failure | n2=en:magnesium | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:magnesium hydroxide 240 mg/ml oral suspension
n1=en:renal failure | n2=en:magnesium hydroxide 240 mg/ml oral suspension | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:magnesium oxide 140 mg oral capsule
n1=en:renal failure | n2=en:magnesium oxide 140 mg oral capsule | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:magnesium sulfate 10 mg/ml injection
n1=en:renal failure | n2=en:magnesium sulfate 10 mg/ml injection | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:median onset of renal failure 19 years
n1=en:renal failure | n2=en:median onset of renal failure 19 years | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:membranoproliferative glomerulonephritis seen on biopsy
n1=en:renal failure | n2=en:membranoproliferative glomerulonephritis seen on biopsy | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:methazolamide 25mg tablet
n1=en:renal failure | n2=en:methazolamide 25mg tablet | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:methotrexate 2.5mg tablet
n1=en:renal failure | n2=en:methotrexate 2.5mg tablet | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:methylene blue 1% injection solution 10 ml vial
n1=en:renal failure | n2=en:methylene blue 1% injection solution 10 ml vial | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:methylene blue 1000 mg oral tablet
n1=en:renal failure | n2=en:methylene blue 1000 mg oral tablet | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:methylene blue 65mg tablet
n1=en:renal failure | n2=en:methylene blue 65mg tablet | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:metolazone
n1=en:renal failure | n2=en:metolazone | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:microcystic tubular dilatations
n1=en:renal failure | n2=en:microcystic tubular dilatations | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:mitomycin
n1=en:renal failure | n2=en:mitomycin | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:morphologic change of kidney due to chronic nephritic syndrome
n1=en:renal failure | n2=en:morphologic change of kidney due to chronic nephritic syndrome | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:nephrolithiasis (uncommon)
n1=en:renal failure | n2=en:nephrolithiasis (uncommon) | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:nephronophthisis
n1=en:renal failure | n2=en:nephronophthisis | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:nephropathy co-occurrent and due to systemic lupus erythematosus
n1=en:renal failure | n2=en:nephropathy co-occurrent and due to systemic lupus erythematosus | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:nephrosclerosis
n1=en:renal failure | n2=en:nephrosclerosis | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:opium 20 mg/ml injectable solution
n1=en:renal failure | n2=en:opium 20 mg/ml injectable solution | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:other disorders of urethra and urinary tract
n1=en:renal failure | n2=en:other disorders of urethra and urinary tract | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:other specified disorders of kidney and ureter
n1=en:renal failure | n2=en:other specified disorders of kidney and ureter | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:paromomycin sulfate
n1=en:renal failure | n2=en:paromomycin sulfate | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:perihilar mesangial deposition of proteinaceous material
n1=en:renal failure | n2=en:perihilar mesangial deposition of proteinaceous material | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:polythiazide
n1=en:renal failure | n2=en:polythiazide | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:postoperative renal failure
n1=en:renal failure | n2=en:postoperative renal failure | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:potassium bicarbonate 99 mg oral capsule
n1=en:renal failure | n2=en:potassium bicarbonate 99 mg oral capsule | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:potassium chloride 3 meq/ml injectable solution
n1=en:renal failure | n2=en:potassium chloride 3 meq/ml injectable solution | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:potassium chloride 4 meq delayed release oral tablet
n1=en:renal failure | n2=en:potassium chloride 4 meq delayed release oral tablet | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:potassium citrate 10 meq extended release oral tablet
n1=en:renal failure | n2=en:potassium citrate 10 meq extended release oral tablet | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:progressive renal failure
n1=en:renal failure | n2=en:progressive renal failure | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:psychogenic disorder of the genitourinary system
n1=en:renal failure | n2=en:psychogenic disorder of the genitourinary system | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:recurrent plasma cell myeloma
n1=en:renal failure | n2=en:recurrent plasma cell myeloma | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:renal abnormalities
n1=en:renal failure | n2=en:renal abnormalities | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:renal cysts (in some patients)
n1=en:renal failure | n2=en:renal cysts (in some patients) | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:renal cysts (less common)
n1=en:renal failure | n2=en:renal cysts (less common) | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:renal failure aggravated
n1=en:renal failure | n2=en:renal failure aggravated | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:renal failure, mild to moderate
n1=en:renal failure | n2=en:renal failure, mild to moderate | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:renal hypertension
n1=en:renal failure | n2=en:renal hypertension | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:renal hypodysplasia
n1=en:renal failure | n2=en:renal hypodysplasia | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:renal hypodysplasia (in some patients)
n1=en:renal failure | n2=en:renal hypodysplasia (in some patients) | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:renal interstitial fibrosis
n1=en:renal failure | n2=en:renal interstitial fibrosis | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:renal stones, bilateral
n1=en:renal failure | n2=en:renal stones, bilateral | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:schimke immunoosseous dysplasia
n1=en:renal failure | n2=en:schimke immunoosseous dysplasia | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:small echogenic kidneys (in some patients)
n1=en:renal failure | n2=en:small echogenic kidneys (in some patients) | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:sodium phosphate 1500 mg oral tablet [osmoprep]
n1=en:renal failure | n2=en:sodium phosphate 1500 mg oral tablet [osmoprep] | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:testosterone cypionate 100 mg/ml injectable solution
n1=en:renal failure | n2=en:testosterone cypionate 100 mg/ml injectable solution | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:testosterone propionate 50mg/ml injection solution 2ml ampule
n1=en:renal failure | n2=en:testosterone propionate 50mg/ml injection solution 2ml ampule | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:testosterone pwdr
n1=en:renal failure | n2=en:testosterone pwdr | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:trichlormethiazide
n1=en:renal failure | n2=en:trichlormethiazide | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:tubulointerstitial fibrosis
n1=en:renal failure | n2=en:tubulointerstitial fibrosis | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:tubulointerstitial medullary cystic kidney disease
n1=en:renal failure | n2=en:tubulointerstitial medullary cystic kidney disease | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:tyrosinemia type i
n1=en:renal failure | n2=en:tyrosinemia type i | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:ureter disorder
n1=en:renal failure | n2=en:ureter disorder | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:urinary incontinence
n1=en:renal failure | n2=en:urinary incontinence | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:urinary incontinence associated with cancer
n1=en:renal failure | n2=en:urinary incontinence associated with cancer | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:urinary system disorder
n1=en:renal failure | n2=en:urinary system disorder | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 147 / 0.659 ->
en:urinary tract infection
n1=en:renal failure | n2=en:urinary tract infection | rel=r_associated | relid=0 | w=147
- en:renal failure --
r_associated #0: 146 / 0.655 ->
en:1 ml ketorolac tromethamine 30 mg/ml cartridge
n1=en:renal failure | n2=en:1 ml ketorolac tromethamine 30 mg/ml cartridge | rel=r_associated | relid=0 | w=146
- en:renal failure --
r_associated #0: 146 / 0.655 ->
en:2500 mg testosterone 0.0162 mg/mg topical gel [androgel]
n1=en:renal failure | n2=en:2500 mg testosterone 0.0162 mg/mg topical gel [androgel] | rel=r_associated | relid=0 | w=146
- en:renal failure --
r_associated #0: 146 / 0.655 ->
en:72 hr fentanyl 0.05 mg/hr transdermal patch
n1=en:renal failure | n2=en:72 hr fentanyl 0.05 mg/hr transdermal patch | rel=r_associated | relid=0 | w=146
- en:renal failure --
r_associated #0: 146 / 0.655 ->
en:abnormal renal function
n1=en:renal failure | n2=en:abnormal renal function | rel=r_associated | relid=0 | w=146
- en:renal failure --
r_associated #0: 146 / 0.655 ->
en:absent kidneys (rare)
n1=en:renal failure | n2=en:absent kidneys (rare) | rel=r_associated | relid=0 | w=146
- en:renal failure --
r_associated #0: 146 / 0.655 ->
en:acute nephritis (rare)
n1=en:renal failure | n2=en:acute nephritis (rare) | rel=r_associated | relid=0 | w=146
- en:renal failure --
r_associated #0: 146 / 0.655 ->
en:amprenavir 50mg capsule
n1=en:renal failure | n2=en:amprenavir 50mg capsule | rel=r_associated | relid=0 | w=146
- en:renal failure --
r_associated #0: 146 / 0.655 ->
en:angiokeratoma corporis diffusum
n1=en:renal failure | n2=en:angiokeratoma corporis diffusum | rel=r_associated | relid=0 | w=146
- en:renal failure --
r_associated #0: 146 / 0.655 ->
en:azotemia
n1=en:renal failure | n2=en:azotemia | rel=r_associated | relid=0 | w=146
- en:renal failure --
r_associated #0: 146 / 0.655 ->
en:brinzolamide 10mg/ml eye drops
n1=en:renal failure | n2=en:brinzolamide 10mg/ml eye drops | rel=r_associated | relid=0 | w=146
- en:renal failure --
r_associated #0: 146 / 0.655 ->
en:chlorothiazide 500mg tablet
n1=en:renal failure | n2=en:chlorothiazide 500mg tablet | rel=r_associated | relid=0 | w=146
- en:renal failure --
r_associated #0: 146 / 0.655 ->
en:chlorthalidone
n1=en:renal failure | n2=en:chlorthalidone | rel=r_associated | relid=0 | w=146
- en:renal failure --
r_associated #0: 146 / 0.655 ->
en:chlorthalidone 50mg tablet
n1=en:renal failure | n2=en:chlorthalidone 50mg tablet | rel=r_associated | relid=0 | w=146
- en:renal failure --
r_associated #0: 146 / 0.655 ->
en:chronic interstitial nephritis
n1=en:renal failure | n2=en:chronic interstitial nephritis | rel=r_associated | relid=0 | w=146
- en:renal failure --
r_associated #0: 146 / 0.655 ->
en:cyclosporine 250mg/5ml oily infusion concentrate
n1=en:renal failure | n2=en:cyclosporine 250mg/5ml oily infusion concentrate | rel=r_associated | relid=0 | w=146
- en:renal failure --
r_associated #0: 146 / 0.655 ->
en:cystic dilation of tubules (in some patients)
n1=en:renal failure | n2=en:cystic dilation of tubules (in some patients) | rel=r_associated | relid=0 | w=146
- en:renal failure --
r_associated #0: 146 / 0.655 ->
en:decreased renal function
n1=en:renal failure | n2=en:decreased renal function | rel=r_associated | relid=0 | w=146
- en:renal failure --
r_associated #0: 146 / 0.655 ->
en:dialysis
n1=en:renal failure | n2=en:dialysis | rel=r_associated | relid=0 | w=146
- en:renal failure --
r_associated #0: 146 / 0.655 ->
en:diatrizoate meglumine 28.5%/diatrizoate na 29.1% inj
n1=en:renal failure | n2=en:diatrizoate meglumine 28.5%/diatrizoate na 29.1% inj | rel=r_associated | relid=0 | w=146
- en:renal failure --
r_associated #0: 146 / 0.655 ->
en:dibasic potassium phosphate 1.66 meq/ml / monobasic potassium phosphate 1.65 meq/ml injectable solution
n1=en:renal failure | n2=en:dibasic potassium phosphate 1.66 meq/ml / monobasic potassium phosphate 1.65 meq/ml injectable solution | rel=r_associated | relid=0 | w=146
- en:renal failure --
r_associated #0: 146 / 0.655 ->
en:dilated renal pelvis (rare)
n1=en:renal failure | n2=en:dilated renal pelvis (rare) | rel=r_associated | relid=0 | w=146
- en:renal failure --
r_associated #0: 146 / 0.655 ->
en:diphenidol hydrochloride
n1=en:renal failure | n2=en:diphenidol hydrochloride | rel=r_associated | relid=0 | w=146
- en:renal failure --
r_associated #0: 146 / 0.655 ->
en:disorder of kidney and ureter, unspecified
n1=en:renal failure | n2=en:disorder of kidney and ureter, unspecified | rel=r_associated | relid=0 | w=146
- en:renal failure --
r_associated #0: 146 / 0.655 ->
en:disorder of kidney due to lambda light chain disease
n1=en:renal failure | n2=en:disorder of kidney due to lambda light chain disease | rel=r_associated | relid=0 | w=146
- en:renal failure --
r_associated #0: 146 / 0.655 ->
en:end-stage renal disease (1 of 2 patients)
n1=en:renal failure | n2=en:end-stage renal disease (1 of 2 patients) | rel=r_associated | relid=0 | w=146
- en:renal failure --
r_associated #0: 146 / 0.655 ->
en:fentanyl 0.4 mg/actuat mucosal spray
n1=en:renal failure | n2=en:fentanyl 0.4 mg/actuat mucosal spray | rel=r_associated | relid=0 | w=146
- en:renal failure --
r_associated #0: 146 / 0.655 ->
en:fentanyl citrate 200mg lozenge
n1=en:renal failure | n2=en:fentanyl citrate 200mg lozenge | rel=r_associated | relid=0 | w=146
- en:renal failure --
r_associated #0: 146 / 0.655 ->
en:fentanyl citrate 25 ug in 1 ml intravenous injection, solution [fentanyl citrate]
n1=en:renal failure | n2=en:fentanyl citrate 25 ug in 1 ml intravenous injection, solution [fentanyl citrate] | rel=r_associated | relid=0 | w=146
- en:renal failure --
r_associated #0: 146 / 0.655 ->
en:focal cystic changes
n1=en:renal failure | n2=en:focal cystic changes | rel=r_associated | relid=0 | w=146
- en:renal failure --
r_associated #0: 146 / 0.655 ->
en:focal segmental glomerulosclerosis (less common)
n1=en:renal failure | n2=en:focal segmental glomerulosclerosis (less common) | rel=r_associated | relid=0 | w=146
- en:renal failure --
r_associated #0: 146 / 0.655 ->
en:glomerular crescents (rare), seen on biopsy
n1=en:renal failure | n2=en:glomerular crescents (rare), seen on biopsy | rel=r_associated | relid=0 | w=146
- en:renal failure --
r_associated #0: 146 / 0.655 ->
en:hemolytic uremic syndrome
n1=en:renal failure | n2=en:hemolytic uremic syndrome | rel=r_associated | relid=0 | w=146
- en:renal failure --
r_associated #0: 146 / 0.655 ->
en:hydrochlorothiazide 12.5 mg oral tablet
n1=en:renal failure | n2=en:hydrochlorothiazide 12.5 mg oral tablet | rel=r_associated | relid=0 | w=146
- en:renal failure --
r_associated #0: 146 / 0.655 ->
en:hyperoxaluria
n1=en:renal failure | n2=en:hyperoxaluria | rel=r_associated | relid=0 | w=146
- en:renal failure --
r_associated #0: 146 / 0.655 ->
en:hyperuricemic nephropathy, familial juvenile, 3
n1=en:renal failure | n2=en:hyperuricemic nephropathy, familial juvenile, 3 | rel=r_associated | relid=0 | w=146
- en:renal failure --
r_associated #0: 146 / 0.655 ->
en:indapamide 1.25 mg oral tablet
n1=en:renal failure | n2=en:indapamide 1.25 mg oral tablet | rel=r_associated | relid=0 | w=146
- en:renal failure --
r_associated #0: 146 / 0.655 ->
en:ipsilateral renal agenesis
n1=en:renal failure | n2=en:ipsilateral renal agenesis | rel=r_associated | relid=0 | w=146
- en:renal failure --
r_associated #0: 146 / 0.655 ->
en:kidney angiomyolipoma
n1=en:renal failure | n2=en:kidney angiomyolipoma | rel=r_associated | relid=0 | w=146
- en:renal failure --
r_associated #0: 146 / 0.655 ->
en:low fractional excretion of uric acid
n1=en:renal failure | n2=en:low fractional excretion of uric acid | rel=r_associated | relid=0 | w=146
- en:renal failure --
r_associated #0: 146 / 0.655 ->
en:magnesium hydroxide
n1=en:renal failure | n2=en:magnesium hydroxide | rel=r_associated | relid=0 | w=146
- en:renal failure --
r_associated #0: 146 / 0.655 ->
en:magnesium trisilicate
n1=en:renal failure | n2=en:magnesium trisilicate | rel=r_associated | relid=0 | w=146
- en:renal failure --
r_associated #0: 146 / 0.655 ->
en:malignant bladder neoplasm
n1=en:renal failure | n2=en:malignant bladder neoplasm | rel=r_associated | relid=0 | w=146
- en:renal failure --
r_associated #0: 146 / 0.655 ->
en:membranoproliferative glomerulonephritis (26%)
n1=en:renal failure | n2=en:membranoproliferative glomerulonephritis (26%) | rel=r_associated | relid=0 | w=146
- en:renal failure --
r_associated #0: 146 / 0.655 ->
en:membranous glomerulonephritis (in some patients)
n1=en:renal failure | n2=en:membranous glomerulonephritis (in some patients) | rel=r_associated | relid=0 | w=146
- en:renal failure --
r_associated #0: 146 / 0.655 ->
en:mesangial and subendothelial granular or fibrillar deposits which show immunoreactivity to fibronectin
n1=en:renal failure | n2=en:mesangial and subendothelial granular or fibrillar deposits which show immunoreactivity to fibronectin | rel=r_associated | relid=0 | w=146
- en:renal failure --
r_associated #0: 146 / 0.655 ->
en:mesangial cell proliferation
n1=en:renal failure | n2=en:mesangial cell proliferation | rel=r_associated | relid=0 | w=146
- en:renal failure --
r_associated #0: 146 / 0.655 ->
en:metformin hydrochloride 100mg/ml oral solution
n1=en:renal failure | n2=en:metformin hydrochloride 100mg/ml oral solution | rel=r_associated | relid=0 | w=146
- en:renal failure --
r_associated #0: 146 / 0.655 ->
en:methotrexate sodium
n1=en:renal failure | n2=en:methotrexate sodium | rel=r_associated | relid=0 | w=146
- en:renal failure --
r_associated #0: 146 / 0.655 ->
en:metolazone 5mg tablet
n1=en:renal failure | n2=en:metolazone 5mg tablet | rel=r_associated | relid=0 | w=146
- en:renal failure --
r_associated #0: 146 / 0.655 ->
en:multicystic kidney (rare, in males)
n1=en:renal failure | n2=en:multicystic kidney (rare, in males) | rel=r_associated | relid=0 | w=146
- en:renal failure --
r_associated #0: 146 / 0.655 ->
en:nephrogenic diabetes insipidus (less common)
n1=en:renal failure | n2=en:nephrogenic diabetes insipidus (less common) | rel=r_associated | relid=0 | w=146
- en:renal failure --
r_associated #0: 146 / 0.655 ->
en:nephronophthisis (less common)
n1=en:renal failure | n2=en:nephronophthisis (less common) | rel=r_associated | relid=0 | w=146
- en:renal failure --
r_associated #0: 146 / 0.655 ->
en:nephropathy due to secondary diabetes mellitus
n1=en:renal failure | n2=en:nephropathy due to secondary diabetes mellitus | rel=r_associated | relid=0 | w=146
- en:renal failure --
r_associated #0: 146 / 0.655 ->
en:nephrosis
n1=en:renal failure | n2=en:nephrosis | rel=r_associated | relid=0 | w=146
- en:renal failure --
r_associated #0: 146 / 0.655 ->
en:no renal failure
n1=en:renal failure | n2=en:no renal failure | rel=r_associated | relid=0 | w=146
- en:renal failure --
r_associated #0: 146 / 0.655 ->
en:obstructive nephropathy
n1=en:renal failure | n2=en:obstructive nephropathy | rel=r_associated | relid=0 | w=146
- en:renal failure --
r_associated #0: 146 / 0.655 ->
en:pelvic dilation
n1=en:renal failure | n2=en:pelvic dilation | rel=r_associated | relid=0 | w=146
- en:renal failure --
r_associated #0: 146 / 0.655 ->
en:pelvic dilation (some patients)
n1=en:renal failure | n2=en:pelvic dilation (some patients) | rel=r_associated | relid=0 | w=146
- en:renal failure --
r_associated #0: 146 / 0.655 ->
en:pelvic kidney
n1=en:renal failure | n2=en:pelvic kidney | rel=r_associated | relid=0 | w=146
- en:renal failure --
r_associated #0: 146 / 0.655 ->
en:perinephritis
n1=en:renal failure | n2=en:perinephritis | rel=r_associated | relid=0 | w=146
- en:renal failure --
r_associated #0: 146 / 0.655 ->
en:potassium bicarbonate 20 meq effervescent oral tablet
n1=en:renal failure | n2=en:potassium bicarbonate 20 meq effervescent oral tablet | rel=r_associated | relid=0 | w=146
- en:renal failure --
r_associated #0: 146 / 0.655 ->
en:potassium chloride 0.167 meq/ml oral solution
n1=en:renal failure | n2=en:potassium chloride 0.167 meq/ml oral solution | rel=r_associated | relid=0 | w=146
- en:renal failure --
r_associated #0: 146 / 0.655 ->
en:potassium chloride 2.4 meq/ml injectable solution
n1=en:renal failure | n2=en:potassium chloride 2.4 meq/ml injectable solution | rel=r_associated | relid=0 | w=146
- en:renal failure --
r_associated #0: 146 / 0.655 ->
en:potassium citrate 15 meq extended release oral tablet
n1=en:renal failure | n2=en:potassium citrate 15 meq extended release oral tablet | rel=r_associated | relid=0 | w=146
- en:renal failure --
r_associated #0: 146 / 0.655 ->
en:potassium citrate 5 meq extended release oral tablet
n1=en:renal failure | n2=en:potassium citrate 5 meq extended release oral tablet | rel=r_associated | relid=0 | w=146
- en:renal failure --
r_associated #0: 146 / 0.655 ->
en:proteinuria, severe
n1=en:renal failure | n2=en:proteinuria, severe | rel=r_associated | relid=0 | w=146
- en:renal failure --
r_associated #0: 146 / 0.655 ->
en:pseudoxanthoma elasticum
n1=en:renal failure | n2=en:pseudoxanthoma elasticum | rel=r_associated | relid=0 | w=146
- en:renal failure --
r_associated #0: 146 / 0.655 ->
en:reduced excretion of calcium
n1=en:renal failure | n2=en:reduced excretion of calcium | rel=r_associated | relid=0 | w=146
- en:renal failure --
r_associated #0: 146 / 0.655 ->
en:reduced fractional excretion of uric acid
n1=en:renal failure | n2=en:reduced fractional excretion of uric acid | rel=r_associated | relid=0 | w=146
- en:renal failure --
r_associated #0: 146 / 0.655 ->
en:renal agenesis, left-sided (1/4 patients)
n1=en:renal failure | n2=en:renal agenesis, left-sided (1/4 patients) | rel=r_associated | relid=0 | w=146
- en:renal failure --
r_associated #0: 146 / 0.655 ->
en:renal aldosterone resistance
n1=en:renal failure | n2=en:renal aldosterone resistance | rel=r_associated | relid=0 | w=146
- en:renal failure --
r_associated #0: 146 / 0.655 ->
en:renal aplasia (less common)
n1=en:renal failure | n2=en:renal aplasia (less common) | rel=r_associated | relid=0 | w=146
- en:renal failure --
r_associated #0: 146 / 0.655 ->
en:renal artery obstruction
n1=en:renal failure | n2=en:renal artery obstruction | rel=r_associated | relid=0 | w=146
- en:renal failure --
r_associated #0: 146 / 0.655 ->
en:renal failure neonatal
n1=en:renal failure | n2=en:renal failure neonatal | rel=r_associated | relid=0 | w=146
- en:renal failure --
r_associated #0: 146 / 0.655 ->
en:renal hematuria
n1=en:renal failure | n2=en:renal hematuria | rel=r_associated | relid=0 | w=146
- en:renal failure --
r_associated #0: 146 / 0.655 ->
en:renal impairment neonatal
n1=en:renal failure | n2=en:renal impairment neonatal | rel=r_associated | relid=0 | w=146
- en:renal failure --
r_associated #0: 146 / 0.655 ->
en:renal lymphangiectasia
n1=en:renal failure | n2=en:renal lymphangiectasia | rel=r_associated | relid=0 | w=146
- en:renal failure --
r_associated #0: 146 / 0.655 ->
en:renal mesangiolipidosis
n1=en:renal failure | n2=en:renal mesangiolipidosis | rel=r_associated | relid=0 | w=146
- en:renal failure --
r_associated #0: 146 / 0.655 ->
en:renal tubulopathy
n1=en:renal failure | n2=en:renal tubulopathy | rel=r_associated | relid=0 | w=146
- en:renal failure --
r_associated #0: 146 / 0.655 ->
en:ribavirin
n1=en:renal failure | n2=en:ribavirin | rel=r_associated | relid=0 | w=146
- en:renal failure --
r_associated #0: 146 / 0.655 ->
en:ribavirin 600 mg oral tablet 7 day pack
n1=en:renal failure | n2=en:ribavirin 600 mg oral tablet 7 day pack | rel=r_associated | relid=0 | w=146
- en:renal failure --
r_associated #0: 146 / 0.655 ->
en:rupture of kidney
n1=en:renal failure | n2=en:rupture of kidney | rel=r_associated | relid=0 | w=146
- en:renal failure --
r_associated #0: 146 / 0.655 ->
en:small renal cysts
n1=en:renal failure | n2=en:small renal cysts | rel=r_associated | relid=0 | w=146
- en:renal failure --
r_associated #0: 146 / 0.655 ->
en:sodium phosphate, dibasic
n1=en:renal failure | n2=en:sodium phosphate, dibasic | rel=r_associated | relid=0 | w=146
- en:renal failure --
r_associated #0: 146 / 0.655 ->
en:swollen podocytes
n1=en:renal failure | n2=en:swollen podocytes | rel=r_associated | relid=0 | w=146
- en:renal failure --
r_associated #0: 146 / 0.655 ->
en:systemic lupus erythematosus co-occurrent and due to nephrosis
n1=en:renal failure | n2=en:systemic lupus erythematosus co-occurrent and due to nephrosis | rel=r_associated | relid=0 | w=146
- en:renal failure --
r_associated #0: 146 / 0.655 ->
en:testosterone propionate
n1=en:renal failure | n2=en:testosterone propionate | rel=r_associated | relid=0 | w=146
- en:renal failure --
r_associated #0: 146 / 0.655 ->
en:testosterone propionate pwdr
n1=en:renal failure | n2=en:testosterone propionate pwdr | rel=r_associated | relid=0 | w=146
- en:renal failure --
r_associated #0: 146 / 0.655 ->
en:thickening and disorganization of the glomerular basement membrane
n1=en:renal failure | n2=en:thickening and disorganization of the glomerular basement membrane | rel=r_associated | relid=0 | w=146
- en:renal failure --
r_associated #0: 146 / 0.655 ->
en:thickening of the glomerular basement membrane on renal biopsy
n1=en:renal failure | n2=en:thickening of the glomerular basement membrane on renal biopsy | rel=r_associated | relid=0 | w=146
- en:renal failure --
r_associated #0: 146 / 0.655 ->
en:thinning of the glomerular basement membrane (early in the disease)
n1=en:renal failure | n2=en:thinning of the glomerular basement membrane (early in the disease) | rel=r_associated | relid=0 | w=146
- en:renal failure --
r_associated #0: 146 / 0.655 ->
en:tubular defect in presecretory reabsorption of urate
n1=en:renal failure | n2=en:tubular defect in presecretory reabsorption of urate | rel=r_associated | relid=0 | w=146
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:0.2 ml methotrexate 50 mg/ml auto-injector
n1=en:renal failure | n2=en:0.2 ml methotrexate 50 mg/ml auto-injector | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:24 hr metformin hydrochloride 1000 mg extended release oral tablet
n1=en:renal failure | n2=en:24 hr metformin hydrochloride 1000 mg extended release oral tablet | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:24 hr metformin hydrochloride 500 mg extended release oral tablet [glumetza]
n1=en:renal failure | n2=en:24 hr metformin hydrochloride 500 mg extended release oral tablet [glumetza] | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:adrenal hyperplasia, bilateral
n1=en:renal failure | n2=en:adrenal hyperplasia, bilateral | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:adult onset polycystic kidney (50%)
n1=en:renal failure | n2=en:adult onset polycystic kidney (50%) | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:amelogenesis imperfecta nephrocalcinosis
n1=en:renal failure | n2=en:amelogenesis imperfecta nephrocalcinosis | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:anemia of renal disease
n1=en:renal failure | n2=en:anemia of renal disease | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:antibody deposits
n1=en:renal failure | n2=en:antibody deposits | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:azostix (blood urea nitrogen) test strip
n1=en:renal failure | n2=en:azostix (blood urea nitrogen) test strip | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:calcifediol 0.05 mg oral capsule
n1=en:renal failure | n2=en:calcifediol 0.05 mg oral capsule | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:calyceal diverticulum
n1=en:renal failure | n2=en:calyceal diverticulum | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:chlorothiazide 500mg powder for injection solution vial
n1=en:renal failure | n2=en:chlorothiazide 500mg powder for injection solution vial | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:chronic renal failure
n1=en:renal failure | n2=en:chronic renal failure | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:chronic/endstage renal failure
n1=en:renal failure | n2=en:chronic/endstage renal failure | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:collapsing glomerulopathy
n1=en:renal failure | n2=en:collapsing glomerulopathy | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:complication of internal anastomosis and/or bypass of urinary tract including that involving intestinal tract
n1=en:renal failure | n2=en:complication of internal anastomosis and/or bypass of urinary tract including that involving intestinal tract | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:congenital anomaly of fetal kidney
n1=en:renal failure | n2=en:congenital anomaly of fetal kidney | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:cyclosporine 50 mg oral capsule [sandimmune]
n1=en:renal failure | n2=en:cyclosporine 50 mg oral capsule [sandimmune] | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:cyclosporine, modified 100 mg oral capsule [neoral]
n1=en:renal failure | n2=en:cyclosporine, modified 100 mg oral capsule [neoral] | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:cystic dysplasia, early (in some patients)
n1=en:renal failure | n2=en:cystic dysplasia, early (in some patients) | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:deformities of the calyceal system
n1=en:renal failure | n2=en:deformities of the calyceal system | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:degenerative cysts
n1=en:renal failure | n2=en:degenerative cysts | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:dense deposit disease
n1=en:renal failure | n2=en:dense deposit disease | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:denuded tubules
n1=en:renal failure | n2=en:denuded tubules | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:diatrizoate meglumine
n1=en:renal failure | n2=en:diatrizoate meglumine | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:diatrizoate meglumine + diatrizoate sodium 520mg/80mg solution
n1=en:renal failure | n2=en:diatrizoate meglumine + diatrizoate sodium 520mg/80mg solution | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:diatrizoate na 20% inj
n1=en:renal failure | n2=en:diatrizoate na 20% inj | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:diphenidol hydrochloride 25mg tablet
n1=en:renal failure | n2=en:diphenidol hydrochloride 25mg tablet | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:dofetilide 500micrograms capsule
n1=en:renal failure | n2=en:dofetilide 500micrograms capsule | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:double renal pelvis (in some patients)
n1=en:renal failure | n2=en:double renal pelvis (in some patients) | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:duodenorenal fistula
n1=en:renal failure | n2=en:duodenorenal fistula | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:dysplastic kidney (1 patient)
n1=en:renal failure | n2=en:dysplastic kidney (1 patient) | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:elevated aldosterone secretion
n1=en:renal failure | n2=en:elevated aldosterone secretion | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:fentanyl 12micrograms/hour patch
n1=en:renal failure | n2=en:fentanyl 12micrograms/hour patch | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:fentanyl 300micrograms lozenge
n1=en:renal failure | n2=en:fentanyl 300micrograms lozenge | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:focal capillary obliteration
n1=en:renal failure | n2=en:focal capillary obliteration | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:focal segmental glomerulosclerosis (patient a)
n1=en:renal failure | n2=en:focal segmental glomerulosclerosis (patient a) | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:focal tubular dystrophy
n1=en:renal failure | n2=en:focal tubular dystrophy | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:fondaparinux sodium 12.5mg/ml injection solution 0.8ml prefilled syringe
n1=en:renal failure | n2=en:fondaparinux sodium 12.5mg/ml injection solution 0.8ml prefilled syringe | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:foreign body in genitourinary tract
n1=en:renal failure | n2=en:foreign body in genitourinary tract | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:foreign body in kidney
n1=en:renal failure | n2=en:foreign body in kidney | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:genitourinary system infection
n1=en:renal failure | n2=en:genitourinary system infection | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:glomerular capillary-loop deposits (rare), seen on biopsy
n1=en:renal failure | n2=en:glomerular capillary-loop deposits (rare), seen on biopsy | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:glomerulocystic dysplasia
n1=en:renal failure | n2=en:glomerulocystic dysplasia | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:history of renal failure
n1=en:renal failure | n2=en:history of renal failure | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:hydronephrosis (rare)
n1=en:renal failure | n2=en:hydronephrosis (rare) | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:impaired renal concentrating ability
n1=en:renal failure | n2=en:impaired renal concentrating ability | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:kidney replacement disorder
n1=en:renal failure | n2=en:kidney replacement disorder | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:lipid accumulation in kidney, especially in proximal convoluted tubules
n1=en:renal failure | n2=en:lipid accumulation in kidney, especially in proximal convoluted tubules | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:magnesium 133mg plus protein tab
n1=en:renal failure | n2=en:magnesium 133mg plus protein tab | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:magnesium carbonate
n1=en:renal failure | n2=en:magnesium carbonate | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:magnesium carbonate blocks
n1=en:renal failure | n2=en:magnesium carbonate blocks | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:magnesium sulfate 10%(0.4mmol/ml) injection
n1=en:renal failure | n2=en:magnesium sulfate 10%(0.4mmol/ml) injection | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:magnesium sulfate 40meq/5gm pwdr
n1=en:renal failure | n2=en:magnesium sulfate 40meq/5gm pwdr | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:magnesium sulfate 5%(4gm/100ml) intravenous
n1=en:renal failure | n2=en:magnesium sulfate 5%(4gm/100ml) intravenous | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:mesangial igm deposition
n1=en:renal failure | n2=en:mesangial igm deposition | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:mesangial matrix expansion
n1=en:renal failure | n2=en:mesangial matrix expansion | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:metaxalone 400mg tablet
n1=en:renal failure | n2=en:metaxalone 400mg tablet | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:methotrexate na 2.5mg tab dose pack,8
n1=en:renal failure | n2=en:methotrexate na 2.5mg tab dose pack,8 | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:minimal change disease (lipoid nephrosis) on renal biopsy
n1=en:renal failure | n2=en:minimal change disease (lipoid nephrosis) on renal biopsy | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:multicystic dysplastic kidneys (prenatal onset)
n1=en:renal failure | n2=en:multicystic dysplastic kidneys (prenatal onset) | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:nephritis
n1=en:renal failure | n2=en:nephritis | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:nephritis, acute tubulointerstitial (mononuclear infiltrate)
n1=en:renal failure | n2=en:nephritis, acute tubulointerstitial (mononuclear infiltrate) | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:nephrotic syndrome (in some patients)
n1=en:renal failure | n2=en:nephrotic syndrome (in some patients) | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:normal kidneys (in some patients)
n1=en:renal failure | n2=en:normal kidneys (in some patients) | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:nutritional and metabolic diseases
n1=en:renal failure | n2=en:nutritional and metabolic diseases | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:opium 10mg/ml tincture
n1=en:renal failure | n2=en:opium 10mg/ml tincture | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:pelvic kidney (1 patient)
n1=en:renal failure | n2=en:pelvic kidney (1 patient) | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:polythiazide 4mg tablet
n1=en:renal failure | n2=en:polythiazide 4mg tablet | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:polyuria
n1=en:renal failure | n2=en:polyuria | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:potassium acetate 2 meq/ml injectable solution
n1=en:renal failure | n2=en:potassium acetate 2 meq/ml injectable solution | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:potassium chloride 0.125 meq/ml oral solution
n1=en:renal failure | n2=en:potassium chloride 0.125 meq/ml oral solution | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:potassium chloride 25meq tablet
n1=en:renal failure | n2=en:potassium chloride 25meq tablet | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:potassium chloride 7.5% syrup
n1=en:renal failure | n2=en:potassium chloride 7.5% syrup | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:potassium gluconate 1.33 meq/ml oral solution
n1=en:renal failure | n2=en:potassium gluconate 1.33 meq/ml oral solution | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:potassium tripolyphosphate
n1=en:renal failure | n2=en:potassium tripolyphosphate | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:potassium,chelated
n1=en:renal failure | n2=en:potassium,chelated | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:primary hyperoxaluria type i
n1=en:renal failure | n2=en:primary hyperoxaluria type i | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:propofol infusion syndrome
n1=en:renal failure | n2=en:propofol infusion syndrome | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:proximal renal tubular acidosis
n1=en:renal failure | n2=en:proximal renal tubular acidosis | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:proximal tubulopathy, generalized
n1=en:renal failure | n2=en:proximal tubulopathy, generalized | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:pseudomembranous, calcified plaques in the renal collecting system (rare)
n1=en:renal failure | n2=en:pseudomembranous, calcified plaques in the renal collecting system (rare) | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:refractory plasma cell myeloma
n1=en:renal failure | n2=en:refractory plasma cell myeloma | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:renal abnormalities (in some patients)
n1=en:renal failure | n2=en:renal abnormalities (in some patients) | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:renal agenesis (in some patients)
n1=en:renal failure | n2=en:renal agenesis (in some patients) | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:renal anomalies (less common)
n1=en:renal failure | n2=en:renal anomalies (less common) | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:renal capsule
n1=en:renal failure | n2=en:renal capsule | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:renal colic (in some patients)
n1=en:renal failure | n2=en:renal colic (in some patients) | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:renal disorders in systemic disease
n1=en:renal failure | n2=en:renal disorders in systemic disease | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:renal failure associated with renal vascular disease
n1=en:renal failure | n2=en:renal failure associated with renal vascular disease | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:renal failure, endstage (in some patients)
n1=en:renal failure | n2=en:renal failure, endstage (in some patients) | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:renal hemorrhage
n1=en:renal failure | n2=en:renal hemorrhage | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:renal tumors (in about 27% of patients)
n1=en:renal failure | n2=en:renal tumors (in about 27% of patients) | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:scleroderma renal crisis
n1=en:renal failure | n2=en:scleroderma renal crisis | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:segmental capillary wall thickening
n1=en:renal failure | n2=en:segmental capillary wall thickening | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:small kidney (rare)
n1=en:renal failure | n2=en:small kidney (rare) | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:small medullary cysts
n1=en:renal failure | n2=en:small medullary cysts | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:sodium phosphate, dibasic 142 mg/ml / sodium phosphate, monobasic 276 mg/ml injectable solution
n1=en:renal failure | n2=en:sodium phosphate, dibasic 142 mg/ml / sodium phosphate, monobasic 276 mg/ml injectable solution | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:sodium phosphate,tribasic pwdr
n1=en:renal failure | n2=en:sodium phosphate,tribasic pwdr | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:sotalol hydrochloride 120mg tablet
n1=en:renal failure | n2=en:sotalol hydrochloride 120mg tablet | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:sotalol hydrochloride 80mg tablet
n1=en:renal failure | n2=en:sotalol hydrochloride 80mg tablet | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:testosterone 20 mg/ml topical cream
n1=en:renal failure | n2=en:testosterone 20 mg/ml topical cream | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:testosterone enanthate
n1=en:renal failure | n2=en:testosterone enanthate | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:thin glomerular basement membrane
n1=en:renal failure | n2=en:thin glomerular basement membrane | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:unilateral renal aplasia (rare)
n1=en:renal failure | n2=en:unilateral renal aplasia (rare) | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:uric acid urolithiasis
n1=en:renal failure | n2=en:uric acid urolithiasis | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 144 / 0.646 ->
en:wegener granulomatosis
n1=en:renal failure | n2=en:wegener granulomatosis | rel=r_associated | relid=0 | w=144
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:0.4 ml methotrexate 50 mg/ml auto-injector
n1=en:renal failure | n2=en:0.4 ml methotrexate 50 mg/ml auto-injector | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:24 hr galantamine hydrobromide 24 mg extended release oral capsule
n1=en:renal failure | n2=en:24 hr galantamine hydrobromide 24 mg extended release oral capsule | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:4 ml methotrexate 25 mg/ml injection
n1=en:renal failure | n2=en:4 ml methotrexate 25 mg/ml injection | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:72 hr fentanyl 0.0625 mg/hr transdermal patch
n1=en:renal failure | n2=en:72 hr fentanyl 0.0625 mg/hr transdermal patch | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:abnormally placed kidney (dystopic)
n1=en:renal failure | n2=en:abnormally placed kidney (dystopic) | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:acute kidney failure and chronic kidney disease (n17-n19)
n1=en:renal failure | n2=en:acute kidney failure and chronic kidney disease (n17-n19) | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:adrenal hypoplasia
n1=en:renal failure | n2=en:adrenal hypoplasia | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:ammonium chloride
n1=en:renal failure | n2=en:ammonium chloride | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:cakut
n1=en:renal failure | n2=en:cakut | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:calcinosis of the renal parenchyma
n1=en:renal failure | n2=en:calcinosis of the renal parenchyma | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:cerebral atrophy
n1=en:renal failure | n2=en:cerebral atrophy | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:chronic inflammatory infiltrate, mild
n1=en:renal failure | n2=en:chronic inflammatory infiltrate, mild | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:cisplatin
n1=en:renal failure | n2=en:cisplatin | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:complement component 3 deficiency, autosomal recessive
n1=en:renal failure | n2=en:complement component 3 deficiency, autosomal recessive | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:crossed fused renal ectopia
n1=en:renal failure | n2=en:crossed fused renal ectopia | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:cyclosporine, modified 100 mg/ml oral solution [gengraf]
n1=en:renal failure | n2=en:cyclosporine, modified 100 mg/ml oral solution [gengraf] | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:cystic dysplasia
n1=en:renal failure | n2=en:cystic dysplasia | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:death in first weeks of life without dialysis
n1=en:renal failure | n2=en:death in first weeks of life without dialysis | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:decreased renal tubular phosphate excretion
n1=en:renal failure | n2=en:decreased renal tubular phosphate excretion | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:diatrizoate meglumine 660 mg in 1 ml / diatrizoate sodium 100 mg in 1 ml intravenous solution [md-76r]
n1=en:renal failure | n2=en:diatrizoate meglumine 660 mg in 1 ml / diatrizoate sodium 100 mg in 1 ml intravenous solution [md-76r] | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:disruption of pelviureteric junction
n1=en:renal failure | n2=en:disruption of pelviureteric junction | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:dorzolamide
n1=en:renal failure | n2=en:dorzolamide | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:duplex renal system
n1=en:renal failure | n2=en:duplex renal system | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:early-onset end-stage renal disease
n1=en:renal failure | n2=en:early-onset end-stage renal disease | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:ergocalciferol 500000 unt/ml injectable solution
n1=en:renal failure | n2=en:ergocalciferol 500000 unt/ml injectable solution | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:ergocalciferol 8000 unt/ml oral solution
n1=en:renal failure | n2=en:ergocalciferol 8000 unt/ml oral solution | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:exercise-induced acute renal failure with acute tubular necrosis
n1=en:renal failure | n2=en:exercise-induced acute renal failure with acute tubular necrosis | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:familial juvenile gout
n1=en:renal failure | n2=en:familial juvenile gout | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:fatty infiltration
n1=en:renal failure | n2=en:fatty infiltration | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:fenofibrate 160 mg oral tablet
n1=en:renal failure | n2=en:fenofibrate 160 mg oral tablet | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:fentanyl 0.3 mg sublingual tablet
n1=en:renal failure | n2=en:fentanyl 0.3 mg sublingual tablet | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:fentanyl 0.6 mg sublingual tablet
n1=en:renal failure | n2=en:fentanyl 0.6 mg sublingual tablet | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:fentanyl 0.8 mg sublingual tablet
n1=en:renal failure | n2=en:fentanyl 0.8 mg sublingual tablet | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:fentanyl 200microgram buccal soluble film
n1=en:renal failure | n2=en:fentanyl 200microgram buccal soluble film | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:fondaparinux
n1=en:renal failure | n2=en:fondaparinux | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:glomerular cysts
n1=en:renal failure | n2=en:glomerular cysts | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:glomerulonephropathy
n1=en:renal failure | n2=en:glomerulonephropathy | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:glomerulosclerosis and fibrosis
n1=en:renal failure | n2=en:glomerulosclerosis and fibrosis | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:glomerulus
n1=en:renal failure | n2=en:glomerulus | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:hemolytic uremic syndrome (in some patients)
n1=en:renal failure | n2=en:hemolytic uremic syndrome (in some patients) | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:hydroflumethiazide
n1=en:renal failure | n2=en:hydroflumethiazide | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:hyperchromatic nuclei
n1=en:renal failure | n2=en:hyperchromatic nuclei | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:increased echogenicity (1 of 2 patients)
n1=en:renal failure | n2=en:increased echogenicity (1 of 2 patients) | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:increased glomerular cellularity
n1=en:renal failure | n2=en:increased glomerular cellularity | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:interstitial fibrosis
n1=en:renal failure | n2=en:interstitial fibrosis | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:interstitial nephritis
n1=en:renal failure | n2=en:interstitial nephritis | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:jeune syndrome
n1=en:renal failure | n2=en:jeune syndrome | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:ketorolac tromethamine 10mg tablet
n1=en:renal failure | n2=en:ketorolac tromethamine 10mg tablet | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:kidney lobe
n1=en:renal failure | n2=en:kidney lobe | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:light chain deposition disease
n1=en:renal failure | n2=en:light chain deposition disease | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:magaldrate
n1=en:renal failure | n2=en:magaldrate | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:magaldrate 480 mg chewable tablet
n1=en:renal failure | n2=en:magaldrate 480 mg chewable tablet | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:magaldrate 480 mg oral tablet
n1=en:renal failure | n2=en:magaldrate 480 mg oral tablet | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:magnesium chloride 200 mg/ml injectable solution
n1=en:renal failure | n2=en:magnesium chloride 200 mg/ml injectable solution | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:magnesium citrate cap/tab
n1=en:renal failure | n2=en:magnesium citrate cap/tab | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:magnesium glycinate cap/tab
n1=en:renal failure | n2=en:magnesium glycinate cap/tab | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:magnesium sulfate 100 mg oral capsule
n1=en:renal failure | n2=en:magnesium sulfate 100 mg oral capsule | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:magnesium sulfate 1000 mg oral granules
n1=en:renal failure | n2=en:magnesium sulfate 1000 mg oral granules | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:metformin hydrochloride 500 mg oral tablet
n1=en:renal failure | n2=en:metformin hydrochloride 500 mg oral tablet | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:methotrexate 2.5mg/ml injection solution 2ml vial
n1=en:renal failure | n2=en:methotrexate 2.5mg/ml injection solution 2ml vial | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:methotrexate na 20mg/vil inj
n1=en:renal failure | n2=en:methotrexate na 20mg/vil inj | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:metolazone 10mg tablet
n1=en:renal failure | n2=en:metolazone 10mg tablet | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:minimal change disease on renal biopsy
n1=en:renal failure | n2=en:minimal change disease on renal biopsy | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:myoglobinuria
n1=en:renal failure | n2=en:myoglobinuria | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:nephritis and nephropathy, not specified as acute or chronic
n1=en:renal failure | n2=en:nephritis and nephropathy, not specified as acute or chronic | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:nephrocalcinosis is absent
n1=en:renal failure | n2=en:nephrocalcinosis is absent | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:nephrolithiasis (in some patients)
n1=en:renal failure | n2=en:nephrolithiasis (in some patients) | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:nephronophthisis (1 of 2 patients)
n1=en:renal failure | n2=en:nephronophthisis (1 of 2 patients) | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:nephronophthisis (rare)
n1=en:renal failure | n2=en:nephronophthisis (rare) | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:nephronophthisis-like nephropathy
n1=en:renal failure | n2=en:nephronophthisis-like nephropathy | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:nephropathy induced by unspecifed drug, medicament or biological substance
n1=en:renal failure | n2=en:nephropathy induced by unspecifed drug, medicament or biological substance | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:nephrotic syndrome, type 4
n1=en:renal failure | n2=en:nephrotic syndrome, type 4 | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:no complement deposition
n1=en:renal failure | n2=en:no complement deposition | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:normal distal tubule acid excretion
n1=en:renal failure | n2=en:normal distal tubule acid excretion | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:opium
n1=en:renal failure | n2=en:opium | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:pancreatorenal syndrome
n1=en:renal failure | n2=en:pancreatorenal syndrome | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:polyuria (in some)
n1=en:renal failure | n2=en:polyuria (in some) | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:potassium chloride 2 meq/ml oral solution
n1=en:renal failure | n2=en:potassium chloride 2 meq/ml oral solution | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:potassium gluconate 6.66 meq oral tablet
n1=en:renal failure | n2=en:potassium gluconate 6.66 meq oral tablet | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:proximal renal tubular defect
n1=en:renal failure | n2=en:proximal renal tubular defect | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:reduced renal corticomedullary differentiation
n1=en:renal failure | n2=en:reduced renal corticomedullary differentiation | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:renal anomalies (67% of patients)
n1=en:renal failure | n2=en:renal anomalies (67% of patients) | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:renal biopsy shows focal tubular atrophy (in 33%)
n1=en:renal failure | n2=en:renal biopsy shows focal tubular atrophy (in 33%) | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:renal coccidiosis
n1=en:renal failure | n2=en:renal coccidiosis | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:renal cysts (33%)
n1=en:renal failure | n2=en:renal cysts (33%) | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:renal disease, uncharacterized (in some patients)
n1=en:renal failure | n2=en:renal disease, uncharacterized (in some patients) | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:renal dysplasia and retinal aplasia (disorder)
n1=en:renal failure | n2=en:renal dysplasia and retinal aplasia (disorder) | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:renal failure adverse event
n1=en:renal failure | n2=en:renal failure adverse event | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:renal failure may occur with myoglobinuria
n1=en:renal failure | n2=en:renal failure may occur with myoglobinuria | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:renal hypoplasia (1 patient)
n1=en:renal failure | n2=en:renal hypoplasia (1 patient) | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:renal impairment caused by polyomavirus
n1=en:renal failure | n2=en:renal impairment caused by polyomavirus | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:renal osteodystrophy
n1=en:renal failure | n2=en:renal osteodystrophy | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:renal potassium wasting
n1=en:renal failure | n2=en:renal potassium wasting | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:renal-hepatic-pancreatic dysplasia 1
n1=en:renal failure | n2=en:renal-hepatic-pancreatic dysplasia 1 | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:sclerosing glomerulonephropathy
n1=en:renal failure | n2=en:sclerosing glomerulonephropathy | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:sotalol
n1=en:renal failure | n2=en:sotalol | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:stricture of pelviureteric junction
n1=en:renal failure | n2=en:stricture of pelviureteric junction | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:testosterone 10 mg/actuat topical gel
n1=en:renal failure | n2=en:testosterone 10 mg/actuat topical gel | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:testosterone 100 mg/ml injectable solution
n1=en:renal failure | n2=en:testosterone 100 mg/ml injectable solution | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:traumatic anuria
n1=en:renal failure | n2=en:traumatic anuria | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:tubular atrophy
n1=en:renal failure | n2=en:tubular atrophy | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:uremia syndrome
n1=en:renal failure | n2=en:uremia syndrome | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:urine casts
n1=en:renal failure | n2=en:urine casts | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 143 / 0.641 ->
en:vascular structure of kidney
n1=en:renal failure | n2=en:vascular structure of kidney | rel=r_associated | relid=0 | w=143
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:0.4 ml fondaparinux sodium 12.5 mg/ml prefilled syringe
n1=en:renal failure | n2=en:0.4 ml fondaparinux sodium 12.5 mg/ml prefilled syringe | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:1 ml ketorolac tromethamine 15 mg/ml cartridge
n1=en:renal failure | n2=en:1 ml ketorolac tromethamine 15 mg/ml cartridge | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:24 hr testosterone 0.208 mg/hr transdermal patch [testoderm]
n1=en:renal failure | n2=en:24 hr testosterone 0.208 mg/hr transdermal patch [testoderm] | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:acitretin 10mg capsule
n1=en:renal failure | n2=en:acitretin 10mg capsule | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:acitretin 25mg capsule
n1=en:renal failure | n2=en:acitretin 25mg capsule | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:acrivastine
n1=en:renal failure | n2=en:acrivastine | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:acute nephropathy
n1=en:renal failure | n2=en:acute nephropathy | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:adenine phosphoribosyltransferase deficiency
n1=en:renal failure | n2=en:adenine phosphoribosyltransferase deficiency | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:attenuation of the glomerular basement membrane
n1=en:renal failure | n2=en:attenuation of the glomerular basement membrane | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:bardet-biedl syndrome 18
n1=en:renal failure | n2=en:bardet-biedl syndrome 18 | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:bilateral renal aplasia
n1=en:renal failure | n2=en:bilateral renal aplasia | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:bilateral renal hamartomas
n1=en:renal failure | n2=en:bilateral renal hamartomas | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:biopsy shows decreased cytochrome c oxidase
n1=en:renal failure | n2=en:biopsy shows decreased cytochrome c oxidase | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:blood urea nitrogen measurement
n1=en:renal failure | n2=en:blood urea nitrogen measurement | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:calcification of renal arteries
n1=en:renal failure | n2=en:calcification of renal arteries | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:calyceal dilation
n1=en:renal failure | n2=en:calyceal dilation | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:candidiasis of urogenital site
n1=en:renal failure | n2=en:candidiasis of urogenital site | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:chloral hydrate 250mg/5ml syrup
n1=en:renal failure | n2=en:chloral hydrate 250mg/5ml syrup | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:chloral hydrate 650 mg rectal suppository
n1=en:renal failure | n2=en:chloral hydrate 650 mg rectal suppository | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:chlorothiazide
n1=en:renal failure | n2=en:chlorothiazide | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:chlorthalidone 15mg tablet
n1=en:renal failure | n2=en:chlorthalidone 15mg tablet | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:cip-fenofibrate 50mg capsule
n1=en:renal failure | n2=en:cip-fenofibrate 50mg capsule | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:congenital nephrotic syndrome - diffuse mesangial sclerosis
n1=en:renal failure | n2=en:congenital nephrotic syndrome - diffuse mesangial sclerosis | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:cyclosporine 50 mg/ml oral solution
n1=en:renal failure | n2=en:cyclosporine 50 mg/ml oral solution | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:cyclosporine, modified 100 mg/ml oral solution
n1=en:renal failure | n2=en:cyclosporine, modified 100 mg/ml oral solution | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:cystic kidney disease with ventriculomegaly
n1=en:renal failure | n2=en:cystic kidney disease with ventriculomegaly | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:cystic kidneys (may be observed prenatally)
n1=en:renal failure | n2=en:cystic kidneys (may be observed prenatally) | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:cystic kidneys (rare)
n1=en:renal failure | n2=en:cystic kidneys (rare) | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:cystinuria
n1=en:renal failure | n2=en:cystinuria | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:dextrothyroxine 2 mg oral tablet
n1=en:renal failure | n2=en:dextrothyroxine 2 mg oral tablet | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:dextrothyroxine 4 mg oral tablet
n1=en:renal failure | n2=en:dextrothyroxine 4 mg oral tablet | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:dextrothyroxine sodium
n1=en:renal failure | n2=en:dextrothyroxine sodium | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:diabetic nephropathy
n1=en:renal failure | n2=en:diabetic nephropathy | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:diatrizoate 600 mg/ml injectable solution
n1=en:renal failure | n2=en:diatrizoate 600 mg/ml injectable solution | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:diffuse sclerotic glomerulonephritis
n1=en:renal failure | n2=en:diffuse sclerotic glomerulonephritis | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:dilated calyces (in some patients)
n1=en:renal failure | n2=en:dilated calyces (in some patients) | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:double right kidney
n1=en:renal failure | n2=en:double right kidney | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:ds stage iii plasma cell myeloma
n1=en:renal failure | n2=en:ds stage iii plasma cell myeloma | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:effacement of podocyte foot processes
n1=en:renal failure | n2=en:effacement of podocyte foot processes | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:enlarged glomeruli
n1=en:renal failure | n2=en:enlarged glomeruli | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:enlarged mitochondria with paracrystalline inclusions
n1=en:renal failure | n2=en:enlarged mitochondria with paracrystalline inclusions | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:entire kidney
n1=en:renal failure | n2=en:entire kidney | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:fenofibrate
n1=en:renal failure | n2=en:fenofibrate | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:fentanyl 0.1 mg sublingual tablet
n1=en:renal failure | n2=en:fentanyl 0.1 mg sublingual tablet | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:fentanyl 0.2 mg sublingual tablet
n1=en:renal failure | n2=en:fentanyl 0.2 mg sublingual tablet | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:fentanyl 0.8 mg/actuat mucosal spray
n1=en:renal failure | n2=en:fentanyl 0.8 mg/actuat mucosal spray | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:fentanyl 1600micrograms lozenge
n1=en:renal failure | n2=en:fentanyl 1600micrograms lozenge | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:fentanyl 4mcg/ml nacl 0.9% inj,bag,250ml
n1=en:renal failure | n2=en:fentanyl 4mcg/ml nacl 0.9% inj,bag,250ml | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:fentanyl citrate 800mg lozenge
n1=en:renal failure | n2=en:fentanyl citrate 800mg lozenge | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:gemfibrozil 600mg tablet
n1=en:renal failure | n2=en:gemfibrozil 600mg tablet | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:glomerular basement membrane normal
n1=en:renal failure | n2=en:glomerular basement membrane normal | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:glomerulonephritis
n1=en:renal failure | n2=en:glomerulonephritis | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:hematuria
n1=en:renal failure | n2=en:hematuria | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:hemoglobinuria (in some patients)
n1=en:renal failure | n2=en:hemoglobinuria (in some patients) | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:hereditary nephritis
n1=en:renal failure | n2=en:hereditary nephritis | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:histologically normal adrenal gland (in some patients)
n1=en:renal failure | n2=en:histologically normal adrenal gland (in some patients) | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:hydrochlorothiazide 50mg tablet
n1=en:renal failure | n2=en:hydrochlorothiazide 50mg tablet | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:hydronephrosis (1 patient)
n1=en:renal failure | n2=en:hydronephrosis (1 patient) | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:hypercalciuria
n1=en:renal failure | n2=en:hypercalciuria | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:hyperkalemia, diminished renal excretion
n1=en:renal failure | n2=en:hyperkalemia, diminished renal excretion | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:hypoplastic kidneys (in 2 of 3 siblings)
n1=en:renal failure | n2=en:hypoplastic kidneys (in 2 of 3 siblings) | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:impaired renal uric acid clearance
n1=en:renal failure | n2=en:impaired renal uric acid clearance | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:increased renal salt reabsorption
n1=en:renal failure | n2=en:increased renal salt reabsorption | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:ketorolac tromethamine 0.4% ophthalmic solution
n1=en:renal failure | n2=en:ketorolac tromethamine 0.4% ophthalmic solution | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:kidney cortex necrosis
n1=en:renal failure | n2=en:kidney cortex necrosis | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:kidney cyst
n1=en:renal failure | n2=en:kidney cyst | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:lecithin acyltransferase deficiency
n1=en:renal failure | n2=en:lecithin acyltransferase deficiency | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:magaldrate 108 mg/ml oral suspension
n1=en:renal failure | n2=en:magaldrate 108 mg/ml oral suspension | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:magnesium citrate oral solution
n1=en:renal failure | n2=en:magnesium citrate oral solution | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:magnesium gluconate
n1=en:renal failure | n2=en:magnesium gluconate | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:magnesium oxide
n1=en:renal failure | n2=en:magnesium oxide | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:magnesium oxide 250 mg oral tablet
n1=en:renal failure | n2=en:magnesium oxide 250 mg oral tablet | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:magnesium oxide 500 mg oral capsule
n1=en:renal failure | n2=en:magnesium oxide 500 mg oral capsule | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:monoclonal immunoglobulin deposition disease
n1=en:renal failure | n2=en:monoclonal immunoglobulin deposition disease | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:multiple organ failure
n1=en:renal failure | n2=en:multiple organ failure | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:nephrogenic rests (rare, in males)
n1=en:renal failure | n2=en:nephrogenic rests (rare, in males) | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:nephropathies and tubular disorders nec
n1=en:renal failure | n2=en:nephropathies and tubular disorders nec | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:noninflammatory disorder of the female genital organs
n1=en:renal failure | n2=en:noninflammatory disorder of the female genital organs | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:opium alkaloids hydrochloride
n1=en:renal failure | n2=en:opium alkaloids hydrochloride | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:paromomycin sulfate 250mg capsule
n1=en:renal failure | n2=en:paromomycin sulfate 250mg capsule | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:pediatric terminology
n1=en:renal failure | n2=en:pediatric terminology | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:pelvic inflammatory disease
n1=en:renal failure | n2=en:pelvic inflammatory disease | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:pelvicalyceal dilatation
n1=en:renal failure | n2=en:pelvicalyceal dilatation | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:phenolsulfonphthalein 6 mg/ml injectable solution
n1=en:renal failure | n2=en:phenolsulfonphthalein 6 mg/ml injectable solution | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:phospho-soda
n1=en:renal failure | n2=en:phospho-soda | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:phosphorus 3mmol/sodium 4meq/ml inj
n1=en:renal failure | n2=en:phosphorus 3mmol/sodium 4meq/ml inj | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:potassium chloride 0.3 meq/ml injectable solution
n1=en:renal failure | n2=en:potassium chloride 0.3 meq/ml injectable solution | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:potassium chloride 2.67 meq/ml oral solution
n1=en:renal failure | n2=en:potassium chloride 2.67 meq/ml oral solution | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:potassium citrate
n1=en:renal failure | n2=en:potassium citrate | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:potassium phosphate monobasic
n1=en:renal failure | n2=en:potassium phosphate monobasic | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:probenecid
n1=en:renal failure | n2=en:probenecid | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:rare mesangial igm deposition
n1=en:renal failure | n2=en:rare mesangial igm deposition | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:renal anasarca
n1=en:renal failure | n2=en:renal anasarca | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:renal calcium wasting
n1=en:renal failure | n2=en:renal calcium wasting | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:renal cortex
n1=en:renal failure | n2=en:renal cortex | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:renal cortical microcysts
n1=en:renal failure | n2=en:renal cortical microcysts | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:renal corticomedullary cysts
n1=en:renal failure | n2=en:renal corticomedullary cysts | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:renal dysplasia (in some patients)
n1=en:renal failure | n2=en:renal dysplasia (in some patients) | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:renal ectopia (rare)
n1=en:renal failure | n2=en:renal ectopia (rare) | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:renal failure chronic aggravated
n1=en:renal failure | n2=en:renal failure chronic aggravated | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:renal failure:find:pt:^patient:ord:mds
n1=en:renal failure | n2=en:renal failure:find:pt:^patient:ord:mds | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:renal function aggravated
n1=en:renal failure | n2=en:renal function aggravated | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:renal hypoplasia (less common)
n1=en:renal failure | n2=en:renal hypoplasia (less common) | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:renal insufficiency (in some patients)
n1=en:renal failure | n2=en:renal insufficiency (in some patients) | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:renal pelvis fibroepithelial polyp
n1=en:renal failure | n2=en:renal pelvis fibroepithelial polyp | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:renal tubular degeneration
n1=en:renal failure | n2=en:renal tubular degeneration | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:ribavirin 40mg/ml oral solution
n1=en:renal failure | n2=en:ribavirin 40mg/ml oral solution | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:right kidney
n1=en:renal failure | n2=en:right kidney | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:scarred glomerular tufts
n1=en:renal failure | n2=en:scarred glomerular tufts | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:secondary renal insufficiency
n1=en:renal failure | n2=en:secondary renal insufficiency | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:sepsis due to urinary tract infection
n1=en:renal failure | n2=en:sepsis due to urinary tract infection | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:simple cyst of kidney
n1=en:renal failure | n2=en:simple cyst of kidney | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:small kidneys (in some patients)
n1=en:renal failure | n2=en:small kidneys (in some patients) | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:sodium phosphate, dibasic, anhydrous
n1=en:renal failure | n2=en:sodium phosphate, dibasic, anhydrous | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:sodium phosphate, monobasic
n1=en:renal failure | n2=en:sodium phosphate, monobasic | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:some sclerotic glomeruli
n1=en:renal failure | n2=en:some sclerotic glomeruli | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:sotalol hydrochloride 5 mg/ml oral solution
n1=en:renal failure | n2=en:sotalol hydrochloride 5 mg/ml oral solution | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:structural abnormalities, mild
n1=en:renal failure | n2=en:structural abnormalities, mild | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:structural and functional abnormalities of the kidney
n1=en:renal failure | n2=en:structural and functional abnormalities of the kidney | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:swelling of endothelial cells
n1=en:renal failure | n2=en:swelling of endothelial cells | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:tegaserod
n1=en:renal failure | n2=en:tegaserod | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:testosterone 0.02 mg/mg topical ointment
n1=en:renal failure | n2=en:testosterone 0.02 mg/mg topical ointment | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:testosterone cypionate
n1=en:renal failure | n2=en:testosterone cypionate | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:testosterone cypionate 200 mg/ml injectable solution
n1=en:renal failure | n2=en:testosterone cypionate 200 mg/ml injectable solution | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:tubulopathy (patient a)
n1=en:renal failure | n2=en:tubulopathy (patient a) | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:urinary complication
n1=en:renal failure | n2=en:urinary complication | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:urinary tract toxicity
n1=en:renal failure | n2=en:urinary tract toxicity | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:urination
n1=en:renal failure | n2=en:urination | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 142 / 0.637 ->
en:volume depletion, renal, due to output loss (renal deficit)
n1=en:renal failure | n2=en:volume depletion, renal, due to output loss (renal deficit) | rel=r_associated | relid=0 | w=142
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:0.35 ml methotrexate 50 mg/ml auto-injector
n1=en:renal failure | n2=en:0.35 ml methotrexate 50 mg/ml auto-injector | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:0.4 ml methotrexate 18.8 mg/ml auto-injector
n1=en:renal failure | n2=en:0.4 ml methotrexate 18.8 mg/ml auto-injector | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:0.6 ml methotrexate 50 mg/ml auto-injector
n1=en:renal failure | n2=en:0.6 ml methotrexate 50 mg/ml auto-injector | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:2 ml ketorolac tromethamine 30 mg/ml prefilled syringe
n1=en:renal failure | n2=en:2 ml ketorolac tromethamine 30 mg/ml prefilled syringe | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:2 ml methotrexate 25 mg/ml injection
n1=en:renal failure | n2=en:2 ml methotrexate 25 mg/ml injection | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:24 hr galantamine hydrobromide 16 mg extended release oral capsule
n1=en:renal failure | n2=en:24 hr galantamine hydrobromide 16 mg extended release oral capsule | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:2500 mg testosterone 0.01 mg/mg topical gel [androgel]
n1=en:renal failure | n2=en:2500 mg testosterone 0.01 mg/mg topical gel [androgel] | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:72 hr fentanyl 0.0875 mg/hr transdermal patch
n1=en:renal failure | n2=en:72 hr fentanyl 0.0875 mg/hr transdermal patch | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:abnormal renal pelvises
n1=en:renal failure | n2=en:abnormal renal pelvises | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:absence of corticomedullary differentiation (ultrasound)
n1=en:renal failure | n2=en:absence of corticomedullary differentiation (ultrasound) | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:absent renal function
n1=en:renal failure | n2=en:absent renal function | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:acute renal failure
n1=en:renal failure | n2=en:acute renal failure | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:adhesions of kidney
n1=en:renal failure | n2=en:adhesions of kidney | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:ammonium chloride 500 mg delayed release oral tablet
n1=en:renal failure | n2=en:ammonium chloride 500 mg delayed release oral tablet | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:ask-upmark kidney
n1=en:renal failure | n2=en:ask-upmark kidney | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:bendroflumethiazide 10 mg oral tablet
n1=en:renal failure | n2=en:bendroflumethiazide 10 mg oral tablet | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:blood urea nitrogen test device
n1=en:renal failure | n2=en:blood urea nitrogen test device | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:brachymesomelia renal syndrome
n1=en:renal failure | n2=en:brachymesomelia renal syndrome | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:brinzolamide
n1=en:renal failure | n2=en:brinzolamide | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:calcifediol anhydrous
n1=en:renal failure | n2=en:calcifediol anhydrous | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:calciferol 1.25mg tablet
n1=en:renal failure | n2=en:calciferol 1.25mg tablet | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:calcium nephrolithiasis
n1=en:renal failure | n2=en:calcium nephrolithiasis | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:capecitabine
n1=en:renal failure | n2=en:capecitabine | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:cfhr5 deficiency
n1=en:renal failure | n2=en:cfhr5 deficiency | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:chloral hydrate 500 mg oral capsule
n1=en:renal failure | n2=en:chloral hydrate 500 mg oral capsule | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:chloral hydrate 500mg/5ml syrup
n1=en:renal failure | n2=en:chloral hydrate 500mg/5ml syrup | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:chlorothiazide 250mg/5ml oral suspension
n1=en:renal failure | n2=en:chlorothiazide 250mg/5ml oral suspension | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:chlorthalidone 25mg tablet
n1=en:renal failure | n2=en:chlorthalidone 25mg tablet | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:cisapride 10mg tablet
n1=en:renal failure | n2=en:cisapride 10mg tablet | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:cisapride 5mg/5ml oral suspension
n1=en:renal failure | n2=en:cisapride 5mg/5ml oral suspension | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:cisplatin 1 mg/ml injectable solution
n1=en:renal failure | n2=en:cisplatin 1 mg/ml injectable solution | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:complement component deposition
n1=en:renal failure | n2=en:complement component deposition | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:congenital anomaly of the kidney
n1=en:renal failure | n2=en:congenital anomaly of the kidney | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:congenital genitourinary abnormality
n1=en:renal failure | n2=en:congenital genitourinary abnormality | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:congenital hypoplasia of kidney
n1=en:renal failure | n2=en:congenital hypoplasia of kidney | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:congenital kidney disorder
n1=en:renal failure | n2=en:congenital kidney disorder | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:creatinine
n1=en:renal failure | n2=en:creatinine | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:cystic renal dysplasia
n1=en:renal failure | n2=en:cystic renal dysplasia | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:cysts may be absent in over 50% of patients
n1=en:renal failure | n2=en:cysts may be absent in over 50% of patients | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:decreased tubular resorption of phosphate (in some patients)
n1=en:renal failure | n2=en:decreased tubular resorption of phosphate (in some patients) | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:diabetes insipidus
n1=en:renal failure | n2=en:diabetes insipidus | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:end-stage renal disease (in some patients)
n1=en:renal failure | n2=en:end-stage renal disease (in some patients) | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:female genital diseases
n1=en:renal failure | n2=en:female genital diseases | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:fenofibrate 130 mg oral capsule
n1=en:renal failure | n2=en:fenofibrate 130 mg oral capsule | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:fenofibrate 30 mg oral capsule
n1=en:renal failure | n2=en:fenofibrate 30 mg oral capsule | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:fenofibrate 43 mg oral capsule
n1=en:renal failure | n2=en:fenofibrate 43 mg oral capsule | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:fentanyl 0.2 mg/actuat mucosal spray
n1=en:renal failure | n2=en:fentanyl 0.2 mg/actuat mucosal spray | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:fentanyl 1.2mg buccal soluble film
n1=en:renal failure | n2=en:fentanyl 1.2mg buccal soluble film | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:fentanyl 600micrograms lozenge
n1=en:renal failure | n2=en:fentanyl 600micrograms lozenge | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:fistula from renal pelvis
n1=en:renal failure | n2=en:fistula from renal pelvis | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:focal glomerulosclerosis (in 33%)
n1=en:renal failure | n2=en:focal glomerulosclerosis (in 33%) | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:focal medullary hypoplasia
n1=en:renal failure | n2=en:focal medullary hypoplasia | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:focal tubular atrophy
n1=en:renal failure | n2=en:focal tubular atrophy | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:fused kidneys (rare)
n1=en:renal failure | n2=en:fused kidneys (rare) | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:galantamine 4mg tablet
n1=en:renal failure | n2=en:galantamine 4mg tablet | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:galantamine 8mg tablet
n1=en:renal failure | n2=en:galantamine 8mg tablet | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:hydrochlorothiazide 100 mg oral tablet
n1=en:renal failure | n2=en:hydrochlorothiazide 100 mg oral tablet | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:hydrochlorothiazide 25mg tablet
n1=en:renal failure | n2=en:hydrochlorothiazide 25mg tablet | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:hydronephrosis
n1=en:renal failure | n2=en:hydronephrosis | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:hypercalciuria (in some patients)
n1=en:renal failure | n2=en:hypercalciuria (in some patients) | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:hyperechogenic kidneys (in some patients)
n1=en:renal failure | n2=en:hyperechogenic kidneys (in some patients) | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:impaired renal function (in some patients)
n1=en:renal failure | n2=en:impaired renal function (in some patients) | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:impaired renal function disorder
n1=en:renal failure | n2=en:impaired renal function disorder | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:indapamide
n1=en:renal failure | n2=en:indapamide | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:intraoperative and postprocedural complications and disorders of genitourinary system, not elsewhere classified
n1=en:renal failure | n2=en:intraoperative and postprocedural complications and disorders of genitourinary system, not elsewhere classified | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:ischemic nephropathy
n1=en:renal failure | n2=en:ischemic nephropathy | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:isolated non-nephrotic proteinuria
n1=en:renal failure | n2=en:isolated non-nephrotic proteinuria | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:isolated renal cyst (rare)
n1=en:renal failure | n2=en:isolated renal cyst (rare) | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:kidney disorder
n1=en:renal failure | n2=en:kidney disorder | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:magnesium hydroxide 311 mg chewable tablet
n1=en:renal failure | n2=en:magnesium hydroxide 311 mg chewable tablet | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:magnesium oxide 400 mg oral tablet
n1=en:renal failure | n2=en:magnesium oxide 400 mg oral tablet | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:magnesium oxide 420 mg oral tablet
n1=en:renal failure | n2=en:magnesium oxide 420 mg oral tablet | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:magnesium sulfate 12.5%(1meq/ml) injection 8ml vial
n1=en:renal failure | n2=en:magnesium sulfate 12.5%(1meq/ml) injection 8ml vial | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:malignant neoplasm of genitourinary organ
n1=en:renal failure | n2=en:malignant neoplasm of genitourinary organ | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:membranoproliferative glomerulonephritis (in about 26%)
n1=en:renal failure | n2=en:membranoproliferative glomerulonephritis (in about 26%) | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:mesangial, transmembranous, subepithelial, and subendothelial fibrillar deposits which show immunoreactivity to fibronectin
n1=en:renal failure | n2=en:mesangial, transmembranous, subepithelial, and subendothelial fibrillar deposits which show immunoreactivity to fibronectin | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:metformin hydrochloride 1000 mg oral tablet
n1=en:renal failure | n2=en:metformin hydrochloride 1000 mg oral tablet | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:methazolamide
n1=en:renal failure | n2=en:methazolamide | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:methocarbamol 100mg/ml injection solution ampule
n1=en:renal failure | n2=en:methocarbamol 100mg/ml injection solution ampule | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:methyclothiazide 2.5mg tablet
n1=en:renal failure | n2=en:methyclothiazide 2.5mg tablet | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:methylmalonic acidemia with homocystinuria
n1=en:renal failure | n2=en:methylmalonic acidemia with homocystinuria | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:multicystic dysplastic kidney
n1=en:renal failure | n2=en:multicystic dysplastic kidney | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:multiple renal cysts
n1=en:renal failure | n2=en:multiple renal cysts | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:nephrolithiasis (hcs and 2p21del)
n1=en:renal failure | n2=en:nephrolithiasis (hcs and 2p21del) | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:nephropathy due to acquired urinary tract obstruction
n1=en:renal failure | n2=en:nephropathy due to acquired urinary tract obstruction | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:nephrovisceral fistula
n1=en:renal failure | n2=en:nephrovisceral fistula | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:no nephritis
n1=en:renal failure | n2=en:no nephritis | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:noninflammatory disorders of female genital tract
n1=en:renal failure | n2=en:noninflammatory disorders of female genital tract | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:normal renal ultrasound at ages 4 and 7
n1=en:renal failure | n2=en:normal renal ultrasound at ages 4 and 7 | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:other disorders of kidney and ureter
n1=en:renal failure | n2=en:other disorders of kidney and ureter | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:paregoric
n1=en:renal failure | n2=en:paregoric | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:podocyte effacement
n1=en:renal failure | n2=en:podocyte effacement | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:polythiazide 1mg tablet
n1=en:renal failure | n2=en:polythiazide 1mg tablet | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:potassium bicarbonate 10 meq effervescent oral tablet
n1=en:renal failure | n2=en:potassium bicarbonate 10 meq effervescent oral tablet | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:potassium chloride
n1=en:renal failure | n2=en:potassium chloride | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:potassium chloride 2.4 meq delayed release oral tablet
n1=en:renal failure | n2=en:potassium chloride 2.4 meq delayed release oral tablet | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:potassium chloride 8 meq extended release oral capsule
n1=en:renal failure | n2=en:potassium chloride 8 meq extended release oral capsule | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:potassium gluconate
n1=en:renal failure | n2=en:potassium gluconate | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:potassium gluconate 2.5 meq oral tablet
n1=en:renal failure | n2=en:potassium gluconate 2.5 meq oral tablet | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:potassium phosphate, dibasic
n1=en:renal failure | n2=en:potassium phosphate, dibasic | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:progression to end stage renal failure in late adulthood (fifth to seventh decade)
n1=en:renal failure | n2=en:progression to end stage renal failure in late adulthood (fifth to seventh decade) | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:prominent epithelial luminal budding (1 of 2 patients)
n1=en:renal failure | n2=en:prominent epithelial luminal budding (1 of 2 patients) | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:protein-losing nephropathy
n1=en:renal failure | n2=en:protein-losing nephropathy | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:proteinuria (in 2 of 3 siblings)
n1=en:renal failure | n2=en:proteinuria (in 2 of 3 siblings) | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:pyelectasia
n1=en:renal failure | n2=en:pyelectasia | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:quinethazone 50 mg oral tablet
n1=en:renal failure | n2=en:quinethazone 50 mg oral tablet | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:recurrent urinary tract infection
n1=en:renal failure | n2=en:recurrent urinary tract infection | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:reflux nephropathy
n1=en:renal failure | n2=en:reflux nephropathy | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:renal amyloidosis (iowa type 107680.0010, systemic nonneuronopathic 107680.0016)
n1=en:renal failure | n2=en:renal amyloidosis (iowa type 107680.0010, systemic nonneuronopathic 107680.0016) | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:renal artery stenosis
n1=en:renal failure | n2=en:renal artery stenosis | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:renal biopsy shows diffuse mesangial sclerosis
n1=en:renal failure | n2=en:renal biopsy shows diffuse mesangial sclerosis | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:renal biopsy shows glomerular sclerosis
n1=en:renal failure | n2=en:renal biopsy shows glomerular sclerosis | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:renal biopsy shows medullary cysts
n1=en:renal failure | n2=en:renal biopsy shows medullary cysts | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:renal biopsy shows tubulointerstitial fibrosis
n1=en:renal failure | n2=en:renal biopsy shows tubulointerstitial fibrosis | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:renal cystic dysplasia (1 patient)
n1=en:renal failure | n2=en:renal cystic dysplasia (1 patient) | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:renal dysplasia/aplasia
n1=en:renal failure | n2=en:renal dysplasia/aplasia | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:renal function disorder
n1=en:renal failure | n2=en:renal function disorder | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:renal insufficiency aggravated
n1=en:renal failure | n2=en:renal insufficiency aggravated | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:renal parenchyma
n1=en:renal failure | n2=en:renal parenchyma | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:renal pelvis
n1=en:renal failure | n2=en:renal pelvis | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:renal salt wasting
n1=en:renal failure | n2=en:renal salt wasting | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:renal tuberculosis
n1=en:renal failure | n2=en:renal tuberculosis | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:renal tubular disorder
n1=en:renal failure | n2=en:renal tubular disorder | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:sclerotic glomeruli, 50% to 75%
n1=en:renal failure | n2=en:sclerotic glomeruli, 50% to 75% | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:single fused kidneys
n1=en:renal failure | n2=en:single fused kidneys | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:small kidney (reported in 1 patient)
n1=en:renal failure | n2=en:small kidney (reported in 1 patient) | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:sodium phosphate, monobasic, monohydrate
n1=en:renal failure | n2=en:sodium phosphate, monobasic, monohydrate | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:steroid-resistant nephrotic syndrome
n1=en:renal failure | n2=en:steroid-resistant nephrotic syndrome | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:subendothelial deposits
n1=en:renal failure | n2=en:subendothelial deposits | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:sulfadoxine
n1=en:renal failure | n2=en:sulfadoxine | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:tegaserod 2 mg oral tablet
n1=en:renal failure | n2=en:tegaserod 2 mg oral tablet | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:testosterone 15mg transdermal patch
n1=en:renal failure | n2=en:testosterone 15mg transdermal patch | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:thrombotic microangiopathic nephropathy
n1=en:renal failure | n2=en:thrombotic microangiopathic nephropathy | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 141 / 0.632 ->
en:urinary tract dilatation (in some patients)
n1=en:renal failure | n2=en:urinary tract dilatation (in some patients) | rel=r_associated | relid=0 | w=141
- en:renal failure --
r_associated #0: 139 / 0.623 ->
en:renal insufficiency
n1=en:renal failure | n2=en:renal insufficiency | rel=r_associated | relid=0 | w=139
- en:renal failure --
r_associated #0: 137 / 0.614 ->
insuffisance rénale
n1=en:renal failure | n2=insuffisance rénale | rel=r_associated | relid=0 | w=137
- en:renal failure --
r_associated #0: 135 / 0.605 ->
processus pathologique
n1=en:renal failure | n2=processus pathologique | rel=r_associated | relid=0 | w=135
- en:renal failure --
r_associated #0: 115 / 0.516 ->
en:0.55 ml methotrexate 50 mg/ml auto-injector
n1=en:renal failure | n2=en:0.55 ml methotrexate 50 mg/ml auto-injector | rel=r_associated | relid=0 | w=115
- en:renal failure --
r_associated #0: 115 / 0.516 ->
en:10 ml methotrexate 25 mg/ml injection
n1=en:renal failure | n2=en:10 ml methotrexate 25 mg/ml injection | rel=r_associated | relid=0 | w=115
- en:renal failure --
r_associated #0: 115 / 0.516 ->
en:20 ml ammonium chloride 5 meq/ml injection
n1=en:renal failure | n2=en:20 ml ammonium chloride 5 meq/ml injection | rel=r_associated | relid=0 | w=115
- en:renal failure --
r_associated #0: 115 / 0.516 ->
en:24 hr metformin hydrochloride 500 mg extended release oral tablet
n1=en:renal failure | n2=en:24 hr metformin hydrochloride 500 mg extended release oral tablet | rel=r_associated | relid=0 | w=115
- en:renal failure --
r_associated #0: 115 / 0.516 ->
en:5000 mg testosterone 0.01 mg/mg topical gel [testim]
n1=en:renal failure | n2=en:5000 mg testosterone 0.01 mg/mg topical gel [testim] | rel=r_associated | relid=0 | w=115
- en:renal failure --
r_associated #0: 115 / 0.516 ->
en:anuria
n1=en:renal failure | n2=en:anuria | rel=r_associated | relid=0 | w=115
- en:renal failure --
r_associated #0: 115 / 0.516 ->
en:benzthiazide
n1=en:renal failure | n2=en:benzthiazide | rel=r_associated | relid=0 | w=115
- en:renal failure --
r_associated #0: 115 / 0.516 ->
en:biopsy shows effacement of foot processes
n1=en:renal failure | n2=en:biopsy shows effacement of foot processes | rel=r_associated | relid=0 | w=115
- en:renal failure --
r_associated #0: 115 / 0.516 ->
en:capecitabine 500mg tablet
n1=en:renal failure | n2=en:capecitabine 500mg tablet | rel=r_associated | relid=0 | w=115
- en:renal failure --
r_associated #0: 115 / 0.516 ->
en:childhood kidney disorder
n1=en:renal failure | n2=en:childhood kidney disorder | rel=r_associated | relid=0 | w=115
- en:renal failure --
r_associated #0: 115 / 0.516 ->
en:chronic nephritis
n1=en:renal failure | n2=en:chronic nephritis | rel=r_associated | relid=0 | w=115
- en:renal failure --
r_associated #0: 115 / 0.516 ->
en:cisplatin 500micrograms/ml infusion concentrate 20ml vial
n1=en:renal failure | n2=en:cisplatin 500micrograms/ml infusion concentrate 20ml vial | rel=r_associated | relid=0 | w=115
- en:renal failure --
r_associated #0: 115 / 0.516 ->
en:citric acid
n1=en:renal failure | n2=en:citric acid | rel=r_associated | relid=0 | w=115
- en:renal failure --
r_associated #0: 115 / 0.516 ->
en:complement component deposits
n1=en:renal failure | n2=en:complement component deposits | rel=r_associated | relid=0 | w=115
- en:renal failure --
r_associated #0: 115 / 0.516 ->
en:cyclosporine, modified 25 mg oral capsule [neoral]
n1=en:renal failure | n2=en:cyclosporine, modified 25 mg oral capsule [neoral] | rel=r_associated | relid=0 | w=115
- en:renal failure --
r_associated #0: 115 / 0.516 ->
en:cystic kidney disease
n1=en:renal failure | n2=en:cystic kidney disease | rel=r_associated | relid=0 | w=115
- en:renal failure --
r_associated #0: 115 / 0.516 ->
en:disorder of the genitourinary system
n1=en:renal failure | n2=en:disorder of the genitourinary system | rel=r_associated | relid=0 | w=115
- en:renal failure --
r_associated #0: 115 / 0.516 ->
en:dofetilide 250micrograms capsule
n1=en:renal failure | n2=en:dofetilide 250micrograms capsule | rel=r_associated | relid=0 | w=115
- en:renal failure --
r_associated #0: 115 / 0.516 ->
en:edetate disodium anhydrous 150mg/ml injection solution 20ml vial
n1=en:renal failure | n2=en:edetate disodium anhydrous 150mg/ml injection solution 20ml vial | rel=r_associated | relid=0 | w=115
- en:renal failure --
r_associated #0: 115 / 0.516 ->
en:fenofibrate 40mg tablet
n1=en:renal failure | n2=en:fenofibrate 40mg tablet | rel=r_associated | relid=0 | w=115
- en:renal failure --
r_associated #0: 115 / 0.516 ->
en:fentanyl 25micrograms/hour patch
n1=en:renal failure | n2=en:fentanyl 25micrograms/hour patch | rel=r_associated | relid=0 | w=115
- en:renal failure --
r_associated #0: 115 / 0.516 ->
en:galantamine 12mg tablet
n1=en:renal failure | n2=en:galantamine 12mg tablet | rel=r_associated | relid=0 | w=115
- en:renal failure --
r_associated #0: 115 / 0.516 ->
en:galantamine 4mg/ml s/f oral solution
n1=en:renal failure | n2=en:galantamine 4mg/ml s/f oral solution | rel=r_associated | relid=0 | w=115
- en:renal failure --
r_associated #0: 115 / 0.516 ->
en:galantamine hydrobromide
n1=en:renal failure | n2=en:galantamine hydrobromide | rel=r_associated | relid=0 | w=115
- en:renal failure --
r_associated #0: 115 / 0.516 ->
en:hydrochlorothiazide
n1=en:renal failure | n2=en:hydrochlorothiazide | rel=r_associated | relid=0 | w=115
- en:renal failure --
r_associated #0: 115 / 0.516 ->
en:hydrochlorothiazide 12.5mg capsule
n1=en:renal failure | n2=en:hydrochlorothiazide 12.5mg capsule | rel=r_associated | relid=0 | w=115
- en:renal failure --
r_associated #0: 115 / 0.516 ->
en:hyperplasia
n1=en:renal failure | n2=en:hyperplasia | rel=r_associated | relid=0 | w=115
- en:renal failure --
r_associated #0: 115 / 0.516 ->
en:hyperplasia of zona glomerulosa of adrenal gland
n1=en:renal failure | n2=en:hyperplasia of zona glomerulosa of adrenal gland | rel=r_associated | relid=0 | w=115
- en:renal failure --
r_associated #0: 115 / 0.516 ->
en:hypoplastic kidneys (in some patients)
n1=en:renal failure | n2=en:hypoplastic kidneys (in some patients) | rel=r_associated | relid=0 | w=115
- en:renal failure --
r_associated #0: 115 / 0.516 ->
en:interstitial cystitis
n1=en:renal failure | n2=en:interstitial cystitis | rel=r_associated | relid=0 | w=115
- en:renal failure --
r_associated #0: 115 / 0.516 ->
en:kidney disease, end-stage
n1=en:renal failure | n2=en:kidney disease, end-stage | rel=r_associated | relid=0 | w=115
- en:renal failure --
r_associated #0: 115 / 0.516 ->
en:kidney neoplasm
n1=en:renal failure | n2=en:kidney neoplasm | rel=r_associated | relid=0 | w=115
- en:renal failure --
r_associated #0: 115 / 0.516 ->
en:kidney papillary necrosis
n1=en:renal failure | n2=en:kidney papillary necrosis | rel=r_associated | relid=0 | w=115
- en:renal failure --
r_associated #0: 115 / 0.516 ->
en:kidney transplantation
n1=en:renal failure | n2=en:kidney transplantation | rel=r_associated | relid=0 | w=115
- en:renal failure --
r_associated #0: 115 / 0.516 ->
en:kidney wilms tumor
n1=en:renal failure | n2=en:kidney wilms tumor | rel=r_associated | relid=0 | w=115
- en:renal failure --
r_associated #0: 115 / 0.516 ->
en:magnesium phosphate
n1=en:renal failure | n2=en:magnesium phosphate | rel=r_associated | relid=0 | w=115
- en:renal failure --
r_associated #0: 115 / 0.516 ->
en:magnesium stearate
n1=en:renal failure | n2=en:magnesium stearate | rel=r_associated | relid=0 | w=115
- en:renal failure --
r_associated #0: 115 / 0.516 ->
en:metolazone 500micrograms tablet
n1=en:renal failure | n2=en:metolazone 500micrograms tablet | rel=r_associated | relid=0 | w=115
- en:renal failure --
r_associated #0: 115 / 0.516 ->
en:nephrocutaneous fistula
n1=en:renal failure | n2=en:nephrocutaneous fistula | rel=r_associated | relid=0 | w=115
- en:renal failure --
r_associated #0: 115 / 0.516 ->
en:pediatric nephrology terminology
n1=en:renal failure | n2=en:pediatric nephrology terminology | rel=r_associated | relid=0 | w=115
- en:renal failure --
r_associated #0: 115 / 0.516 ->
en:potassium gluconate 2.6 meq oral tablet
n1=en:renal failure | n2=en:potassium gluconate 2.6 meq oral tablet | rel=r_associated | relid=0 | w=115
- en:renal failure --
r_associated #0: 115 / 0.516 ->
en:potassium gluconate 5 meq oral tablet
n1=en:renal failure | n2=en:potassium gluconate 5 meq oral tablet | rel=r_associated | relid=0 | w=115
- en:renal failure --
r_associated #0: 115 / 0.516 ->
en:prerenal failure
n1=en:renal failure | n2=en:prerenal failure | rel=r_associated | relid=0 | w=115
- en:renal failure --
r_associated #0: 115 / 0.516 ->
en:proximal tubulopathy
n1=en:renal failure | n2=en:proximal tubulopathy | rel=r_associated | relid=0 | w=115
- en:renal failure --
r_associated #0: 115 / 0.516 ->
en:renal biopsy shows chronic interstitial nephritis
n1=en:renal failure | n2=en:renal biopsy shows chronic interstitial nephritis | rel=r_associated | relid=0 | w=115
- en:renal failure --
r_associated #0: 115 / 0.516 ->
en:renal failure in adulthood
n1=en:renal failure | n2=en:renal failure in adulthood | rel=r_associated | relid=0 | w=115
- en:renal failure --
r_associated #0: 115 / 0.516 ->
en:renal juxtaglomerular cell hypertrophy/hyperplasia
n1=en:renal failure | n2=en:renal juxtaglomerular cell hypertrophy/hyperplasia | rel=r_associated | relid=0 | w=115
- en:renal failure --
r_associated #0: 115 / 0.516 ->
en:renal tubular insufficiency (1 patient)
n1=en:renal failure | n2=en:renal tubular insufficiency (1 patient) | rel=r_associated | relid=0 | w=115
- en:renal failure --
r_associated #0: 115 / 0.516 ->
en:testosterone propionate 25 mg/ml injectable solution
n1=en:renal failure | n2=en:testosterone propionate 25 mg/ml injectable solution | rel=r_associated | relid=0 | w=115
- en:renal failure --
r_associated #0: 115 / 0.516 ->
en:tribavirin 6g inhalation (pdr for recon)
n1=en:renal failure | n2=en:tribavirin 6g inhalation (pdr for recon) | rel=r_associated | relid=0 | w=115
- en:renal failure --
r_associated #0: 115 / 0.516 ->
en:tubulointerstitial atrophy
n1=en:renal failure | n2=en:tubulointerstitial atrophy | rel=r_associated | relid=0 | w=115
- en:renal failure --
r_associated #0: 115 / 0.516 ->
en:vacuolization of glomerular and tubular epithelial cells
n1=en:renal failure | n2=en:vacuolization of glomerular and tubular epithelial cells | rel=r_associated | relid=0 | w=115
- en:renal failure --
r_associated #0: 114 / 0.511 ->
en:24 hr metformin hydrochloride 1000 mg extended release oral tablet [fortamet]
n1=en:renal failure | n2=en:24 hr metformin hydrochloride 1000 mg extended release oral tablet [fortamet] | rel=r_associated | relid=0 | w=114
- en:renal failure --
r_associated #0: 114 / 0.511 ->
en:absent kidney
n1=en:renal failure | n2=en:absent kidney | rel=r_associated | relid=0 | w=114
- en:renal failure --
r_associated #0: 114 / 0.511 ->
en:action myoclonus renal failure syndrome
n1=en:renal failure | n2=en:action myoclonus renal failure syndrome | rel=r_associated | relid=0 | w=114
- en:renal failure --
r_associated #0: 114 / 0.511 ->
en:ammonium chloride 488 mg oral tablet
n1=en:renal failure | n2=en:ammonium chloride 488 mg oral tablet | rel=r_associated | relid=0 | w=114
- en:renal failure --
r_associated #0: 114 / 0.511 ->
en:cisplatin 50 mg injection
n1=en:renal failure | n2=en:cisplatin 50 mg injection | rel=r_associated | relid=0 | w=114
- en:renal failure --
r_associated #0: 114 / 0.511 ->
en:citric acid granules
n1=en:renal failure | n2=en:citric acid granules | rel=r_associated | relid=0 | w=114
- en:renal failure --
r_associated #0: 114 / 0.511 ->
en:congenital pelviureteric junction obstruction
n1=en:renal failure | n2=en:congenital pelviureteric junction obstruction | rel=r_associated | relid=0 | w=114
- en:renal failure --
r_associated #0: 114 / 0.511 ->
en:fenofibrate 90 mg oral capsule
n1=en:renal failure | n2=en:fenofibrate 90 mg oral capsule | rel=r_associated | relid=0 | w=114
- en:renal failure --
r_associated #0: 114 / 0.511 ->
en:gemfibrozil 300mg capsule
n1=en:renal failure | n2=en:gemfibrozil 300mg capsule | rel=r_associated | relid=0 | w=114
- en:renal failure --
r_associated #0: 114 / 0.511 ->
en:magnesium 192mg tab
n1=en:renal failure | n2=en:magnesium 192mg tab | rel=r_associated | relid=0 | w=114
- en:renal failure --
r_associated #0: 114 / 0.511 ->
en:magnesium sulfate
n1=en:renal failure | n2=en:magnesium sulfate | rel=r_associated | relid=0 | w=114
- en:renal failure --
r_associated #0: 114 / 0.511 ->
en:neoplasm of uncertain behavior of genitourinary organs
n1=en:renal failure | n2=en:neoplasm of uncertain behavior of genitourinary organs | rel=r_associated | relid=0 | w=114
- en:renal failure --
r_associated #0: 114 / 0.511 ->
en:nephrocalcinosis (rare)
n1=en:renal failure | n2=en:nephrocalcinosis (rare) | rel=r_associated | relid=0 | w=114
- en:renal failure --
r_associated #0: 114 / 0.511 ->
en:potassium bitartrate pwdr
n1=en:renal failure | n2=en:potassium bitartrate pwdr | rel=r_associated | relid=0 | w=114
- en:renal failure --
r_associated #0: 114 / 0.511 ->
en:potassium chloride 4 meq/ml oral solution
n1=en:renal failure | n2=en:potassium chloride 4 meq/ml oral solution | rel=r_associated | relid=0 | w=114
- en:renal failure --
r_associated #0: 114 / 0.511 ->
en:primary amyloidosis
n1=en:renal failure | n2=en:primary amyloidosis | rel=r_associated | relid=0 | w=114
- en:renal failure --
r_associated #0: 114 / 0.511 ->
en:renal failure (most common cause of death) (iowa type 107680.0010)
n1=en:renal failure | n2=en:renal failure (most common cause of death) (iowa type 107680.0010) | rel=r_associated | relid=0 | w=114
- en:renal failure --
r_associated #0: 114 / 0.511 ->
en:single kidney (seen in patients with contiguous gene defect)
n1=en:renal failure | n2=en:single kidney (seen in patients with contiguous gene defect) | rel=r_associated | relid=0 | w=114
- en:renal failure --
r_associated #0: 114 / 0.511 ->
en:splitting of the glomerular basement membrane
n1=en:renal failure | n2=en:splitting of the glomerular basement membrane | rel=r_associated | relid=0 | w=114
- en:renal failure --
r_associated #0: 114 / 0.511 ->
en:volume excess, primary renal sodium retention
n1=en:renal failure | n2=en:volume excess, primary renal sodium retention | rel=r_associated | relid=0 | w=114
- en:renal failure --
r_associated #0: 113 / 0.507 ->
en:a subset of patients develop renal insufficiency with decreased creatinine clearance
n1=en:renal failure | n2=en:a subset of patients develop renal insufficiency with decreased creatinine clearance | rel=r_associated | relid=0 | w=113
- en:renal failure --
r_associated #0: 113 / 0.507 ->
en:blood urea nitrogen increased
n1=en:renal failure | n2=en:blood urea nitrogen increased | rel=r_associated | relid=0 | w=113
- en:renal failure --
r_associated #0: 113 / 0.507 ->
en:chronic thrombotic microangiopathy
n1=en:renal failure | n2=en:chronic thrombotic microangiopathy | rel=r_associated | relid=0 | w=113
- en:renal failure --
r_associated #0: 113 / 0.507 ->
en:diatrizoate meglumine 85% inj
n1=en:renal failure | n2=en:diatrizoate meglumine 85% inj | rel=r_associated | relid=0 | w=113
- en:renal failure --
r_associated #0: 113 / 0.507 ->
en:end stage renal disease (age 6-35 years)
n1=en:renal failure | n2=en:end stage renal disease (age 6-35 years) | rel=r_associated | relid=0 | w=113
- en:renal failure --
r_associated #0: 113 / 0.507 ->
en:familial primary hypomagnesemia
n1=en:renal failure | n2=en:familial primary hypomagnesemia | rel=r_associated | relid=0 | w=113
- en:renal failure --
r_associated #0: 113 / 0.507 ->
en:fentanyl 600microgram buccal soluble film
n1=en:renal failure | n2=en:fentanyl 600microgram buccal soluble film | rel=r_associated | relid=0 | w=113
- en:renal failure --
r_associated #0: 113 / 0.507 ->
en:hematuria, gross and microscopic
n1=en:renal failure | n2=en:hematuria, gross and microscopic | rel=r_associated | relid=0 | w=113
- en:renal failure --
r_associated #0: 113 / 0.507 ->
en:loss of podocyte foot processes
n1=en:renal failure | n2=en:loss of podocyte foot processes | rel=r_associated | relid=0 | w=113
- en:renal failure --
r_associated #0: 113 / 0.507 ->
en:magnesium carbonate 260 mg oral capsule
n1=en:renal failure | n2=en:magnesium carbonate 260 mg oral capsule | rel=r_associated | relid=0 | w=113
- en:renal failure --
r_associated #0: 113 / 0.507 ->
en:potassium acetate
n1=en:renal failure | n2=en:potassium acetate | rel=r_associated | relid=0 | w=113
- en:renal failure --
r_associated #0: 113 / 0.507 ->
en:potassium chloride 6.7 meq delayed release oral tablet
n1=en:renal failure | n2=en:potassium chloride 6.7 meq delayed release oral tablet | rel=r_associated | relid=0 | w=113
- en:renal failure --
r_associated #0: 113 / 0.507 ->
en:renal failure, slowly progressive
n1=en:renal failure | n2=en:renal failure, slowly progressive | rel=r_associated | relid=0 | w=113
- en:renal failure --
r_associated #0: 113 / 0.507 ->
en:renal scarring
n1=en:renal failure | n2=en:renal scarring | rel=r_associated | relid=0 | w=113
- en:renal failure --
r_associated #0: 113 / 0.507 ->
en:small kidney
n1=en:renal failure | n2=en:small kidney | rel=r_associated | relid=0 | w=113
- en:renal failure --
r_associated #0: 113 / 0.507 ->
en:tubular calcification (in some patients)
n1=en:renal failure | n2=en:tubular calcification (in some patients) | rel=r_associated | relid=0 | w=113
- en:renal failure --
r_associated #0: 113 / 0.507 ->
en:unilateral renal pelviectasis (rare)
n1=en:renal failure | n2=en:unilateral renal pelviectasis (rare) | rel=r_associated | relid=0 | w=113
- en:renal failure --
r_associated #0: 112 / 0.502 ->
en:abnormal mitochondria in podocytes
n1=en:renal failure | n2=en:abnormal mitochondria in podocytes | rel=r_associated | relid=0 | w=112
- en:renal failure --
r_associated #0: 112 / 0.502 ->
en:autosomal recessive polycystic kidney disease
n1=en:renal failure | n2=en:autosomal recessive polycystic kidney disease | rel=r_associated | relid=0 | w=112
- en:renal failure --
r_associated #0: 112 / 0.502 ->
en:benzthiazide 50 mg oral tablet
n1=en:renal failure | n2=en:benzthiazide 50 mg oral tablet | rel=r_associated | relid=0 | w=112
- en:renal failure --
r_associated #0: 112 / 0.502 ->
en:congenital lobulation of kidney
n1=en:renal failure | n2=en:congenital lobulation of kidney | rel=r_associated | relid=0 | w=112
- en:renal failure --
r_associated #0: 112 / 0.502 ->
en:ds stage ii plasma cell myeloma
n1=en:renal failure | n2=en:ds stage ii plasma cell myeloma | rel=r_associated | relid=0 | w=112
- en:renal failure --
r_associated #0: 112 / 0.502 ->
en:ectopic kidney (2 patients)
n1=en:renal failure | n2=en:ectopic kidney (2 patients) | rel=r_associated | relid=0 | w=112
- en:renal failure --
r_associated #0: 112 / 0.502 ->
en:fenofibrate 200 mg oral capsule
n1=en:renal failure | n2=en:fenofibrate 200 mg oral capsule | rel=r_associated | relid=0 | w=112
- en:renal failure --
r_associated #0: 112 / 0.502 ->
en:glomerulopathy with fibronectin deposits 2 (disorder)
n1=en:renal failure | n2=en:glomerulopathy with fibronectin deposits 2 (disorder) | rel=r_associated | relid=0 | w=112
- en:renal failure --
r_associated #0: 112 / 0.502 ->
en:horseshoe kidney (rare)
n1=en:renal failure | n2=en:horseshoe kidney (rare) | rel=r_associated | relid=0 | w=112
- en:renal failure --
r_associated #0: 112 / 0.502 ->
en:hypoplastic/dysplastic kidney
n1=en:renal failure | n2=en:hypoplastic/dysplastic kidney | rel=r_associated | relid=0 | w=112
- en:renal failure --
r_associated #0: 112 / 0.502 ->
en:kidney functional
n1=en:renal failure | n2=en:kidney functional | rel=r_associated | relid=0 | w=112
- en:renal failure --
r_associated #0: 112 / 0.502 ->
en:magnesium sulfate 0.8 mg/mg topical ointment
n1=en:renal failure | n2=en:magnesium sulfate 0.8 mg/mg topical ointment | rel=r_associated | relid=0 | w=112
- en:renal failure --
r_associated #0: 112 / 0.502 ->
en:magnesium sulfate 10gm/1000ml intravenous
n1=en:renal failure | n2=en:magnesium sulfate 10gm/1000ml intravenous | rel=r_associated | relid=0 | w=112
- en:renal failure --
r_associated #0: 112 / 0.502 ->
en:methocarbamol 500mg tablet
n1=en:renal failure | n2=en:methocarbamol 500mg tablet | rel=r_associated | relid=0 | w=112
- en:renal failure --
r_associated #0: 112 / 0.502 ->
en:methotrexate 10mg tablet
n1=en:renal failure | n2=en:methotrexate 10mg tablet | rel=r_associated | relid=0 | w=112
- en:renal failure --
r_associated #0: 112 / 0.502 ->
en:methylene blue 55 mg oral tablet
n1=en:renal failure | n2=en:methylene blue 55 mg oral tablet | rel=r_associated | relid=0 | w=112
- en:renal failure --
r_associated #0: 112 / 0.502 ->
en:obstructive uropathy
n1=en:renal failure | n2=en:obstructive uropathy | rel=r_associated | relid=0 | w=112
- en:renal failure --
r_associated #0: 112 / 0.502 ->
en:renal calculi (rare)
n1=en:renal failure | n2=en:renal calculi (rare) | rel=r_associated | relid=0 | w=112
- en:renal failure --
r_associated #0: 112 / 0.502 ->
en:renal cysts (1 patient)
n1=en:renal failure | n2=en:renal cysts (1 patient) | rel=r_associated | relid=0 | w=112
- en:renal failure --
r_associated #0: 112 / 0.502 ->
en:renal rickets
n1=en:renal failure | n2=en:renal rickets | rel=r_associated | relid=0 | w=112
- en:renal failure --
r_associated #0: 112 / 0.502 ->
en:sulfabenzamide
n1=en:renal failure | n2=en:sulfabenzamide | rel=r_associated | relid=0 | w=112
- en:renal failure --
r_associated #0: 112 / 0.502 ->
en:testosterone 75mg pellet implant
n1=en:renal failure | n2=en:testosterone 75mg pellet implant | rel=r_associated | relid=0 | w=112
- en:renal failure --
r_associated #0: 111 / 0.498 ->
en:0.3 ml methotrexate 50 mg/ml auto-injector
n1=en:renal failure | n2=en:0.3 ml methotrexate 50 mg/ml auto-injector | rel=r_associated | relid=0 | w=111
- en:renal failure --
r_associated #0: 111 / 0.498 ->
en:24 hr testosterone 0.167 mg/hr transdermal patch
n1=en:renal failure | n2=en:24 hr testosterone 0.167 mg/hr transdermal patch | rel=r_associated | relid=0 | w=111
- en:renal failure --
r_associated #0: 111 / 0.498 ->
en:60 actuat testosterone 5.5 mg/actuat nasal gel
n1=en:renal failure | n2=en:60 actuat testosterone 5.5 mg/actuat nasal gel | rel=r_associated | relid=0 | w=111
- en:renal failure --
r_associated #0: 111 / 0.498 ->
en:chloral hydrate 250 mg oral capsule
n1=en:renal failure | n2=en:chloral hydrate 250 mg oral capsule | rel=r_associated | relid=0 | w=111
- en:renal failure --
r_associated #0: 111 / 0.498 ->
en:chlorthalidone 100 mg oral tablet
n1=en:renal failure | n2=en:chlorthalidone 100 mg oral tablet | rel=r_associated | relid=0 | w=111
- en:renal failure --
r_associated #0: 111 / 0.498 ->
en:ctrp terminology
n1=en:renal failure | n2=en:ctrp terminology | rel=r_associated | relid=0 | w=111
- en:renal failure --
r_associated #0: 111 / 0.498 ->
en:cysts contain eosinophilic proteinaceous material
n1=en:renal failure | n2=en:cysts contain eosinophilic proteinaceous material | rel=r_associated | relid=0 | w=111
- en:renal failure --
r_associated #0: 111 / 0.498 ->
en:diffuse mesangial sclerosis (less common)
n1=en:renal failure | n2=en:diffuse mesangial sclerosis (less common) | rel=r_associated | relid=0 | w=111
- en:renal failure --
r_associated #0: 111 / 0.498 ->
en:fenofibrate micronized 134mg capsule
n1=en:renal failure | n2=en:fenofibrate micronized 134mg capsule | rel=r_associated | relid=0 | w=111
- en:renal failure --
r_associated #0: 111 / 0.498 ->
en:fentanyl citrate
n1=en:renal failure | n2=en:fentanyl citrate | rel=r_associated | relid=0 | w=111
- en:renal failure --
r_associated #0: 111 / 0.498 ->
en:foscarnet
n1=en:renal failure | n2=en:foscarnet | rel=r_associated | relid=0 | w=111
- en:renal failure --
r_associated #0: 111 / 0.498 ->
en:horseshoe kidney
n1=en:renal failure | n2=en:horseshoe kidney | rel=r_associated | relid=0 | w=111
- en:renal failure --
r_associated #0: 111 / 0.498 ->
en:hydroflumethiazide 50mg tablet
n1=en:renal failure | n2=en:hydroflumethiazide 50mg tablet | rel=r_associated | relid=0 | w=111
- en:renal failure --
r_associated #0: 111 / 0.498 ->
en:interstitial nephropathy
n1=en:renal failure | n2=en:interstitial nephropathy | rel=r_associated | relid=0 | w=111
- en:renal failure --
r_associated #0: 111 / 0.498 ->
en:ketorolac tromethamine
n1=en:renal failure | n2=en:ketorolac tromethamine | rel=r_associated | relid=0 | w=111
- en:renal failure --
r_associated #0: 111 / 0.498 ->
en:magnesium hydroxide 325 mg oral tablet
n1=en:renal failure | n2=en:magnesium hydroxide 325 mg oral tablet | rel=r_associated | relid=0 | w=111
- en:renal failure --
r_associated #0: 111 / 0.498 ->
en:metabolic renal disease
n1=en:renal failure | n2=en:metabolic renal disease | rel=r_associated | relid=0 | w=111
- en:renal failure --
r_associated #0: 111 / 0.498 ->
en:pelviureteric junction obstruction
n1=en:renal failure | n2=en:pelviureteric junction obstruction | rel=r_associated | relid=0 | w=111
- en:renal failure --
r_associated #0: 111 / 0.498 ->
en:potassium bicarbonate pwdr
n1=en:renal failure | n2=en:potassium bicarbonate pwdr | rel=r_associated | relid=0 | w=111
- en:renal failure --
r_associated #0: 111 / 0.498 ->
en:potassium chloride 0.2 meq/ml injectable solution
n1=en:renal failure | n2=en:potassium chloride 0.2 meq/ml injectable solution | rel=r_associated | relid=0 | w=111
- en:renal failure --
r_associated #0: 111 / 0.498 ->
en:potassium,chelated 99 mg oral tablet
n1=en:renal failure | n2=en:potassium,chelated 99 mg oral tablet | rel=r_associated | relid=0 | w=111
- en:renal failure --
r_associated #0: 111 / 0.498 ->
en:renal disorders in inherited disease
n1=en:renal failure | n2=en:renal disorders in inherited disease | rel=r_associated | relid=0 | w=111
- en:renal failure --
r_associated #0: 111 / 0.498 ->
en:renal infarct
n1=en:renal failure | n2=en:renal infarct | rel=r_associated | relid=0 | w=111
- en:renal failure --
r_associated #0: 111 / 0.498 ->
en:renal tubular acidosis
n1=en:renal failure | n2=en:renal tubular acidosis | rel=r_associated | relid=0 | w=111
- en:renal failure --
r_associated #0: 111 / 0.498 ->
en:reproductive system disorder
n1=en:renal failure | n2=en:reproductive system disorder | rel=r_associated | relid=0 | w=111
- en:renal failure --
r_associated #0: 111 / 0.498 ->
en:stroma of kidney
n1=en:renal failure | n2=en:stroma of kidney | rel=r_associated | relid=0 | w=111
- en:renal failure --
r_associated #0: 111 / 0.498 ->
en:urinary complications of care
n1=en:renal failure | n2=en:urinary complications of care | rel=r_associated | relid=0 | w=111
- en:renal failure --
r_associated #0: 111 / 0.498 ->
en:vacuolization in distal and collecting tubules
n1=en:renal failure | n2=en:vacuolization in distal and collecting tubules | rel=r_associated | relid=0 | w=111
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:{16 (methotrexate 2.5 mg oral tablet) } pack
n1=en:renal failure | n2=en:{16 (methotrexate 2.5 mg oral tablet) } pack | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:1 ml ketorolac tromethamine 15 mg/ml injection
n1=en:renal failure | n2=en:1 ml ketorolac tromethamine 15 mg/ml injection | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:1 ml ketorolac tromethamine 15 mg/ml prefilled syringe
n1=en:renal failure | n2=en:1 ml ketorolac tromethamine 15 mg/ml prefilled syringe | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:24 hr galantamine hydrobromide 8 mg extended release oral capsule
n1=en:renal failure | n2=en:24 hr galantamine hydrobromide 8 mg extended release oral capsule | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:24 hr metformin hydrochloride 1000 mg extended release oral tablet [glumetza]
n1=en:renal failure | n2=en:24 hr metformin hydrochloride 1000 mg extended release oral tablet [glumetza] | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:24 hr metformin hydrochloride 500 mg extended release oral tablet [fortamet]
n1=en:renal failure | n2=en:24 hr metformin hydrochloride 500 mg extended release oral tablet [fortamet] | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:24 hr testosterone 0.0833 mg/hr transdermal patch
n1=en:renal failure | n2=en:24 hr testosterone 0.0833 mg/hr transdermal patch | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:24 hr testosterone 0.208 mg/hr transdermal patch [androderm]
n1=en:renal failure | n2=en:24 hr testosterone 0.208 mg/hr transdermal patch [androderm] | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:2500 mg testosterone 0.01 mg/mg topical gel
n1=en:renal failure | n2=en:2500 mg testosterone 0.01 mg/mg topical gel | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:5000 mg testosterone 0.01 mg/mg topical gel [androgel]
n1=en:renal failure | n2=en:5000 mg testosterone 0.01 mg/mg topical gel [androgel] | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:72 hr fentanyl 0.075 mg/hr transdermal patch
n1=en:renal failure | n2=en:72 hr fentanyl 0.075 mg/hr transdermal patch | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:72 hr fentanyl 0.1 mg/hr transdermal patch
n1=en:renal failure | n2=en:72 hr fentanyl 0.1 mg/hr transdermal patch | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:abnormal urine
n1=en:renal failure | n2=en:abnormal urine | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:abnormality of the prostate
n1=en:renal failure | n2=en:abnormality of the prostate | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:acute kidney injury
n1=en:renal failure | n2=en:acute kidney injury | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:acute nephrotic syndrome (1 patient)
n1=en:renal failure | n2=en:acute nephrotic syndrome (1 patient) | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:albinism with hemorrhagic diathesis and pigmented reticuloendothelial cells
n1=en:renal failure | n2=en:albinism with hemorrhagic diathesis and pigmented reticuloendothelial cells | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:angitis kidney
n1=en:renal failure | n2=en:angitis kidney | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:arterionephrosclerosis
n1=en:renal failure | n2=en:arterionephrosclerosis | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:bardet-biedl syndrome 16
n1=en:renal failure | n2=en:bardet-biedl syndrome 16 | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:bardet-biedl syndrome 19
n1=en:renal failure | n2=en:bardet-biedl syndrome 19 | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:bendrofluazide 2.5mg tablet
n1=en:renal failure | n2=en:bendrofluazide 2.5mg tablet | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:bendroflumethiazide
n1=en:renal failure | n2=en:bendroflumethiazide | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:bladder disorder
n1=en:renal failure | n2=en:bladder disorder | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:capecitabine 150mg tablet
n1=en:renal failure | n2=en:capecitabine 150mg tablet | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:chloral hydrate 500 mg rectal suppository
n1=en:renal failure | n2=en:chloral hydrate 500 mg rectal suppository | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:chronic pyelonephritis
n1=en:renal failure | n2=en:chronic pyelonephritis | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:cip-fenofibrate 150mg capsule
n1=en:renal failure | n2=en:cip-fenofibrate 150mg capsule | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:clofibrate
n1=en:renal failure | n2=en:clofibrate | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:cockayne syndrome, type i
n1=en:renal failure | n2=en:cockayne syndrome, type i | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:congenital renal atrophy
n1=en:renal failure | n2=en:congenital renal atrophy | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:corticomedullary cysts
n1=en:renal failure | n2=en:corticomedullary cysts | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:cyclosporine
n1=en:renal failure | n2=en:cyclosporine | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:cyclosporine 25 mg oral capsule [sandimmune]
n1=en:renal failure | n2=en:cyclosporine 25 mg oral capsule [sandimmune] | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:cyclosporine, modified 50 mg oral capsule
n1=en:renal failure | n2=en:cyclosporine, modified 50 mg oral capsule | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:cyclothiazide 2 mg oral tablet
n1=en:renal failure | n2=en:cyclothiazide 2 mg oral tablet | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:cystic changes in the kidney
n1=en:renal failure | n2=en:cystic changes in the kidney | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:cystic kidneys (in some patients)
n1=en:renal failure | n2=en:cystic kidneys (in some patients) | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:decreased numbers of glomeruli
n1=en:renal failure | n2=en:decreased numbers of glomeruli | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:decreased numbers of nephrons
n1=en:renal failure | n2=en:decreased numbers of nephrons | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:decreased or absent laminin beta-2 immunoreactivity in the glomerular basement membrane
n1=en:renal failure | n2=en:decreased or absent laminin beta-2 immunoreactivity in the glomerular basement membrane | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:deficient nephron differentiation
n1=en:renal failure | n2=en:deficient nephron differentiation | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:deposition of igg and complement seen on renal biopsy (in some patients)
n1=en:renal failure | n2=en:deposition of igg and complement seen on renal biopsy (in some patients) | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:diatrizoate na 42% liquid,oral
n1=en:renal failure | n2=en:diatrizoate na 42% liquid,oral | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:diatrizoic acid
n1=en:renal failure | n2=en:diatrizoic acid | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:diffuse glomerular basement membrane lamellation
n1=en:renal failure | n2=en:diffuse glomerular basement membrane lamellation | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:dilated bowman capsules
n1=en:renal failure | n2=en:dilated bowman capsules | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:disease of renal parenchyma
n1=en:renal failure | n2=en:disease of renal parenchyma | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:dorzolamide hydrochloride
n1=en:renal failure | n2=en:dorzolamide hydrochloride | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:duplication of the renal pelvis (1 patient)
n1=en:renal failure | n2=en:duplication of the renal pelvis (1 patient) | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:echodense kidneys on ultrasound
n1=en:renal failure | n2=en:echodense kidneys on ultrasound | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:echogenic kidneys with thick-walled pelvises (in some patients)
n1=en:renal failure | n2=en:echogenic kidneys with thick-walled pelvises (in some patients) | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:end stage renal disease (33% of patients)
n1=en:renal failure | n2=en:end stage renal disease (33% of patients) | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:end-stage renal disease develops in childhood
n1=en:renal failure | n2=en:end-stage renal disease develops in childhood | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:enlarged kidneys due to extramedullary hematopoiesis
n1=en:renal failure | n2=en:enlarged kidneys due to extramedullary hematopoiesis | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:fentanyl
n1=en:renal failure | n2=en:fentanyl | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:fentanyl 0.05 mg/ml injection
n1=en:renal failure | n2=en:fentanyl 0.05 mg/ml injection | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:fentanyl 0.1 mg/actuat mucosal spray
n1=en:renal failure | n2=en:fentanyl 0.1 mg/actuat mucosal spray | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:fentanyl 100micrograms buccal tablet
n1=en:renal failure | n2=en:fentanyl 100micrograms buccal tablet | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:fentanyl 100micrograms/2ml injection
n1=en:renal failure | n2=en:fentanyl 100micrograms/2ml injection | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:fentanyl 1200micrograms lozenge
n1=en:renal failure | n2=en:fentanyl 1200micrograms lozenge | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:fentanyl 400micrograms lozenge
n1=en:renal failure | n2=en:fentanyl 400micrograms lozenge | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:fentanyl citrate 10 ug in 1 ml intravenous injection, solution [fentanyl citrate]
n1=en:renal failure | n2=en:fentanyl citrate 10 ug in 1 ml intravenous injection, solution [fentanyl citrate] | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:foot process effacement
n1=en:renal failure | n2=en:foot process effacement | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:galactose-deficient iga1 deposits in the glomerular mesangium, with or without igm and igg
n1=en:renal failure | n2=en:galactose-deficient iga1 deposits in the glomerular mesangium, with or without igm and igg | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:galantamine
n1=en:renal failure | n2=en:galantamine | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:genital diseases, male
n1=en:renal failure | n2=en:genital diseases, male | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:glomerular dysfunction (variable)
n1=en:renal failure | n2=en:glomerular dysfunction (variable) | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:glomerulonephritis and nephrotic syndrome
n1=en:renal failure | n2=en:glomerulonephritis and nephrotic syndrome | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:glycosuria
n1=en:renal failure | n2=en:glycosuria | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:glycosuria, renal
n1=en:renal failure | n2=en:glycosuria, renal | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:graham boyle troxell syndrome
n1=en:renal failure | n2=en:graham boyle troxell syndrome | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:hematuria, macroscopic (seen in children and young adults coincident with mucosal infection)
n1=en:renal failure | n2=en:hematuria, macroscopic (seen in children and young adults coincident with mucosal infection) | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:hilar area of the kidney
n1=en:renal failure | n2=en:hilar area of the kidney | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:hiv-associated nephropathy
n1=en:renal failure | n2=en:hiv-associated nephropathy | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:hydrochlorothiazide 100 mg/ml oral solution
n1=en:renal failure | n2=en:hydrochlorothiazide 100 mg/ml oral solution | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:hydronephrosis (in some patients)
n1=en:renal failure | n2=en:hydronephrosis (in some patients) | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:hydronephrosis (secondary to ureteral compression from hydrometrocolpos)
n1=en:renal failure | n2=en:hydronephrosis (secondary to ureteral compression from hydrometrocolpos) | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:hypotonic urine (in some patients)
n1=en:renal failure | n2=en:hypotonic urine (in some patients) | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:impaired renal absorption of cationic amino acids
n1=en:renal failure | n2=en:impaired renal absorption of cationic amino acids | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:impaired renal function (variable)
n1=en:renal failure | n2=en:impaired renal function (variable) | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:increased risk for wilms tumor
n1=en:renal failure | n2=en:increased risk for wilms tumor | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:infection of kidney
n1=en:renal failure | n2=en:infection of kidney | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:injury to kidney
n1=en:renal failure | n2=en:injury to kidney | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:isosthenuria
n1=en:renal failure | n2=en:isosthenuria | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:juxtaglomerular apparatus
n1=en:renal failure | n2=en:juxtaglomerular apparatus | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:kidney
n1=en:renal failure | n2=en:kidney | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:kidney biopsy shows absence of differentiated proximal tubules
n1=en:renal failure | n2=en:kidney biopsy shows absence of differentiated proximal tubules | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:kidney failure if untreated
n1=en:renal failure | n2=en:kidney failure if untreated | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:late effects of genitourinary system tuberculosis
n1=en:renal failure | n2=en:late effects of genitourinary system tuberculosis | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:magnesium aluminum silicate
n1=en:renal failure | n2=en:magnesium aluminum silicate | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:magnesium chloride
n1=en:renal failure | n2=en:magnesium chloride | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:magnesium glycinate
n1=en:renal failure | n2=en:magnesium glycinate | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:male genital abnormalities
n1=en:renal failure | n2=en:male genital abnormalities | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:medullary sponge kidney (rare)
n1=en:renal failure | n2=en:medullary sponge kidney (rare) | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:membranoproliferative glomerulonephritis (in some patients)
n1=en:renal failure | n2=en:membranoproliferative glomerulonephritis (in some patients) | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:methotrexate 25 mg/ml injection
n1=en:renal failure | n2=en:methotrexate 25 mg/ml injection | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:methyclothiazide
n1=en:renal failure | n2=en:methyclothiazide | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:methyclothiazide 5mg tablet
n1=en:renal failure | n2=en:methyclothiazide 5mg tablet | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:microcystic dysplasia
n1=en:renal failure | n2=en:microcystic dysplasia | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:microcystic kidney
n1=en:renal failure | n2=en:microcystic kidney | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:microvillus transformation of the podocytes
n1=en:renal failure | n2=en:microvillus transformation of the podocytes | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:mitomycin 10mg powder for injection solution vial
n1=en:renal failure | n2=en:mitomycin 10mg powder for injection solution vial | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:muckle-wells syndrome
n1=en:renal failure | n2=en:muckle-wells syndrome | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:nail-patella syndrome
n1=en:renal failure | n2=en:nail-patella syndrome | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:nephritis nec in mdr10
n1=en:renal failure | n2=en:nephritis nec in mdr10 | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:nephritis, nephrotic syndrome, and nephrosis
n1=en:renal failure | n2=en:nephritis, nephrotic syndrome, and nephrosis | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:nephrocalcinosis
n1=en:renal failure | n2=en:nephrocalcinosis | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:nephronophthisis (1 patient)
n1=en:renal failure | n2=en:nephronophthisis (1 patient) | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:nephronophthisis 16
n1=en:renal failure | n2=en:nephronophthisis 16 | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:nephropathy
n1=en:renal failure | n2=en:nephropathy | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:nephrotic syndrome, steroid-nonresponsive
n1=en:renal failure | n2=en:nephrotic syndrome, steroid-nonresponsive | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:no evidence of renal cysts
n1=en:renal failure | n2=en:no evidence of renal cysts | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:non-protein nitrogen blood increased result
n1=en:renal failure | n2=en:non-protein nitrogen blood increased result | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:opium, powdered
n1=en:renal failure | n2=en:opium, powdered | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:parenchymal renal hypertension
n1=en:renal failure | n2=en:parenchymal renal hypertension | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:pelvicalyceal dilatation (in 1 of 6 patients)
n1=en:renal failure | n2=en:pelvicalyceal dilatation (in 1 of 6 patients) | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:polycystic kidney disease 1
n1=en:renal failure | n2=en:polycystic kidney disease 1 | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:postrenal failure
n1=en:renal failure | n2=en:postrenal failure | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:potassium acetate 0.2 meq/ml injectable solution
n1=en:renal failure | n2=en:potassium acetate 0.2 meq/ml injectable solution | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:potassium bitartrate
n1=en:renal failure | n2=en:potassium bitartrate | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:potassium chloride 0.1 meq/ml injectable solution
n1=en:renal failure | n2=en:potassium chloride 0.1 meq/ml injectable solution | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:potassium chloride 10 meq extended release oral capsule
n1=en:renal failure | n2=en:potassium chloride 10 meq extended release oral capsule | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:potassium chloride 10 meq extended release oral tablet [k-dur]
n1=en:renal failure | n2=en:potassium chloride 10 meq extended release oral tablet [k-dur] | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:potassium chloride 10 meq oral tablet
n1=en:renal failure | n2=en:potassium chloride 10 meq oral tablet | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:potassium chloride 8 meq oral tablet
n1=en:renal failure | n2=en:potassium chloride 8 meq oral tablet | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:potassium gluconate 2.2 meq oral tablet
n1=en:renal failure | n2=en:potassium gluconate 2.2 meq oral tablet | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:primary systemic amyloidosis
n1=en:renal failure | n2=en:primary systemic amyloidosis | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:primitive renal tubules may exist
n1=en:renal failure | n2=en:primitive renal tubules may exist | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:probenecid 500mg tablet
n1=en:renal failure | n2=en:probenecid 500mg tablet | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:proximal tubulopathy (1 patient)
n1=en:renal failure | n2=en:proximal tubulopathy (1 patient) | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:pyelonephritis
n1=en:renal failure | n2=en:pyelonephritis | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:recurrent benign hematuria syndrome
n1=en:renal failure | n2=en:recurrent benign hematuria syndrome | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:reduced renal function (in some patients with structural anomalies)
n1=en:renal failure | n2=en:reduced renal function (in some patients with structural anomalies) | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:renal agenesis/hypoplasia (in some patients)
n1=en:renal failure | n2=en:renal agenesis/hypoplasia (in some patients) | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:renal amyloidosis, late-onset
n1=en:renal failure | n2=en:renal amyloidosis, late-onset | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:renal amyloidosis, late-onset (uncommon)
n1=en:renal failure | n2=en:renal amyloidosis, late-onset (uncommon) | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:renal anomalies (27%)
n1=en:renal failure | n2=en:renal anomalies (27%) | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:renal cell
n1=en:renal failure | n2=en:renal cell | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:renal cell carcinoma (e.g., 193300.0002)
n1=en:renal failure | n2=en:renal cell carcinoma (e.g., 193300.0002) | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:renal cortex calcification (in some patients)
n1=en:renal failure | n2=en:renal cortex calcification (in some patients) | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:renal cortical cysts
n1=en:renal failure | n2=en:renal cortical cysts | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:renal cysts and diabetes syndrome
n1=en:renal failure | n2=en:renal cysts and diabetes syndrome | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:renal disease (in some patients)
n1=en:renal failure | n2=en:renal disease (in some patients) | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:renal disease in pregnancy and/or puerperium without hypertension
n1=en:renal failure | n2=en:renal disease in pregnancy and/or puerperium without hypertension | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:renal dysplasia
n1=en:renal failure | n2=en:renal dysplasia | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:renal failure by age 3
n1=en:renal failure | n2=en:renal failure by age 3 | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:renal failure following abortion and ectopic and molar pregnancy
n1=en:renal failure | n2=en:renal failure following abortion and ectopic and molar pregnancy | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:renal fibrosis
n1=en:renal failure | n2=en:renal fibrosis | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:renal glucose wasting
n1=en:renal failure | n2=en:renal glucose wasting | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:renal hypoplasia/aplasia
n1=en:renal failure | n2=en:renal hypoplasia/aplasia | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:renal insufficiency (in 2 of 3 siblings)
n1=en:renal failure | n2=en:renal insufficiency (in 2 of 3 siblings) | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:renal involvement (in 39%)
n1=en:renal failure | n2=en:renal involvement (in 39%) | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:renal medulla
n1=en:renal failure | n2=en:renal medulla | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:renal medullary dysplasia
n1=en:renal failure | n2=en:renal medullary dysplasia | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:renal nutcracker syndrome
n1=en:renal failure | n2=en:renal nutcracker syndrome | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:renal parenchymal disease
n1=en:renal failure | n2=en:renal parenchymal disease | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:renal toxicity
n1=en:renal failure | n2=en:renal toxicity | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:renal tubular transport, inborn errors
n1=en:renal failure | n2=en:renal tubular transport, inborn errors | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:ribavirin 200mg capsule
n1=en:renal failure | n2=en:ribavirin 200mg capsule | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:serum creatinine raised
n1=en:renal failure | n2=en:serum creatinine raised | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:sodium diatrizoate 25% infusion solution 250 ml bottle
n1=en:renal failure | n2=en:sodium diatrizoate 25% infusion solution 250 ml bottle | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:sodium phosphate 1.5g tablet
n1=en:renal failure | n2=en:sodium phosphate 1.5g tablet | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:sotalol hydrochloride 240mg tablet
n1=en:renal failure | n2=en:sotalol hydrochloride 240mg tablet | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:splitting of the basement membrane
n1=en:renal failure | n2=en:splitting of the basement membrane | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:tegaserod 6 mg oral tablet
n1=en:renal failure | n2=en:tegaserod 6 mg oral tablet | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:testosterone enanthate 100mg/testosterone propionate 25mg/ml inj
n1=en:renal failure | n2=en:testosterone enanthate 100mg/testosterone propionate 25mg/ml inj | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:thickened tubular basement membrane
n1=en:renal failure | n2=en:thickened tubular basement membrane | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:thickening of the glomerular basement membrane (later in the disease)
n1=en:renal failure | n2=en:thickening of the glomerular basement membrane (later in the disease) | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:trichlormethiazide 2 mg oral tablet
n1=en:renal failure | n2=en:trichlormethiazide 2 mg oral tablet | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:tubular cysts
n1=en:renal failure | n2=en:tubular cysts | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:uremia
n1=en:renal failure | n2=en:uremia | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:urethra disorder
n1=en:renal failure | n2=en:urethra disorder | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:urinary frequency
n1=en:renal failure | n2=en:urinary frequency | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:urofacial syndrome 2
n1=en:renal failure | n2=en:urofacial syndrome 2 | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:urological system complication of procedure
n1=en:renal failure | n2=en:urological system complication of procedure | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:wilms tumor-aniridia-genitourinary anomalies-mental retardation syndrome
n1=en:renal failure | n2=en:wilms tumor-aniridia-genitourinary anomalies-mental retardation syndrome | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 110 / 0.493 ->
en:zellweger syndrome
n1=en:renal failure | n2=en:zellweger syndrome | rel=r_associated | relid=0 | w=110
- en:renal failure --
r_associated #0: 109 / 0.489 ->
en:absent renal peroxisomes
n1=en:renal failure | n2=en:absent renal peroxisomes | rel=r_associated | relid=0 | w=109
- en:renal failure --
r_associated #0: 109 / 0.489 ->
en:acute glomerulonephritis
n1=en:renal failure | n2=en:acute glomerulonephritis | rel=r_associated | relid=0 | w=109
- en:renal failure --
r_associated #0: 109 / 0.489 ->
en:cyclosporine, modified 25 mg oral capsule
n1=en:renal failure | n2=en:cyclosporine, modified 25 mg oral capsule | rel=r_associated | relid=0 | w=109
- en:renal failure --
r_associated #0: 109 / 0.489 ->
en:defect in renal tubular reabsorption of mg(2+)
n1=en:renal failure | n2=en:defect in renal tubular reabsorption of mg(2+) | rel=r_associated | relid=0 | w=109
- en:renal failure --
r_associated #0: 109 / 0.489 ->
en:dilated cystic tubules
n1=en:renal failure | n2=en:dilated cystic tubules | rel=r_associated | relid=0 | w=109
- en:renal failure --
r_associated #0: 109 / 0.489 ->
en:fibrocystic renal degeneration
n1=en:renal failure | n2=en:fibrocystic renal degeneration | rel=r_associated | relid=0 | w=109
- en:renal failure --
r_associated #0: 109 / 0.489 ->
en:foscarnet sodium 24 mg/ml injection
n1=en:renal failure | n2=en:foscarnet sodium 24 mg/ml injection | rel=r_associated | relid=0 | w=109
- en:renal failure --
r_associated #0: 109 / 0.489 ->
en:glomerulosclerosis
n1=en:renal failure | n2=en:glomerulosclerosis | rel=r_associated | relid=0 | w=109
- en:renal failure --
r_associated #0: 109 / 0.489 ->
en:hematuria (in some patients)
n1=en:renal failure | n2=en:hematuria (in some patients) | rel=r_associated | relid=0 | w=109
- en:renal failure --
r_associated #0: 109 / 0.489 ->
en:increased npn
n1=en:renal failure | n2=en:increased npn | rel=r_associated | relid=0 | w=109
- en:renal failure --
r_associated #0: 109 / 0.489 ->
en:kidney part
n1=en:renal failure | n2=en:kidney part | rel=r_associated | relid=0 | w=109
- en:renal failure --
r_associated #0: 109 / 0.489 ->
en:renal anomalies (in some)
n1=en:renal failure | n2=en:renal anomalies (in some) | rel=r_associated | relid=0 | w=109
- en:renal failure --
r_associated #0: 109 / 0.489 ->
en:testosterone undecanoate
n1=en:renal failure | n2=en:testosterone undecanoate | rel=r_associated | relid=0 | w=109
- en:renal failure --
r_associated #0: 109 / 0.489 ->
en:transplanted kidney
n1=en:renal failure | n2=en:transplanted kidney | rel=r_associated | relid=0 | w=109
- en:renal failure --
r_associated #0: 109 / 0.489 ->
en:tubulopathy (1 family)
n1=en:renal failure | n2=en:tubulopathy (1 family) | rel=r_associated | relid=0 | w=109
- en:renal failure --
r_associated #0: 108 / 0.484 ->
en:dilation of renal tubules, mild
n1=en:renal failure | n2=en:dilation of renal tubules, mild | rel=r_associated | relid=0 | w=108
- en:renal failure --
r_associated #0: 108 / 0.484 ->
en:methotrexate 15 mg oral tablet
n1=en:renal failure | n2=en:methotrexate 15 mg oral tablet | rel=r_associated | relid=0 | w=108
- en:renal failure --
r_associated #0: 108 / 0.484 ->
en:metolazone 2.5mg tablet
n1=en:renal failure | n2=en:metolazone 2.5mg tablet | rel=r_associated | relid=0 | w=108
- en:renal failure --
r_associated #0: 108 / 0.484 ->
en:nephron
n1=en:renal failure | n2=en:nephron | rel=r_associated | relid=0 | w=108
- en:renal failure --
r_associated #0: 108 / 0.484 ->
en:patient problem
n1=en:renal failure | n2=en:patient problem | rel=r_associated | relid=0 | w=108
- en:renal failure --
r_associated #0: 108 / 0.484 ->
en:podocytes show microvillous transformation
n1=en:renal failure | n2=en:podocytes show microvillous transformation | rel=r_associated | relid=0 | w=108
- en:renal failure --
r_associated #0: 108 / 0.484 ->
en:potassium chloride 1.33 meq/ml oral solution
n1=en:renal failure | n2=en:potassium chloride 1.33 meq/ml oral solution | rel=r_associated | relid=0 | w=108
- en:renal failure --
r_associated #0: 108 / 0.484 ->
en:renal hypertrophy
n1=en:renal failure | n2=en:renal hypertrophy | rel=r_associated | relid=0 | w=108
- en:renal failure --
r_associated #0: 108 / 0.484 ->
en:stenosis of calyceal neck
n1=en:renal failure | n2=en:stenosis of calyceal neck | rel=r_associated | relid=0 | w=108
- en:renal failure --
r_associated #0: 108 / 0.484 ->
en:testosterone 30mg topical solution
n1=en:renal failure | n2=en:testosterone 30mg topical solution | rel=r_associated | relid=0 | w=108
- en:renal failure --
r_associated #0: 107 / 0.48 ->
en:acitretin 17.5 mg oral capsule
n1=en:renal failure | n2=en:acitretin 17.5 mg oral capsule | rel=r_associated | relid=0 | w=107
- en:renal failure --
r_associated #0: 107 / 0.48 ->
en:chloral hydrate 325 mg rectal suppository
n1=en:renal failure | n2=en:chloral hydrate 325 mg rectal suppository | rel=r_associated | relid=0 | w=107
- en:renal failure --
r_associated #0: 107 / 0.48 ->
en:congenital absence of kidney
n1=en:renal failure | n2=en:congenital absence of kidney | rel=r_associated | relid=0 | w=107
- en:renal failure --
r_associated #0: 107 / 0.48 ->
en:end stage renal disease (seen in 20-40% of patients by 20 years after biopsy)
n1=en:renal failure | n2=en:end stage renal disease (seen in 20-40% of patients by 20 years after biopsy) | rel=r_associated | relid=0 | w=107
- en:renal failure --
r_associated #0: 107 / 0.48 ->
en:fentanyl 0.8 mg buccal tablet
n1=en:renal failure | n2=en:fentanyl 0.8 mg buccal tablet | rel=r_associated | relid=0 | w=107
- en:renal failure --
r_associated #0: 107 / 0.48 ->
en:interstitial inflammation
n1=en:renal failure | n2=en:interstitial inflammation | rel=r_associated | relid=0 | w=107
- en:renal failure --
r_associated #0: 107 / 0.48 ->
en:magnesium aspartate
n1=en:renal failure | n2=en:magnesium aspartate | rel=r_associated | relid=0 | w=107
- en:renal failure --
r_associated #0: 107 / 0.48 ->
en:magnesium hydroxide 78 mg/ml oral suspension
n1=en:renal failure | n2=en:magnesium hydroxide 78 mg/ml oral suspension | rel=r_associated | relid=0 | w=107
- en:renal failure --
r_associated #0: 107 / 0.48 ->
en:magnesium hydroxide 80 mg/ml oral suspension
n1=en:renal failure | n2=en:magnesium hydroxide 80 mg/ml oral suspension | rel=r_associated | relid=0 | w=107
- en:renal failure --
r_associated #0: 107 / 0.48 ->
en:renal hemangioblastoma
n1=en:renal failure | n2=en:renal hemangioblastoma | rel=r_associated | relid=0 | w=107
- en:renal failure --
r_associated #0: 106 / 0.475 ->
en:magnesium citrate powder
n1=en:renal failure | n2=en:magnesium citrate powder | rel=r_associated | relid=0 | w=106
- en:renal failure --
r_associated #0: 106 / 0.475 ->
en:nephrocalcinosis (in some patients)
n1=en:renal failure | n2=en:nephrocalcinosis (in some patients) | rel=r_associated | relid=0 | w=106
- en:renal failure --
r_associated #0: 106 / 0.475 ->
en:no kidney disease
n1=en:renal failure | n2=en:no kidney disease | rel=r_associated | relid=0 | w=106
- en:renal failure --
r_associated #0: 106 / 0.475 ->
en:ostomy
n1=en:renal failure | n2=en:ostomy | rel=r_associated | relid=0 | w=106
- en:renal failure --
r_associated #0: 106 / 0.475 ->
en:potassium chloride 8 meq delayed release oral tablet
n1=en:renal failure | n2=en:potassium chloride 8 meq delayed release oral tablet | rel=r_associated | relid=0 | w=106
- en:renal failure --
r_associated #0: 104 / 0.466 ->
en:0.25 ml methotrexate 50 mg/ml auto-injector
n1=en:renal failure | n2=en:0.25 ml methotrexate 50 mg/ml auto-injector | rel=r_associated | relid=0 | w=104
- en:renal failure --
r_associated #0: 104 / 0.466 ->
en:50 ml magnesium sulfate 40 mg/ml injection
n1=en:renal failure | n2=en:50 ml magnesium sulfate 40 mg/ml injection | rel=r_associated | relid=0 | w=104
- en:renal failure --
r_associated #0: 104 / 0.466 ->
en:echogenic kidneys
n1=en:renal failure | n2=en:echogenic kidneys | rel=r_associated | relid=0 | w=104
- en:renal failure --
r_associated #0: 104 / 0.466 ->
en:end-stage renal failure (in some patients)
n1=en:renal failure | n2=en:end-stage renal failure (in some patients) | rel=r_associated | relid=0 | w=104
- en:renal failure --
r_associated #0: 104 / 0.466 ->
en:fentanyl 0.04 mg transdermal patch
n1=en:renal failure | n2=en:fentanyl 0.04 mg transdermal patch | rel=r_associated | relid=0 | w=104
- en:renal failure --
r_associated #0: 104 / 0.466 ->
en:fused kidney
n1=en:renal failure | n2=en:fused kidney | rel=r_associated | relid=0 | w=104
- en:renal failure --
r_associated #0: 104 / 0.466 ->
en:global glomerulosclerosis
n1=en:renal failure | n2=en:global glomerulosclerosis | rel=r_associated | relid=0 | w=104
- en:renal failure --
r_associated #0: 104 / 0.466 ->
en:glomerular tufts
n1=en:renal failure | n2=en:glomerular tufts | rel=r_associated | relid=0 | w=104
- en:renal failure --
r_associated #0: 104 / 0.466 ->
en:hand foot uterus syndrome
n1=en:renal failure | n2=en:hand foot uterus syndrome | rel=r_associated | relid=0 | w=104
- en:renal failure --
r_associated #0: 104 / 0.466 ->
en:hydrochlorothiazide 10 mg/ml oral solution
n1=en:renal failure | n2=en:hydrochlorothiazide 10 mg/ml oral solution | rel=r_associated | relid=0 | w=104
- en:renal failure --
r_associated #0: 104 / 0.466 ->
en:inability to concentrate urine
n1=en:renal failure | n2=en:inability to concentrate urine | rel=r_associated | relid=0 | w=104
- en:renal failure --
r_associated #0: 104 / 0.466 ->
en:kidneys and urinary system
n1=en:renal failure | n2=en:kidneys and urinary system | rel=r_associated | relid=0 | w=104
- en:renal failure --
r_associated #0: 104 / 0.466 ->
en:malrotation of kidney
n1=en:renal failure | n2=en:malrotation of kidney | rel=r_associated | relid=0 | w=104
- en:renal failure --
r_associated #0: 104 / 0.466 ->
en:membranous glomerulonephritis
n1=en:renal failure | n2=en:membranous glomerulonephritis | rel=r_associated | relid=0 | w=104
- en:renal failure --
r_associated #0: 104 / 0.466 ->
en:mesangial proliferative glomerulonephritis (in some patients)
n1=en:renal failure | n2=en:mesangial proliferative glomerulonephritis (in some patients) | rel=r_associated | relid=0 | w=104
- en:renal failure --
r_associated #0: 104 / 0.466 ->
en:methotrexate 1000 mg injection
n1=en:renal failure | n2=en:methotrexate 1000 mg injection | rel=r_associated | relid=0 | w=104
- en:renal failure --
r_associated #0: 104 / 0.466 ->
en:neonatal research network terminology
n1=en:renal failure | n2=en:neonatal research network terminology | rel=r_associated | relid=0 | w=104
- en:renal failure --
r_associated #0: 104 / 0.466 ->
en:other disorders of urinary system
n1=en:renal failure | n2=en:other disorders of urinary system | rel=r_associated | relid=0 | w=104
- en:renal failure --
r_associated #0: 104 / 0.466 ->
en:potassium gluconate 2 meq oral tablet
n1=en:renal failure | n2=en:potassium gluconate 2 meq oral tablet | rel=r_associated | relid=0 | w=104
- en:renal failure --
r_associated #0: 104 / 0.466 ->
en:proteinuria
n1=en:renal failure | n2=en:proteinuria | rel=r_associated | relid=0 | w=104
- en:renal failure --
r_associated #0: 104 / 0.466 ->
en:renal lobule
n1=en:renal failure | n2=en:renal lobule | rel=r_associated | relid=0 | w=104
- en:renal failure --
r_associated #0: 104 / 0.466 ->
en:renal pyramid
n1=en:renal failure | n2=en:renal pyramid | rel=r_associated | relid=0 | w=104
- en:renal failure --
r_associated #0: 104 / 0.466 ->
en:renal stones (in one patient)
n1=en:renal failure | n2=en:renal stones (in one patient) | rel=r_associated | relid=0 | w=104
- en:renal failure --
r_associated #0: 104 / 0.466 ->
en:renal tubular cell atrophy with corticomedullary cysts
n1=en:renal failure | n2=en:renal tubular cell atrophy with corticomedullary cysts | rel=r_associated | relid=0 | w=104
- en:renal failure --
r_associated #0: 104 / 0.466 ->
en:renal tubule
n1=en:renal failure | n2=en:renal tubule | rel=r_associated | relid=0 | w=104
- en:renal failure --
r_associated #0: 104 / 0.466 ->
en:ribavirin 200mg tablet
n1=en:renal failure | n2=en:ribavirin 200mg tablet | rel=r_associated | relid=0 | w=104
- en:renal failure --
r_associated #0: 104 / 0.466 ->
en:testicular hydrocele
n1=en:renal failure | n2=en:testicular hydrocele | rel=r_associated | relid=0 | w=104
- en:renal failure --
r_associated #0: 104 / 0.466 ->
en:testosterone 50mg/ml suspension
n1=en:renal failure | n2=en:testosterone 50mg/ml suspension | rel=r_associated | relid=0 | w=104
- en:renal failure --
r_associated #0: 104 / 0.466 ->
en:townes-brocks syndrome
n1=en:renal failure | n2=en:townes-brocks syndrome | rel=r_associated | relid=0 | w=104
- en:renal failure --
r_associated #0: 103 / 0.462 ->
en:0.45 ml methotrexate 50 mg/ml auto-injector
n1=en:renal failure | n2=en:0.45 ml methotrexate 50 mg/ml auto-injector | rel=r_associated | relid=0 | w=103
- en:renal failure --
r_associated #0: 103 / 0.462 ->
en:72 hr fentanyl 0.0375 mg/hr transdermal patch
n1=en:renal failure | n2=en:72 hr fentanyl 0.0375 mg/hr transdermal patch | rel=r_associated | relid=0 | w=103
- en:renal failure --
r_associated #0: 103 / 0.462 ->
en:amprenavir
n1=en:renal failure | n2=en:amprenavir | rel=r_associated | relid=0 | w=103
- en:renal failure --
r_associated #0: 103 / 0.462 ->
en:atrophic zona glomerulosa of adrenal gland (rare)
n1=en:renal failure | n2=en:atrophic zona glomerulosa of adrenal gland (rare) | rel=r_associated | relid=0 | w=103
- en:renal failure --
r_associated #0: 103 / 0.462 ->
en:atrophy of kidney
n1=en:renal failure | n2=en:atrophy of kidney | rel=r_associated | relid=0 | w=103
- en:renal failure --
r_associated #0: 103 / 0.462 ->
en:cystic tubular dilatation in the corticomedullary area and medulla
n1=en:renal failure | n2=en:cystic tubular dilatation in the corticomedullary area and medulla | rel=r_associated | relid=0 | w=103
- en:renal failure --
r_associated #0: 103 / 0.462 ->
en:dorzolamide 2% ophthalmic solution
n1=en:renal failure | n2=en:dorzolamide 2% ophthalmic solution | rel=r_associated | relid=0 | w=103
- en:renal failure --
r_associated #0: 103 / 0.462 ->
en:ectopic kidney
n1=en:renal failure | n2=en:ectopic kidney | rel=r_associated | relid=0 | w=103
- en:renal failure --
r_associated #0: 103 / 0.462 ->
en:ectopic kidneys (rare)
n1=en:renal failure | n2=en:ectopic kidneys (rare) | rel=r_associated | relid=0 | w=103
- en:renal failure --
r_associated #0: 103 / 0.462 ->
en:enlarged kidneys without obstruction
n1=en:renal failure | n2=en:enlarged kidneys without obstruction | rel=r_associated | relid=0 | w=103
- en:renal failure --
r_associated #0: 103 / 0.462 ->
en:ergocalciferol 25000 unt oral capsule
n1=en:renal failure | n2=en:ergocalciferol 25000 unt oral capsule | rel=r_associated | relid=0 | w=103
- en:renal failure --
r_associated #0: 103 / 0.462 ->
en:healed pyelonephritis
n1=en:renal failure | n2=en:healed pyelonephritis | rel=r_associated | relid=0 | w=103
- en:renal failure --
r_associated #0: 103 / 0.462 ->
en:hydroureter
n1=en:renal failure | n2=en:hydroureter | rel=r_associated | relid=0 | w=103
- en:renal failure --
r_associated #0: 103 / 0.462 ->
en:hypoplastic glomerulocystic kidney disease
n1=en:renal failure | n2=en:hypoplastic glomerulocystic kidney disease | rel=r_associated | relid=0 | w=103
- en:renal failure --
r_associated #0: 103 / 0.462 ->
en:indapamide 2.5 mg oral tablet
n1=en:renal failure | n2=en:indapamide 2.5 mg oral tablet | rel=r_associated | relid=0 | w=103
- en:renal failure --
r_associated #0: 103 / 0.462 ->
en:magnesium hydroxide 81 mg/ml oral suspension
n1=en:renal failure | n2=en:magnesium hydroxide 81 mg/ml oral suspension | rel=r_associated | relid=0 | w=103
- en:renal failure --
r_associated #0: 103 / 0.462 ->
en:medullary cystic disease
n1=en:renal failure | n2=en:medullary cystic disease | rel=r_associated | relid=0 | w=103
- en:renal failure --
r_associated #0: 103 / 0.462 ->
en:narrowing of the ureteropelvic junctions
n1=en:renal failure | n2=en:narrowing of the ureteropelvic junctions | rel=r_associated | relid=0 | w=103
- en:renal failure --
r_associated #0: 103 / 0.462 ->
en:oligomeganephronia
n1=en:renal failure | n2=en:oligomeganephronia | rel=r_associated | relid=0 | w=103
- en:renal failure --
r_associated #0: 103 / 0.462 ->
en:pigmenturia
n1=en:renal failure | n2=en:pigmenturia | rel=r_associated | relid=0 | w=103
- en:renal failure --
r_associated #0: 103 / 0.462 ->
en:polyuria (in some patients)
n1=en:renal failure | n2=en:polyuria (in some patients) | rel=r_associated | relid=0 | w=103
- en:renal failure --
r_associated #0: 103 / 0.462 ->
en:potassium acetate 4 meq/ml injectable solution
n1=en:renal failure | n2=en:potassium acetate 4 meq/ml injectable solution | rel=r_associated | relid=0 | w=103
- en:renal failure --
r_associated #0: 103 / 0.462 ->
en:renal agenesis, unilateral (in some patients)
n1=en:renal failure | n2=en:renal agenesis, unilateral (in some patients) | rel=r_associated | relid=0 | w=103
- en:renal failure --
r_associated #0: 103 / 0.462 ->
en:renal anomalies (in some patients)
n1=en:renal failure | n2=en:renal anomalies (in some patients) | rel=r_associated | relid=0 | w=103
- en:renal failure --
r_associated #0: 103 / 0.462 ->
en:renal hypoplasia (rare)
n1=en:renal failure | n2=en:renal hypoplasia (rare) | rel=r_associated | relid=0 | w=103
- en:renal failure --
r_associated #0: 103 / 0.462 ->
en:renal structural anomalies (reported in 1 family)
n1=en:renal failure | n2=en:renal structural anomalies (reported in 1 family) | rel=r_associated | relid=0 | w=103
- en:renal failure --
r_associated #0: 103 / 0.462 ->
en:trichlormethiazide 4mg tablet
n1=en:renal failure | n2=en:trichlormethiazide 4mg tablet | rel=r_associated | relid=0 | w=103
- en:renal failure --
r_associated #0: 103 / 0.462 ->
en:uremic coma
n1=en:renal failure | n2=en:uremic coma | rel=r_associated | relid=0 | w=103
- en:renal failure --
r_associated #0: 102 / 0.457 ->
en:abnormality of the bladder
n1=en:renal failure | n2=en:abnormality of the bladder | rel=r_associated | relid=0 | w=102
- en:renal failure --
r_associated #0: 102 / 0.457 ->
en:acute prerenal failure
n1=en:renal failure | n2=en:acute prerenal failure | rel=r_associated | relid=0 | w=102
- en:renal failure --
r_associated #0: 102 / 0.457 ->
en:ammonium chloride 0.4 meq/ml injectable solution
n1=en:renal failure | n2=en:ammonium chloride 0.4 meq/ml injectable solution | rel=r_associated | relid=0 | w=102
- en:renal failure --
r_associated #0: 102 / 0.457 ->
en:anuric renal failure
n1=en:renal failure | n2=en:anuric renal failure | rel=r_associated | relid=0 | w=102
- en:renal failure --
r_associated #0: 102 / 0.457 ->
en:bendroflumethiazide 5 mg oral tablet
n1=en:renal failure | n2=en:bendroflumethiazide 5 mg oral tablet | rel=r_associated | relid=0 | w=102
- en:renal failure --
r_associated #0: 102 / 0.457 ->
en:calyceal fistula
n1=en:renal failure | n2=en:calyceal fistula | rel=r_associated | relid=0 | w=102
- en:renal failure --
r_associated #0: 102 / 0.457 ->
en:collapsing fsgs
n1=en:renal failure | n2=en:collapsing fsgs | rel=r_associated | relid=0 | w=102
- en:renal failure --
r_associated #0: 102 / 0.457 ->
en:disorder of kidney due to kappa light chain disease
n1=en:renal failure | n2=en:disorder of kidney due to kappa light chain disease | rel=r_associated | relid=0 | w=102
- en:renal failure --
r_associated #0: 102 / 0.457 ->
en:duplication of renal pelvis
n1=en:renal failure | n2=en:duplication of renal pelvis | rel=r_associated | relid=0 | w=102
- en:renal failure --
r_associated #0: 102 / 0.457 ->
en:fenofibrate 145mg tablet
n1=en:renal failure | n2=en:fenofibrate 145mg tablet | rel=r_associated | relid=0 | w=102
- en:renal failure --
r_associated #0: 102 / 0.457 ->
en:fetal pyelectasis
n1=en:renal failure | n2=en:fetal pyelectasis | rel=r_associated | relid=0 | w=102
- en:renal failure --
r_associated #0: 102 / 0.457 ->
en:hexahydrate, foscarnet sodium
n1=en:renal failure | n2=en:hexahydrate, foscarnet sodium | rel=r_associated | relid=0 | w=102
- en:renal failure --
r_associated #0: 102 / 0.457 ->
en:magnesium chloride 535 mg delayed release oral tablet
n1=en:renal failure | n2=en:magnesium chloride 535 mg delayed release oral tablet | rel=r_associated | relid=0 | w=102
- en:renal failure --
r_associated #0: 102 / 0.457 ->
en:magnesium sulfate 20 mg/ml injection
n1=en:renal failure | n2=en:magnesium sulfate 20 mg/ml injection | rel=r_associated | relid=0 | w=102
- en:renal failure --
r_associated #0: 102 / 0.457 ->
en:microcystic change
n1=en:renal failure | n2=en:microcystic change | rel=r_associated | relid=0 | w=102
- en:renal failure --
r_associated #0: 102 / 0.457 ->
en:potassium phosphate
n1=en:renal failure | n2=en:potassium phosphate | rel=r_associated | relid=0 | w=102
- en:renal failure --
r_associated #0: 102 / 0.457 ->
en:proteinuria syndrome
n1=en:renal failure | n2=en:proteinuria syndrome | rel=r_associated | relid=0 | w=102
- en:renal failure --
r_associated #0: 102 / 0.457 ->
en:renal adysplasia
n1=en:renal failure | n2=en:renal adysplasia | rel=r_associated | relid=0 | w=102
- en:renal failure --
r_associated #0: 102 / 0.457 ->
en:renal failure (in some patients)
n1=en:renal failure | n2=en:renal failure (in some patients) | rel=r_associated | relid=0 | w=102
- en:renal failure --
r_associated #0: 102 / 0.457 ->
en:renal malposition (rare)
n1=en:renal failure | n2=en:renal malposition (rare) | rel=r_associated | relid=0 | w=102
- en:renal failure --
r_associated #0: 102 / 0.457 ->
en:renal medullary washout
n1=en:renal failure | n2=en:renal medullary washout | rel=r_associated | relid=0 | w=102
- en:renal failure --
r_associated #0: 102 / 0.457 ->
en:renal secondary osteodystrophia fibrosa
n1=en:renal failure | n2=en:renal secondary osteodystrophia fibrosa | rel=r_associated | relid=0 | w=102
- en:renal failure --
r_associated #0: 102 / 0.457 ->
en:sotalol hydrochloride 160mg tablet
n1=en:renal failure | n2=en:sotalol hydrochloride 160mg tablet | rel=r_associated | relid=0 | w=102
- en:renal failure --
r_associated #0: 102 / 0.457 ->
en:urolithiasis
n1=en:renal failure | n2=en:urolithiasis | rel=r_associated | relid=0 | w=102
- en:renal failure --
r_associated #0: 101 / 0.453 ->
en:0.5 ml methotrexate 50 mg/ml auto-injector
n1=en:renal failure | n2=en:0.5 ml methotrexate 50 mg/ml auto-injector | rel=r_associated | relid=0 | w=101
- en:renal failure --
r_associated #0: 101 / 0.453 ->
en:50 ml magnesium sulfate 80 mg/ml injection
n1=en:renal failure | n2=en:50 ml magnesium sulfate 80 mg/ml injection | rel=r_associated | relid=0 | w=101
- en:renal failure --
r_associated #0: 101 / 0.453 ->
en:chlorothiazide sodium
n1=en:renal failure | n2=en:chlorothiazide sodium | rel=r_associated | relid=0 | w=101
- en:renal failure --
r_associated #0: 101 / 0.453 ->
en:cyclosporine 25 mg oral capsule
n1=en:renal failure | n2=en:cyclosporine 25 mg oral capsule | rel=r_associated | relid=0 | w=101
- en:renal failure --
r_associated #0: 101 / 0.453 ->
en:cyclosporine ophthalmic emulsion 0.05%
n1=en:renal failure | n2=en:cyclosporine ophthalmic emulsion 0.05% | rel=r_associated | relid=0 | w=101
- en:renal failure --
r_associated #0: 101 / 0.453 ->
en:cystic kidney
n1=en:renal failure | n2=en:cystic kidney | rel=r_associated | relid=0 | w=101
- en:renal failure --
r_associated #0: 101 / 0.453 ->
en:diatrizoate meglumine 30%/edetate ca disodium 0.05mg/ml inj
n1=en:renal failure | n2=en:diatrizoate meglumine 30%/edetate ca disodium 0.05mg/ml inj | rel=r_associated | relid=0 | w=101
- en:renal failure --
r_associated #0: 101 / 0.453 ->
en:familial juvenile nephronophthisis
n1=en:renal failure | n2=en:familial juvenile nephronophthisis | rel=r_associated | relid=0 | w=101
- en:renal failure --
r_associated #0: 101 / 0.453 ->
en:fentanyl 0.1 mg oral lozenge
n1=en:renal failure | n2=en:fentanyl 0.1 mg oral lozenge | rel=r_associated | relid=0 | w=101
- en:renal failure --
r_associated #0: 101 / 0.453 ->
en:fentanyl 0.4 mg sublingual tablet
n1=en:renal failure | n2=en:fentanyl 0.4 mg sublingual tablet | rel=r_associated | relid=0 | w=101
- en:renal failure --
r_associated #0: 101 / 0.453 ->
en:glomerulopathy
n1=en:renal failure | n2=en:glomerulopathy | rel=r_associated | relid=0 | w=101
- en:renal failure --
r_associated #0: 101 / 0.453 ->
en:hypoplastic renal arteries (rare)
n1=en:renal failure | n2=en:hypoplastic renal arteries (rare) | rel=r_associated | relid=0 | w=101
- en:renal failure --
r_associated #0: 101 / 0.453 ->
en:magnesium 500mg tab
n1=en:renal failure | n2=en:magnesium 500mg tab | rel=r_associated | relid=0 | w=101
- en:renal failure --
r_associated #0: 101 / 0.453 ->
en:metformin
n1=en:renal failure | n2=en:metformin | rel=r_associated | relid=0 | w=101
- en:renal failure --
r_associated #0: 101 / 0.453 ->
en:methazolamide 50mg tablet
n1=en:renal failure | n2=en:methazolamide 50mg tablet | rel=r_associated | relid=0 | w=101
- en:renal failure --
r_associated #0: 101 / 0.453 ->
en:methocarbamol 750mg tablet
n1=en:renal failure | n2=en:methocarbamol 750mg tablet | rel=r_associated | relid=0 | w=101
- en:renal failure --
r_associated #0: 101 / 0.453 ->
en:methylene blue
n1=en:renal failure | n2=en:methylene blue | rel=r_associated | relid=0 | w=101
- en:renal failure --
r_associated #0: 101 / 0.453 ->
en:nephrolithiasis (rare)
n1=en:renal failure | n2=en:nephrolithiasis (rare) | rel=r_associated | relid=0 | w=101
- en:renal failure --
r_associated #0: 101 / 0.453 ->
en:potassium bicarbonate 0.208 meq/ml oral solution
n1=en:renal failure | n2=en:potassium bicarbonate 0.208 meq/ml oral solution | rel=r_associated | relid=0 | w=101
- en:renal failure --
r_associated #0: 101 / 0.453 ->
en:structure of superior pole of kidney
n1=en:renal failure | n2=en:structure of superior pole of kidney | rel=r_associated | relid=0 | w=101
- en:renal failure --
r_associated #0: 101 / 0.453 ->
en:therapeutic testosterone
n1=en:renal failure | n2=en:therapeutic testosterone | rel=r_associated | relid=0 | w=101
- en:renal failure --
r_associated #0: 101 / 0.453 ->
en:uromodulin reduced or absent in urine
n1=en:renal failure | n2=en:uromodulin reduced or absent in urine | rel=r_associated | relid=0 | w=101
- en:renal failure --
r_associated #0: 99 / 0.444 ->
en:kidney failure
n1=en:renal failure | n2=en:kidney failure | rel=r_associated | relid=0 | w=99
- en:renal failure --
r_associated #0: 82 / 0.368 ->
défaillance
n1=en:renal failure | n2=défaillance | rel=r_associated | relid=0 | w=82
- en:renal failure --
r_associated #0: 78 / 0.35 ->
défaillance du rein
n1=en:renal failure | n2=défaillance du rein | rel=r_associated | relid=0 | w=78
- en:renal failure --
r_associated #0: 77 / 0.345 ->
insuffisance
n1=en:renal failure | n2=insuffisance | rel=r_associated | relid=0 | w=77
- en:renal failure --
r_associated #0: 68 / 0.305 ->
insuffisance du rein
n1=en:renal failure | n2=insuffisance du rein | rel=r_associated | relid=0 | w=68
- en:renal failure --
r_associated #0: 67 / 0.3 ->
maladie
n1=en:renal failure | n2=maladie | rel=r_associated | relid=0 | w=67
- en:renal failure --
r_associated #0: 67 / 0.3 ->
maladie
(médecine)
n1=en:renal failure | n2=maladie (médecine) | rel=r_associated | relid=0 | w=67
- en:renal failure --
r_associated #0: 67 / 0.3 ->
reins
n1=en:renal failure | n2=reins | rel=r_associated | relid=0 | w=67
- en:renal failure --
r_associated #0: 65 / 0.291 ->
insuffisance rénale aiguë
n1=en:renal failure | n2=insuffisance rénale aiguë | rel=r_associated | relid=0 | w=65
- en:renal failure --
r_associated #0: 65 / 0.291 ->
maladies
n1=en:renal failure | n2=maladies | rel=r_associated | relid=0 | w=65
- en:renal failure --
r_associated #0: 65 / 0.291 ->
rénale
n1=en:renal failure | n2=rénale | rel=r_associated | relid=0 | w=65
- en:renal failure --
r_associated #0: 64 / 0.287 ->
dialyse
n1=en:renal failure | n2=dialyse | rel=r_associated | relid=0 | w=64
- en:renal failure --
r_associated #0: 62 / 0.278 ->
rein
n1=en:renal failure | n2=rein | rel=r_associated | relid=0 | w=62
- en:renal failure --
r_associated #0: 60 / 0.269 ->
en:nephrotic syndrome
n1=en:renal failure | n2=en:nephrotic syndrome | rel=r_associated | relid=0 | w=60
- en:renal failure --
r_associated #0: 59 / 0.265 ->
en:renovascular hypertension
n1=en:renal failure | n2=en:renovascular hypertension | rel=r_associated | relid=0 | w=59
- en:renal failure --
r_associated #0: 57 / 0.256 ->
en:hyperuricemic nephropathy, familial juvenile 2
n1=en:renal failure | n2=en:hyperuricemic nephropathy, familial juvenile 2 | rel=r_associated | relid=0 | w=57
- en:renal failure --
r_associated #0: 55 / 0.247 ->
en:diatrizoate sodium 50% injection solution vial
n1=en:renal failure | n2=en:diatrizoate sodium 50% injection solution vial | rel=r_associated | relid=0 | w=55
- en:renal failure --
r_associated #0: 55 / 0.247 ->
en:heavy chain deposition disease
n1=en:renal failure | n2=en:heavy chain deposition disease | rel=r_associated | relid=0 | w=55
- en:renal failure --
r_associated #0: 55 / 0.247 ->
en:hyperechogenic kidneys
n1=en:renal failure | n2=en:hyperechogenic kidneys | rel=r_associated | relid=0 | w=55
- en:renal failure --
r_associated #0: 55 / 0.247 ->
en:magnesium amino acids chelate
n1=en:renal failure | n2=en:magnesium amino acids chelate | rel=r_associated | relid=0 | w=55
- en:renal failure --
r_associated #0: 55 / 0.247 ->
en:neonatal anuria
n1=en:renal failure | n2=en:neonatal anuria | rel=r_associated | relid=0 | w=55
- en:renal failure --
r_associated #0: 55 / 0.247 ->
en:paromomycin
n1=en:renal failure | n2=en:paromomycin | rel=r_associated | relid=0 | w=55
- en:renal failure --
r_associated #0: 55 / 0.247 ->
en:renal malrotation (rare)
n1=en:renal failure | n2=en:renal malrotation (rare) | rel=r_associated | relid=0 | w=55
- en:renal failure --
r_associated #0: 54 / 0.242 ->
en:low alkaline phosphatase of renal origin
n1=en:renal failure | n2=en:low alkaline phosphatase of renal origin | rel=r_associated | relid=0 | w=54
- en:renal failure --
r_associated #0: 51 / 0.229 ->
en:isothenuria
n1=en:renal failure | n2=en:isothenuria | rel=r_associated | relid=0 | w=51
- en:renal failure --
r_associated #0: 51 / 0.229 ->
en:renal coloboma syndrome
n1=en:renal failure | n2=en:renal coloboma syndrome | rel=r_associated | relid=0 | w=51
- en:renal failure --
r_associated #0: 50 / 0.224 ->
en:{20 (methotrexate 2.5 mg oral tablet) } pack
n1=en:renal failure | n2=en:{20 (methotrexate 2.5 mg oral tablet) } pack | rel=r_associated | relid=0 | w=50
- en:renal failure --
r_associated #0: 50 / 0.224 ->
en:{7 (ribavirin 200 mg oral tablet) / 7 (ribavirin 400 mg oral tablet) } pack
n1=en:renal failure | n2=en:{7 (ribavirin 200 mg oral tablet) / 7 (ribavirin 400 mg oral tablet) } pack | rel=r_associated | relid=0 | w=50
- en:renal failure --
r_associated #0: 50 / 0.224 ->
en:0.15 ml methotrexate 50 mg/ml auto-injector
n1=en:renal failure | n2=en:0.15 ml methotrexate 50 mg/ml auto-injector | rel=r_associated | relid=0 | w=50
- en:renal failure --
r_associated #0: 50 / 0.224 ->
en:1 ml ketorolac tromethamine 30 mg/ml prefilled syringe
n1=en:renal failure | n2=en:1 ml ketorolac tromethamine 30 mg/ml prefilled syringe | rel=r_associated | relid=0 | w=50
- en:renal failure --
r_associated #0: 50 / 0.224 ->
en:2 ml fentanyl 0.05 mg/ml cartridge
n1=en:renal failure | n2=en:2 ml fentanyl 0.05 mg/ml cartridge | rel=r_associated | relid=0 | w=50
- en:renal failure --
r_associated #0: 50 / 0.224 ->
en:abnormal glomerular filtration rate
n1=en:renal failure | n2=en:abnormal glomerular filtration rate | rel=r_associated | relid=0 | w=50
- en:renal failure --
r_associated #0: 50 / 0.224 ->
en:abnormality of renal excretion
n1=en:renal failure | n2=en:abnormality of renal excretion | rel=r_associated | relid=0 | w=50
- en:renal failure --
r_associated #0: 50 / 0.224 ->
en:absent/poor corticomedullary differentiation (some patients)
n1=en:renal failure | n2=en:absent/poor corticomedullary differentiation (some patients) | rel=r_associated | relid=0 | w=50
- en:renal failure --
r_associated #0: 50 / 0.224 ->
en:acute renal failure with renal papillary necrosis
n1=en:renal failure | n2=en:acute renal failure with renal papillary necrosis | rel=r_associated | relid=0 | w=50
- en:renal failure --
r_associated #0: 50 / 0.224 ->
en:alstrom syndrome
n1=en:renal failure | n2=en:alstrom syndrome | rel=r_associated | relid=0 | w=50
- en:renal failure --
r_associated #0: 50 / 0.224 ->
en:altered basement membrane
n1=en:renal failure | n2=en:altered basement membrane | rel=r_associated | relid=0 | w=50
- en:renal failure --
r_associated #0: 50 / 0.224 ->
en:atrophic tubules
n1=en:renal failure | n2=en:atrophic tubules | rel=r_associated | relid=0 | w=50
- en:renal failure --
r_associated #0: 50 / 0.224 ->
en:basement membrane alterations in bowman capsule, tubules, and interstitial capillaries, with irregular thickening, splitting into multiple layers, and electron-lucent areas
n1=en:renal failure | n2=en:basement membrane alterations in bowman capsule, tubules, and interstitial capillaries, with irregular thickening, splitting into multiple layers, and electron-lucent areas | rel=r_associated | relid=0 | w=50
- en:renal failure --
r_associated #0: 50 / 0.224 ->
en:benzthiazide 25 mg oral tablet
n1=en:renal failure | n2=en:benzthiazide 25 mg oral tablet | rel=r_associated | relid=0 | w=50
- en:renal failure --
r_associated #0: 50 / 0.224 ->
en:cisapride
n1=en:renal failure | n2=en:cisapride | rel=r_associated | relid=0 | w=50
- en:renal failure --
r_associated #0: 50 / 0.224 ->
en:cisplatin 10mg/vial powder for injection
n1=en:renal failure | n2=en:cisplatin 10mg/vial powder for injection | rel=r_associated | relid=0 | w=50
- en:renal failure --
r_associated #0: 50 / 0.224 ->
en:citric acid monohydrate
n1=en:renal failure | n2=en:citric acid monohydrate | rel=r_associated | relid=0 | w=50
- en:renal failure --
r_associated #0: 50 / 0.224 ->
en:cockayne syndrome, type ii
n1=en:renal failure | n2=en:cockayne syndrome, type ii | rel=r_associated | relid=0 | w=50
- en:renal failure --
r_associated #0: 50 / 0.224 ->
en:coital disorder
n1=en:renal failure | n2=en:coital disorder | rel=r_associated | relid=0 | w=50
- en:renal failure --
r_associated #0: 50 / 0.224 ->
en:cystic tubular dilatation in the cortex and medulla
n1=en:renal failure | n2=en:cystic tubular dilatation in the cortex and medulla | rel=r_associated | relid=0 | w=50
- en:renal failure --
r_associated #0: 50 / 0.224 ->
en:dofetilide
n1=en:renal failure | n2=en:dofetilide | rel=r_associated | relid=0 | w=50
- en:renal failure --
r_associated #0: 50 / 0.224 ->
en:duplicated collecting system
n1=en:renal failure | n2=en:duplicated collecting system | rel=r_associated | relid=0 | w=50
- en:renal failure --
r_associated #0: 50 / 0.224 ->
en:electron microscopy shows foot-process effacement
n1=en:renal failure | n2=en:electron microscopy shows foot-process effacement | rel=r_associated | relid=0 | w=50
- en:renal failure --
r_associated #0: 50 / 0.224 ->
en:enlarged polycystic kidneys (detectable prenatally)
n1=en:renal failure | n2=en:enlarged polycystic kidneys (detectable prenatally) | rel=r_associated | relid=0 | w=50
- en:renal failure --
r_associated #0: 50 / 0.224 ->
en:familial mediterranean fever, autosomal dominant
n1=en:renal failure | n2=en:familial mediterranean fever, autosomal dominant | rel=r_associated | relid=0 | w=50
- en:renal failure --
r_associated #0: 50 / 0.224 ->
en:family history of renal failure syndrome
n1=en:renal failure | n2=en:family history of renal failure syndrome | rel=r_associated | relid=0 | w=50
- en:renal failure --
r_associated #0: 50 / 0.224 ->
en:glomerular filtration rate decreased
n1=en:renal failure | n2=en:glomerular filtration rate decreased | rel=r_associated | relid=0 | w=50
- en:renal failure --
r_associated #0: 50 / 0.224 ->
en:gout, hprt-related
n1=en:renal failure | n2=en:gout, hprt-related | rel=r_associated | relid=0 | w=50
- en:renal failure --
r_associated #0: 50 / 0.224 ->
en:hematuria complication
n1=en:renal failure | n2=en:hematuria complication | rel=r_associated | relid=0 | w=50
- en:renal failure --
r_associated #0: 50 / 0.224 ->
en:hematuria, gross (in some patients)
n1=en:renal failure | n2=en:hematuria, gross (in some patients) | rel=r_associated | relid=0 | w=50
- en:renal failure --
r_associated #0: 50 / 0.224 ->
en:hyperechogenic kidneys or renal cysts on prenatal ultrasound
n1=en:renal failure | n2=en:hyperechogenic kidneys or renal cysts on prenatal ultrasound | rel=r_associated | relid=0 | w=50
- en:renal failure --
r_associated #0: 50 / 0.224 ->
en:hyperuricemia
n1=en:renal failure | n2=en:hyperuricemia | rel=r_associated | relid=0 | w=50
- en:renal failure --
r_associated #0: 50 / 0.224 ->
en:large nuclei (karyomegaly) in renal tubules seen renal biopsy
n1=en:renal failure | n2=en:large nuclei (karyomegaly) in renal tubules seen renal biopsy | rel=r_associated | relid=0 | w=50
- en:renal failure --
r_associated #0: 50 / 0.224 ->
en:magaldrate 96 mg/ml oral suspension
n1=en:renal failure | n2=en:magaldrate 96 mg/ml oral suspension | rel=r_associated | relid=0 | w=50
- en:renal failure --
r_associated #0: 50 / 0.224 ->
en:megacalicosis, unilateral (rare)
n1=en:renal failure | n2=en:megacalicosis, unilateral (rare) | rel=r_associated | relid=0 | w=50
- en:renal failure --
r_associated #0: 50 / 0.224 ->
en:metformin hydrochloride 850 mg oral tablet
n1=en:renal failure | n2=en:metformin hydrochloride 850 mg oral tablet | rel=r_associated | relid=0 | w=50
- en:renal failure --
r_associated #0: 50 / 0.224 ->
en:normal kidneys
n1=en:renal failure | n2=en:normal kidneys | rel=r_associated | relid=0 | w=50
- en:renal failure --
r_associated #0: 50 / 0.224 ->
en:patchy deposition of igg and igm
n1=en:renal failure | n2=en:patchy deposition of igg and igm | rel=r_associated | relid=0 | w=50
- en:renal failure --
r_associated #0: 50 / 0.224 ->
en:pediatric adverse events terminology
n1=en:renal failure | n2=en:pediatric adverse events terminology | rel=r_associated | relid=0 | w=50
- en:renal failure --
r_associated #0: 50 / 0.224 ->
en:potassium bicarbonate
n1=en:renal failure | n2=en:potassium bicarbonate | rel=r_associated | relid=0 | w=50
- en:renal failure --
r_associated #0: 50 / 0.224 ->
en:potassium chloride 1.5 meq/ml injectable solution
n1=en:renal failure | n2=en:potassium chloride 1.5 meq/ml injectable solution | rel=r_associated | relid=0 | w=50
- en:renal failure --
r_associated #0: 50 / 0.224 ->
en:potassium chloride 20 meq extended release oral tablet
n1=en:renal failure | n2=en:potassium chloride 20 meq extended release oral tablet | rel=r_associated | relid=0 | w=50
- en:renal failure --
r_associated #0: 50 / 0.224 ->
en:potassium chloride 20 meq extended release oral tablet [k-dur]
n1=en:renal failure | n2=en:potassium chloride 20 meq extended release oral tablet [k-dur] | rel=r_associated | relid=0 | w=50
- en:renal failure --
r_associated #0: 50 / 0.224 ->
en:pre-renal acute kidney injury
n1=en:renal failure | n2=en:pre-renal acute kidney injury | rel=r_associated | relid=0 | w=50
- en:renal failure --
r_associated #0: 50 / 0.224 ->
en:renal duplication (10%)
n1=en:renal failure | n2=en:renal duplication (10%) | rel=r_associated | relid=0 | w=50
- en:renal failure --
r_associated #0: 50 / 0.224 ->
en:renal dysplasia (wws)
n1=en:renal failure | n2=en:renal dysplasia (wws) | rel=r_associated | relid=0 | w=50
- en:renal failure --
r_associated #0: 50 / 0.224 ->
en:renal stone
n1=en:renal failure | n2=en:renal stone | rel=r_associated | relid=0 | w=50
- en:renal failure --
r_associated #0: 50 / 0.224 ->
en:reversible renal failure
n1=en:renal failure | n2=en:reversible renal failure | rel=r_associated | relid=0 | w=50
- en:renal failure --
r_associated #0: 50 / 0.224 ->
en:sodium phosphate, dibasic 398 mg / sodium phosphate,monobasic,monohydrate 1102 mg oral tablet [visicol]
n1=en:renal failure | n2=en:sodium phosphate, dibasic 398 mg / sodium phosphate,monobasic,monohydrate 1102 mg oral tablet [visicol] | rel=r_associated | relid=0 | w=50
- en:renal failure --
r_associated #0: 50 / 0.224 ->
en:sotalol hydrochloride
n1=en:renal failure | n2=en:sotalol hydrochloride | rel=r_associated | relid=0 | w=50
- en:renal failure --
r_associated #0: 50 / 0.224 ->
en:structural renal abnormalities
n1=en:renal failure | n2=en:structural renal abnormalities | rel=r_associated | relid=0 | w=50
- en:renal failure --
r_associated #0: 50 / 0.224 ->
en:testosterone propionate 100 mg/ml injectable solution
n1=en:renal failure | n2=en:testosterone propionate 100 mg/ml injectable solution | rel=r_associated | relid=0 | w=50
- en:renal failure --
r_associated #0: 50 / 0.224 ->
en:unilateral renal agenesis
n1=en:renal failure | n2=en:unilateral renal agenesis | rel=r_associated | relid=0 | w=50
- en:renal failure --
r_associated #0: 50 / 0.224 ->
en:uric acid nephrolithiasis
n1=en:renal failure | n2=en:uric acid nephrolithiasis | rel=r_associated | relid=0 | w=50
- en:renal failure --
r_associated #0: 50 / 0.224 ->
en:x-linked recessive nephrolithiasis with renal failure
n1=en:renal failure | n2=en:x-linked recessive nephrolithiasis with renal failure | rel=r_associated | relid=0 | w=50
- en:renal failure --
r_associated #0: 49 / 0.22 ->
réduction néphronique
n1=en:renal failure | n2=réduction néphronique | rel=r_associated | relid=0 | w=49
- en:renal failure --
r_associated #0: 49 / 0.22 ->
urémigène
n1=en:renal failure | n2=urémigène | rel=r_associated | relid=0 | w=49
- en:renal failure --
r_associated #0: 47 / 0.211 ->
érythropoïétine et insuffisance rénale chronique
n1=en:renal failure | n2=érythropoïétine et insuffisance rénale chronique | rel=r_associated | relid=0 | w=47
- en:renal failure --
r_associated #0: 47 / 0.211 ->
hypocalcémie
n1=en:renal failure | n2=hypocalcémie | rel=r_associated | relid=0 | w=47
- en:renal failure --
r_associated #0: 46 / 0.206 ->
encéphalopathie pancréatique
n1=en:renal failure | n2=encéphalopathie pancréatique | rel=r_associated | relid=0 | w=46
- en:renal failure --
r_associated #0: 46 / 0.206 ->
épuration extrarénale (méthodes de)
n1=en:renal failure | n2=épuration extrarénale (méthodes de) | rel=r_associated | relid=0 | w=46
- en:renal failure --
r_associated #0: 46 / 0.206 ->
uricémie
n1=en:renal failure | n2=uricémie | rel=r_associated | relid=0 | w=46
- en:renal failure --
r_associated #0: 45 / 0.202 ->
cristaux d'oxalate de calcium
n1=en:renal failure | n2=cristaux d'oxalate de calcium | rel=r_associated | relid=0 | w=45
- en:renal failure --
r_associated #0: 45 / 0.202 ->
en:{7 (ribavirin 400 mg oral tablet) / 7 (ribavirin 600 mg oral tablet) } pack
n1=en:renal failure | n2=en:{7 (ribavirin 400 mg oral tablet) / 7 (ribavirin 600 mg oral tablet) } pack | rel=r_associated | relid=0 | w=45
- en:renal failure --
r_associated #0: 45 / 0.202 ->
en:tubular dilation (1 of 2 patients)
n1=en:renal failure | n2=en:tubular dilation (1 of 2 patients) | rel=r_associated | relid=0 | w=45
- en:renal failure --
r_associated #0: 45 / 0.202 ->
gastrinémie
n1=en:renal failure | n2=gastrinémie | rel=r_associated | relid=0 | w=45
- en:renal failure --
r_associated #0: 45 / 0.202 ->
syndrome de Frasier
n1=en:renal failure | n2=syndrome de Frasier | rel=r_associated | relid=0 | w=45
- en:renal failure --
r_associated #0: 44 / 0.197 ->
hyperkaliémie
n1=en:renal failure | n2=hyperkaliémie | rel=r_associated | relid=0 | w=44
- en:renal failure --
r_associated #0: 44 / 0.197 ->
insuffisance rénale aigüe
n1=en:renal failure | n2=insuffisance rénale aigüe | rel=r_associated | relid=0 | w=44
- en:renal failure --
r_associated #0: 44 / 0.197 ->
nécrose corticale rénale bilatérale
n1=en:renal failure | n2=nécrose corticale rénale bilatérale | rel=r_associated | relid=0 | w=44
- en:renal failure --
r_associated #0: 43 / 0.193 ->
transplantation rénale
n1=en:renal failure | n2=transplantation rénale | rel=r_associated | relid=0 | w=43
- en:renal failure --
r_associated #0: 42 / 0.188 ->
hyperuricémie
n1=en:renal failure | n2=hyperuricémie | rel=r_associated | relid=0 | w=42
- en:renal failure --
r_associated #0: 42 / 0.188 ->
syndrome émail-rein
n1=en:renal failure | n2=syndrome émail-rein | rel=r_associated | relid=0 | w=42
- en:renal failure --
r_associated #0: 42 / 0.188 ->
urémique
n1=en:renal failure | n2=urémique | rel=r_associated | relid=0 | w=42
- en:renal failure --
r_associated #0: 41 / 0.184 ->
néphropathie
n1=en:renal failure | n2=néphropathie | rel=r_associated | relid=0 | w=41
- en:renal failure --
r_associated #0: 41 / 0.184 ->
oxalose osseuse
n1=en:renal failure | n2=oxalose osseuse | rel=r_associated | relid=0 | w=41
- en:renal failure --
r_associated #0: 40 / 0.179 ->
néphropathie tubulo-interstitielle aigüe
n1=en:renal failure | n2=néphropathie tubulo-interstitielle aigüe | rel=r_associated | relid=0 | w=40
- en:renal failure --
r_associated #0: 40 / 0.179 ->
syndrome HIVAN
n1=en:renal failure | n2=syndrome HIVAN | rel=r_associated | relid=0 | w=40
- en:renal failure --
r_associated #0: 36 / 0.161 ->
HIVAN (syndrome)
n1=en:renal failure | n2=HIVAN (syndrome) | rel=r_associated | relid=0 | w=36
- en:renal failure --
r_associated #0: 36 / 0.161 ->
néphropathie diabétique
n1=en:renal failure | n2=néphropathie diabétique | rel=r_associated | relid=0 | w=36
- en:renal failure --
r_associated #0: 35 / 0.157 ->
insuffisance d'adhérence leucocytaire (syndrome d')
n1=en:renal failure | n2=insuffisance d'adhérence leucocytaire (syndrome d') | rel=r_associated | relid=0 | w=35
- en:renal failure --
r_associated #0: 35 / 0.157 ->
maladie des reins
n1=en:renal failure | n2=maladie des reins | rel=r_associated | relid=0 | w=35
- en:renal failure --
r_associated #0: 29 / 0.13 ->
néphrose
n1=en:renal failure | n2=néphrose | rel=r_associated | relid=0 | w=29
- en:renal failure --
r_associated #0: 28 / 0.126 ->
en:hypovolemic shock conditions (smq)
n1=en:renal failure | n2=en:hypovolemic shock conditions (smq) | rel=r_associated | relid=0 | w=28
- en:renal failure --
r_associated #0: 28 / 0.126 ->
en:retroperitoneal fibrosis (smq)
n1=en:renal failure | n2=en:retroperitoneal fibrosis (smq) | rel=r_associated | relid=0 | w=28
- en:renal failure --
r_associated #0: 27 / 0.121 ->
en:acute renal failure (smq)
n1=en:renal failure | n2=en:acute renal failure (smq) | rel=r_associated | relid=0 | w=27
- en:renal failure --
r_associated #0: 27 / 0.121 ->
système urinaire
n1=en:renal failure | n2=système urinaire | rel=r_associated | relid=0 | w=27
- en:renal failure --
r_associated #0: 26 / 0.117 ->
en:medicine
n1=en:renal failure | n2=en:medicine | rel=r_associated | relid=0 | w=26
- en:renal failure --
r_associated #0: 25 / 0.112 ->
en:renal
n1=en:renal failure | n2=en:renal | rel=r_associated | relid=0 | w=25
- en:renal failure --
r_associated #0: 24 / 0.108 ->
en:chronic kidney disease (smq)
n1=en:renal failure | n2=en:chronic kidney disease (smq) | rel=r_associated | relid=0 | w=24
- en:renal failure --
r_associated #0: 23 / 0.103 ->
tubulopathie rénale
n1=en:renal failure | n2=tubulopathie rénale | rel=r_associated | relid=0 | w=23
- en:renal failure --
r_associated #0: 21 / 0.094 ->
en:urinary system
n1=en:renal failure | n2=en:urinary system | rel=r_associated | relid=0 | w=21
- en:renal failure --
r_associated #0: 20 / 0.09 ->
absence de la fonction rénale
n1=en:renal failure | n2=absence de la fonction rénale | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
amylose primitive systémique
n1=en:renal failure | n2=amylose primitive systémique | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
anurie
n1=en:renal failure | n2=anurie | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
appareil urinaire
n1=en:renal failure | n2=appareil urinaire | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
autre affection précisée du rein et de l'uretère
n1=en:renal failure | n2=autre affection précisée du rein et de l'uretère | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
azote non protéinique augmenté
n1=en:renal failure | n2=azote non protéinique augmenté | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
azote non protéique augmenté
n1=en:renal failure | n2=azote non protéique augmenté | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
azotémie
n1=en:renal failure | n2=azotémie | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
calcul coralliforme
n1=en:renal failure | n2=calcul coralliforme | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
calcul dendritique
n1=en:renal failure | n2=calcul dendritique | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
calcul du rein
n1=en:renal failure | n2=calcul du rein | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
calcul intrarénal
n1=en:renal failure | n2=calcul intrarénal | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
calcul rénal
n1=en:renal failure | n2=calcul rénal | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
coma urémique
n1=en:renal failure | n2=coma urémique | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
crush syndrome
n1=en:renal failure | n2=crush syndrome | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
cystite interstitielle
n1=en:renal failure | n2=cystite interstitielle | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
défaillance multi-viscérale
n1=en:renal failure | n2=défaillance multi-viscérale | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
défaillance multiviscérale
n1=en:renal failure | n2=défaillance multiviscérale | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
défaillance polyviscérale
n1=en:renal failure | n2=défaillance polyviscérale | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
défaillance rénale chronique
n1=en:renal failure | n2=défaillance rénale chronique | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
diabète (accidents vasculaires cérébraux du)
n1=en:renal failure | n2=diabète (accidents vasculaires cérébraux du) | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
diabète insipide
n1=en:renal failure | n2=diabète insipide | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
diabète insipide néphrogénique
n1=en:renal failure | n2=diabète insipide néphrogénique | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
diabète, photomyoclonies, surdité, néphropathie et dysfonction cérébrale
n1=en:renal failure | n2=diabète, photomyoclonies, surdité, néphropathie et dysfonction cérébrale | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
diverticule caliciel
n1=en:renal failure | n2=diverticule caliciel | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
dysfonction sexuelle
n1=en:renal failure | n2=dysfonction sexuelle | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
dysfonctionnement sexuel
n1=en:renal failure | n2=dysfonctionnement sexuel | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
en:aconuresis
n1=en:renal failure | n2=en:aconuresis | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
en:adult osteomalacia, unspecified
n1=en:renal failure | n2=en:adult osteomalacia, unspecified | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
en:arterial hypertension
n1=en:renal failure | n2=en:arterial hypertension | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
en:Bywater's syndrome
n1=en:renal failure | n2=en:Bywater's syndrome | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
en:central diabetes insipidus
n1=en:renal failure | n2=en:central diabetes insipidus | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
en:chronic kidney failure
n1=en:renal failure | n2=en:chronic kidney failure | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
en:chronic renal dysfunction/failure
n1=en:renal failure | n2=en:chronic renal dysfunction/failure | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
en:cortical necrosis of the kidney
n1=en:renal failure | n2=en:cortical necrosis of the kidney | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
en:crush injury
n1=en:renal failure | n2=en:crush injury | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
en:deafness
n1=en:renal failure | n2=en:deafness | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
en:foetal renal impairment
n1=en:renal failure | n2=en:foetal renal impairment | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
en:glomerulonephiitis
n1=en:renal failure | n2=en:glomerulonephiitis | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
en:high blood pressure
n1=en:renal failure | n2=en:high blood pressure | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
en:kidney diseases
n1=en:renal failure | n2=en:kidney diseases | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
en:kidney stone
n1=en:renal failure | n2=en:kidney stone | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
en:kleds' disease
n1=en:renal failure | n2=en:kleds' disease | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
en:light chain disease
n1=en:renal failure | n2=en:light chain disease | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
en:MOF
n1=en:renal failure | n2=en:MOF | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
en:multisystem organ failure
n1=en:renal failure | n2=en:multisystem organ failure | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
en:nephrauxe
n1=en:renal failure | n2=en:nephrauxe | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
en:nephritic lithiasis
n1=en:renal failure | n2=en:nephritic lithiasis | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
en:nephronum
n1=en:renal failure | n2=en:nephronum | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
en:photomyoclonus
n1=en:renal failure | n2=en:photomyoclonus | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
en:renal failure, ctcae
n1=en:renal failure | n2=en:renal failure, ctcae | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
en:rhabdomyolysis/myopathy (smq)
n1=en:renal failure | n2=en:rhabdomyolysis/myopathy (smq) | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
en:sexual dysfunction
n1=en:renal failure | n2=en:sexual dysfunction | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
en:staghorn calculus
n1=en:renal failure | n2=en:staghorn calculus | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
en:systema urinarium
n1=en:renal failure | n2=en:systema urinarium | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
en:tachycardia
n1=en:renal failure | n2=en:tachycardia | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
en:TURP syndrome
n1=en:renal failure | n2=en:TURP syndrome | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
en:uracratia
n1=en:renal failure | n2=en:uracratia | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
en:Wegener granulomatosis
n1=en:renal failure | n2=en:Wegener granulomatosis | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
en:Zellweger syndrome
n1=en:renal failure | n2=en:Zellweger syndrome | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
épuration extrarénale
n1=en:renal failure | n2=épuration extrarénale | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
épuration extrarénale (méthodes d')
n1=en:renal failure | n2=épuration extrarénale (méthodes d') | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
erreurs innées du transport tubulaire rénal
n1=en:renal failure | n2=erreurs innées du transport tubulaire rénal | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
fibrose rénale
n1=en:renal failure | n2=fibrose rénale | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
glomérulite
n1=en:renal failure | n2=glomérulite | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
glomérulonéphrite
n1=en:renal failure | n2=glomérulonéphrite | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
glomerulonéphrite
n1=en:renal failure | n2=glomerulonéphrite | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
glomérulonéphrite aigüe
n1=en:renal failure | n2=glomérulonéphrite aigüe | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
glomérulonéphrite chronique
n1=en:renal failure | n2=glomérulonéphrite chronique | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
glomérulonéphrite extramembraneuse
n1=en:renal failure | n2=glomérulonéphrite extramembraneuse | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
glomérulosclérose
n1=en:renal failure | n2=glomérulosclérose | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
gros rein
n1=en:renal failure | n2=gros rein | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
hématurie
n1=en:renal failure | n2=hématurie | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
hématurie macroscopique
n1=en:renal failure | n2=hématurie macroscopique | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
hématurie microscopique
n1=en:renal failure | n2=hématurie microscopique | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
hépatorénal (syndrome)
n1=en:renal failure | n2=hépatorénal (syndrome) | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
hta
n1=en:renal failure | n2=hta | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
HTA
n1=en:renal failure | n2=HTA | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
HTA
(hypertension artérielle)
n1=en:renal failure | n2=HTA (hypertension artérielle) | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
hydronéphrose
n1=en:renal failure | n2=hydronéphrose | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
hydruretère
n1=en:renal failure | n2=hydruretère | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
hypercalciurie
n1=en:renal failure | n2=hypercalciurie | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
hyperplasie du rein
n1=en:renal failure | n2=hyperplasie du rein | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
hypertélorisme, hypospadias, polysyndactylie (syndrome)
n1=en:renal failure | n2=hypertélorisme, hypospadias, polysyndactylie (syndrome) | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
hypertension
n1=en:renal failure | n2=hypertension | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
hypertension artérielle
n1=en:renal failure | n2=hypertension artérielle | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
hypertension d'origine rénale
n1=en:renal failure | n2=hypertension d'origine rénale | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
hypertension rénale parenchymateuse
n1=en:renal failure | n2=hypertension rénale parenchymateuse | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
hypertrophie du rein
n1=en:renal failure | n2=hypertrophie du rein | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
hypertrophie rénale
n1=en:renal failure | n2=hypertrophie rénale | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
hypoaldostéronisme hyporéninémique
n1=en:renal failure | n2=hypoaldostéronisme hyporéninémique | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
hypoplasie segmentaire du rein
n1=en:renal failure | n2=hypoplasie segmentaire du rein | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
incontinence d'urine
n1=en:renal failure | n2=incontinence d'urine | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
incontinence paradoxale
n1=en:renal failure | n2=incontinence paradoxale | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
incontinence urinaire
n1=en:renal failure | n2=incontinence urinaire | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
infarctus rénal
n1=en:renal failure | n2=infarctus rénal | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
Insuffisance rénale aiguë
n1=en:renal failure | n2=Insuffisance rénale aiguë | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
insuffisance rénale chronique
n1=en:renal failure | n2=insuffisance rénale chronique | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
insuffisance staturale d'origine rénale
n1=en:renal failure | n2=insuffisance staturale d'origine rénale | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
IRC
n1=en:renal failure | n2=IRC | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
IRC
(médecine)
n1=en:renal failure | n2=IRC (médecine) | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
lésion traumatique du rein
n1=en:renal failure | n2=lésion traumatique du rein | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
lésion traumatique rénale
n1=en:renal failure | n2=lésion traumatique rénale | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
lithiase du rein
n1=en:renal failure | n2=lithiase du rein | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
lithiase rénale
n1=en:renal failure | n2=lithiase rénale | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
lithiase urinaire
n1=en:renal failure | n2=lithiase urinaire | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
maladie des chaînes légères
n1=en:renal failure | n2=maladie des chaînes légères | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
nécrose tubulaire aigüe
n1=en:renal failure | n2=nécrose tubulaire aigüe | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
néphrite
n1=en:renal failure | n2=néphrite | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
néphroblastomatose
n1=en:renal failure | n2=néphroblastomatose | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
néphrocalcinose
n1=en:renal failure | n2=néphrocalcinose | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
néphrolithiase
n1=en:renal failure | n2=néphrolithiase | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
néphron
n1=en:renal failure | n2=néphron | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
néphropathie amyloïde
n1=en:renal failure | n2=néphropathie amyloïde | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
néphropathie héréditaire
n1=en:renal failure | n2=néphropathie héréditaire | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
néphropathie hypertensive
n1=en:renal failure | n2=néphropathie hypertensive | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
néphropathie interstitielle
n1=en:renal failure | n2=néphropathie interstitielle | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
néphropathie obstructive
n1=en:renal failure | n2=néphropathie obstructive | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
oligo-anurie
n1=en:renal failure | n2=oligo-anurie | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
onycho-ostéodysostose
n1=en:renal failure | n2=onycho-ostéodysostose | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
onycho-patellaire (syndrome)
n1=en:renal failure | n2=onycho-patellaire (syndrome) | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
ostéodystrophie azotémique
n1=en:renal failure | n2=ostéodystrophie azotémique | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
ostéodystrophie rénale
n1=en:renal failure | n2=ostéodystrophie rénale | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
ostéomalacie de l'adulte
n1=en:renal failure | n2=ostéomalacie de l'adulte | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
ostéomalacie infantile et juvénile
n1=en:renal failure | n2=ostéomalacie infantile et juvénile | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
ostéomalacie résistante à la vitamine d
n1=en:renal failure | n2=ostéomalacie résistante à la vitamine d | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
pah
n1=en:renal failure | n2=pah | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
périnéphrite
n1=en:renal failure | n2=périnéphrite | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
polyurie
n1=en:renal failure | n2=polyurie | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
pyélite
n1=en:renal failure | n2=pyélite | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
rachitisme rénal
n1=en:renal failure | n2=rachitisme rénal | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
rein non fonctionnel
n1=en:renal failure | n2=rein non fonctionnel | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
stade d'insuffisance rénale terminale
n1=en:renal failure | n2=stade d'insuffisance rénale terminale | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
sténose infundibulaire
n1=en:renal failure | n2=sténose infundibulaire | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
syndrome d'écrasement
n1=en:renal failure | n2=syndrome d'écrasement | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
syndrome de Bywater
n1=en:renal failure | n2=syndrome de Bywater | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
syndrome de bywaters
n1=en:renal failure | n2=syndrome de bywaters | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
syndrome de Bywaters
n1=en:renal failure | n2=syndrome de Bywaters | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
syndrome de défaillance multiviscérale
n1=en:renal failure | n2=syndrome de défaillance multiviscérale | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
syndrome de Randall
n1=en:renal failure | n2=syndrome de Randall | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
syndrome hépato-rénal
n1=en:renal failure | n2=syndrome hépato-rénal | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
syndrome hépatorénal
n1=en:renal failure | n2=syndrome hépatorénal | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
tachycardie, hypertension, microphtalmie et hyperglycinurie
n1=en:renal failure | n2=tachycardie, hypertension, microphtalmie et hyperglycinurie | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
th
n1=en:renal failure | n2=th | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
trouble sexuel
n1=en:renal failure | n2=trouble sexuel | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
troubles héréditaires du transport tubulaire rénal
n1=en:renal failure | n2=troubles héréditaires du transport tubulaire rénal | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
tuberculose uro-génitale
n1=en:renal failure | n2=tuberculose uro-génitale | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
tuberculose urogénitale
n1=en:renal failure | n2=tuberculose urogénitale | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
tubule rénal
n1=en:renal failure | n2=tubule rénal | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
tubulopathies avec fuite phosphatée
n1=en:renal failure | n2=tubulopathies avec fuite phosphatée | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 20 / 0.09 ->
vessie hyperactive
n1=en:renal failure | n2=vessie hyperactive | rel=r_associated | relid=0 | w=20
- en:renal failure --
r_associated #0: 15 / 0.067 ->
insuffisance rénale aigu
n1=en:renal failure | n2=insuffisance rénale aigu | rel=r_associated | relid=0 | w=15
- en:renal failure --
r_associated #0: 10 / 0.045 ->
syndrome
n1=en:renal failure | n2=syndrome | rel=r_associated | relid=0 | w=10
- en:renal failure --
r_associated #0: 5 / 0.022 ->
Médecine
n1=en:renal failure | n2=Médecine | rel=r_associated | relid=0 | w=5
- en:renal failure --
r_associated #0: 2 / 0.009 ->
effet indésirable
n1=en:renal failure | n2=effet indésirable | rel=r_associated | relid=0 | w=2
- en:renal failure --
r_associated #0: 2 / 0.009 ->
pathologie
n1=en:renal failure | n2=pathologie | rel=r_associated | relid=0 | w=2
- en:renal failure --
r_associated #0: 2 / 0.009 ->
processus
n1=en:renal failure | n2=processus | rel=r_associated | relid=0 | w=2
- en:renal failure --
r_associated #0: 1 / 0.004 ->
en:kidney disease
n1=en:renal failure | n2=en:kidney disease | rel=r_associated | relid=0 | w=1
- en:renal failure --
r_associated #0: 1 / 0.004 ->
en:renal disorder
n1=en:renal failure | n2=en:renal disorder | rel=r_associated | relid=0 | w=1
- en:renal failure --
r_associated #0: 1 / 0.004 ->
maladie rénale
n1=en:renal failure | n2=maladie rénale | rel=r_associated | relid=0 | w=1
| ≈ 1948 relations entrantes
- en:hyperplasia of kidney ---
r_associated #0: 566 -->
en:renal failure
n1=en:hyperplasia of kidney | n2=en:renal failure | rel=r_associated | relid=0 | w=566
- hyperplasie du rein ---
r_associated #0: 565 -->
en:renal failure
n1=hyperplasie du rein | n2=en:renal failure | rel=r_associated | relid=0 | w=565
- insuffisance staturale d'origine rénale ---
r_associated #0: 234 -->
en:renal failure
n1=insuffisance staturale d'origine rénale | n2=en:renal failure | rel=r_associated | relid=0 | w=234
- ostéomalacie résistante à la vitamine d ---
r_associated #0: 233 -->
en:renal failure
n1=ostéomalacie résistante à la vitamine d | n2=en:renal failure | rel=r_associated | relid=0 | w=233
- néphrolithiase ---
r_associated #0: 231 -->
en:renal failure
n1=néphrolithiase | n2=en:renal failure | rel=r_associated | relid=0 | w=231
- calcul intrarénal ---
r_associated #0: 230 -->
en:renal failure
n1=calcul intrarénal | n2=en:renal failure | rel=r_associated | relid=0 | w=230
- en:renal osteodystrophy ---
r_associated #0: 230 -->
en:renal failure
n1=en:renal osteodystrophy | n2=en:renal failure | rel=r_associated | relid=0 | w=230
- ostéodystrophie azotémique ---
r_associated #0: 230 -->
en:renal failure
n1=ostéodystrophie azotémique | n2=en:renal failure | rel=r_associated | relid=0 | w=230
- en:nephrolithiasis ---
r_associated #0: 229 -->
en:renal failure
n1=en:nephrolithiasis | n2=en:renal failure | rel=r_associated | relid=0 | w=229
- lithiase du rein ---
r_associated #0: 225 -->
en:renal failure
n1=lithiase du rein | n2=en:renal failure | rel=r_associated | relid=0 | w=225
- ostéomalacie de l'adulte ---
r_associated #0: 224 -->
en:renal failure
n1=ostéomalacie de l'adulte | n2=en:renal failure | rel=r_associated | relid=0 | w=224
- calcul du rein ---
r_associated #0: 220 -->
en:renal failure
n1=calcul du rein | n2=en:renal failure | rel=r_associated | relid=0 | w=220
- lithiase rénale ---
r_associated #0: 220 -->
en:renal failure
n1=lithiase rénale | n2=en:renal failure | rel=r_associated | relid=0 | w=220
- ostéomalacie infantile et juvénile ---
r_associated #0: 213 -->
en:renal failure
n1=ostéomalacie infantile et juvénile | n2=en:renal failure | rel=r_associated | relid=0 | w=213
- calcul rénal ---
r_associated #0: 205 -->
en:renal failure
n1=calcul rénal | n2=en:renal failure | rel=r_associated | relid=0 | w=205
- rachitisme rénal ---
r_associated #0: 205 -->
en:renal failure
n1=rachitisme rénal | n2=en:renal failure | rel=r_associated | relid=0 | w=205
- ostéodystrophie rénale ---
r_associated #0: 200 -->
en:renal failure
n1=ostéodystrophie rénale | n2=en:renal failure | rel=r_associated | relid=0 | w=200
- calcul coralliforme ---
r_associated #0: 196 -->
en:renal failure
n1=calcul coralliforme | n2=en:renal failure | rel=r_associated | relid=0 | w=196
- calcul dendritique ---
r_associated #0: 195 -->
en:renal failure
n1=calcul dendritique | n2=en:renal failure | rel=r_associated | relid=0 | w=195
- en:nephrosis ---
r_associated #0: 195 -->
en:renal failure
n1=en:nephrosis | n2=en:renal failure | rel=r_associated | relid=0 | w=195
- en:staghorn calculus ---
r_associated #0: 195 -->
en:renal failure
n1=en:staghorn calculus | n2=en:renal failure | rel=r_associated | relid=0 | w=195
- néphrose ---
r_associated #0: 194 -->
en:renal failure
n1=néphrose | n2=en:renal failure | rel=r_associated | relid=0 | w=194
- défaillance polyviscérale ---
r_associated #0: 193 -->
en:renal failure
n1=défaillance polyviscérale | n2=en:renal failure | rel=r_associated | relid=0 | w=193
- en:amyloid nephropathy ---
r_associated #0: 192 -->
en:renal failure
n1=en:amyloid nephropathy | n2=en:renal failure | rel=r_associated | relid=0 | w=192
- néphropathie amyloïde ---
r_associated #0: 190 -->
en:renal failure
n1=néphropathie amyloïde | n2=en:renal failure | rel=r_associated | relid=0 | w=190
- en:multiple organ failure ---
r_associated #0: 185 -->
en:renal failure
n1=en:multiple organ failure | n2=en:renal failure | rel=r_associated | relid=0 | w=185
- défaillance multi-viscérale ---
r_associated #0: 183 -->
en:renal failure
n1=défaillance multi-viscérale | n2=en:renal failure | rel=r_associated | relid=0 | w=183
- défaillance multiviscérale ---
r_associated #0: 180 -->
en:renal failure
n1=défaillance multiviscérale | n2=en:renal failure | rel=r_associated | relid=0 | w=180
- médecine ---
r_associated #0: 177 -->
en:renal failure
n1=médecine | n2=en:renal failure | rel=r_associated | relid=0 | w=177
- en:renal rickets ---
r_associated #0: 175 -->
en:renal failure
n1=en:renal rickets | n2=en:renal failure | rel=r_associated | relid=0 | w=175
- en:adult osteomalacia, unspecified ---
r_associated #0: 173 -->
en:renal failure
n1=en:adult osteomalacia, unspecified | n2=en:renal failure | rel=r_associated | relid=0 | w=173
- insuffisance rénale non précisée ---
r_associated #0: 173 -->
en:renal failure
n1=insuffisance rénale non précisée | n2=en:renal failure | rel=r_associated | relid=0 | w=173
- syndrome d'insuffisance rénale ---
r_associated #0: 171 -->
en:renal failure
n1=syndrome d'insuffisance rénale | n2=en:renal failure | rel=r_associated | relid=0 | w=171
- défaillance rénale chronique ---
r_associated #0: 170 -->
en:renal failure
n1=défaillance rénale chronique | n2=en:renal failure | rel=r_associated | relid=0 | w=170
- syndrome de défaillance multiviscérale ---
r_associated #0: 170 -->
en:renal failure
n1=syndrome de défaillance multiviscérale | n2=en:renal failure | rel=r_associated | relid=0 | w=170
- en:chronic kidney insufficiency ---
r_associated #0: 169 -->
en:renal failure
n1=en:chronic kidney insufficiency | n2=en:renal failure | rel=r_associated | relid=0 | w=169
- défaillance rénale ---
r_associated #0: 166 -->
en:renal failure
n1=défaillance rénale | n2=en:renal failure | rel=r_associated | relid=0 | w=166
- insuffisance rénale ---
r_associated #0: 163 -->
en:renal failure
n1=insuffisance rénale | n2=en:renal failure | rel=r_associated | relid=0 | w=163
- non précisée, insuffisance rénale ---
r_associated #0: 163 -->
en:renal failure
n1=non précisée, insuffisance rénale | n2=en:renal failure | rel=r_associated | relid=0 | w=163
- insuffisance rénale chronique ---
r_associated #0: 161 -->
en:renal failure
n1=insuffisance rénale chronique | n2=en:renal failure | rel=r_associated | relid=0 | w=161
- IRC
(médecine) ---
r_associated #0: 160 -->
en:renal failure
n1=IRC (médecine) | n2=en:renal failure | rel=r_associated | relid=0 | w=160
- en:kidney failure ---
r_associated #0: 160 -->
en:renal failure
n1=en:kidney failure | n2=en:renal failure | rel=r_associated | relid=0 | w=160
- défaillance du rein ---
r_associated #0: 154 -->
en:renal failure
n1=défaillance du rein | n2=en:renal failure | rel=r_associated | relid=0 | w=154
- en:hydroureter ---
r_associated #0: 152 -->
en:renal failure
n1=en:hydroureter | n2=en:renal failure | rel=r_associated | relid=0 | w=152
- hydruretère ---
r_associated #0: 150 -->
en:renal failure
n1=hydruretère | n2=en:renal failure | rel=r_associated | relid=0 | w=150
- en:chronic kidney failure ---
r_associated #0: 145 -->
en:renal failure
n1=en:chronic kidney failure | n2=en:renal failure | rel=r_associated | relid=0 | w=145
- système urinaire ---
r_associated #0: 137 -->
en:renal failure
n1=système urinaire | n2=en:renal failure | rel=r_associated | relid=0 | w=137
- en:urinary system ---
r_associated #0: 135 -->
en:renal failure
n1=en:urinary system | n2=en:renal failure | rel=r_associated | relid=0 | w=135
- en:absent renal function ---
r_associated #0: 109 -->
en:renal failure
n1=en:absent renal function | n2=en:renal failure | rel=r_associated | relid=0 | w=109
- en:injury to kidney ---
r_associated #0: 109 -->
en:renal failure
n1=en:injury to kidney | n2=en:renal failure | rel=r_associated | relid=0 | w=109
- absence de la fonction rénale ---
r_associated #0: 108 -->
en:renal failure
n1=absence de la fonction rénale | n2=en:renal failure | rel=r_associated | relid=0 | w=108
- glomérulonéphrite ---
r_associated #0: 107 -->
en:renal failure
n1=glomérulonéphrite | n2=en:renal failure | rel=r_associated | relid=0 | w=107
- en:hypertension ---
r_associated #0: 106 -->
en:renal failure
n1=en:hypertension | n2=en:renal failure | rel=r_associated | relid=0 | w=106
- lésion traumatique du rein ---
r_associated #0: 105 -->
en:renal failure
n1=lésion traumatique du rein | n2=en:renal failure | rel=r_associated | relid=0 | w=105
- lésion traumatique rénale ---
r_associated #0: 105 -->
en:renal failure
n1=lésion traumatique rénale | n2=en:renal failure | rel=r_associated | relid=0 | w=105
- en:glomerulonephritis ---
r_associated #0: 104 -->
en:renal failure
n1=en:glomerulonephritis | n2=en:renal failure | rel=r_associated | relid=0 | w=104
- glomerulonéphrite ---
r_associated #0: 104 -->
en:renal failure
n1=glomerulonéphrite | n2=en:renal failure | rel=r_associated | relid=0 | w=104
- hypertension ---
r_associated #0: 104 -->
en:renal failure
n1=hypertension | n2=en:renal failure | rel=r_associated | relid=0 | w=104
- en:hypoaldosteronism, hyporeninemic ---
r_associated #0: 96 -->
en:renal failure
n1=en:hypoaldosteronism, hyporeninemic | n2=en:renal failure | rel=r_associated | relid=0 | w=96
- hypoaldostéronisme hyporéninémique ---
r_associated #0: 95 -->
en:renal failure
n1=hypoaldostéronisme hyporéninémique | n2=en:renal failure | rel=r_associated | relid=0 | w=95
- en:renal insufficiency ---
r_associated #0: 94 -->
en:renal failure
n1=en:renal insufficiency | n2=en:renal failure | rel=r_associated | relid=0 | w=94
- en:high blood pressure ---
r_associated #0: 90 -->
en:renal failure
n1=en:high blood pressure | n2=en:renal failure | rel=r_associated | relid=0 | w=90
- diabète insipide ---
r_associated #0: 85 -->
en:renal failure
n1=diabète insipide | n2=en:renal failure | rel=r_associated | relid=0 | w=85
- en:parenchymal renal hypertension ---
r_associated #0: 84 -->
en:renal failure
n1=en:parenchymal renal hypertension | n2=en:renal failure | rel=r_associated | relid=0 | w=84
- troubles héréditaires du transport tubulaire rénal ---
r_associated #0: 84 -->
en:renal failure
n1=troubles héréditaires du transport tubulaire rénal | n2=en:renal failure | rel=r_associated | relid=0 | w=84
- en:renal tubular transport, inborn errors ---
r_associated #0: 83 -->
en:renal failure
n1=en:renal tubular transport, inborn errors | n2=en:renal failure | rel=r_associated | relid=0 | w=83
- en:diabetes insipidus ---
r_associated #0: 81 -->
en:renal failure
n1=en:diabetes insipidus | n2=en:renal failure | rel=r_associated | relid=0 | w=81
- hypertension artérielle ---
r_associated #0: 80 -->
en:renal failure
n1=hypertension artérielle | n2=en:renal failure | rel=r_associated | relid=0 | w=80
- hypertension rénale parenchymateuse ---
r_associated #0: 80 -->
en:renal failure
n1=hypertension rénale parenchymateuse | n2=en:renal failure | rel=r_associated | relid=0 | w=80
- insuffisance rénale aiguë ---
r_associated #0: 80 -->
en:renal failure
n1=insuffisance rénale aiguë | n2=en:renal failure | rel=r_associated | relid=0 | w=80
- néphrite ---
r_associated #0: 80 -->
en:renal failure
n1=néphrite | n2=en:renal failure | rel=r_associated | relid=0 | w=80
- en:nephritis ---
r_associated #0: 79 -->
en:renal failure
n1=en:nephritis | n2=en:renal failure | rel=r_associated | relid=0 | w=79
- en:acute renal failure ---
r_associated #0: 78 -->
en:renal failure
n1=en:acute renal failure | n2=en:renal failure | rel=r_associated | relid=0 | w=78
- autre affection précisée du rein et de l'uretère ---
r_associated #0: 75 -->
en:renal failure
n1=autre affection précisée du rein et de l'uretère | n2=en:renal failure | rel=r_associated | relid=0 | w=75
- en:nephritic lithiasis ---
r_associated #0: 75 -->
en:renal failure
n1=en:nephritic lithiasis | n2=en:renal failure | rel=r_associated | relid=0 | w=75
- erreurs innées du transport tubulaire rénal ---
r_associated #0: 71 -->
en:renal failure
n1=erreurs innées du transport tubulaire rénal | n2=en:renal failure | rel=r_associated | relid=0 | w=71
- dysfonctionnement sexuel ---
r_associated #0: 70 -->
en:renal failure
n1=dysfonctionnement sexuel | n2=en:renal failure | rel=r_associated | relid=0 | w=70
- en:sexual dysfunction ---
r_associated #0: 69 -->
en:renal failure
n1=en:sexual dysfunction | n2=en:renal failure | rel=r_associated | relid=0 | w=69
- en:crush syndrome ---
r_associated #0: 66 -->
en:renal failure
n1=en:crush syndrome | n2=en:renal failure | rel=r_associated | relid=0 | w=66
- HTA
(hypertension artérielle) ---
r_associated #0: 65 -->
en:renal failure
n1=HTA (hypertension artérielle) | n2=en:renal failure | rel=r_associated | relid=0 | w=65
- tuberculose uro-génitale ---
r_associated #0: 63 -->
en:renal failure
n1=tuberculose uro-génitale | n2=en:renal failure | rel=r_associated | relid=0 | w=63
- crush syndrome ---
r_associated #0: 62 -->
en:renal failure
n1=crush syndrome | n2=en:renal failure | rel=r_associated | relid=0 | w=62
- trouble sexuel ---
r_associated #0: 61 -->
en:renal failure
n1=trouble sexuel | n2=en:renal failure | rel=r_associated | relid=0 | w=61
- tuberculose urogénitale ---
r_associated #0: 60 -->
en:renal failure
n1=tuberculose urogénitale | n2=en:renal failure | rel=r_associated | relid=0 | w=60
- maladie des chaînes légères ---
r_associated #0: 59 -->
en:renal failure
n1=maladie des chaînes légères | n2=en:renal failure | rel=r_associated | relid=0 | w=59
- néphron ---
r_associated #0: 59 -->
en:renal failure
n1=néphron | n2=en:renal failure | rel=r_associated | relid=0 | w=59
- en:light chain deposition disease ---
r_associated #0: 58 -->
en:renal failure
n1=en:light chain deposition disease | n2=en:renal failure | rel=r_associated | relid=0 | w=58
- en:nephron ---
r_associated #0: 57 -->
en:renal failure
n1=en:nephron | n2=en:renal failure | rel=r_associated | relid=0 | w=57
- azote non protéinique augmenté ---
r_associated #0: 56 -->
en:renal failure
n1=azote non protéinique augmenté | n2=en:renal failure | rel=r_associated | relid=0 | w=56
- en:kidney stone ---
r_associated #0: 56 -->
en:renal failure
n1=en:kidney stone | n2=en:renal failure | rel=r_associated | relid=0 | w=56
- syndrome hépatorénal ---
r_associated #0: 56 -->
en:renal failure
n1=syndrome hépatorénal | n2=en:renal failure | rel=r_associated | relid=0 | w=56
- IRC ---
r_associated #0: 55 -->
en:renal failure
n1=IRC | n2=en:renal failure | rel=r_associated | relid=0 | w=55
- en:chronic renal failure ---
r_associated #0: 55 -->
en:renal failure
n1=en:chronic renal failure | n2=en:renal failure | rel=r_associated | relid=0 | w=55
- syndrome hépato-rénal ---
r_associated #0: 55 -->
en:renal failure
n1=syndrome hépato-rénal | n2=en:renal failure | rel=r_associated | relid=0 | w=55
- en:increased npn ---
r_associated #0: 54 -->
en:renal failure
n1=en:increased npn | n2=en:renal failure | rel=r_associated | relid=0 | w=54
- syndrome d'écrasement ---
r_associated #0: 54 -->
en:renal failure
n1=syndrome d'écrasement | n2=en:renal failure | rel=r_associated | relid=0 | w=54
- hypertrophie du rein ---
r_associated #0: 51 -->
en:renal failure
n1=hypertrophie du rein | n2=en:renal failure | rel=r_associated | relid=0 | w=51
- hypertrophie rénale ---
r_associated #0: 51 -->
en:renal failure
n1=hypertrophie rénale | n2=en:renal failure | rel=r_associated | relid=0 | w=51
- Insuffisance rénale aiguë ---
r_associated #0: 50 -->
en:renal failure
n1=Insuffisance rénale aiguë | n2=en:renal failure | rel=r_associated | relid=0 | w=50
- hta ---
r_associated #0: 50 -->
en:renal failure
n1=hta | n2=en:renal failure | rel=r_associated | relid=0 | w=50
- syndrome de Randall ---
r_associated #0: 50 -->
en:renal failure
n1=syndrome de Randall | n2=en:renal failure | rel=r_associated | relid=0 | w=50
- épuration extrarénale (méthodes d') ---
r_associated #0: 50 -->
en:renal failure
n1=épuration extrarénale (méthodes d') | n2=en:renal failure | rel=r_associated | relid=0 | w=50
- en:systema urinarium ---
r_associated #0: 49 -->
en:renal failure
n1=en:systema urinarium | n2=en:renal failure | rel=r_associated | relid=0 | w=49
- en:dialysis ---
r_associated #0: 48 -->
en:renal failure
n1=en:dialysis | n2=en:renal failure | rel=r_associated | relid=0 | w=48
- azote non protéique augmenté ---
r_associated #0: 46 -->
en:renal failure
n1=azote non protéique augmenté | n2=en:renal failure | rel=r_associated | relid=0 | w=46
- en:kidney diseases ---
r_associated #0: 46 -->
en:renal failure
n1=en:kidney diseases | n2=en:renal failure | rel=r_associated | relid=0 | w=46
- en:renal tuberculosis ---
r_associated #0: 46 -->
en:renal failure
n1=en:renal tuberculosis | n2=en:renal failure | rel=r_associated | relid=0 | w=46
- glomérulonéphrite extramembraneuse ---
r_associated #0: 46 -->
en:renal failure
n1=glomérulonéphrite extramembraneuse | n2=en:renal failure | rel=r_associated | relid=0 | w=46
- tachycardie, hypertension, microphtalmie et hyperglycinurie ---
r_associated #0: 46 -->
en:renal failure
n1=tachycardie, hypertension, microphtalmie et hyperglycinurie | n2=en:renal failure | rel=r_associated | relid=0 | w=46
- en:anuric renal failure ---
r_associated #0: 43 -->
en:renal failure
n1=en:anuric renal failure | n2=en:renal failure | rel=r_associated | relid=0 | w=43
- en:foetal renal impairment ---
r_associated #0: 43 -->
en:renal failure
n1=en:foetal renal impairment | n2=en:renal failure | rel=r_associated | relid=0 | w=43
- en:nephrauxe ---
r_associated #0: 43 -->
en:renal failure
n1=en:nephrauxe | n2=en:renal failure | rel=r_associated | relid=0 | w=43
- en:patient problem ---
r_associated #0: 43 -->
en:renal failure
n1=en:patient problem | n2=en:renal failure | rel=r_associated | relid=0 | w=43
- en:volume depletion, renal, due to effector loss (hormonal deficit) ---
r_associated #0: 43 -->
en:renal failure
n1=en:volume depletion, renal, due to effector loss (hormonal deficit) | n2=en:renal failure | rel=r_associated | relid=0 | w=43
- glomérulonéphrite extra-membraneuse ---
r_associated #0: 43 -->
en:renal failure
n1=glomérulonéphrite extra-membraneuse | n2=en:renal failure | rel=r_associated | relid=0 | w=43
- syndrome de Bywater ---
r_associated #0: 43 -->
en:renal failure
n1=syndrome de Bywater | n2=en:renal failure | rel=r_associated | relid=0 | w=43
- diabète, photomyoclonies, surdité, néphropathie et dysfonction cérébrale ---
r_associated #0: 42 -->
en:renal failure
n1=diabète, photomyoclonies, surdité, néphropathie et dysfonction cérébrale | n2=en:renal failure | rel=r_associated | relid=0 | w=42
- en:anemia of renal disease ---
r_associated #0: 42 -->
en:renal failure
n1=en:anemia of renal disease | n2=en:renal failure | rel=r_associated | relid=0 | w=42
- en:calcium oxalate/carbonate urolithiasis ---
r_associated #0: 42 -->
en:renal failure
n1=en:calcium oxalate/carbonate urolithiasis | n2=en:renal failure | rel=r_associated | relid=0 | w=42
- en:coital disorder ---
r_associated #0: 42 -->
en:renal failure
n1=en:coital disorder | n2=en:renal failure | rel=r_associated | relid=0 | w=42
- en:glomerulonephritis, autoimmune ---
r_associated #0: 42 -->
en:renal failure
n1=en:glomerulonephritis, autoimmune | n2=en:renal failure | rel=r_associated | relid=0 | w=42
- en:interstitial inflammation ---
r_associated #0: 42 -->
en:renal failure
n1=en:interstitial inflammation | n2=en:renal failure | rel=r_associated | relid=0 | w=42
- en:membranous glomerulonephritis ---
r_associated #0: 42 -->
en:renal failure
n1=en:membranous glomerulonephritis | n2=en:renal failure | rel=r_associated | relid=0 | w=42
- en:nephropathy induced by unspecifed drug, medicament or biological substance ---
r_associated #0: 42 -->
en:renal failure
n1=en:nephropathy induced by unspecifed drug, medicament or biological substance | n2=en:renal failure | rel=r_associated | relid=0 | w=42
- en:renal agenesis, left-sided (1/4 patients) ---
r_associated #0: 42 -->
en:renal failure
n1=en:renal agenesis, left-sided (1/4 patients) | n2=en:renal failure | rel=r_associated | relid=0 | w=42
- en:tachycardia ---
r_associated #0: 42 -->
en:renal failure
n1=en:tachycardia | n2=en:renal failure | rel=r_associated | relid=0 | w=42
- en:crush injury ---
r_associated #0: 41 -->
en:renal failure
n1=en:crush injury | n2=en:renal failure | rel=r_associated | relid=0 | w=41
- en:hepatorenal syndrome ---
r_associated #0: 41 -->
en:renal failure
n1=en:hepatorenal syndrome | n2=en:renal failure | rel=r_associated | relid=0 | w=41
- en:nephropathy ---
r_associated #0: 41 -->
en:renal failure
n1=en:nephropathy | n2=en:renal failure | rel=r_associated | relid=0 | w=41
- en:patient problem codes fda cdrh ---
r_associated #0: 41 -->
en:renal failure
n1=en:patient problem codes fda cdrh | n2=en:renal failure | rel=r_associated | relid=0 | w=41
- en:renal hypodysplasia ---
r_associated #0: 41 -->
en:renal failure
n1=en:renal hypodysplasia | n2=en:renal failure | rel=r_associated | relid=0 | w=41
- en:sodium phosphate,tribasic pwdr ---
r_associated #0: 41 -->
en:renal failure
n1=en:sodium phosphate,tribasic pwdr | n2=en:renal failure | rel=r_associated | relid=0 | w=41
- en:urinary system disorder ---
r_associated #0: 41 -->
en:renal failure
n1=en:urinary system disorder | n2=en:renal failure | rel=r_associated | relid=0 | w=41
- néphropathie ---
r_associated #0: 41 -->
en:renal failure
n1=néphropathie | n2=en:renal failure | rel=r_associated | relid=0 | w=41
- oligo-anurie ---
r_associated #0: 41 -->
en:renal failure
n1=oligo-anurie | n2=en:renal failure | rel=r_associated | relid=0 | w=41
- pyélite ---
r_associated #0: 41 -->
en:renal failure
n1=pyélite | n2=en:renal failure | rel=r_associated | relid=0 | w=41
- sténose infundibulaire ---
r_associated #0: 41 -->
en:renal failure
n1=sténose infundibulaire | n2=en:renal failure | rel=r_associated | relid=0 | w=41
- amylose primitive systémique ---
r_associated #0: 40 -->
en:renal failure
n1=amylose primitive systémique | n2=en:renal failure | rel=r_associated | relid=0 | w=40
- en:acute kidney insufficiency ---
r_associated #0: 40 -->
en:renal failure
n1=en:acute kidney insufficiency | n2=en:renal failure | rel=r_associated | relid=0 | w=40
- en:bardet-biedl syndrome 19 ---
r_associated #0: 40 -->
en:renal failure
n1=en:bardet-biedl syndrome 19 | n2=en:renal failure | rel=r_associated | relid=0 | w=40
- en:hypertensive nephropathy ---
r_associated #0: 40 -->
en:renal failure
n1=en:hypertensive nephropathy | n2=en:renal failure | rel=r_associated | relid=0 | w=40
- en:infundibular stenosis ---
r_associated #0: 40 -->
en:renal failure
n1=en:infundibular stenosis | n2=en:renal failure | rel=r_associated | relid=0 | w=40
- en:intraoperative and postprocedural complications and disorders of genitourinary system, not elsewhere classified ---
r_associated #0: 40 -->
en:renal failure
n1=en:intraoperative and postprocedural complications and disorders of genitourinary system, not elsewhere classified | n2=en:renal failure | rel=r_associated | relid=0 | w=40
- en:overactive bladder ---
r_associated #0: 40 -->
en:renal failure
n1=en:overactive bladder | n2=en:renal failure | rel=r_associated | relid=0 | w=40
- en:rhabdomyolysis/myopathy (smq) ---
r_associated #0: 40 -->
en:renal failure
n1=en:rhabdomyolysis/myopathy (smq) | n2=en:renal failure | rel=r_associated | relid=0 | w=40
- nécrose corticale rénale bilatérale ---
r_associated #0: 40 -->
en:renal failure
n1=nécrose corticale rénale bilatérale | n2=en:renal failure | rel=r_associated | relid=0 | w=40
- polyurie ---
r_associated #0: 40 -->
en:renal failure
n1=polyurie | n2=en:renal failure | rel=r_associated | relid=0 | w=40
- syndrome de Bywaters ---
r_associated #0: 40 -->
en:renal failure
n1=syndrome de Bywaters | n2=en:renal failure | rel=r_associated | relid=0 | w=40
- syndrome de bywaters ---
r_associated #0: 40 -->
en:renal failure
n1=syndrome de bywaters | n2=en:renal failure | rel=r_associated | relid=0 | w=40
- vessie hyperactive ---
r_associated #0: 40 -->
en:renal failure
n1=vessie hyperactive | n2=en:renal failure | rel=r_associated | relid=0 | w=40
- épuration extrarénale ---
r_associated #0: 40 -->
en:renal failure
n1=épuration extrarénale | n2=en:renal failure | rel=r_associated | relid=0 | w=40
- en:anuria ---
r_associated #0: 39 -->
en:renal failure
n1=en:anuria | n2=en:renal failure | rel=r_associated | relid=0 | w=39
- en:cystic kidneys (rare) ---
r_associated #0: 39 -->
en:renal failure
n1=en:cystic kidneys (rare) | n2=en:renal failure | rel=r_associated | relid=0 | w=39
- en:interstitial cell infiltrate ---
r_associated #0: 39 -->
en:renal failure
n1=en:interstitial cell infiltrate | n2=en:renal failure | rel=r_associated | relid=0 | w=39
- en:kidney cortex necrosis ---
r_associated #0: 39 -->
en:renal failure
n1=en:kidney cortex necrosis | n2=en:renal failure | rel=r_associated | relid=0 | w=39
- en:microcystic kidney ---
r_associated #0: 39 -->
en:renal failure
n1=en:microcystic kidney | n2=en:renal failure | rel=r_associated | relid=0 | w=39
- en:primary amyloidosis ---
r_associated #0: 39 -->
en:renal failure
n1=en:primary amyloidosis | n2=en:renal failure | rel=r_associated | relid=0 | w=39
- en:pyelitis ---
r_associated #0: 39 -->
en:renal failure
n1=en:pyelitis | n2=en:renal failure | rel=r_associated | relid=0 | w=39
- en:renal biopsy shows diffuse mesangial sclerosis ---
r_associated #0: 39 -->
en:renal failure
n1=en:renal biopsy shows diffuse mesangial sclerosis | n2=en:renal failure | rel=r_associated | relid=0 | w=39
- en:sclerosing glomerulonephropathy ---
r_associated #0: 39 -->
en:renal failure
n1=en:sclerosing glomerulonephropathy | n2=en:renal failure | rel=r_associated | relid=0 | w=39
- néphroblastomatose ---
r_associated #0: 39 -->
en:renal failure
n1=néphroblastomatose | n2=en:renal failure | rel=r_associated | relid=0 | w=39
- en:bilateral hydronephrosis ---
r_associated #0: 38 -->
en:renal failure
n1=en:bilateral hydronephrosis | n2=en:renal failure | rel=r_associated | relid=0 | w=38
- en:dilated calyces (rare) ---
r_associated #0: 38 -->
en:renal failure
n1=en:dilated calyces (rare) | n2=en:renal failure | rel=r_associated | relid=0 | w=38
- en:median onset of renal failure 19 years ---
r_associated #0: 38 -->
en:renal failure
n1=en:median onset of renal failure 19 years | n2=en:renal failure | rel=r_associated | relid=0 | w=38
- en:multicystic dysplastic kidneys (prenatal onset) ---
r_associated #0: 38 -->
en:renal failure
n1=en:multicystic dysplastic kidneys (prenatal onset) | n2=en:renal failure | rel=r_associated | relid=0 | w=38
- en:nephroblastomatosis ---
r_associated #0: 38 -->
en:renal failure
n1=en:nephroblastomatosis | n2=en:renal failure | rel=r_associated | relid=0 | w=38
- en:renal failure aggravated ---
r_associated #0: 38 -->
en:renal failure
n1=en:renal failure aggravated | n2=en:renal failure | rel=r_associated | relid=0 | w=38
- en:turp syndrome ---
r_associated #0: 38 -->
en:renal failure
n1=en:turp syndrome | n2=en:renal failure | rel=r_associated | relid=0 | w=38
- incontinence paradoxale ---
r_associated #0: 38 -->
en:renal failure
n1=incontinence paradoxale | n2=en:renal failure | rel=r_associated | relid=0 | w=38
- en:dilated renal pelvis (rare) ---
r_associated #0: 37 -->
en:renal failure
n1=en:dilated renal pelvis (rare) | n2=en:renal failure | rel=r_associated | relid=0 | w=37
- en:nephronum ---
r_associated #0: 37 -->
en:renal failure
n1=en:nephronum | n2=en:renal failure | rel=r_associated | relid=0 | w=37
- en:prerenal failure ---
r_associated #0: 37 -->
en:renal failure
n1=en:prerenal failure | n2=en:renal failure | rel=r_associated | relid=0 | w=37
- en:renal dysplasia due to fetal exposure to angiotensin converting enzyme inhibitor ---
r_associated #0: 37 -->
en:renal failure
n1=en:renal dysplasia due to fetal exposure to angiotensin converting enzyme inhibitor | n2=en:renal failure | rel=r_associated | relid=0 | w=37
- en:renal function abnormal glomer ---
r_associated #0: 37 -->
en:renal failure
n1=en:renal function abnormal glomer | n2=en:renal failure | rel=r_associated | relid=0 | w=37
- en:renal hypertrophy ---
r_associated #0: 37 -->
en:renal failure
n1=en:renal hypertrophy | n2=en:renal failure | rel=r_associated | relid=0 | w=37
- nécrose tubulaire aigüe ---
r_associated #0: 37 -->
en:renal failure
n1=nécrose tubulaire aigüe | n2=en:renal failure | rel=r_associated | relid=0 | w=37
- onycho-ostéodysostose ---
r_associated #0: 37 -->
en:renal failure
n1=onycho-ostéodysostose | n2=en:renal failure | rel=r_associated | relid=0 | w=37
- coma urémique ---
r_associated #0: 36 -->
en:renal failure
n1=coma urémique | n2=en:renal failure | rel=r_associated | relid=0 | w=36
- diabète insipide néphrogénique ---
r_associated #0: 36 -->
en:renal failure
n1=diabète insipide néphrogénique | n2=en:renal failure | rel=r_associated | relid=0 | w=36
- en:acute tubular necrosis ---
r_associated #0: 36 -->
en:renal failure
n1=en:acute tubular necrosis | n2=en:renal failure | rel=r_associated | relid=0 | w=36
- en:disorder of kidney due to lambda light chain disease ---
r_associated #0: 36 -->
en:renal failure
n1=en:disorder of kidney due to lambda light chain disease | n2=en:renal failure | rel=r_associated | relid=0 | w=36
- en:polyuria ---
r_associated #0: 36 -->
en:renal failure
n1=en:polyuria | n2=en:renal failure | rel=r_associated | relid=0 | w=36
- hydronéphrose ---
r_associated #0: 36 -->
en:renal failure
n1=hydronéphrose | n2=en:renal failure | rel=r_associated | relid=0 | w=36
- néphropathie hypertensive ---
r_associated #0: 36 -->
en:renal failure
n1=néphropathie hypertensive | n2=en:renal failure | rel=r_associated | relid=0 | w=36
- néphropathie héréditaire ---
r_associated #0: 36 -->
en:renal failure
n1=néphropathie héréditaire | n2=en:renal failure | rel=r_associated | relid=0 | w=36
- th ---
r_associated #0: 36 -->
en:renal failure
n1=th | n2=en:renal failure | rel=r_associated | relid=0 | w=36
- en:absence of corticomedullary differentiation (ultrasound) ---
r_associated #0: 35 -->
en:renal failure
n1=en:absence of corticomedullary differentiation (ultrasound) | n2=en:renal failure | rel=r_associated | relid=0 | w=35
- en:acute genitourinary disorder ---
r_associated #0: 35 -->
en:renal failure
n1=en:acute genitourinary disorder | n2=en:renal failure | rel=r_associated | relid=0 | w=35
- en:azostix (blood urea nitrogen) test strip ---
r_associated #0: 35 -->
en:renal failure
n1=en:azostix (blood urea nitrogen) test strip | n2=en:renal failure | rel=r_associated | relid=0 | w=35
- en:blood urea nitrogen measurement ---
r_associated #0: 35 -->
en:renal failure
n1=en:blood urea nitrogen measurement | n2=en:renal failure | rel=r_associated | relid=0 | w=35
- en:candidiasis of urogenital site ---
r_associated #0: 35 -->
en:renal failure
n1=en:candidiasis of urogenital site | n2=en:renal failure | rel=r_associated | relid=0 | w=35
- en:chronic glomerulonephritis ---
r_associated #0: 35 -->
en:renal failure
n1=en:chronic glomerulonephritis | n2=en:renal failure | rel=r_associated | relid=0 | w=35
- en:chronic kidney disease (smq) ---
r_associated #0: 35 -->
en:renal failure
n1=en:chronic kidney disease (smq) | n2=en:renal failure | rel=r_associated | relid=0 | w=35
- en:chronic kidney disease, stage 5 ---
r_associated #0: 35 -->
en:renal failure
n1=en:chronic kidney disease, stage 5 | n2=en:renal failure | rel=r_associated | relid=0 | w=35
- en:complication of external stoma of urinary tract ---
r_associated #0: 35 -->
en:renal failure
n1=en:complication of external stoma of urinary tract | n2=en:renal failure | rel=r_associated | relid=0 | w=35
- en:congenital renal atrophy ---
r_associated #0: 35 -->
en:renal failure
n1=en:congenital renal atrophy | n2=en:renal failure | rel=r_associated | relid=0 | w=35
- en:defective urinary concentrating ability ---
r_associated #0: 35 -->
en:renal failure
n1=en:defective urinary concentrating ability | n2=en:renal failure | rel=r_associated | relid=0 | w=35
- en:dilated bowman capsules ---
r_associated #0: 35 -->
en:renal failure
n1=en:dilated bowman capsules | n2=en:renal failure | rel=r_associated | relid=0 | w=35
- en:ds stage iii plasma cell myeloma ---
r_associated #0: 35 -->
en:renal failure
n1=en:ds stage iii plasma cell myeloma | n2=en:renal failure | rel=r_associated | relid=0 | w=35
- en:glomerulosclerosis ---
r_associated #0: 35 -->
en:renal failure
n1=en:glomerulosclerosis | n2=en:renal failure | rel=r_associated | relid=0 | w=35
- en:hereditary nephritis ---
r_associated #0: 35 -->
en:renal failure
n1=en:hereditary nephritis | n2=en:renal failure | rel=r_associated | relid=0 | w=35
- en:horseshoe kidney (1 patient) ---
r_associated #0: 35 -->
en:renal failure
n1=en:horseshoe kidney (1 patient) | n2=en:renal failure | rel=r_associated | relid=0 | w=35
- en:horseshoe kidney (rare) ---
r_associated #0: 35 -->
en:renal failure
n1=en:horseshoe kidney (rare) | n2=en:renal failure | rel=r_associated | relid=0 | w=35
- en:hydronephrosis (male) ---
r_associated #0: 35 -->
en:renal failure
n1=en:hydronephrosis (male) | n2=en:renal failure | rel=r_associated | relid=0 | w=35
- en:hyperkalemia, diminished renal excretion ---
r_associated #0: 35 -->
en:renal failure
n1=en:hyperkalemia, diminished renal excretion | n2=en:renal failure | rel=r_associated | relid=0 | w=35
- en:increased renal salt reabsorption ---
r_associated #0: 35 -->
en:renal failure
n1=en:increased renal salt reabsorption | n2=en:renal failure | rel=r_associated | relid=0 | w=35
- en:kidney necrosis ---
r_associated #0: 35 -->
en:renal failure
n1=en:kidney necrosis | n2=en:renal failure | rel=r_associated | relid=0 | w=35
- en:kidney papillary necrosis ---
r_associated #0: 35 -->
en:renal failure
n1=en:kidney papillary necrosis | n2=en:renal failure | rel=r_associated | relid=0 | w=35
- en:malakoplakia of kidney ---
r_associated #0: 35 -->
en:renal failure
n1=en:malakoplakia of kidney | n2=en:renal failure | rel=r_associated | relid=0 | w=35
- en:malignant kidney neoplasm ---
r_associated #0: 35 -->
en:renal failure
n1=en:malignant kidney neoplasm | n2=en:renal failure | rel=r_associated | relid=0 | w=35
- en:mesangial and subendothelial granular or fibrillar deposits which show immunoreactivity to fibronectin ---
r_associated #0: 35 -->
en:renal failure
n1=en:mesangial and subendothelial granular or fibrillar deposits which show immunoreactivity to fibronectin | n2=en:renal failure | rel=r_associated | relid=0 | w=35
- en:microcystic dysplasia ---
r_associated #0: 35 -->
en:renal failure
n1=en:microcystic dysplasia | n2=en:renal failure | rel=r_associated | relid=0 | w=35
- en:microscopic hematuria ---
r_associated #0: 35 -->
en:renal failure
n1=en:microscopic hematuria | n2=en:renal failure | rel=r_associated | relid=0 | w=35
- en:neoplasm of uncertain behavior of genitourinary organs ---
r_associated #0: 35 -->
en:renal failure
n1=en:neoplasm of uncertain behavior of genitourinary organs | n2=en:renal failure | rel=r_associated | relid=0 | w=35
- en:normal glomerular function ---
r_associated #0: 35 -->
en:renal failure
n1=en:normal glomerular function | n2=en:renal failure | rel=r_associated | relid=0 | w=35
- en:oliguria ---
r_associated #0: 35 -->
en:renal failure
n1=en:oliguria | n2=en:renal failure | rel=r_associated | relid=0 | w=35
- en:other disorders of urinary system ---
r_associated #0: 35 -->
en:renal failure
n1=en:other disorders of urinary system | n2=en:renal failure | rel=r_associated | relid=0 | w=35
- en:pediatric terminology ---
r_associated #0: 35 -->
en:renal failure
n1=en:pediatric terminology | n2=en:renal failure | rel=r_associated | relid=0 | w=35
- en:pelvic inflammatory disease ---
r_associated #0: 35 -->
en:renal failure
n1=en:pelvic inflammatory disease | n2=en:renal failure | rel=r_associated | relid=0 | w=35
- en:postrenal failure ---
r_associated #0: 35 -->
en:renal failure
n1=en:postrenal failure | n2=en:renal failure | rel=r_associated | relid=0 | w=35
- en:proximal tubulopathy ---
r_associated #0: 35 -->
en:renal failure
n1=en:proximal tubulopathy | n2=en:renal failure | rel=r_associated | relid=0 | w=35
- en:pyelectasia ---
r_associated #0: 35 -->
en:renal failure
n1=en:pyelectasia | n2=en:renal failure | rel=r_associated | relid=0 | w=35
- en:renal anomalies (67% of patients) ---
r_associated #0: 35 -->
en:renal failure
n1=en:renal anomalies (67% of patients) | n2=en:renal failure | rel=r_associated | relid=0 | w=35
- en:renal biopsy shows chronic interstitial nephritis ---
r_associated #0: 35 -->
en:renal failure
n1=en:renal biopsy shows chronic interstitial nephritis | n2=en:renal failure | rel=r_associated | relid=0 | w=35
- en:renal cystic dysplasia (1 patient) ---
r_associated #0: 35 -->
en:renal failure
n1=en:renal cystic dysplasia (1 patient) | n2=en:renal failure | rel=r_associated | relid=0 | w=35
- en:renal cysts and diabetes syndrome ---
r_associated #0: 35 -->
en:renal failure
n1=en:renal cysts and diabetes syndrome | n2=en:renal failure | rel=r_associated | relid=0 | w=35
- en:renal disorders in inherited disease ---
r_associated #0: 35 -->
en:renal failure
n1=en:renal disorders in inherited disease | n2=en:renal failure | rel=r_associated | relid=0 | w=35
- en:renal disorders in systemic disease ---
r_associated #0: 35 -->
en:renal failure
n1=en:renal disorders in systemic disease | n2=en:renal failure | rel=r_associated | relid=0 | w=35
- en:renal dysplasia and retinal aplasia (disorder) ---
r_associated #0: 35 -->
en:renal failure
n1=en:renal dysplasia and retinal aplasia (disorder) | n2=en:renal failure | rel=r_associated | relid=0 | w=35
- en:renal hemorrhage ---
r_associated #0: 35 -->
en:renal failure
n1=en:renal hemorrhage | n2=en:renal failure | rel=r_associated | relid=0 | w=35
- en:renal insufficiency aggravated ---
r_associated #0: 35 -->
en:renal failure
n1=en:renal insufficiency aggravated | n2=en:renal failure | rel=r_associated | relid=0 | w=35
- en:renal tubular degeneration ---
r_associated #0: 35 -->
en:renal failure
n1=en:renal tubular degeneration | n2=en:renal failure | rel=r_associated | relid=0 | w=35
- en:simple cyst of kidney ---
r_associated #0: 35 -->
en:renal failure
n1=en:simple cyst of kidney | n2=en:renal failure | rel=r_associated | relid=0 | w=35
- en:structure of superior pole of kidney ---
r_associated #0: 35 -->
en:renal failure
n1=en:structure of superior pole of kidney | n2=en:renal failure | rel=r_associated | relid=0 | w=35
- en:tabular atrophy ---
r_associated #0: 35 -->
en:renal failure
n1=en:tabular atrophy | n2=en:renal failure | rel=r_associated | relid=0 | w=35
- en:uremic coma ---
r_associated #0: 35 -->
en:renal failure
n1=en:uremic coma | n2=en:renal failure | rel=r_associated | relid=0 | w=35
- en:urinary tract dilatation (in some patients) ---
r_associated #0: 35 -->
en:renal failure
n1=en:urinary tract dilatation (in some patients) | n2=en:renal failure | rel=r_associated | relid=0 | w=35
- en:urine casts ---
r_associated #0: 35 -->
en:renal failure
n1=en:urine casts | n2=en:renal failure | rel=r_associated | relid=0 | w=35
- en:urological system complication of procedure ---
r_associated #0: 35 -->
en:renal failure
n1=en:urological system complication of procedure | n2=en:renal failure | rel=r_associated | relid=0 | w=35
- en:adenine phosphoribosyltransferase deficiency ---
r_associated #0: 34 -->
en:renal failure
n1=en:adenine phosphoribosyltransferase deficiency | n2=en:renal failure | rel=r_associated | relid=0 | w=34
- en:adrenal hyperplasia ---
r_associated #0: 34 -->
en:renal failure
n1=en:adrenal hyperplasia | n2=en:renal failure | rel=r_associated | relid=0 | w=34
- en:adrenal hyperplasia, bilateral ---
r_associated #0: 34 -->
en:renal failure
n1=en:adrenal hyperplasia, bilateral | n2=en:renal failure | rel=r_associated | relid=0 | w=34
- en:calcinosis of the renal parenchyma ---
r_associated #0: 34 -->
en:renal failure
n1=en:calcinosis of the renal parenchyma | n2=en:renal failure | rel=r_associated | relid=0 | w=34
- en:chronic nephritis ---
r_associated #0: 34 -->
en:renal failure
n1=en:chronic nephritis | n2=en:renal failure | rel=r_associated | relid=0 | w=34
- en:ctrp terminology ---
r_associated #0: 34 -->
en:renal failure
n1=en:ctrp terminology | n2=en:renal failure | rel=r_associated | relid=0 | w=34
- en:disease of renal parenchyma ---
r_associated #0: 34 -->
en:renal failure
n1=en:disease of renal parenchyma | n2=en:renal failure | rel=r_associated | relid=0 | w=34
- en:double renal pelvis (in some patients) ---
r_associated #0: 34 -->
en:renal failure
n1=en:double renal pelvis (in some patients) | n2=en:renal failure | rel=r_associated | relid=0 | w=34
- en:dysplastic kidney (1 patient) ---
r_associated #0: 34 -->
en:renal failure
n1=en:dysplastic kidney (1 patient) | n2=en:renal failure | rel=r_associated | relid=0 | w=34
- en:echogenic kidneys ---
r_associated #0: 34 -->
en:renal failure
n1=en:echogenic kidneys | n2=en:renal failure | rel=r_associated | relid=0 | w=34
- en:electron microscopy shows foot-process effacement ---
r_associated #0: 34 -->
en:renal failure
n1=en:electron microscopy shows foot-process effacement | n2=en:renal failure | rel=r_associated | relid=0 | w=34
- en:end stage renal disease (33% of patients) ---
r_associated #0: 34 -->
en:renal failure
n1=en:end stage renal disease (33% of patients) | n2=en:renal failure | rel=r_associated | relid=0 | w=34
- en:glomerular basement membrane normal ---
r_associated #0: 34 -->
en:renal failure
n1=en:glomerular basement membrane normal | n2=en:renal failure | rel=r_associated | relid=0 | w=34
- en:hydronephrosis ---
r_associated #0: 34 -->
en:renal failure
n1=en:hydronephrosis | n2=en:renal failure | rel=r_associated | relid=0 | w=34
- en:impaired renal absorption of cationic amino acids ---
r_associated #0: 34 -->
en:renal failure
n1=en:impaired renal absorption of cationic amino acids | n2=en:renal failure | rel=r_associated | relid=0 | w=34
- en:impaired renal function disorder ---
r_associated #0: 34 -->
en:renal failure
n1=en:impaired renal function disorder | n2=en:renal failure | rel=r_associated | relid=0 | w=34
- en:kidney biopsy shows absence of differentiated proximal tubules ---
r_associated #0: 34 -->
en:renal failure
n1=en:kidney biopsy shows absence of differentiated proximal tubules | n2=en:renal failure | rel=r_associated | relid=0 | w=34
- en:kidney disorder ---
r_associated #0: 34 -->
en:renal failure
n1=en:kidney disorder | n2=en:renal failure | rel=r_associated | relid=0 | w=34
- en:mild proteinuria (in some patients) ---
r_associated #0: 34 -->
en:renal failure
n1=en:mild proteinuria (in some patients) | n2=en:renal failure | rel=r_associated | relid=0 | w=34
- en:nail-patella syndrome ---
r_associated #0: 34 -->
en:renal failure
n1=en:nail-patella syndrome | n2=en:renal failure | rel=r_associated | relid=0 | w=34
- en:nephritis nec in mdr10 ---
r_associated #0: 34 -->
en:renal failure
n1=en:nephritis nec in mdr10 | n2=en:renal failure | rel=r_associated | relid=0 | w=34
- en:nephrocutaneous fistula ---
r_associated #0: 34 -->
en:renal failure
n1=en:nephrocutaneous fistula | n2=en:renal failure | rel=r_associated | relid=0 | w=34
- en:nephrogenic diabetes insipidus (less common) ---
r_associated #0: 34 -->
en:renal failure
n1=en:nephrogenic diabetes insipidus (less common) | n2=en:renal failure | rel=r_associated | relid=0 | w=34
- en:nephronophthisis (less common) ---
r_associated #0: 34 -->
en:renal failure
n1=en:nephronophthisis (less common) | n2=en:renal failure | rel=r_associated | relid=0 | w=34
- en:nephronophthisis (rare) ---
r_associated #0: 34 -->
en:renal failure
n1=en:nephronophthisis (rare) | n2=en:renal failure | rel=r_associated | relid=0 | w=34
- en:pediatric adverse events terminology ---
r_associated #0: 34 -->
en:renal failure
n1=en:pediatric adverse events terminology | n2=en:renal failure | rel=r_associated | relid=0 | w=34
- en:primitive renal tubules may exist ---
r_associated #0: 34 -->
en:renal failure
n1=en:primitive renal tubules may exist | n2=en:renal failure | rel=r_associated | relid=0 | w=34
- en:recurrent benign hematuria syndrome ---
r_associated #0: 34 -->
en:renal failure
n1=en:recurrent benign hematuria syndrome | n2=en:renal failure | rel=r_associated | relid=0 | w=34
- en:refractory plasma cell myeloma ---
r_associated #0: 34 -->
en:renal failure
n1=en:refractory plasma cell myeloma | n2=en:renal failure | rel=r_associated | relid=0 | w=34
- en:renal biopsy showed interstitial fibrosis ---
r_associated #0: 34 -->
en:renal failure
n1=en:renal biopsy showed interstitial fibrosis | n2=en:renal failure | rel=r_associated | relid=0 | w=34
- en:renal biopsy shows glomerular sclerosis ---
r_associated #0: 34 -->
en:renal failure
n1=en:renal biopsy shows glomerular sclerosis | n2=en:renal failure | rel=r_associated | relid=0 | w=34
- en:renal failure neonatal ---
r_associated #0: 34 -->
en:renal failure
n1=en:renal failure neonatal | n2=en:renal failure | rel=r_associated | relid=0 | w=34
- en:reversible renal failure ---
r_associated #0: 34 -->
en:renal failure
n1=en:reversible renal failure | n2=en:renal failure | rel=r_associated | relid=0 | w=34
- en:rupture of kidney ---
r_associated #0: 34 -->
en:renal failure
n1=en:rupture of kidney | n2=en:renal failure | rel=r_associated | relid=0 | w=34
- en:thickening and disorganization of the glomerular basement membrane ---
r_associated #0: 34 -->
en:renal failure
n1=en:thickening and disorganization of the glomerular basement membrane | n2=en:renal failure | rel=r_associated | relid=0 | w=34
- en:traumatic anuria ---
r_associated #0: 34 -->
en:renal failure
n1=en:traumatic anuria | n2=en:renal failure | rel=r_associated | relid=0 | w=34
- en:tubular cysts ---
r_associated #0: 34 -->
en:renal failure
n1=en:tubular cysts | n2=en:renal failure | rel=r_associated | relid=0 | w=34
- en:tubular dilation (1 of 2 patients) ---
r_associated #0: 34 -->
en:renal failure
n1=en:tubular dilation (1 of 2 patients) | n2=en:renal failure | rel=r_associated | relid=0 | w=34
- en:ultrasound shows hyperechoic kidneys ---
r_associated #0: 34 -->
en:renal failure
n1=en:ultrasound shows hyperechoic kidneys | n2=en:renal failure | rel=r_associated | relid=0 | w=34
- infarctus rénal ---
r_associated #0: 34 -->
en:renal failure
n1=infarctus rénal | n2=en:renal failure | rel=r_associated | relid=0 | w=34
- onycho-patellaire (syndrome) ---
r_associated #0: 34 -->
en:renal failure
n1=onycho-patellaire (syndrome) | n2=en:renal failure | rel=r_associated | relid=0 | w=34
- stade d'insuffisance rénale terminale ---
r_associated #0: 34 -->
en:renal failure
n1=stade d'insuffisance rénale terminale | n2=en:renal failure | rel=r_associated | relid=0 | w=34
- en:central diabetes insipidus ---
r_associated #0: 33 -->
en:renal failure
n1=en:central diabetes insipidus | n2=en:renal failure | rel=r_associated | relid=0 | w=33
- en:nephrogenic diabetes insipidus ---
r_associated #0: 33 -->
en:renal failure
n1=en:nephrogenic diabetes insipidus | n2=en:renal failure | rel=r_associated | relid=0 | w=33
- hypertension d'origine rénale ---
r_associated #0: 33 -->
en:renal failure
n1=hypertension d'origine rénale | n2=en:renal failure | rel=r_associated | relid=0 | w=33
- pah ---
r_associated #0: 33 -->
en:renal failure
n1=pah | n2=en:renal failure | rel=r_associated | relid=0 | w=33
- tubule rénal ---
r_associated #0: 33 -->
en:renal failure
n1=tubule rénal | n2=en:renal failure | rel=r_associated | relid=0 | w=33
- en:absence of renal corticomedullary differentiation ---
r_associated #0: 32 -->
en:renal failure
n1=en:absence of renal corticomedullary differentiation | n2=en:renal failure | rel=r_associated | relid=0 | w=32
- en:acute nephropathy ---
r_associated #0: 32 -->
en:renal failure
n1=en:acute nephropathy | n2=en:renal failure | rel=r_associated | relid=0 | w=32
- en:anatomic structures ---
r_associated #0: 32 -->
en:renal failure
n1=en:anatomic structures | n2=en:renal failure | rel=r_associated | relid=0 | w=32
- en:angiokeratoma corporis diffusum ---
r_associated #0: 32 -->
en:renal failure
n1=en:angiokeratoma corporis diffusum | n2=en:renal failure | rel=r_associated | relid=0 | w=32
- en:arterial hypertension ---
r_associated #0: 32 -->
en:renal failure
n1=en:arterial hypertension | n2=en:renal failure | rel=r_associated | relid=0 | w=32
- en:childhood kidney disorder ---
r_associated #0: 32 -->
en:renal failure
n1=en:childhood kidney disorder | n2=en:renal failure | rel=r_associated | relid=0 | w=32
- en:chronic/endstage renal failure ---
r_associated #0: 32 -->
en:renal failure
n1=en:chronic/endstage renal failure | n2=en:renal failure | rel=r_associated | relid=0 | w=32
- en:congenital anomaly of fetal kidney ---
r_associated #0: 32 -->
en:renal failure
n1=en:congenital anomaly of fetal kidney | n2=en:renal failure | rel=r_associated | relid=0 | w=32
- en:cystic kidney disease ---
r_associated #0: 32 -->
en:renal failure
n1=en:cystic kidney disease | n2=en:renal failure | rel=r_associated | relid=0 | w=32
- en:decreased kidney volume (1 patient) ---
r_associated #0: 32 -->
en:renal failure
n1=en:decreased kidney volume (1 patient) | n2=en:renal failure | rel=r_associated | relid=0 | w=32
- en:diabetic end stage renal disease ---
r_associated #0: 32 -->
en:renal failure
n1=en:diabetic end stage renal disease | n2=en:renal failure | rel=r_associated | relid=0 | w=32
- en:disruption of pelviureteric junction ---
r_associated #0: 32 -->
en:renal failure
n1=en:disruption of pelviureteric junction | n2=en:renal failure | rel=r_associated | relid=0 | w=32
- en:duplication of renal pelvis ---
r_associated #0: 32 -->
en:renal failure
n1=en:duplication of renal pelvis | n2=en:renal failure | rel=r_associated | relid=0 | w=32
- en:elevated aldosterone secretion ---
r_associated #0: 32 -->
en:renal failure
n1=en:elevated aldosterone secretion | n2=en:renal failure | rel=r_associated | relid=0 | w=32
- en:female genital diseases ---
r_associated #0: 32 -->
en:renal failure
n1=en:female genital diseases | n2=en:renal failure | rel=r_associated | relid=0 | w=32
- en:foreign body in genitourinary tract ---
r_associated #0: 32 -->
en:renal failure
n1=en:foreign body in genitourinary tract | n2=en:renal failure | rel=r_associated | relid=0 | w=32
- en:genitourinary tract hemorrhage ---
r_associated #0: 32 -->
en:renal failure
n1=en:genitourinary tract hemorrhage | n2=en:renal failure | rel=r_associated | relid=0 | w=32
- en:global glomerulosclerosis ---
r_associated #0: 32 -->
en:renal failure
n1=en:global glomerulosclerosis | n2=en:renal failure | rel=r_associated | relid=0 | w=32
- en:glomerular filtration rate decreased ---
r_associated #0: 32 -->
en:renal failure
n1=en:glomerular filtration rate decreased | n2=en:renal failure | rel=r_associated | relid=0 | w=32
- en:glomerulocystic dysplasia ---
r_associated #0: 32 -->
en:renal failure
n1=en:glomerulocystic dysplasia | n2=en:renal failure | rel=r_associated | relid=0 | w=32
- en:hypercalciuria ---
r_associated #0: 32 -->
en:renal failure
n1=en:hypercalciuria | n2=en:renal failure | rel=r_associated | relid=0 | w=32
- en:hyperchromatic nuclei ---
r_associated #0: 32 -->
en:renal failure
n1=en:hyperchromatic nuclei | n2=en:renal failure | rel=r_associated | relid=0 | w=32
- en:hypoplastic/dysplastic kidney ---
r_associated #0: 32 -->
en:renal failure
n1=en:hypoplastic/dysplastic kidney | n2=en:renal failure | rel=r_associated | relid=0 | w=32
- en:intralobular nephrogenic rests ---
r_associated #0: 32 -->
en:renal failure
n1=en:intralobular nephrogenic rests | n2=en:renal failure | rel=r_associated | relid=0 | w=32
- en:kidney part ---
r_associated #0: 32 -->
en:renal failure
n1=en:kidney part | n2=en:renal failure | rel=r_associated | relid=0 | w=32
- en:kidney wilms tumor ---
r_associated #0: 32 -->
en:renal failure
n1=en:kidney wilms tumor | n2=en:renal failure | rel=r_associated | relid=0 | w=32
- en:light chain disease ---
r_associated #0: 32 -->
en:renal failure
n1=en:light chain disease | n2=en:renal failure | rel=r_associated | relid=0 | w=32
- en:microcystic change ---
r_associated #0: 32 -->
en:renal failure
n1=en:microcystic change | n2=en:renal failure | rel=r_associated | relid=0 | w=32
- en:minimal change disease on renal biopsy ---
r_associated #0: 32 -->
en:renal failure
n1=en:minimal change disease on renal biopsy | n2=en:renal failure | rel=r_associated | relid=0 | w=32
- en:neonatal renal disorder ---
r_associated #0: 32 -->
en:renal failure
n1=en:neonatal renal disorder | n2=en:renal failure | rel=r_associated | relid=0 | w=32
- en:nephrocalcinosis ---
r_associated #0: 32 -->
en:renal failure
n1=en:nephrocalcinosis | n2=en:renal failure | rel=r_associated | relid=0 | w=32
- en:nephrocalcinosis (rare) ---
r_associated #0: 32 -->
en:renal failure
n1=en:nephrocalcinosis (rare) | n2=en:renal failure | rel=r_associated | relid=0 | w=32
- en:patchy deposition of igg and igm ---
r_associated #0: 32 -->
en:renal failure
n1=en:patchy deposition of igg and igm | n2=en:renal failure | rel=r_associated | relid=0 | w=32
- en:podocytes show microvillous transformation ---
r_associated #0: 32 -->
en:renal failure
n1=en:podocytes show microvillous transformation | n2=en:renal failure | rel=r_associated | relid=0 | w=32
- en:recurrent plasma cell myeloma ---
r_associated #0: 32 -->
en:renal failure
n1=en:recurrent plasma cell myeloma | n2=en:renal failure | rel=r_associated | relid=0 | w=32
- en:reflux nephropathy ---
r_associated #0: 32 -->
en:renal failure
n1=en:reflux nephropathy | n2=en:renal failure | rel=r_associated | relid=0 | w=32
- en:renal abnormalities ---
r_associated #0: 32 -->
en:renal failure
n1=en:renal abnormalities | n2=en:renal failure | rel=r_associated | relid=0 | w=32
- en:renal adysplasia ---
r_associated #0: 32 -->
en:renal failure
n1=en:renal adysplasia | n2=en:renal failure | rel=r_associated | relid=0 | w=32
- en:renal agenesis/hypoplasia (in some patients) ---
r_associated #0: 32 -->
en:renal failure
n1=en:renal agenesis/hypoplasia (in some patients) | n2=en:renal failure | rel=r_associated | relid=0 | w=32
- en:renal function disorder ---
r_associated #0: 32 -->
en:renal failure
n1=en:renal function disorder | n2=en:renal failure | rel=r_associated | relid=0 | w=32
- en:renal hematuria ---
r_associated #0: 32 -->
en:renal failure
n1=en:renal hematuria | n2=en:renal failure | rel=r_associated | relid=0 | w=32
- en:renal impairment neonatal ---
r_associated #0: 32 -->
en:renal failure
n1=en:renal impairment neonatal | n2=en:renal failure | rel=r_associated | relid=0 | w=32
- en:renal infarct ---
r_associated #0: 32 -->
en:renal failure
n1=en:renal infarct | n2=en:renal failure | rel=r_associated | relid=0 | w=32
- en:renal scarring ---
r_associated #0: 32 -->
en:renal failure
n1=en:renal scarring | n2=en:renal failure | rel=r_associated | relid=0 | w=32
- en:secondary renal insufficiency ---
r_associated #0: 32 -->
en:renal failure
n1=en:secondary renal insufficiency | n2=en:renal failure | rel=r_associated | relid=0 | w=32
- en:ureter disorder ---
r_associated #0: 32 -->
en:renal failure
n1=en:ureter disorder | n2=en:renal failure | rel=r_associated | relid=0 | w=32
- glomérulonéphrite aigüe ---
r_associated #0: 32 -->
en:renal failure
n1=glomérulonéphrite aigüe | n2=en:renal failure | rel=r_associated | relid=0 | w=32
- gros rein ---
r_associated #0: 32 -->
en:renal failure
n1=gros rein | n2=en:renal failure | rel=r_associated | relid=0 | w=32
- hépatorénal (syndrome) ---
r_associated #0: 32 -->
en:renal failure
n1=hépatorénal (syndrome) | n2=en:renal failure | rel=r_associated | relid=0 | w=32
- insuffisance rénale aigüe ---
r_associated #0: 32 -->
en:renal failure
n1=insuffisance rénale aigüe | n2=en:renal failure | rel=r_associated | relid=0 | w=32
- chondrocalcinose ---
r_associated #0: 31 -->
en:renal failure
n1=chondrocalcinose | n2=en:renal failure | rel=r_associated | relid=0 | w=31
- dysfonction sexuelle ---
r_associated #0: 31 -->
en:renal failure
n1=dysfonction sexuelle | n2=en:renal failure | rel=r_associated | relid=0 | w=31
- en:acute glomerulonephritis ---
r_associated #0: 31 -->
en:renal failure
n1=en:acute glomerulonephritis | n2=en:renal failure | rel=r_associated | relid=0 | w=31
- en:adrenal cortex atrophy (42%) ---
r_associated #0: 31 -->
en:renal failure
n1=en:adrenal cortex atrophy (42%) | n2=en:renal failure | rel=r_associated | relid=0 | w=31
- en:bladder disorder ---
r_associated #0: 31 -->
en:renal failure
n1=en:bladder disorder | n2=en:renal failure | rel=r_associated | relid=0 | w=31
- en:calyceal fistula ---
r_associated #0: 31 -->
en:renal failure
n1=en:calyceal fistula | n2=en:renal failure | rel=r_associated | relid=0 | w=31
- en:diabetic nephropathy ---
r_associated #0: 31 -->
en:renal failure
n1=en:diabetic nephropathy | n2=en:renal failure | rel=r_associated | relid=0 | w=31
- en:dysplastic renal parenchyma ---
r_associated #0: 31 -->
en:renal failure
n1=en:dysplastic renal parenchyma | n2=en:renal failure | rel=r_associated | relid=0 | w=31
- en:end-stage renal disease (in some patients) ---
r_associated #0: 31 -->
en:renal failure
n1=en:end-stage renal disease (in some patients) | n2=en:renal failure | rel=r_associated | relid=0 | w=31
- en:end-stage renal disease (in some) ---
r_associated #0: 31 -->
en:renal failure
n1=en:end-stage renal disease (in some) | n2=en:renal failure | rel=r_associated | relid=0 | w=31
- en:enlarged mitochondria with paracrystalline inclusions ---
r_associated #0: 31 -->
en:renal failure
n1=en:enlarged mitochondria with paracrystalline inclusions | n2=en:renal failure | rel=r_associated | relid=0 | w=31
- en:focal glomerulosclerosis (in 33%) ---
r_associated #0: 31 -->
en:renal failure
n1=en:focal glomerulosclerosis (in 33%) | n2=en:renal failure | rel=r_associated | relid=0 | w=31
- en:glomerular dysfunction (variable) ---
r_associated #0: 31 -->
en:renal failure
n1=en:glomerular dysfunction (variable) | n2=en:renal failure | rel=r_associated | relid=0 | w=31
- en:hydronephrosis (1 patient) ---
r_associated #0: 31 -->
en:renal failure
n1=en:hydronephrosis (1 patient) | n2=en:renal failure | rel=r_associated | relid=0 | w=31
- en:hydronephrosis (secondary to ureteral compression from hydrometrocolpos) ---
r_associated #0: 31 -->
en:renal failure
n1=en:hydronephrosis (secondary to ureteral compression from hydrometrocolpos) | n2=en:renal failure | rel=r_associated | relid=0 | w=31
- en:hypertrophic podocytes ---
r_associated #0: 31 -->
en:renal failure
n1=en:hypertrophic podocytes | n2=en:renal failure | rel=r_associated | relid=0 | w=31
- en:hypomagnesemia 2, renal ---
r_associated #0: 31 -->
en:renal failure
n1=en:hypomagnesemia 2, renal | n2=en:renal failure | rel=r_associated | relid=0 | w=31
- en:impaired renal concentrating ability ---
r_associated #0: 31 -->
en:renal failure
n1=en:impaired renal concentrating ability | n2=en:renal failure | rel=r_associated | relid=0 | w=31
- en:incontinence ---
r_associated #0: 31 -->
en:renal failure
n1=en:incontinence | n2=en:renal failure | rel=r_associated | relid=0 | w=31
- en:increased echogenicity (1 of 2 patients) ---
r_associated #0: 31 -->
en:renal failure
n1=en:increased echogenicity (1 of 2 patients) | n2=en:renal failure | rel=r_associated | relid=0 | w=31
- en:kidney morphologic ---
r_associated #0: 31 -->
en:renal failure
n1=en:kidney morphologic | n2=en:renal failure | rel=r_associated | relid=0 | w=31
- en:kidney replacement disorder ---
r_associated #0: 31 -->
en:renal failure
n1=en:kidney replacement disorder | n2=en:renal failure | rel=r_associated | relid=0 | w=31
- en:late effects of genitourinary system tuberculosis ---
r_associated #0: 31 -->
en:renal failure
n1=en:late effects of genitourinary system tuberculosis | n2=en:renal failure | rel=r_associated | relid=0 | w=31
- en:low fractional excretion of uric acid ---
r_associated #0: 31 -->
en:renal failure
n1=en:low fractional excretion of uric acid | n2=en:renal failure | rel=r_associated | relid=0 | w=31
- en:morphologic change of kidney due to chronic nephritic syndrome ---
r_associated #0: 31 -->
en:renal failure
n1=en:morphologic change of kidney due to chronic nephritic syndrome | n2=en:renal failure | rel=r_associated | relid=0 | w=31
- en:narrowing of the ureteropelvic junctions ---
r_associated #0: 31 -->
en:renal failure
n1=en:narrowing of the ureteropelvic junctions | n2=en:renal failure | rel=r_associated | relid=0 | w=31
- en:nephritis, tubulointerstitial ---
r_associated #0: 31 -->
en:renal failure
n1=en:nephritis, tubulointerstitial | n2=en:renal failure | rel=r_associated | relid=0 | w=31
- en:nephrogenic rests (rare, in males) ---
r_associated #0: 31 -->
en:renal failure
n1=en:nephrogenic rests (rare, in males) | n2=en:renal failure | rel=r_associated | relid=0 | w=31
- en:nephropathy due to secondary diabetes mellitus ---
r_associated #0: 31 -->
en:renal failure
n1=en:nephropathy due to secondary diabetes mellitus | n2=en:renal failure | rel=r_associated | relid=0 | w=31
- en:pediatric nephrology terminology ---
r_associated #0: 31 -->
en:renal failure
n1=en:pediatric nephrology terminology | n2=en:renal failure | rel=r_associated | relid=0 | w=31
- en:plasma cell myeloma post-transplant lymphoproliferative disorder ---
r_associated #0: 31 -->
en:renal failure
n1=en:plasma cell myeloma post-transplant lymphoproliferative disorder | n2=en:renal failure | rel=r_associated | relid=0 | w=31
- en:postoperative renal failure ---
r_associated #0: 31 -->
en:renal failure
n1=en:postoperative renal failure | n2=en:renal failure | rel=r_associated | relid=0 | w=31
- en:proximal tubulopathy, generalized ---
r_associated #0: 31 -->
en:renal failure
n1=en:proximal tubulopathy, generalized | n2=en:renal failure | rel=r_associated | relid=0 | w=31
- en:recurrent urinary tract infection ---
r_associated #0: 31 -->
en:renal failure
n1=en:recurrent urinary tract infection | n2=en:renal failure | rel=r_associated | relid=0 | w=31
- en:reduced excretion of calcium ---
r_associated #0: 31 -->
en:renal failure
n1=en:reduced excretion of calcium | n2=en:renal failure | rel=r_associated | relid=0 | w=31
- en:renal artery obstruction ---
r_associated #0: 31 -->
en:renal failure
n1=en:renal artery obstruction | n2=en:renal failure | rel=r_associated | relid=0 | w=31
- en:renal calculi (rare) ---
r_associated #0: 31 -->
en:renal failure
n1=en:renal calculi (rare) | n2=en:renal failure | rel=r_associated | relid=0 | w=31
- en:renal coccidiosis ---
r_associated #0: 31 -->
en:renal failure
n1=en:renal coccidiosis | n2=en:renal failure | rel=r_associated | relid=0 | w=31
- en:renal failure, endstage (in some patients) ---
r_associated #0: 31 -->
en:renal failure
n1=en:renal failure, endstage (in some patients) | n2=en:renal failure | rel=r_associated | relid=0 | w=31
- en:segmental capillary wall thickening ---
r_associated #0: 31 -->
en:renal failure
n1=en:segmental capillary wall thickening | n2=en:renal failure | rel=r_associated | relid=0 | w=31
- en:small kidney (reported in 1 patient) ---
r_associated #0: 31 -->
en:renal failure
n1=en:small kidney (reported in 1 patient) | n2=en:renal failure | rel=r_associated | relid=0 | w=31
- en:swollen podocytes ---
r_associated #0: 31 -->
en:renal failure
n1=en:swollen podocytes | n2=en:renal failure | rel=r_associated | relid=0 | w=31
- en:systemic lupus erythematosus co-occurrent and due to nephrosis ---
r_associated #0: 31 -->
en:renal failure
n1=en:systemic lupus erythematosus co-occurrent and due to nephrosis | n2=en:renal failure | rel=r_associated | relid=0 | w=31
- en:uriniferous tubule ---
r_associated #0: 31 -->
en:renal failure
n1=en:uriniferous tubule | n2=en:renal failure | rel=r_associated | relid=0 | w=31
- glomérulite ---
r_associated #0: 31 -->
en:renal failure
n1=glomérulite | n2=en:renal failure | rel=r_associated | relid=0 | w=31
- glomérulonéphrite chronique ---
r_associated #0: 31 -->
en:renal failure
n1=glomérulonéphrite chronique | n2=en:renal failure | rel=r_associated | relid=0 | w=31
- glomérulosclérose ---
r_associated #0: 31 -->
en:renal failure
n1=glomérulosclérose | n2=en:renal failure | rel=r_associated | relid=0 | w=31
- hypercalciurie ---
r_associated #0: 31 -->
en:renal failure
n1=hypercalciurie | n2=en:renal failure | rel=r_associated | relid=0 | w=31
- hématurie microscopique ---
r_associated #0: 31 -->
en:renal failure
n1=hématurie microscopique | n2=en:renal failure | rel=r_associated | relid=0 | w=31
- incontinence urinaire ---
r_associated #0: 31 -->
en:renal failure
n1=incontinence urinaire | n2=en:renal failure | rel=r_associated | relid=0 | w=31
- néphrocalcinose ---
r_associated #0: 31 -->
en:renal failure
n1=néphrocalcinose | n2=en:renal failure | rel=r_associated | relid=0 | w=31
- néphropathie diabétique ---
r_associated #0: 31 -->
en:renal failure
n1=néphropathie diabétique | n2=en:renal failure | rel=r_associated | relid=0 | w=31
- néphropathie interstitielle ---
r_associated #0: 31 -->
en:renal failure
n1=néphropathie interstitielle | n2=en:renal failure | rel=r_associated | relid=0 | w=31
- néphropathie obstructive ---
r_associated #0: 31 -->
en:renal failure
n1=néphropathie obstructive | n2=en:renal failure | rel=r_associated | relid=0 | w=31
- périnéphrite ---
r_associated #0: 31 -->
en:renal failure
n1=périnéphrite | n2=en:renal failure | rel=r_associated | relid=0 | w=31
- énurésie ---
r_associated #0: 31 -->
en:renal failure
n1=énurésie | n2=en:renal failure | rel=r_associated | relid=0 | w=31
- Insuffisance rénale ---
r_associated #0: 30 -->
en:renal failure
n1=Insuffisance rénale | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- cystite interstitielle ---
r_associated #0: 30 -->
en:renal failure
n1=cystite interstitielle | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- diabète (accidents vasculaires cérébraux du) ---
r_associated #0: 30 -->
en:renal failure
n1=diabète (accidents vasculaires cérébraux du) | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:0.2 ml methotrexate 50 mg/ml auto-injector ---
r_associated #0: 30 -->
en:renal failure
n1=en:0.2 ml methotrexate 50 mg/ml auto-injector | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:0.25 ml methotrexate 50 mg/ml auto-injector ---
r_associated #0: 30 -->
en:renal failure
n1=en:0.25 ml methotrexate 50 mg/ml auto-injector | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:0.35 ml methotrexate 50 mg/ml auto-injector ---
r_associated #0: 30 -->
en:renal failure
n1=en:0.35 ml methotrexate 50 mg/ml auto-injector | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:24 hr metformin hydrochloride 1000 mg extended release oral tablet [glumetza] ---
r_associated #0: 30 -->
en:renal failure
n1=en:24 hr metformin hydrochloride 1000 mg extended release oral tablet [glumetza] | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:72 hr fentanyl 0.075 mg/hr transdermal patch ---
r_associated #0: 30 -->
en:renal failure
n1=en:72 hr fentanyl 0.075 mg/hr transdermal patch | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:8 ml methotrexate 25 mg/ml injection ---
r_associated #0: 30 -->
en:renal failure
n1=en:8 ml methotrexate 25 mg/ml injection | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:TURP syndrome ---
r_associated #0: 30 -->
en:renal failure
n1=en:TURP syndrome | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:Zellweger syndrome ---
r_associated #0: 30 -->
en:renal failure
n1=en:Zellweger syndrome | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:abnormal corticomedullary differentiation ---
r_associated #0: 30 -->
en:renal failure
n1=en:abnormal corticomedullary differentiation | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:abnormal nephrogenesis ---
r_associated #0: 30 -->
en:renal failure
n1=en:abnormal nephrogenesis | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:abnormality of the prostate ---
r_associated #0: 30 -->
en:renal failure
n1=en:abnormality of the prostate | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:aconuresis ---
r_associated #0: 30 -->
en:renal failure
n1=en:aconuresis | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:acute prerenal failure ---
r_associated #0: 30 -->
en:renal failure
n1=en:acute prerenal failure | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:amprenavir 50mg capsule ---
r_associated #0: 30 -->
en:renal failure
n1=en:amprenavir 50mg capsule | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:basement membrane alterations in bowman capsule, tubules, and interstitial capillaries, with irregular thickening, splitting into multiple layers, and electron-lucent areas ---
r_associated #0: 30 -->
en:renal failure
n1=en:basement membrane alterations in bowman capsule, tubules, and interstitial capillaries, with irregular thickening, splitting into multiple layers, and electron-lucent areas | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:basement membrane thickening ---
r_associated #0: 30 -->
en:renal failure
n1=en:basement membrane thickening | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:bilateral renal aplasia ---
r_associated #0: 30 -->
en:renal failure
n1=en:bilateral renal aplasia | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:calyceal dilation ---
r_associated #0: 30 -->
en:renal failure
n1=en:calyceal dilation | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:chronic kidney disease ---
r_associated #0: 30 -->
en:renal failure
n1=en:chronic kidney disease | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:cisapride 20mg tablet ---
r_associated #0: 30 -->
en:renal failure
n1=en:cisapride 20mg tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:cisplatin 50 mg injection ---
r_associated #0: 30 -->
en:renal failure
n1=en:cisplatin 50 mg injection | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:complement component deposits ---
r_associated #0: 30 -->
en:renal failure
n1=en:complement component deposits | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:complication of internal anastomosis and/or bypass of urinary tract including that involving intestinal tract ---
r_associated #0: 30 -->
en:renal failure
n1=en:complication of internal anastomosis and/or bypass of urinary tract including that involving intestinal tract | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:congenital anomaly of the kidney ---
r_associated #0: 30 -->
en:renal failure
n1=en:congenital anomaly of the kidney | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:congenital lobulation of kidney ---
r_associated #0: 30 -->
en:renal failure
n1=en:congenital lobulation of kidney | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:cortical necrosis of the kidney ---
r_associated #0: 30 -->
en:renal failure
n1=en:cortical necrosis of the kidney | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:cyclosporine ---
r_associated #0: 30 -->
en:renal failure
n1=en:cyclosporine | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:cyclosporine 250mg/5ml oily infusion concentrate ---
r_associated #0: 30 -->
en:renal failure
n1=en:cyclosporine 250mg/5ml oily infusion concentrate | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:cyclosporine, modified 25 mg oral capsule [neoral] ---
r_associated #0: 30 -->
en:renal failure
n1=en:cyclosporine, modified 25 mg oral capsule [neoral] | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:cyclosporine, modified 50 mg oral capsule ---
r_associated #0: 30 -->
en:renal failure
n1=en:cyclosporine, modified 50 mg oral capsule | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:cystic changes in the kidney ---
r_associated #0: 30 -->
en:renal failure
n1=en:cystic changes in the kidney | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:cystic kidneys (may be observed prenatally) ---
r_associated #0: 30 -->
en:renal failure
n1=en:cystic kidneys (may be observed prenatally) | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:cysts may be absent in over 50% of patients ---
r_associated #0: 30 -->
en:renal failure
n1=en:cysts may be absent in over 50% of patients | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:deficient nephron differentiation ---
r_associated #0: 30 -->
en:renal failure
n1=en:deficient nephron differentiation | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:deposition of igg and complement seen on renal biopsy (in some patients) ---
r_associated #0: 30 -->
en:renal failure
n1=en:deposition of igg and complement seen on renal biopsy (in some patients) | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:diatrizoate meglumine 660 mg in 1 ml / diatrizoate sodium 100 mg in 1 ml intravenous solution [md-76r] ---
r_associated #0: 30 -->
en:renal failure
n1=en:diatrizoate meglumine 660 mg in 1 ml / diatrizoate sodium 100 mg in 1 ml intravenous solution [md-76r] | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:diffuse glomerular basement membrane lamellation ---
r_associated #0: 30 -->
en:renal failure
n1=en:diffuse glomerular basement membrane lamellation | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:diffuse sclerotic glomerulonephritis ---
r_associated #0: 30 -->
en:renal failure
n1=en:diffuse sclerotic glomerulonephritis | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:diphenidol hydrochloride ---
r_associated #0: 30 -->
en:renal failure
n1=en:diphenidol hydrochloride | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:drug-induced nephropathy ---
r_associated #0: 30 -->
en:renal failure
n1=en:drug-induced nephropathy | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:enlarged kidney ---
r_associated #0: 30 -->
en:renal failure
n1=en:enlarged kidney | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:enlarged kidneys without obstruction ---
r_associated #0: 30 -->
en:renal failure
n1=en:enlarged kidneys without obstruction | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:exercise-induced acute renal failure with acute tubular necrosis ---
r_associated #0: 30 -->
en:renal failure
n1=en:exercise-induced acute renal failure with acute tubular necrosis | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:fenofibrate 130 mg oral capsule ---
r_associated #0: 30 -->
en:renal failure
n1=en:fenofibrate 130 mg oral capsule | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:fenofibrate 30 mg oral capsule ---
r_associated #0: 30 -->
en:renal failure
n1=en:fenofibrate 30 mg oral capsule | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:fentanyl 1.2mg buccal soluble film ---
r_associated #0: 30 -->
en:renal failure
n1=en:fentanyl 1.2mg buccal soluble film | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:fentanyl 200micrograms buccal tablet ---
r_associated #0: 30 -->
en:renal failure
n1=en:fentanyl 200micrograms buccal tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:fentanyl 400micrograms lozenge ---
r_associated #0: 30 -->
en:renal failure
n1=en:fentanyl 400micrograms lozenge | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:focal segmental glomerulosclerosis (less common) ---
r_associated #0: 30 -->
en:renal failure
n1=en:focal segmental glomerulosclerosis (less common) | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:frasier syndrome ---
r_associated #0: 30 -->
en:renal failure
n1=en:frasier syndrome | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:galantamine 4mg tablet ---
r_associated #0: 30 -->
en:renal failure
n1=en:galantamine 4mg tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:glomerular crescents (rare), seen on biopsy ---
r_associated #0: 30 -->
en:renal failure
n1=en:glomerular crescents (rare), seen on biopsy | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:glomerular epithelial cytoplasmic vacuolization ---
r_associated #0: 30 -->
en:renal failure
n1=en:glomerular epithelial cytoplasmic vacuolization | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:hand foot uterus syndrome ---
r_associated #0: 30 -->
en:renal failure
n1=en:hand foot uterus syndrome | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:hemolytic uremic syndrome ---
r_associated #0: 30 -->
en:renal failure
n1=en:hemolytic uremic syndrome | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:hiv-associated nephropathy ---
r_associated #0: 30 -->
en:renal failure
n1=en:hiv-associated nephropathy | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:hydronephrosis (in some patients) ---
r_associated #0: 30 -->
en:renal failure
n1=en:hydronephrosis (in some patients) | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:hyperechogenic kidneys (in some patients) ---
r_associated #0: 30 -->
en:renal failure
n1=en:hyperechogenic kidneys (in some patients) | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:hypovolemic shock conditions (smq) ---
r_associated #0: 30 -->
en:renal failure
n1=en:hypovolemic shock conditions (smq) | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:ischemic nephropathy ---
r_associated #0: 30 -->
en:renal failure
n1=en:ischemic nephropathy | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:isosthenuria ---
r_associated #0: 30 -->
en:renal failure
n1=en:isosthenuria | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:ketorolac tromethamine 10mg tablet ---
r_associated #0: 30 -->
en:renal failure
n1=en:ketorolac tromethamine 10mg tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:lipomatosis renis ---
r_associated #0: 30 -->
en:renal failure
n1=en:lipomatosis renis | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:magnesium ---
r_associated #0: 30 -->
en:renal failure
n1=en:magnesium | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:magnesium 192mg tab ---
r_associated #0: 30 -->
en:renal failure
n1=en:magnesium 192mg tab | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:magnesium amino acids chelate ---
r_associated #0: 30 -->
en:renal failure
n1=en:magnesium amino acids chelate | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:magnesium aspartate 615 mg delayed release oral tablet ---
r_associated #0: 30 -->
en:renal failure
n1=en:magnesium aspartate 615 mg delayed release oral tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:magnesium gluconate 200 mg/ml oral solution ---
r_associated #0: 30 -->
en:renal failure
n1=en:magnesium gluconate 200 mg/ml oral solution | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:magnesium gluconate 500 mg oral tablet ---
r_associated #0: 30 -->
en:renal failure
n1=en:magnesium gluconate 500 mg oral tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:magnesium gluconate,dihydrate ---
r_associated #0: 30 -->
en:renal failure
n1=en:magnesium gluconate,dihydrate | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:magnesium sulfate 10 mg/ml injection ---
r_associated #0: 30 -->
en:renal failure
n1=en:magnesium sulfate 10 mg/ml injection | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:magnesium sulfate 100 mg oral capsule ---
r_associated #0: 30 -->
en:renal failure
n1=en:magnesium sulfate 100 mg oral capsule | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:magnesium sulfate anhydrous ---
r_associated #0: 30 -->
en:renal failure
n1=en:magnesium sulfate anhydrous | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:male genital abnormalities ---
r_associated #0: 30 -->
en:renal failure
n1=en:male genital abnormalities | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:mesangial proliferative glomerulonephritis (in some patients) ---
r_associated #0: 30 -->
en:renal failure
n1=en:mesangial proliferative glomerulonephritis (in some patients) | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:metformin hydrochloride 1000 mg oral tablet ---
r_associated #0: 30 -->
en:renal failure
n1=en:metformin hydrochloride 1000 mg oral tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:metformin hydrochloride 850 mg oral tablet ---
r_associated #0: 30 -->
en:renal failure
n1=en:metformin hydrochloride 850 mg oral tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:methotrexate na 2.5mg tab dose pack,8 ---
r_associated #0: 30 -->
en:renal failure
n1=en:methotrexate na 2.5mg tab dose pack,8 | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:methotrexate na 20mg/vil inj ---
r_associated #0: 30 -->
en:renal failure
n1=en:methotrexate na 20mg/vil inj | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:methyclothiazide ---
r_associated #0: 30 -->
en:renal failure
n1=en:methyclothiazide | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:methylene blue ---
r_associated #0: 30 -->
en:renal failure
n1=en:methylene blue | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:microvillus transformation of the podocytes ---
r_associated #0: 30 -->
en:renal failure
n1=en:microvillus transformation of the podocytes | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:mitomycin ---
r_associated #0: 30 -->
en:renal failure
n1=en:mitomycin | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:muckle-wells syndrome ---
r_associated #0: 30 -->
en:renal failure
n1=en:muckle-wells syndrome | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:nephrolithiasis (uncommon) ---
r_associated #0: 30 -->
en:renal failure
n1=en:nephrolithiasis (uncommon) | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:nephropathies and tubular disorders nec ---
r_associated #0: 30 -->
en:renal failure
n1=en:nephropathies and tubular disorders nec | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:nephropathy co-occurrent and due to systemic lupus erythematosus ---
r_associated #0: 30 -->
en:renal failure
n1=en:nephropathy co-occurrent and due to systemic lupus erythematosus | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:non-protein nitrogen blood increased result ---
r_associated #0: 30 -->
en:renal failure
n1=en:non-protein nitrogen blood increased result | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:normal kidneys (in some patients) ---
r_associated #0: 30 -->
en:renal failure
n1=en:normal kidneys (in some patients) | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:opium 20 mg/ml injectable solution ---
r_associated #0: 30 -->
en:renal failure
n1=en:opium 20 mg/ml injectable solution | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:other disorders of female genital tract ---
r_associated #0: 30 -->
en:renal failure
n1=en:other disorders of female genital tract | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:other disorders of the genitourinary system ---
r_associated #0: 30 -->
en:renal failure
n1=en:other disorders of the genitourinary system | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:other specified disorders of kidney and ureter ---
r_associated #0: 30 -->
en:renal failure
n1=en:other specified disorders of kidney and ureter | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:other specified disorders of urinary system ---
r_associated #0: 30 -->
en:renal failure
n1=en:other specified disorders of urinary system | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:paregoric ---
r_associated #0: 30 -->
en:renal failure
n1=en:paregoric | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:paromomycin ---
r_associated #0: 30 -->
en:renal failure
n1=en:paromomycin | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:paromomycin sulfate 250mg capsule ---
r_associated #0: 30 -->
en:renal failure
n1=en:paromomycin sulfate 250mg capsule | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:pelviureteric junction obstruction ---
r_associated #0: 30 -->
en:renal failure
n1=en:pelviureteric junction obstruction | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:phenolsulfonphthalein 6 mg/ml injectable solution ---
r_associated #0: 30 -->
en:renal failure
n1=en:phenolsulfonphthalein 6 mg/ml injectable solution | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:photomyoclonus ---
r_associated #0: 30 -->
en:renal failure
n1=en:photomyoclonus | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:potassium acetate ---
r_associated #0: 30 -->
en:renal failure
n1=en:potassium acetate | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:potassium chloride ---
r_associated #0: 30 -->
en:renal failure
n1=en:potassium chloride | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:potassium chloride 0.3 meq/ml injectable solution ---
r_associated #0: 30 -->
en:renal failure
n1=en:potassium chloride 0.3 meq/ml injectable solution | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:potassium chloride 0.67 meq/ml injectable solution ---
r_associated #0: 30 -->
en:renal failure
n1=en:potassium chloride 0.67 meq/ml injectable solution | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:potassium chloride 2.4 meq delayed release oral tablet ---
r_associated #0: 30 -->
en:renal failure
n1=en:potassium chloride 2.4 meq delayed release oral tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:potassium chloride 20 meq extended release oral tablet ---
r_associated #0: 30 -->
en:renal failure
n1=en:potassium chloride 20 meq extended release oral tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:potassium chloride 6.7 meq extended release oral tablet ---
r_associated #0: 30 -->
en:renal failure
n1=en:potassium chloride 6.7 meq extended release oral tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:potassium citrate 5 meq extended release oral tablet ---
r_associated #0: 30 -->
en:renal failure
n1=en:potassium citrate 5 meq extended release oral tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:potassium gluconate 2 meq oral tablet ---
r_associated #0: 30 -->
en:renal failure
n1=en:potassium gluconate 2 meq oral tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:progression to end stage renal failure in late adulthood (fifth to seventh decade) ---
r_associated #0: 30 -->
en:renal failure
n1=en:progression to end stage renal failure in late adulthood (fifth to seventh decade) | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:pyelonephrosis ---
r_associated #0: 30 -->
en:renal failure
n1=en:pyelonephrosis | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:quinethazone ---
r_associated #0: 30 -->
en:renal failure
n1=en:quinethazone | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:quinethazone 50 mg oral tablet ---
r_associated #0: 30 -->
en:renal failure
n1=en:quinethazone 50 mg oral tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:reduced renal corticomedullary differentiation ---
r_associated #0: 30 -->
en:renal failure
n1=en:reduced renal corticomedullary differentiation | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:renal agenesis, unilateral (1 patient) ---
r_associated #0: 30 -->
en:renal failure
n1=en:renal agenesis, unilateral (1 patient) | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:renal aldosterone resistance ---
r_associated #0: 30 -->
en:renal failure
n1=en:renal aldosterone resistance | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:renal amyloidosis, late-onset (uncommon) ---
r_associated #0: 30 -->
en:renal failure
n1=en:renal amyloidosis, late-onset (uncommon) | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:renal anomalies (major) ---
r_associated #0: 30 -->
en:renal failure
n1=en:renal anomalies (major) | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:renal cortical cysts ---
r_associated #0: 30 -->
en:renal failure
n1=en:renal cortical cysts | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:renal cysts (less common) ---
r_associated #0: 30 -->
en:renal failure
n1=en:renal cysts (less common) | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:renal disease, uncharacterized (in some patients) ---
r_associated #0: 30 -->
en:renal failure
n1=en:renal disease, uncharacterized (in some patients) | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:renal dysplasia ---
r_associated #0: 30 -->
en:renal failure
n1=en:renal dysplasia | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:renal failure chronic aggravated ---
r_associated #0: 30 -->
en:renal failure
n1=en:renal failure chronic aggravated | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:renal failure in adulthood ---
r_associated #0: 30 -->
en:renal failure
n1=en:renal failure in adulthood | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:renal failure, mild ---
r_associated #0: 30 -->
en:renal failure
n1=en:renal failure, mild | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:renal hamartoma ---
r_associated #0: 30 -->
en:renal failure
n1=en:renal hamartoma | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:renal hemangioblastoma ---
r_associated #0: 30 -->
en:renal failure
n1=en:renal hemangioblastoma | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:renal hypertension ---
r_associated #0: 30 -->
en:renal failure
n1=en:renal hypertension | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:renal hypoplasia/aplasia ---
r_associated #0: 30 -->
en:renal failure
n1=en:renal hypoplasia/aplasia | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:renal lymphangiectasia ---
r_associated #0: 30 -->
en:renal failure
n1=en:renal lymphangiectasia | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:renal phosphate wasting (in some patients) ---
r_associated #0: 30 -->
en:renal failure
n1=en:renal phosphate wasting (in some patients) | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:renal tubular acidosis ---
r_associated #0: 30 -->
en:renal failure
n1=en:renal tubular acidosis | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:renal tubular cell atrophy with corticomedullary cysts ---
r_associated #0: 30 -->
en:renal failure
n1=en:renal tubular cell atrophy with corticomedullary cysts | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:renal tubule ---
r_associated #0: 30 -->
en:renal failure
n1=en:renal tubule | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:renal tubulopathy ---
r_associated #0: 30 -->
en:renal failure
n1=en:renal tubulopathy | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:ribavirin ---
r_associated #0: 30 -->
en:renal failure
n1=en:ribavirin | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:ribavirin 40mg/ml oral solution ---
r_associated #0: 30 -->
en:renal failure
n1=en:ribavirin 40mg/ml oral solution | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:serum creatinine raised ---
r_associated #0: 30 -->
en:renal failure
n1=en:serum creatinine raised | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:small echogenic kidneys (in some patients) ---
r_associated #0: 30 -->
en:renal failure
n1=en:small echogenic kidneys (in some patients) | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:sodium phosphate 1.5g tablet ---
r_associated #0: 30 -->
en:renal failure
n1=en:sodium phosphate 1.5g tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:sodium phosphate 1500 mg oral tablet [osmoprep] ---
r_associated #0: 30 -->
en:renal failure
n1=en:sodium phosphate 1500 mg oral tablet [osmoprep] | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:sodium phosphate, tribasic ---
r_associated #0: 30 -->
en:renal failure
n1=en:sodium phosphate, tribasic | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:tegaserod 2 mg oral tablet ---
r_associated #0: 30 -->
en:renal failure
n1=en:tegaserod 2 mg oral tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:tegaserod 6 mg oral tablet ---
r_associated #0: 30 -->
en:renal failure
n1=en:tegaserod 6 mg oral tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:testosterone 10 mg/actuat topical gel ---
r_associated #0: 30 -->
en:renal failure
n1=en:testosterone 10 mg/actuat topical gel | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:testosterone enanthate 100 mg/ml injectable solution ---
r_associated #0: 30 -->
en:renal failure
n1=en:testosterone enanthate 100 mg/ml injectable solution | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:testosterone propionate ---
r_associated #0: 30 -->
en:renal failure
n1=en:testosterone propionate | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:therapeutic testosterone ---
r_associated #0: 30 -->
en:renal failure
n1=en:therapeutic testosterone | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:trichlormethiazide ---
r_associated #0: 30 -->
en:renal failure
n1=en:trichlormethiazide | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:tubular basement membrane disintegration ---
r_associated #0: 30 -->
en:renal failure
n1=en:tubular basement membrane disintegration | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:ureorrhea ---
r_associated #0: 30 -->
en:renal failure
n1=en:ureorrhea | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:urinary fistula complication ---
r_associated #0: 30 -->
en:renal failure
n1=en:urinary fistula complication | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:zellweger syndrome ---
r_associated #0: 30 -->
en:renal failure
n1=en:zellweger syndrome | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:{16 (methotrexate 2.5 mg oral tablet) } pack ---
r_associated #0: 30 -->
en:renal failure
n1=en:{16 (methotrexate 2.5 mg oral tablet) } pack | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- en:{20 (methotrexate 2.5 mg oral tablet) } pack ---
r_associated #0: 30 -->
en:renal failure
n1=en:{20 (methotrexate 2.5 mg oral tablet) } pack | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- hypertélorisme, hypospadias, polysyndactylie (syndrome) ---
r_associated #0: 30 -->
en:renal failure
n1=hypertélorisme, hypospadias, polysyndactylie (syndrome) | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- hypoplasie segmentaire du rein ---
r_associated #0: 30 -->
en:renal failure
n1=hypoplasie segmentaire du rein | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- incontinence d'urine ---
r_associated #0: 30 -->
en:renal failure
n1=incontinence d'urine | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- rein non fonctionnel ---
r_associated #0: 30 -->
en:renal failure
n1=rein non fonctionnel | n2=en:renal failure | rel=r_associated | relid=0 | w=30
- HTA ---
r_associated #0: 29 -->
en:renal failure
n1=HTA | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- appareil urinaire ---
r_associated #0: 29 -->
en:renal failure
n1=appareil urinaire | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:0.4 ml fondaparinux sodium 12.5 mg/ml prefilled syringe ---
r_associated #0: 29 -->
en:renal failure
n1=en:0.4 ml fondaparinux sodium 12.5 mg/ml prefilled syringe | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:24 hr metformin hydrochloride 500 mg extended release oral tablet [glumetza] ---
r_associated #0: 29 -->
en:renal failure
n1=en:24 hr metformin hydrochloride 500 mg extended release oral tablet [glumetza] | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:2500 mg testosterone 0.01 mg/mg topical gel [androgel] ---
r_associated #0: 29 -->
en:renal failure
n1=en:2500 mg testosterone 0.01 mg/mg topical gel [androgel] | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:a subset of patients develop renal insufficiency with decreased creatinine clearance ---
r_associated #0: 29 -->
en:renal failure
n1=en:a subset of patients develop renal insufficiency with decreased creatinine clearance | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:adult onset polycystic kidney (50%) ---
r_associated #0: 29 -->
en:renal failure
n1=en:adult onset polycystic kidney (50%) | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:ammonium chloride 488 mg oral tablet ---
r_associated #0: 29 -->
en:renal failure
n1=en:ammonium chloride 488 mg oral tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:ammonium chloride 500 mg oral tablet ---
r_associated #0: 29 -->
en:renal failure
n1=en:ammonium chloride 500 mg oral tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:amprenavir 150mg capsule ---
r_associated #0: 29 -->
en:renal failure
n1=en:amprenavir 150mg capsule | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:anomalous renal pelvis (rare) ---
r_associated #0: 29 -->
en:renal failure
n1=en:anomalous renal pelvis (rare) | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:atrophy of kidney ---
r_associated #0: 29 -->
en:renal failure
n1=en:atrophy of kidney | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:azotemia ---
r_associated #0: 29 -->
en:renal failure
n1=en:azotemia | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:bardet-biedl syndrome 16 ---
r_associated #0: 29 -->
en:renal failure
n1=en:bardet-biedl syndrome 16 | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:bicarbonate-wasting renal tubular acidosis ---
r_associated #0: 29 -->
en:renal failure
n1=en:bicarbonate-wasting renal tubular acidosis | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:bilateral renal hamartomas ---
r_associated #0: 29 -->
en:renal failure
n1=en:bilateral renal hamartomas | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:blood urea nitrogen increased ---
r_associated #0: 29 -->
en:renal failure
n1=en:blood urea nitrogen increased | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:breast disorder ---
r_associated #0: 29 -->
en:renal failure
n1=en:breast disorder | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:cerebral atrophy ---
r_associated #0: 29 -->
en:renal failure
n1=en:cerebral atrophy | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:chronic disease of genitourinary system ---
r_associated #0: 29 -->
en:renal failure
n1=en:chronic disease of genitourinary system | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:chronic renal dysfunction/failure ---
r_associated #0: 29 -->
en:renal failure
n1=en:chronic renal dysfunction/failure | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:cisapride 5mg/5ml oral suspension ---
r_associated #0: 29 -->
en:renal failure
n1=en:cisapride 5mg/5ml oral suspension | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:clofibrate ---
r_associated #0: 29 -->
en:renal failure
n1=en:clofibrate | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:complement component deposition ---
r_associated #0: 29 -->
en:renal failure
n1=en:complement component deposition | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:congenital single renal cyst ---
r_associated #0: 29 -->
en:renal failure
n1=en:congenital single renal cyst | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:creatinine ---
r_associated #0: 29 -->
en:renal failure
n1=en:creatinine | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:cyclosporine 25 mg oral capsule [sandimmune] ---
r_associated #0: 29 -->
en:renal failure
n1=en:cyclosporine 25 mg oral capsule [sandimmune] | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:cystic dilation of tubules (in some patients) ---
r_associated #0: 29 -->
en:renal failure
n1=en:cystic dilation of tubules (in some patients) | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:cystic dysplasia ---
r_associated #0: 29 -->
en:renal failure
n1=en:cystic dysplasia | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:deposition of complement component c3 in glomerular basement membrane ---
r_associated #0: 29 -->
en:renal failure
n1=en:deposition of complement component c3 in glomerular basement membrane | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:diatrizoate meglumine ---
r_associated #0: 29 -->
en:renal failure
n1=en:diatrizoate meglumine | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:disorder of the genitourinary system ---
r_associated #0: 29 -->
en:renal failure
n1=en:disorder of the genitourinary system | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:dorzolamide hydrochloride ---
r_associated #0: 29 -->
en:renal failure
n1=en:dorzolamide hydrochloride | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:ectopic kidney (2 patients) ---
r_associated #0: 29 -->
en:renal failure
n1=en:ectopic kidney (2 patients) | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:end-stage renal disease by third decade of life ---
r_associated #0: 29 -->
en:renal failure
n1=en:end-stage renal disease by third decade of life | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:familial primary hypomagnesemia ---
r_associated #0: 29 -->
en:renal failure
n1=en:familial primary hypomagnesemia | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:fatty infiltration ---
r_associated #0: 29 -->
en:renal failure
n1=en:fatty infiltration | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:fenofibrate 160 mg oral tablet ---
r_associated #0: 29 -->
en:renal failure
n1=en:fenofibrate 160 mg oral tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:fenofibrate micronized 67mg capsule ---
r_associated #0: 29 -->
en:renal failure
n1=en:fenofibrate micronized 67mg capsule | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:fentanyl 0.4 mg/actuat mucosal spray ---
r_associated #0: 29 -->
en:renal failure
n1=en:fentanyl 0.4 mg/actuat mucosal spray | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:fentanyl 0.8 mg buccal tablet ---
r_associated #0: 29 -->
en:renal failure
n1=en:fentanyl 0.8 mg buccal tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:fentanyl 25micrograms/hour patch ---
r_associated #0: 29 -->
en:renal failure
n1=en:fentanyl 25micrograms/hour patch | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:fentanyl 400microgram buccal soluble film ---
r_associated #0: 29 -->
en:renal failure
n1=en:fentanyl 400microgram buccal soluble film | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:fentanyl citrate ---
r_associated #0: 29 -->
en:renal failure
n1=en:fentanyl citrate | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:focal cystic changes ---
r_associated #0: 29 -->
en:renal failure
n1=en:focal cystic changes | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:focal tubular atrophy ---
r_associated #0: 29 -->
en:renal failure
n1=en:focal tubular atrophy | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:foot process fusion ---
r_associated #0: 29 -->
en:renal failure
n1=en:foot process fusion | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:foscarnet ---
r_associated #0: 29 -->
en:renal failure
n1=en:foscarnet | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:galantamine hydrobromide ---
r_associated #0: 29 -->
en:renal failure
n1=en:galantamine hydrobromide | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:genitourinary system infection ---
r_associated #0: 29 -->
en:renal failure
n1=en:genitourinary system infection | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:glomerular capillary-loop deposits (rare), seen on biopsy ---
r_associated #0: 29 -->
en:renal failure
n1=en:glomerular capillary-loop deposits (rare), seen on biopsy | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:hematuria complication ---
r_associated #0: 29 -->
en:renal failure
n1=en:hematuria complication | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:hematuria, macroscopic (seen in children and young adults coincident with mucosal infection) ---
r_associated #0: 29 -->
en:renal failure
n1=en:hematuria, macroscopic (seen in children and young adults coincident with mucosal infection) | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:hemoglobinuria (in some patients) ---
r_associated #0: 29 -->
en:renal failure
n1=en:hemoglobinuria (in some patients) | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:heterotopic kidney ---
r_associated #0: 29 -->
en:renal failure
n1=en:heterotopic kidney | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:hydroflumethiazide 50mg tablet ---
r_associated #0: 29 -->
en:renal failure
n1=en:hydroflumethiazide 50mg tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:increased echogenicity of entire parenchyma ---
r_associated #0: 29 -->
en:renal failure
n1=en:increased echogenicity of entire parenchyma | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:indapamide ---
r_associated #0: 29 -->
en:renal failure
n1=en:indapamide | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:indapamide 2.5 mg oral tablet ---
r_associated #0: 29 -->
en:renal failure
n1=en:indapamide 2.5 mg oral tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:infection of kidney ---
r_associated #0: 29 -->
en:renal failure
n1=en:infection of kidney | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:inflammatory disorder of genitourinary system ---
r_associated #0: 29 -->
en:renal failure
n1=en:inflammatory disorder of genitourinary system | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:interstitial cystitis ---
r_associated #0: 29 -->
en:renal failure
n1=en:interstitial cystitis | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:isolated renal cyst (rare) ---
r_associated #0: 29 -->
en:renal failure
n1=en:isolated renal cyst (rare) | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:ketorolac trometamol 0.5% ophthalmic solution ---
r_associated #0: 29 -->
en:renal failure
n1=en:ketorolac trometamol 0.5% ophthalmic solution | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:ketorolac trometamol 15.75mg nasal spray ---
r_associated #0: 29 -->
en:renal failure
n1=en:ketorolac trometamol 15.75mg nasal spray | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:kidney circulation disorder ---
r_associated #0: 29 -->
en:renal failure
n1=en:kidney circulation disorder | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:kidney lobe ---
r_associated #0: 29 -->
en:renal failure
n1=en:kidney lobe | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:lipid accumulation in kidney, especially in proximal convoluted tubules ---
r_associated #0: 29 -->
en:renal failure
n1=en:lipid accumulation in kidney, especially in proximal convoluted tubules | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:loss of podocyte foot processes ---
r_associated #0: 29 -->
en:renal failure
n1=en:loss of podocyte foot processes | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:magaldrate 108 mg/ml oral suspension ---
r_associated #0: 29 -->
en:renal failure
n1=en:magaldrate 108 mg/ml oral suspension | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:magaldrate 480 mg oral tablet ---
r_associated #0: 29 -->
en:renal failure
n1=en:magaldrate 480 mg oral tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:magnesium oxide 400 mg oral tablet ---
r_associated #0: 29 -->
en:renal failure
n1=en:magnesium oxide 400 mg oral tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:magnesium oxide 500 mg oral capsule ---
r_associated #0: 29 -->
en:renal failure
n1=en:magnesium oxide 500 mg oral capsule | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:magnesium so4 2meq/ml inj ---
r_associated #0: 29 -->
en:renal failure
n1=en:magnesium so4 2meq/ml inj | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:magnesium sulfate 10%(0.4mmol/ml) injection ---
r_associated #0: 29 -->
en:renal failure
n1=en:magnesium sulfate 10%(0.4mmol/ml) injection | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:magnesium sulfate 5%(4gm/100ml) intravenous ---
r_associated #0: 29 -->
en:renal failure
n1=en:magnesium sulfate 5%(4gm/100ml) intravenous | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:medullary cystic renal disease ---
r_associated #0: 29 -->
en:renal failure
n1=en:medullary cystic renal disease | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:membranoproliferative glomerulonephritis (26%) ---
r_associated #0: 29 -->
en:renal failure
n1=en:membranoproliferative glomerulonephritis (26%) | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:membranoproliferative glomerulonephritis (in about 26%) ---
r_associated #0: 29 -->
en:renal failure
n1=en:membranoproliferative glomerulonephritis (in about 26%) | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:metaxalone ---
r_associated #0: 29 -->
en:renal failure
n1=en:metaxalone | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:methotrexate 25 mg/ml injection ---
r_associated #0: 29 -->
en:renal failure
n1=en:methotrexate 25 mg/ml injection | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:minimal change disease (lipoid nephrosis) on renal biopsy ---
r_associated #0: 29 -->
en:renal failure
n1=en:minimal change disease (lipoid nephrosis) on renal biopsy | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:multicystic kidney (rare, in males) ---
r_associated #0: 29 -->
en:renal failure
n1=en:multicystic kidney (rare, in males) | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:nephrolithiasis (hcs and 2p21del) ---
r_associated #0: 29 -->
en:renal failure
n1=en:nephrolithiasis (hcs and 2p21del) | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:nephrotic syndrome (in some patients) ---
r_associated #0: 29 -->
en:renal failure
n1=en:nephrotic syndrome (in some patients) | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:no complement deposition ---
r_associated #0: 29 -->
en:renal failure
n1=en:no complement deposition | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:no nephritis ---
r_associated #0: 29 -->
en:renal failure
n1=en:no nephritis | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:no renal disease ---
r_associated #0: 29 -->
en:renal failure
n1=en:no renal disease | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:non-neoplastic kidney disorder ---
r_associated #0: 29 -->
en:renal failure
n1=en:non-neoplastic kidney disorder | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:noninflammatory disorder of the female genital organs ---
r_associated #0: 29 -->
en:renal failure
n1=en:noninflammatory disorder of the female genital organs | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:obstructive uropathy ---
r_associated #0: 29 -->
en:renal failure
n1=en:obstructive uropathy | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:ostomy ---
r_associated #0: 29 -->
en:renal failure
n1=en:ostomy | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:other disorders of kidney and ureter ---
r_associated #0: 29 -->
en:renal failure
n1=en:other disorders of kidney and ureter | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:phenolsulfonphthalein ---
r_associated #0: 29 -->
en:renal failure
n1=en:phenolsulfonphthalein | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:polycystic kidney disease ---
r_associated #0: 29 -->
en:renal failure
n1=en:polycystic kidney disease | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:potassium acetate 4 meq/ml injectable solution ---
r_associated #0: 29 -->
en:renal failure
n1=en:potassium acetate 4 meq/ml injectable solution | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:potassium bicarbonate 0.208 meq/ml oral solution ---
r_associated #0: 29 -->
en:renal failure
n1=en:potassium bicarbonate 0.208 meq/ml oral solution | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:potassium bitartrate pwdr ---
r_associated #0: 29 -->
en:renal failure
n1=en:potassium bitartrate pwdr | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:potassium chloride 2 meq/ml oral solution ---
r_associated #0: 29 -->
en:renal failure
n1=en:potassium chloride 2 meq/ml oral solution | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:potassium chloride 3.2 meq/ml injectable solution ---
r_associated #0: 29 -->
en:renal failure
n1=en:potassium chloride 3.2 meq/ml injectable solution | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:potassium chloride 8 meq delayed release oral tablet ---
r_associated #0: 29 -->
en:renal failure
n1=en:potassium chloride 8 meq delayed release oral tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:potassium chloride 8 meq oral tablet ---
r_associated #0: 29 -->
en:renal failure
n1=en:potassium chloride 8 meq oral tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:potassium gluconate 1.33 meq/ml oral solution ---
r_associated #0: 29 -->
en:renal failure
n1=en:potassium gluconate 1.33 meq/ml oral solution | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:potassium gluconate 6.66 meq oral tablet ---
r_associated #0: 29 -->
en:renal failure
n1=en:potassium gluconate 6.66 meq oral tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:primary hyperoxaluria type i ---
r_associated #0: 29 -->
en:renal failure
n1=en:primary hyperoxaluria type i | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:proteinuria (rare) ---
r_associated #0: 29 -->
en:renal failure
n1=en:proteinuria (rare) | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:proteinuria syndrome ---
r_associated #0: 29 -->
en:renal failure
n1=en:proteinuria syndrome | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:proximal renal tubular acidosis ---
r_associated #0: 29 -->
en:renal failure
n1=en:proximal renal tubular acidosis | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:psychogenic disorder of the genitourinary system ---
r_associated #0: 29 -->
en:renal failure
n1=en:psychogenic disorder of the genitourinary system | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:renal anomalies (27%) ---
r_associated #0: 29 -->
en:renal failure
n1=en:renal anomalies (27%) | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:renal artery stenosis ---
r_associated #0: 29 -->
en:renal failure
n1=en:renal artery stenosis | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:renal cell ---
r_associated #0: 29 -->
en:renal failure
n1=en:renal cell | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:renal corticomedullary cysts ---
r_associated #0: 29 -->
en:renal failure
n1=en:renal corticomedullary cysts | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:renal cysts (1 patient) ---
r_associated #0: 29 -->
en:renal failure
n1=en:renal cysts (1 patient) | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:renal dysplasia (in some patients) ---
r_associated #0: 29 -->
en:renal failure
n1=en:renal dysplasia (in some patients) | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:renal failure associated with renal vascular disease ---
r_associated #0: 29 -->
en:renal failure
n1=en:renal failure associated with renal vascular disease | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:renal failure, ctcae ---
r_associated #0: 29 -->
en:renal failure
n1=en:renal failure, ctcae | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:renal failure, mild to moderate ---
r_associated #0: 29 -->
en:renal failure
n1=en:renal failure, mild to moderate | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:renal failure, slowly progressive ---
r_associated #0: 29 -->
en:renal failure
n1=en:renal failure, slowly progressive | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:renal insufficiency (in 2 of 3 siblings) ---
r_associated #0: 29 -->
en:renal failure
n1=en:renal insufficiency (in 2 of 3 siblings) | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:renal parenchyma ---
r_associated #0: 29 -->
en:renal failure
n1=en:renal parenchyma | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:renal parenchymal disease ---
r_associated #0: 29 -->
en:renal failure
n1=en:renal parenchymal disease | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:renal phosphate wasting ---
r_associated #0: 29 -->
en:renal failure
n1=en:renal phosphate wasting | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:renal potassium wasting ---
r_associated #0: 29 -->
en:renal failure
n1=en:renal potassium wasting | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:renal secondary osteodystrophia fibrosa ---
r_associated #0: 29 -->
en:renal failure
n1=en:renal secondary osteodystrophia fibrosa | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:renal tubular disorder ---
r_associated #0: 29 -->
en:renal failure
n1=en:renal tubular disorder | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:ribavirin 400 mg oral tablet ---
r_associated #0: 29 -->
en:renal failure
n1=en:ribavirin 400 mg oral tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:right kidney ---
r_associated #0: 29 -->
en:renal failure
n1=en:right kidney | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:salcedo syndrome ---
r_associated #0: 29 -->
en:renal failure
n1=en:salcedo syndrome | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:schimke immunoosseous dysplasia ---
r_associated #0: 29 -->
en:renal failure
n1=en:schimke immunoosseous dysplasia | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:small echogenic kidneys ---
r_associated #0: 29 -->
en:renal failure
n1=en:small echogenic kidneys | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:steroid-resistant nephrotic syndrome ---
r_associated #0: 29 -->
en:renal failure
n1=en:steroid-resistant nephrotic syndrome | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:stricture of pelviureteric junction ---
r_associated #0: 29 -->
en:renal failure
n1=en:stricture of pelviureteric junction | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:structural and functional abnormalities of the kidney ---
r_associated #0: 29 -->
en:renal failure
n1=en:structural and functional abnormalities of the kidney | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:sulfabenzamide ---
r_associated #0: 29 -->
en:renal failure
n1=en:sulfabenzamide | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:sulfadoxine ---
r_associated #0: 29 -->
en:renal failure
n1=en:sulfadoxine | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:testosterone cypionate 200 mg/ml injectable solution ---
r_associated #0: 29 -->
en:renal failure
n1=en:testosterone cypionate 200 mg/ml injectable solution | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:testosterone enanthate ---
r_associated #0: 29 -->
en:renal failure
n1=en:testosterone enanthate | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:testosterone enanthate 200mg/testosterone propionate 25mg inj ---
r_associated #0: 29 -->
en:renal failure
n1=en:testosterone enanthate 200mg/testosterone propionate 25mg inj | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:thickening of renal arterial walls ---
r_associated #0: 29 -->
en:renal failure
n1=en:thickening of renal arterial walls | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:trichlormethiazide 2 mg oral tablet ---
r_associated #0: 29 -->
en:renal failure
n1=en:trichlormethiazide 2 mg oral tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:trichlormethiazide 4mg tablet ---
r_associated #0: 29 -->
en:renal failure
n1=en:trichlormethiazide 4mg tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:tubular atrophy ---
r_associated #0: 29 -->
en:renal failure
n1=en:tubular atrophy | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:urinary complication ---
r_associated #0: 29 -->
en:renal failure
n1=en:urinary complication | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:urinary incontinence ---
r_associated #0: 29 -->
en:renal failure
n1=en:urinary incontinence | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:vacuolization in distal and collecting tubules ---
r_associated #0: 29 -->
en:renal failure
n1=en:vacuolization in distal and collecting tubules | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- lithiase urinaire ---
r_associated #0: 29 -->
en:renal failure
n1=lithiase urinaire | n2=en:renal failure | rel=r_associated | relid=0 | w=29
- en:0.4 ml methotrexate 62.5 mg/ml auto-injector ---
r_associated #0: 28 -->
en:renal failure
n1=en:0.4 ml methotrexate 62.5 mg/ml auto-injector | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:0.6 ml methotrexate 50 mg/ml auto-injector ---
r_associated #0: 28 -->
en:renal failure
n1=en:0.6 ml methotrexate 50 mg/ml auto-injector | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:1 ml ketorolac tromethamine 30 mg/ml cartridge ---
r_associated #0: 28 -->
en:renal failure
n1=en:1 ml ketorolac tromethamine 30 mg/ml cartridge | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:10 ml methotrexate 25 mg/ml injection ---
r_associated #0: 28 -->
en:renal failure
n1=en:10 ml methotrexate 25 mg/ml injection | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:24 hr galantamine hydrobromide 8 mg extended release oral capsule ---
r_associated #0: 28 -->
en:renal failure
n1=en:24 hr galantamine hydrobromide 8 mg extended release oral capsule | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:24 hr metformin hydrochloride 1000 mg extended release oral tablet ---
r_associated #0: 28 -->
en:renal failure
n1=en:24 hr metformin hydrochloride 1000 mg extended release oral tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:24 hr testosterone 0.208 mg/hr transdermal patch [testoderm] ---
r_associated #0: 28 -->
en:renal failure
n1=en:24 hr testosterone 0.208 mg/hr transdermal patch [testoderm] | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:60 actuat testosterone 5.5 mg/actuat nasal gel ---
r_associated #0: 28 -->
en:renal failure
n1=en:60 actuat testosterone 5.5 mg/actuat nasal gel | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:72 hr fentanyl 0.1 mg/hr transdermal patch ---
r_associated #0: 28 -->
en:renal failure
n1=en:72 hr fentanyl 0.1 mg/hr transdermal patch | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:abnormal renal calyces ---
r_associated #0: 28 -->
en:renal failure
n1=en:abnormal renal calyces | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:abnormal urine ---
r_associated #0: 28 -->
en:renal failure
n1=en:abnormal urine | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:abnormality of the bladder ---
r_associated #0: 28 -->
en:renal failure
n1=en:abnormality of the bladder | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:absent kidneys (rare) ---
r_associated #0: 28 -->
en:renal failure
n1=en:absent kidneys (rare) | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:absent renal peroxisomes ---
r_associated #0: 28 -->
en:renal failure
n1=en:absent renal peroxisomes | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:acrivastine ---
r_associated #0: 28 -->
en:renal failure
n1=en:acrivastine | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:action myoclonus renal failure syndrome ---
r_associated #0: 28 -->
en:renal failure
n1=en:action myoclonus renal failure syndrome | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:acute kidney failure and chronic kidney disease (n17-n19) ---
r_associated #0: 28 -->
en:renal failure
n1=en:acute kidney failure and chronic kidney disease (n17-n19) | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:acute renal failure (smq) ---
r_associated #0: 28 -->
en:renal failure
n1=en:acute renal failure (smq) | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:alstrom syndrome ---
r_associated #0: 28 -->
en:renal failure
n1=en:alstrom syndrome | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:amprenavir ---
r_associated #0: 28 -->
en:renal failure
n1=en:amprenavir | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:ask-upmark kidney ---
r_associated #0: 28 -->
en:renal failure
n1=en:ask-upmark kidney | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:attenuation of the glomerular basement membrane ---
r_associated #0: 28 -->
en:renal failure
n1=en:attenuation of the glomerular basement membrane | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:bardet-biedl syndrome 10 ---
r_associated #0: 28 -->
en:renal failure
n1=en:bardet-biedl syndrome 10 | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:bendroflumethiazide 5 mg extended release oral tablet ---
r_associated #0: 28 -->
en:renal failure
n1=en:bendroflumethiazide 5 mg extended release oral tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:bendroflumethiazide 5 mg oral tablet ---
r_associated #0: 28 -->
en:renal failure
n1=en:bendroflumethiazide 5 mg oral tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:benzthiazide ---
r_associated #0: 28 -->
en:renal failure
n1=en:benzthiazide | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:calcifediol 0.05 mg oral capsule ---
r_associated #0: 28 -->
en:renal failure
n1=en:calcifediol 0.05 mg oral capsule | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:capecitabine 150mg tablet ---
r_associated #0: 28 -->
en:renal failure
n1=en:capecitabine 150mg tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:chronic interstitial nephritis ---
r_associated #0: 28 -->
en:renal failure
n1=en:chronic interstitial nephritis | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:chronic pyelonephritis ---
r_associated #0: 28 -->
en:renal failure
n1=en:chronic pyelonephritis | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:cisplatin 10mg/vial powder for injection ---
r_associated #0: 28 -->
en:renal failure
n1=en:cisplatin 10mg/vial powder for injection | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:congenital nephrotic syndrome - diffuse mesangial sclerosis ---
r_associated #0: 28 -->
en:renal failure
n1=en:congenital nephrotic syndrome - diffuse mesangial sclerosis | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:cyclothiazide ---
r_associated #0: 28 -->
en:renal failure
n1=en:cyclothiazide | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:cystic tubular dilatation in the corticomedullary area and medulla ---
r_associated #0: 28 -->
en:renal failure
n1=en:cystic tubular dilatation in the corticomedullary area and medulla | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:decreased numbers of glomeruli ---
r_associated #0: 28 -->
en:renal failure
n1=en:decreased numbers of glomeruli | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:decreased renal tubular phosphate excretion ---
r_associated #0: 28 -->
en:renal failure
n1=en:decreased renal tubular phosphate excretion | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:diatrizoate na pwdr,oral ---
r_associated #0: 28 -->
en:renal failure
n1=en:diatrizoate na pwdr,oral | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:diffuse mesangial sclerosis (less common) ---
r_associated #0: 28 -->
en:renal failure
n1=en:diffuse mesangial sclerosis (less common) | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:discrete dilatation of the right kidney pelvis (rare) ---
r_associated #0: 28 -->
en:renal failure
n1=en:discrete dilatation of the right kidney pelvis (rare) | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:disorder of kidney and ureter, unspecified ---
r_associated #0: 28 -->
en:renal failure
n1=en:disorder of kidney and ureter, unspecified | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:ds stage ii plasma cell myeloma ---
r_associated #0: 28 -->
en:renal failure
n1=en:ds stage ii plasma cell myeloma | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:duodenorenal fistula ---
r_associated #0: 28 -->
en:renal failure
n1=en:duodenorenal fistula | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:duplex renal system ---
r_associated #0: 28 -->
en:renal failure
n1=en:duplex renal system | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:ectopic kidneys (rare) ---
r_associated #0: 28 -->
en:renal failure
n1=en:ectopic kidneys (rare) | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:effacement of podocyte foot processes ---
r_associated #0: 28 -->
en:renal failure
n1=en:effacement of podocyte foot processes | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:end stage renal disease (age 6-35 years) ---
r_associated #0: 28 -->
en:renal failure
n1=en:end stage renal disease (age 6-35 years) | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:ergocalciferol 500000 unt/ml injectable solution ---
r_associated #0: 28 -->
en:renal failure
n1=en:ergocalciferol 500000 unt/ml injectable solution | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:familial juvenile gout ---
r_associated #0: 28 -->
en:renal failure
n1=en:familial juvenile gout | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:fentanyl ---
r_associated #0: 28 -->
en:renal failure
n1=en:fentanyl | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:fentanyl 0.4 mg sublingual tablet ---
r_associated #0: 28 -->
en:renal failure
n1=en:fentanyl 0.4 mg sublingual tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:fentanyl citrate 10 ug in 1 ml intravenous injection, solution [fentanyl citrate] ---
r_associated #0: 28 -->
en:renal failure
n1=en:fentanyl citrate 10 ug in 1 ml intravenous injection, solution [fentanyl citrate] | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:focal capillary obliteration ---
r_associated #0: 28 -->
en:renal failure
n1=en:focal capillary obliteration | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:fused kidneys (rare) ---
r_associated #0: 28 -->
en:renal failure
n1=en:fused kidneys (rare) | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:genital diseases, male ---
r_associated #0: 28 -->
en:renal failure
n1=en:genital diseases, male | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:glomerular cysts ---
r_associated #0: 28 -->
en:renal failure
n1=en:glomerular cysts | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:glomerulopathy ---
r_associated #0: 28 -->
en:renal failure
n1=en:glomerulopathy | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:glomerulopathy with fibronectin deposits 2 (disorder) ---
r_associated #0: 28 -->
en:renal failure
n1=en:glomerulopathy with fibronectin deposits 2 (disorder) | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:glomerulus ---
r_associated #0: 28 -->
en:renal failure
n1=en:glomerulus | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:graham boyle troxell syndrome ---
r_associated #0: 28 -->
en:renal failure
n1=en:graham boyle troxell syndrome | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:hematuria ---
r_associated #0: 28 -->
en:renal failure
n1=en:hematuria | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:history of renal failure ---
r_associated #0: 28 -->
en:renal failure
n1=en:history of renal failure | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:hyperplasia of zona glomerulosa of adrenal gland ---
r_associated #0: 28 -->
en:renal failure
n1=en:hyperplasia of zona glomerulosa of adrenal gland | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:impaired reabsorption of chloride ---
r_associated #0: 28 -->
en:renal failure
n1=en:impaired reabsorption of chloride | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:impaired renal function (in some patients) ---
r_associated #0: 28 -->
en:renal failure
n1=en:impaired renal function (in some patients) | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:increased glomerular cellularity ---
r_associated #0: 28 -->
en:renal failure
n1=en:increased glomerular cellularity | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:interstitial nephritis ---
r_associated #0: 28 -->
en:renal failure
n1=en:interstitial nephritis | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:interstitial nephropathy ---
r_associated #0: 28 -->
en:renal failure
n1=en:interstitial nephropathy | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:isolated non-nephrotic proteinuria ---
r_associated #0: 28 -->
en:renal failure
n1=en:isolated non-nephrotic proteinuria | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:kidney ---
r_associated #0: 28 -->
en:renal failure
n1=en:kidney | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:kidney cyst ---
r_associated #0: 28 -->
en:renal failure
n1=en:kidney cyst | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:kidney functional ---
r_associated #0: 28 -->
en:renal failure
n1=en:kidney functional | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:kidney vascular disorder ---
r_associated #0: 28 -->
en:renal failure
n1=en:kidney vascular disorder | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:kleds' disease ---
r_associated #0: 28 -->
en:renal failure
n1=en:kleds' disease | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:magaldrate ---
r_associated #0: 28 -->
en:renal failure
n1=en:magaldrate | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:magaldrate 96 mg/ml oral suspension ---
r_associated #0: 28 -->
en:renal failure
n1=en:magaldrate 96 mg/ml oral suspension | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:magnesium carbonate ---
r_associated #0: 28 -->
en:renal failure
n1=en:magnesium carbonate | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:magnesium hydroxide ---
r_associated #0: 28 -->
en:renal failure
n1=en:magnesium hydroxide | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:magnesium hydroxide 325 mg oral tablet ---
r_associated #0: 28 -->
en:renal failure
n1=en:magnesium hydroxide 325 mg oral tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:magnesium oxide 140 mg oral capsule ---
r_associated #0: 28 -->
en:renal failure
n1=en:magnesium oxide 140 mg oral capsule | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:magnesium oxide 250 mg oral tablet ---
r_associated #0: 28 -->
en:renal failure
n1=en:magnesium oxide 250 mg oral tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:magnesium sulfate 0.8 mg/mg topical ointment ---
r_associated #0: 28 -->
en:renal failure
n1=en:magnesium sulfate 0.8 mg/mg topical ointment | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:medullary sponge kidney (rare) ---
r_associated #0: 28 -->
en:renal failure
n1=en:medullary sponge kidney (rare) | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:megacalicosis, unilateral (rare) ---
r_associated #0: 28 -->
en:renal failure
n1=en:megacalicosis, unilateral (rare) | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:membranoproliferative glomerulonephritis (in some patients) ---
r_associated #0: 28 -->
en:renal failure
n1=en:membranoproliferative glomerulonephritis (in some patients) | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:mesangial igm deposition ---
r_associated #0: 28 -->
en:renal failure
n1=en:mesangial igm deposition | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:mesangial matrix expansion ---
r_associated #0: 28 -->
en:renal failure
n1=en:mesangial matrix expansion | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:mesangial, transmembranous, subepithelial, and subendothelial fibrillar deposits which show immunoreactivity to fibronectin ---
r_associated #0: 28 -->
en:renal failure
n1=en:mesangial, transmembranous, subepithelial, and subendothelial fibrillar deposits which show immunoreactivity to fibronectin | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:metabolic renal disease ---
r_associated #0: 28 -->
en:renal failure
n1=en:metabolic renal disease | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:methocarbamol 750mg tablet ---
r_associated #0: 28 -->
en:renal failure
n1=en:methocarbamol 750mg tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:methylene blue 1000 mg oral tablet ---
r_associated #0: 28 -->
en:renal failure
n1=en:methylene blue 1000 mg oral tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:mitomycin 0.2 mg/ml ophthalmic solution ---
r_associated #0: 28 -->
en:renal failure
n1=en:mitomycin 0.2 mg/ml ophthalmic solution | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:multisystem organ failure ---
r_associated #0: 28 -->
en:renal failure
n1=en:multisystem organ failure | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:neonatal research network terminology ---
r_associated #0: 28 -->
en:renal failure
n1=en:neonatal research network terminology | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:nephrocalcinosis is absent ---
r_associated #0: 28 -->
en:renal failure
n1=en:nephrocalcinosis is absent | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:nephronophthisis (1 patient) ---
r_associated #0: 28 -->
en:renal failure
n1=en:nephronophthisis (1 patient) | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:nephronophthisis-like nephropathy ---
r_associated #0: 28 -->
en:renal failure
n1=en:nephronophthisis-like nephropathy | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:nephropathy due to acquired urinary tract obstruction ---
r_associated #0: 28 -->
en:renal failure
n1=en:nephropathy due to acquired urinary tract obstruction | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:no renal failure ---
r_associated #0: 28 -->
en:renal failure
n1=en:no renal failure | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:nutritional and metabolic diseases ---
r_associated #0: 28 -->
en:renal failure
n1=en:nutritional and metabolic diseases | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:other disorders of urethra and urinary tract ---
r_associated #0: 28 -->
en:renal failure
n1=en:other disorders of urethra and urinary tract | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:pigmenturia ---
r_associated #0: 28 -->
en:renal failure
n1=en:pigmenturia | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:polycystic kidney - body part ---
r_associated #0: 28 -->
en:renal failure
n1=en:polycystic kidney - body part | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:polythiazide 1mg tablet ---
r_associated #0: 28 -->
en:renal failure
n1=en:polythiazide 1mg tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:polythiazide 4mg tablet ---
r_associated #0: 28 -->
en:renal failure
n1=en:polythiazide 4mg tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:polyuria (in some) ---
r_associated #0: 28 -->
en:renal failure
n1=en:polyuria (in some) | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:potassium bicarbonate 10 meq effervescent oral tablet ---
r_associated #0: 28 -->
en:renal failure
n1=en:potassium bicarbonate 10 meq effervescent oral tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:potassium bicarbonate 25 meq effervescent oral tablet ---
r_associated #0: 28 -->
en:renal failure
n1=en:potassium bicarbonate 25 meq effervescent oral tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:potassium chloride 10 meq extended release oral tablet ---
r_associated #0: 28 -->
en:renal failure
n1=en:potassium chloride 10 meq extended release oral tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:potassium chloride 10 meq extended release oral tablet [k-dur] ---
r_associated #0: 28 -->
en:renal failure
n1=en:potassium chloride 10 meq extended release oral tablet [k-dur] | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:potassium chloride 13 meq delayed release oral tablet ---
r_associated #0: 28 -->
en:renal failure
n1=en:potassium chloride 13 meq delayed release oral tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:potassium chloride 15 meq extended release oral tablet ---
r_associated #0: 28 -->
en:renal failure
n1=en:potassium chloride 15 meq extended release oral tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:potassium chloride 25meq tablet ---
r_associated #0: 28 -->
en:renal failure
n1=en:potassium chloride 25meq tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:potassium gluconate 2.2 meq oral tablet ---
r_associated #0: 28 -->
en:renal failure
n1=en:potassium gluconate 2.2 meq oral tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:potassium gluconate 2.5 meq oral tablet ---
r_associated #0: 28 -->
en:renal failure
n1=en:potassium gluconate 2.5 meq oral tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:probenecid 500mg tablet ---
r_associated #0: 28 -->
en:renal failure
n1=en:probenecid 500mg tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:pseudoxanthoma elasticum ---
r_associated #0: 28 -->
en:renal failure
n1=en:pseudoxanthoma elasticum | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:pyelonephritis ---
r_associated #0: 28 -->
en:renal failure
n1=en:pyelonephritis | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:reduced renal function (in some patients with structural anomalies) ---
r_associated #0: 28 -->
en:renal failure
n1=en:reduced renal function (in some patients with structural anomalies) | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:renal agenesis (in some patients) ---
r_associated #0: 28 -->
en:renal failure
n1=en:renal agenesis (in some patients) | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:renal agenesis, unilateral (in some patients) ---
r_associated #0: 28 -->
en:renal failure
n1=en:renal agenesis, unilateral (in some patients) | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:renal anomalies (less common) ---
r_associated #0: 28 -->
en:renal failure
n1=en:renal anomalies (less common) | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:renal calculi (urate and calcium oxalate) ---
r_associated #0: 28 -->
en:renal failure
n1=en:renal calculi (urate and calcium oxalate) | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:renal disease in pregnancy and/or puerperium without hypertension ---
r_associated #0: 28 -->
en:renal failure
n1=en:renal disease in pregnancy and/or puerperium without hypertension | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:renal duplication ---
r_associated #0: 28 -->
en:renal failure
n1=en:renal duplication | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:renal duplication (10%) ---
r_associated #0: 28 -->
en:renal failure
n1=en:renal duplication (10%) | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:renal dysplasia/aplasia ---
r_associated #0: 28 -->
en:renal failure
n1=en:renal dysplasia/aplasia | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:renal failure (most common cause of death) (iowa type 107680.0010) ---
r_associated #0: 28 -->
en:renal failure
n1=en:renal failure (most common cause of death) (iowa type 107680.0010) | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:renal failure may occur ---
r_associated #0: 28 -->
en:renal failure
n1=en:renal failure may occur | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:renal function aggravated ---
r_associated #0: 28 -->
en:renal failure
n1=en:renal function aggravated | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:renal medullary washout ---
r_associated #0: 28 -->
en:renal failure
n1=en:renal medullary washout | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:renal mesangiolipidosis ---
r_associated #0: 28 -->
en:renal failure
n1=en:renal mesangiolipidosis | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:renal sodium wasting ---
r_associated #0: 28 -->
en:renal failure
n1=en:renal sodium wasting | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:ribavirin 200mg tablet ---
r_associated #0: 28 -->
en:renal failure
n1=en:ribavirin 200mg tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:single fused kidneys ---
r_associated #0: 28 -->
en:renal failure
n1=en:single fused kidneys | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:single kidney ---
r_associated #0: 28 -->
en:renal failure
n1=en:single kidney | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:small medullary cysts ---
r_associated #0: 28 -->
en:renal failure
n1=en:small medullary cysts | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:sodium phosphate dihydrate ---
r_associated #0: 28 -->
en:renal failure
n1=en:sodium phosphate dihydrate | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:sodium phosphate, dibasic ---
r_associated #0: 28 -->
en:renal failure
n1=en:sodium phosphate, dibasic | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:sotalol hydrochloride 240mg tablet ---
r_associated #0: 28 -->
en:renal failure
n1=en:sotalol hydrochloride 240mg tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:tegaserod maleate ---
r_associated #0: 28 -->
en:renal failure
n1=en:tegaserod maleate | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:testosterone cypionate 100 mg/ml injectable solution ---
r_associated #0: 28 -->
en:renal failure
n1=en:testosterone cypionate 100 mg/ml injectable solution | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:testosterone enanthate 200 mg/ml injectable solution ---
r_associated #0: 28 -->
en:renal failure
n1=en:testosterone enanthate 200 mg/ml injectable solution | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:transplanted kidney complication ---
r_associated #0: 28 -->
en:renal failure
n1=en:transplanted kidney complication | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:tribavirin 6g inhalation (pdr for recon) ---
r_associated #0: 28 -->
en:renal failure
n1=en:tribavirin 6g inhalation (pdr for recon) | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:tubular defect in presecretory reabsorption of urate ---
r_associated #0: 28 -->
en:renal failure
n1=en:tubular defect in presecretory reabsorption of urate | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:tubulointerstitial medullary cystic kidney disease ---
r_associated #0: 28 -->
en:renal failure
n1=en:tubulointerstitial medullary cystic kidney disease | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:tumors of the kidney (may progress to malignancy in less than 2%) ---
r_associated #0: 28 -->
en:renal failure
n1=en:tumors of the kidney (may progress to malignancy in less than 2%) | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:tyrosinemia type i ---
r_associated #0: 28 -->
en:renal failure
n1=en:tyrosinemia type i | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:unilateral renal agenesis ---
r_associated #0: 28 -->
en:renal failure
n1=en:unilateral renal agenesis | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:urethra disorder ---
r_associated #0: 28 -->
en:renal failure
n1=en:urethra disorder | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:urinary complications of care ---
r_associated #0: 28 -->
en:renal failure
n1=en:urinary complications of care | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:urinary incontinence associated with cancer ---
r_associated #0: 28 -->
en:renal failure
n1=en:urinary incontinence associated with cancer | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:wegener granulomatosis ---
r_associated #0: 28 -->
en:renal failure
n1=en:wegener granulomatosis | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- en:wilms tumor-aniridia-genitourinary anomalies-mental retardation syndrome ---
r_associated #0: 28 -->
en:renal failure
n1=en:wilms tumor-aniridia-genitourinary anomalies-mental retardation syndrome | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- hématurie macroscopique ---
r_associated #0: 28 -->
en:renal failure
n1=hématurie macroscopique | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- syndrome de Juhel-Renoy ---
r_associated #0: 28 -->
en:renal failure
n1=syndrome de Juhel-Renoy | n2=en:renal failure | rel=r_associated | relid=0 | w=28
- diverticule caliciel ---
r_associated #0: 27 -->
en:renal failure
n1=diverticule caliciel | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:0.55 ml methotrexate 50 mg/ml auto-injector ---
r_associated #0: 27 -->
en:renal failure
n1=en:0.55 ml methotrexate 50 mg/ml auto-injector | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:2 ml ketorolac tromethamine 30 mg/ml prefilled syringe ---
r_associated #0: 27 -->
en:renal failure
n1=en:2 ml ketorolac tromethamine 30 mg/ml prefilled syringe | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:2 ml methotrexate 25 mg/ml injection ---
r_associated #0: 27 -->
en:renal failure
n1=en:2 ml methotrexate 25 mg/ml injection | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:50 ml magnesium sulfate 80 mg/ml injection ---
r_associated #0: 27 -->
en:renal failure
n1=en:50 ml magnesium sulfate 80 mg/ml injection | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:MOF ---
r_associated #0: 27 -->
en:renal failure
n1=en:MOF | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:abnormal glomeruli seen on biopsy ---
r_associated #0: 27 -->
en:renal failure
n1=en:abnormal glomeruli seen on biopsy | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:abnormal renal pelvises ---
r_associated #0: 27 -->
en:renal failure
n1=en:abnormal renal pelvises | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:acute nephritis (rare) ---
r_associated #0: 27 -->
en:renal failure
n1=en:acute nephritis (rare) | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:adhesions of kidney ---
r_associated #0: 27 -->
en:renal failure
n1=en:adhesions of kidney | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:alteration in patterns of urinary elimination ---
r_associated #0: 27 -->
en:renal failure
n1=en:alteration in patterns of urinary elimination | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:aneurysm of renal artery ---
r_associated #0: 27 -->
en:renal failure
n1=en:aneurysm of renal artery | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:angitis kidney ---
r_associated #0: 27 -->
en:renal failure
n1=en:angitis kidney | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:autosomal recessive polycystic kidney disease ---
r_associated #0: 27 -->
en:renal failure
n1=en:autosomal recessive polycystic kidney disease | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:benzthiazide 50 mg oral tablet ---
r_associated #0: 27 -->
en:renal failure
n1=en:benzthiazide 50 mg oral tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:bilateral ureteropelvic junction stenosis ---
r_associated #0: 27 -->
en:renal failure
n1=en:bilateral ureteropelvic junction stenosis | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:biopsy shows dilated proximal tubules ---
r_associated #0: 27 -->
en:renal failure
n1=en:biopsy shows dilated proximal tubules | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:brinzolamide ---
r_associated #0: 27 -->
en:renal failure
n1=en:brinzolamide | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:calyceal diverticulum ---
r_associated #0: 27 -->
en:renal failure
n1=en:calyceal diverticulum | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:chloral hydrate 500mg/5ml syrup ---
r_associated #0: 27 -->
en:renal failure
n1=en:chloral hydrate 500mg/5ml syrup | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:chlorothiazide ---
r_associated #0: 27 -->
en:renal failure
n1=en:chlorothiazide | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:cisplatin pwdr ---
r_associated #0: 27 -->
en:renal failure
n1=en:cisplatin pwdr | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:citrus naringinine ---
r_associated #0: 27 -->
en:renal failure
n1=en:citrus naringinine | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:collapsing fsgs ---
r_associated #0: 27 -->
en:renal failure
n1=en:collapsing fsgs | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:collapsing glomerulopathy ---
r_associated #0: 27 -->
en:renal failure
n1=en:collapsing glomerulopathy | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:congenital hypoplasia of kidney ---
r_associated #0: 27 -->
en:renal failure
n1=en:congenital hypoplasia of kidney | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:congenital kidney disorder ---
r_associated #0: 27 -->
en:renal failure
n1=en:congenital kidney disorder | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:congenital pelviureteric junction obstruction ---
r_associated #0: 27 -->
en:renal failure
n1=en:congenital pelviureteric junction obstruction | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:cyclosporine 25 mg oral capsule ---
r_associated #0: 27 -->
en:renal failure
n1=en:cyclosporine 25 mg oral capsule | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:cyclosporine 50 mg oral capsule [sandimmune] ---
r_associated #0: 27 -->
en:renal failure
n1=en:cyclosporine 50 mg oral capsule [sandimmune] | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:cystic renal dysplasia ---
r_associated #0: 27 -->
en:renal failure
n1=en:cystic renal dysplasia | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:deafness ---
r_associated #0: 27 -->
en:renal failure
n1=en:deafness | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:decreased or absent laminin beta-2 immunoreactivity in the glomerular basement membrane ---
r_associated #0: 27 -->
en:renal failure
n1=en:decreased or absent laminin beta-2 immunoreactivity in the glomerular basement membrane | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:denuded tubules ---
r_associated #0: 27 -->
en:renal failure
n1=en:denuded tubules | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:diatrizoate 600 mg/ml injectable solution ---
r_associated #0: 27 -->
en:renal failure
n1=en:diatrizoate 600 mg/ml injectable solution | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:diatrizoate meglumine 180mg + iodine 85mg/ml (18%) injection solution 300ml bottle ---
r_associated #0: 27 -->
en:renal failure
n1=en:diatrizoate meglumine 180mg + iodine 85mg/ml (18%) injection solution 300ml bottle | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:diatrizoate meglumine 50%/diatrizoate na 25% inj ---
r_associated #0: 27 -->
en:renal failure
n1=en:diatrizoate meglumine 50%/diatrizoate na 25% inj | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:diatrizoate meglumine 60%/diatrizoate na 30% inj ---
r_associated #0: 27 -->
en:renal failure
n1=en:diatrizoate meglumine 60%/diatrizoate na 30% inj | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:dilation of renal tubules, mild ---
r_associated #0: 27 -->
en:renal failure
n1=en:dilation of renal tubules, mild | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:diphenidol hydrochloride 25mg tablet ---
r_associated #0: 27 -->
en:renal failure
n1=en:diphenidol hydrochloride 25mg tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:disorder of kidney co-occurrent with human immunodeficiency virus infection ---
r_associated #0: 27 -->
en:renal failure
n1=en:disorder of kidney co-occurrent with human immunodeficiency virus infection | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:early-onset end-stage renal disease ---
r_associated #0: 27 -->
en:renal failure
n1=en:early-onset end-stage renal disease | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:end-stage renal disease develops in childhood ---
r_associated #0: 27 -->
en:renal failure
n1=en:end-stage renal disease develops in childhood | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:ergocalciferol 8000 unt/ml oral solution ---
r_associated #0: 27 -->
en:renal failure
n1=en:ergocalciferol 8000 unt/ml oral solution | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:fenofibrate 120mg tablet ---
r_associated #0: 27 -->
en:renal failure
n1=en:fenofibrate 120mg tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:fenofibrate 200 mg oral capsule ---
r_associated #0: 27 -->
en:renal failure
n1=en:fenofibrate 200 mg oral capsule | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:fenofibrate micronized 50mg tablet ---
r_associated #0: 27 -->
en:renal failure
n1=en:fenofibrate micronized 50mg tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:fentanyl 0.1 mg sublingual tablet ---
r_associated #0: 27 -->
en:renal failure
n1=en:fentanyl 0.1 mg sublingual tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:fentanyl 0.2 mg/actuat mucosal spray ---
r_associated #0: 27 -->
en:renal failure
n1=en:fentanyl 0.2 mg/actuat mucosal spray | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:fentanyl 0.4 mg/actuat nasal spray ---
r_associated #0: 27 -->
en:renal failure
n1=en:fentanyl 0.4 mg/actuat nasal spray | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:fentanyl 0.6 mg sublingual tablet ---
r_associated #0: 27 -->
en:renal failure
n1=en:fentanyl 0.6 mg sublingual tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:fentanyl 0.8 mg/actuat mucosal spray ---
r_associated #0: 27 -->
en:renal failure
n1=en:fentanyl 0.8 mg/actuat mucosal spray | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:fentanyl 1200micrograms lozenge ---
r_associated #0: 27 -->
en:renal failure
n1=en:fentanyl 1200micrograms lozenge | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:fentanyl 1600micrograms lozenge ---
r_associated #0: 27 -->
en:renal failure
n1=en:fentanyl 1600micrograms lozenge | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:fentanyl 200micrograms lozenge ---
r_associated #0: 27 -->
en:renal failure
n1=en:fentanyl 200micrograms lozenge | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:fentanyl citrate 200mg lozenge ---
r_associated #0: 27 -->
en:renal failure
n1=en:fentanyl citrate 200mg lozenge | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:fentanyl citrate 25 ug in 1 ml intravenous injection, solution [fentanyl citrate] ---
r_associated #0: 27 -->
en:renal failure
n1=en:fentanyl citrate 25 ug in 1 ml intravenous injection, solution [fentanyl citrate] | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:fentanyl citrate 800mg lozenge ---
r_associated #0: 27 -->
en:renal failure
n1=en:fentanyl citrate 800mg lozenge | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:fistula from renal pelvis ---
r_associated #0: 27 -->
en:renal failure
n1=en:fistula from renal pelvis | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:focal tubular dystrophy ---
r_associated #0: 27 -->
en:renal failure
n1=en:focal tubular dystrophy | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:fondaparinux sodium 12.5mg/ml injection solution 0.8ml prefilled syringe ---
r_associated #0: 27 -->
en:renal failure
n1=en:fondaparinux sodium 12.5mg/ml injection solution 0.8ml prefilled syringe | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:foscarnet sodium 24 mg/ml injection ---
r_associated #0: 27 -->
en:renal failure
n1=en:foscarnet sodium 24 mg/ml injection | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:gemfibrozil 600mg tablet ---
r_associated #0: 27 -->
en:renal failure
n1=en:gemfibrozil 600mg tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:glomerulopathy with giant fibrillar deposits ---
r_associated #0: 27 -->
en:renal failure
n1=en:glomerulopathy with giant fibrillar deposits | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:gout, hprt-related ---
r_associated #0: 27 -->
en:renal failure
n1=en:gout, hprt-related | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:healed glomerulonephritis ---
r_associated #0: 27 -->
en:renal failure
n1=en:healed glomerulonephritis | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:healed pyelonephritis ---
r_associated #0: 27 -->
en:renal failure
n1=en:healed pyelonephritis | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:hematuria, gross (in some patients) ---
r_associated #0: 27 -->
en:renal failure
n1=en:hematuria, gross (in some patients) | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:hydrochlorothiazide 12.5mg capsule ---
r_associated #0: 27 -->
en:renal failure
n1=en:hydrochlorothiazide 12.5mg capsule | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:hydrochlorothiazide 25mg tablet ---
r_associated #0: 27 -->
en:renal failure
n1=en:hydrochlorothiazide 25mg tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:hyperechogenic kidneys or renal cysts on prenatal ultrasound ---
r_associated #0: 27 -->
en:renal failure
n1=en:hyperechogenic kidneys or renal cysts on prenatal ultrasound | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:hypoplastic renal arteries (rare) ---
r_associated #0: 27 -->
en:renal failure
n1=en:hypoplastic renal arteries (rare) | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:impaired renal function (variable) ---
r_associated #0: 27 -->
en:renal failure
n1=en:impaired renal function (variable) | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:increased renal tubular phosphate reabsorption ---
r_associated #0: 27 -->
en:renal failure
n1=en:increased renal tubular phosphate reabsorption | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:ipsilateral renal agenesis ---
r_associated #0: 27 -->
en:renal failure
n1=en:ipsilateral renal agenesis | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:jeune syndrome ---
r_associated #0: 27 -->
en:renal failure
n1=en:jeune syndrome | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:joubert syndrome type 4 ---
r_associated #0: 27 -->
en:renal failure
n1=en:joubert syndrome type 4 | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:juxtaglomerular apparatus ---
r_associated #0: 27 -->
en:renal failure
n1=en:juxtaglomerular apparatus | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:ketorolac tromethamine 0.4% ophthalmic solution ---
r_associated #0: 27 -->
en:renal failure
n1=en:ketorolac tromethamine 0.4% ophthalmic solution | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:kidney disease, end-stage ---
r_associated #0: 27 -->
en:renal failure
n1=en:kidney disease, end-stage | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:kidney failure if untreated ---
r_associated #0: 27 -->
en:renal failure
n1=en:kidney failure if untreated | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:kidney transplantation ---
r_associated #0: 27 -->
en:renal failure
n1=en:kidney transplantation | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:magnesium glycinate cap/tab ---
r_associated #0: 27 -->
en:renal failure
n1=en:magnesium glycinate cap/tab | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:magnesium hydroxide 311 mg chewable tablet ---
r_associated #0: 27 -->
en:renal failure
n1=en:magnesium hydroxide 311 mg chewable tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:magnesium hydroxide 80 mg/ml oral suspension ---
r_associated #0: 27 -->
en:renal failure
n1=en:magnesium hydroxide 80 mg/ml oral suspension | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:magnesium oxide ---
r_associated #0: 27 -->
en:renal failure
n1=en:magnesium oxide | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:magnesium phosphate ---
r_associated #0: 27 -->
en:renal failure
n1=en:magnesium phosphate | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:mesangial cell proliferation ---
r_associated #0: 27 -->
en:renal failure
n1=en:mesangial cell proliferation | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:metaxalone 800mg tablet ---
r_associated #0: 27 -->
en:renal failure
n1=en:metaxalone 800mg tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:metformin hydrochloride 750mg m/r tablet ---
r_associated #0: 27 -->
en:renal failure
n1=en:metformin hydrochloride 750mg m/r tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:methotrexate 1000 mg injection ---
r_associated #0: 27 -->
en:renal failure
n1=en:methotrexate 1000 mg injection | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:methylene blue 65mg tablet ---
r_associated #0: 27 -->
en:renal failure
n1=en:methylene blue 65mg tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:methylmalonic acidemia with homocystinuria ---
r_associated #0: 27 -->
en:renal failure
n1=en:methylmalonic acidemia with homocystinuria | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:metolazone 5mg tablet ---
r_associated #0: 27 -->
en:renal failure
n1=en:metolazone 5mg tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:myoglobinuria ---
r_associated #0: 27 -->
en:renal failure
n1=en:myoglobinuria | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:nephritis and nephropathy, not specified as acute or chronic ---
r_associated #0: 27 -->
en:renal failure
n1=en:nephritis and nephropathy, not specified as acute or chronic | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:nephritis, nephrotic syndrome, and nephrosis ---
r_associated #0: 27 -->
en:renal failure
n1=en:nephritis, nephrotic syndrome, and nephrosis | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:nephrolithiasis (rare) ---
r_associated #0: 27 -->
en:renal failure
n1=en:nephrolithiasis (rare) | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:nephrotic syndrome, steroid-nonresponsive ---
r_associated #0: 27 -->
en:renal failure
n1=en:nephrotic syndrome, steroid-nonresponsive | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:no kidney disease ---
r_associated #0: 27 -->
en:renal failure
n1=en:no kidney disease | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:noninflammatory disorders of female genital tract ---
r_associated #0: 27 -->
en:renal failure
n1=en:noninflammatory disorders of female genital tract | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:normal kidneys ---
r_associated #0: 27 -->
en:renal failure
n1=en:normal kidneys | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:normal renal ultrasound at ages 4 and 7 ---
r_associated #0: 27 -->
en:renal failure
n1=en:normal renal ultrasound at ages 4 and 7 | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:obstructive nephropathy ---
r_associated #0: 27 -->
en:renal failure
n1=en:obstructive nephropathy | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:osteolysis, hereditary, of carpal bones with or without nephropathy ---
r_associated #0: 27 -->
en:renal failure
n1=en:osteolysis, hereditary, of carpal bones with or without nephropathy | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:pelvic dilation ---
r_associated #0: 27 -->
en:renal failure
n1=en:pelvic dilation | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:pelvic kidney ---
r_associated #0: 27 -->
en:renal failure
n1=en:pelvic kidney | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:pelvic kidney (1 patient) ---
r_associated #0: 27 -->
en:renal failure
n1=en:pelvic kidney (1 patient) | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:pelvicalyceal dilatation ---
r_associated #0: 27 -->
en:renal failure
n1=en:pelvicalyceal dilatation | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:perinephritis ---
r_associated #0: 27 -->
en:renal failure
n1=en:perinephritis | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:phospho-soda ---
r_associated #0: 27 -->
en:renal failure
n1=en:phospho-soda | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:potassium acetate 0.2 meq/ml injectable solution ---
r_associated #0: 27 -->
en:renal failure
n1=en:potassium acetate 0.2 meq/ml injectable solution | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:potassium chloride 6.7 meq delayed release oral tablet ---
r_associated #0: 27 -->
en:renal failure
n1=en:potassium chloride 6.7 meq delayed release oral tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:potassium gluconate 5 meq oral tablet ---
r_associated #0: 27 -->
en:renal failure
n1=en:potassium gluconate 5 meq oral tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:potassium,chelated 99 mg oral tablet ---
r_associated #0: 27 -->
en:renal failure
n1=en:potassium,chelated 99 mg oral tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:protein-losing nephropathy ---
r_associated #0: 27 -->
en:renal failure
n1=en:protein-losing nephropathy | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:proteinuria ---
r_associated #0: 27 -->
en:renal failure
n1=en:proteinuria | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:proteinuria, severe ---
r_associated #0: 27 -->
en:renal failure
n1=en:proteinuria, severe | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:renal anomalies (in some) ---
r_associated #0: 27 -->
en:renal failure
n1=en:renal anomalies (in some) | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:renal aplasia (less common) ---
r_associated #0: 27 -->
en:renal failure
n1=en:renal aplasia (less common) | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:renal biopsy shows tubular atrophy ---
r_associated #0: 27 -->
en:renal failure
n1=en:renal biopsy shows tubular atrophy | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:renal biopsy shows tubulointerstitial fibrosis ---
r_associated #0: 27 -->
en:renal failure
n1=en:renal biopsy shows tubulointerstitial fibrosis | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:renal calcification (in some patients) ---
r_associated #0: 27 -->
en:renal failure
n1=en:renal calcification (in some patients) | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:renal cell carcinoma (e.g., 193300.0002) ---
r_associated #0: 27 -->
en:renal failure
n1=en:renal cell carcinoma (e.g., 193300.0002) | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:renal complication of procedure ---
r_associated #0: 27 -->
en:renal failure
n1=en:renal complication of procedure | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:renal fibrosis ---
r_associated #0: 27 -->
en:renal failure
n1=en:renal fibrosis | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:renal impairment ---
r_associated #0: 27 -->
en:renal failure
n1=en:renal impairment | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:renal impairment caused by polyomavirus ---
r_associated #0: 27 -->
en:renal failure
n1=en:renal impairment caused by polyomavirus | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:renal involvement (in 39%) ---
r_associated #0: 27 -->
en:renal failure
n1=en:renal involvement (in 39%) | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:renal tubular acidosis (in some patients) ---
r_associated #0: 27 -->
en:renal failure
n1=en:renal tubular acidosis (in some patients) | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:renal tubular insufficiency (1 patient) ---
r_associated #0: 27 -->
en:renal failure
n1=en:renal tubular insufficiency (1 patient) | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:renal tumors (in about 27% of patients) ---
r_associated #0: 27 -->
en:renal failure
n1=en:renal tumors (in about 27% of patients) | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:retroperitoneal fibrosis (smq) ---
r_associated #0: 27 -->
en:renal failure
n1=en:retroperitoneal fibrosis (smq) | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:single kidney (seen in patients with contiguous gene defect) ---
r_associated #0: 27 -->
en:renal failure
n1=en:single kidney (seen in patients with contiguous gene defect) | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:small kidney ---
r_associated #0: 27 -->
en:renal failure
n1=en:small kidney | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:splitting of the basement membrane ---
r_associated #0: 27 -->
en:renal failure
n1=en:splitting of the basement membrane | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:testosterone 6mg/24hours transdermal patch ---
r_associated #0: 27 -->
en:renal failure
n1=en:testosterone 6mg/24hours transdermal patch | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:testosterone cypionate ---
r_associated #0: 27 -->
en:renal failure
n1=en:testosterone cypionate | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:testosterone cypionate 50 mg/ml injectable solution ---
r_associated #0: 27 -->
en:renal failure
n1=en:testosterone cypionate 50 mg/ml injectable solution | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:thin glomerular basement membrane ---
r_associated #0: 27 -->
en:renal failure
n1=en:thin glomerular basement membrane | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:thinning of the glomerular basement membrane (early in the disease) ---
r_associated #0: 27 -->
en:renal failure
n1=en:thinning of the glomerular basement membrane (early in the disease) | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:uracratia ---
r_associated #0: 27 -->
en:renal failure
n1=en:uracratia | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:uremia ---
r_associated #0: 27 -->
en:renal failure
n1=en:uremia | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:uric acid nephrolithiasis ---
r_associated #0: 27 -->
en:renal failure
n1=en:uric acid nephrolithiasis | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:uric acid urolithiasis ---
r_associated #0: 27 -->
en:renal failure
n1=en:uric acid urolithiasis | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:urogenital injury ---
r_associated #0: 27 -->
en:renal failure
n1=en:urogenital injury | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:vascular structure of kidney ---
r_associated #0: 27 -->
en:renal failure
n1=en:vascular structure of kidney | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:vesicoureteral reflux (rare) ---
r_associated #0: 27 -->
en:renal failure
n1=en:vesicoureteral reflux (rare) | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- en:{12 (methotrexate 2.5 mg oral tablet) } pack ---
r_associated #0: 27 -->
en:renal failure
n1=en:{12 (methotrexate 2.5 mg oral tablet) } pack | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- fibrose rénale ---
r_associated #0: 27 -->
en:renal failure
n1=fibrose rénale | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- hématurie ---
r_associated #0: 27 -->
en:renal failure
n1=hématurie | n2=en:renal failure | rel=r_associated | relid=0 | w=27
- anurie ---
r_associated #0: 26 -->
en:renal failure
n1=anurie | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- azotémie ---
r_associated #0: 26 -->
en:renal failure
n1=azotémie | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:0.3 ml methotrexate 50 mg/ml auto-injector ---
r_associated #0: 26 -->
en:renal failure
n1=en:0.3 ml methotrexate 50 mg/ml auto-injector | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:1 ml ketorolac tromethamine 15 mg/ml cartridge ---
r_associated #0: 26 -->
en:renal failure
n1=en:1 ml ketorolac tromethamine 15 mg/ml cartridge | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:1 ml ketorolac tromethamine 15 mg/ml prefilled syringe ---
r_associated #0: 26 -->
en:renal failure
n1=en:1 ml ketorolac tromethamine 15 mg/ml prefilled syringe | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:24 hr metformin hydrochloride 1000 mg extended release oral tablet [fortamet] ---
r_associated #0: 26 -->
en:renal failure
n1=en:24 hr metformin hydrochloride 1000 mg extended release oral tablet [fortamet] | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:4 ml methotrexate 25 mg/ml injection ---
r_associated #0: 26 -->
en:renal failure
n1=en:4 ml methotrexate 25 mg/ml injection | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:Bywater's syndrome ---
r_associated #0: 26 -->
en:renal failure
n1=en:Bywater's syndrome | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:Wegener granulomatosis ---
r_associated #0: 26 -->
en:renal failure
n1=en:Wegener granulomatosis | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:abnormally placed kidney (dystopic) ---
r_associated #0: 26 -->
en:renal failure
n1=en:abnormally placed kidney (dystopic) | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:absent kidney ---
r_associated #0: 26 -->
en:renal failure
n1=en:absent kidney | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:absent/poor corticomedullary differentiation (some patients) ---
r_associated #0: 26 -->
en:renal failure
n1=en:absent/poor corticomedullary differentiation (some patients) | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:acute kidney injury ---
r_associated #0: 26 -->
en:renal failure
n1=en:acute kidney injury | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:acute renal failure with renal papillary necrosis ---
r_associated #0: 26 -->
en:renal failure
n1=en:acute renal failure with renal papillary necrosis | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:adult fanconi syndrome ---
r_associated #0: 26 -->
en:renal failure
n1=en:adult fanconi syndrome | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:altered basement membrane ---
r_associated #0: 26 -->
en:renal failure
n1=en:altered basement membrane | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:antibody deposits ---
r_associated #0: 26 -->
en:renal failure
n1=en:antibody deposits | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:bardet-biedl syndrome 18 ---
r_associated #0: 26 -->
en:renal failure
n1=en:bardet-biedl syndrome 18 | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:bendroflumethiazide ---
r_associated #0: 26 -->
en:renal failure
n1=en:bendroflumethiazide | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:biopsy shows decreased cytochrome c oxidase ---
r_associated #0: 26 -->
en:renal failure
n1=en:biopsy shows decreased cytochrome c oxidase | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:biopsy shows effacement of foot processes ---
r_associated #0: 26 -->
en:renal failure
n1=en:biopsy shows effacement of foot processes | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:calciferol 1.25mg tablet ---
r_associated #0: 26 -->
en:renal failure
n1=en:calciferol 1.25mg tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:cardiorenal syndrome ---
r_associated #0: 26 -->
en:renal failure
n1=en:cardiorenal syndrome | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:chlorothiazide sodium ---
r_associated #0: 26 -->
en:renal failure
n1=en:chlorothiazide sodium | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:chlorthalidone ---
r_associated #0: 26 -->
en:renal failure
n1=en:chlorthalidone | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:chlorthalidone 15mg tablet ---
r_associated #0: 26 -->
en:renal failure
n1=en:chlorthalidone 15mg tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:chronic thrombotic microangiopathy ---
r_associated #0: 26 -->
en:renal failure
n1=en:chronic thrombotic microangiopathy | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:cip-fenofibrate 50mg capsule ---
r_associated #0: 26 -->
en:renal failure
n1=en:cip-fenofibrate 50mg capsule | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:cisplatin ---
r_associated #0: 26 -->
en:renal failure
n1=en:cisplatin | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:cisplatin 500micrograms/ml infusion concentrate 20ml vial ---
r_associated #0: 26 -->
en:renal failure
n1=en:cisplatin 500micrograms/ml infusion concentrate 20ml vial | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:citric acid ---
r_associated #0: 26 -->
en:renal failure
n1=en:citric acid | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:coach syndrome ---
r_associated #0: 26 -->
en:renal failure
n1=en:coach syndrome | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:cyclosporine 100 mg oral capsule ---
r_associated #0: 26 -->
en:renal failure
n1=en:cyclosporine 100 mg oral capsule | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:cyclosporine 100 mg oral capsule [sandimmune] ---
r_associated #0: 26 -->
en:renal failure
n1=en:cyclosporine 100 mg oral capsule [sandimmune] | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:cyclosporine ophthalmic emulsion 0.05% ---
r_associated #0: 26 -->
en:renal failure
n1=en:cyclosporine ophthalmic emulsion 0.05% | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:cyclosporine, modified 100 mg oral capsule [gengraf] ---
r_associated #0: 26 -->
en:renal failure
n1=en:cyclosporine, modified 100 mg oral capsule [gengraf] | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:cystic kidney ---
r_associated #0: 26 -->
en:renal failure
n1=en:cystic kidney | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:cystic nephroma ---
r_associated #0: 26 -->
en:renal failure
n1=en:cystic nephroma | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:cystic renal dysplasia (less common) ---
r_associated #0: 26 -->
en:renal failure
n1=en:cystic renal dysplasia (less common) | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:cysts contain eosinophilic proteinaceous material ---
r_associated #0: 26 -->
en:renal failure
n1=en:cysts contain eosinophilic proteinaceous material | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:dark urine following exercise ---
r_associated #0: 26 -->
en:renal failure
n1=en:dark urine following exercise | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:decreased renal function ---
r_associated #0: 26 -->
en:renal failure
n1=en:decreased renal function | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:dextrothyroxine 1 mg oral tablet ---
r_associated #0: 26 -->
en:renal failure
n1=en:dextrothyroxine 1 mg oral tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:diatrizoate meglumine 28.5%/diatrizoate na 29.1% inj ---
r_associated #0: 26 -->
en:renal failure
n1=en:diatrizoate meglumine 28.5%/diatrizoate na 29.1% inj | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:diatrizoate meglumine 300mg + iodine 141mg/ml (30%) injection solution 300ml bottle ---
r_associated #0: 26 -->
en:renal failure
n1=en:diatrizoate meglumine 300mg + iodine 141mg/ml (30%) injection solution 300ml bottle | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:dibasic potassium phosphate 1.66 meq/ml / monobasic potassium phosphate 1.65 meq/ml injectable solution ---
r_associated #0: 26 -->
en:renal failure
n1=en:dibasic potassium phosphate 1.66 meq/ml / monobasic potassium phosphate 1.65 meq/ml injectable solution | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:dilated cystic tubules ---
r_associated #0: 26 -->
en:renal failure
n1=en:dilated cystic tubules | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:discoloration of kidney ---
r_associated #0: 26 -->
en:renal failure
n1=en:discoloration of kidney | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:disorder of kidney due to kappa light chain disease ---
r_associated #0: 26 -->
en:renal failure
n1=en:disorder of kidney due to kappa light chain disease | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:dofetilide 125micrograms capsule ---
r_associated #0: 26 -->
en:renal failure
n1=en:dofetilide 125micrograms capsule | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:duplicated kidneys (rare) ---
r_associated #0: 26 -->
en:renal failure
n1=en:duplicated kidneys (rare) | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:ectopic kidney ---
r_associated #0: 26 -->
en:renal failure
n1=en:ectopic kidney | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:edetate disodium ---
r_associated #0: 26 -->
en:renal failure
n1=en:edetate disodium | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:effacement of epithelial foot processes ---
r_associated #0: 26 -->
en:renal failure
n1=en:effacement of epithelial foot processes | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:end stage renal disease (seen in 20-40% of patients by 20 years after biopsy) ---
r_associated #0: 26 -->
en:renal failure
n1=en:end stage renal disease (seen in 20-40% of patients by 20 years after biopsy) | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:end-stage renal failure (in some patients) ---
r_associated #0: 26 -->
en:renal failure
n1=en:end-stage renal failure (in some patients) | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:enlarged glomeruli ---
r_associated #0: 26 -->
en:renal failure
n1=en:enlarged glomeruli | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:enlarged, hyperechogenic kidneys (ultrasound) ---
r_associated #0: 26 -->
en:renal failure
n1=en:enlarged, hyperechogenic kidneys (ultrasound) | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:entire kidney ---
r_associated #0: 26 -->
en:renal failure
n1=en:entire kidney | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:ergocalciferol ---
r_associated #0: 26 -->
en:renal failure
n1=en:ergocalciferol | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:fenofibrate 90 mg oral capsule ---
r_associated #0: 26 -->
en:renal failure
n1=en:fenofibrate 90 mg oral capsule | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:fentanyl 0.04 mg transdermal patch ---
r_associated #0: 26 -->
en:renal failure
n1=en:fentanyl 0.04 mg transdermal patch | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:fentanyl 0.1 mg/actuat nasal spray ---
r_associated #0: 26 -->
en:renal failure
n1=en:fentanyl 0.1 mg/actuat nasal spray | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:fentanyl 0.3 mg sublingual tablet ---
r_associated #0: 26 -->
en:renal failure
n1=en:fentanyl 0.3 mg sublingual tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:fentanyl 300micrograms lozenge ---
r_associated #0: 26 -->
en:renal failure
n1=en:fentanyl 300micrograms lozenge | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:fentanyl 600microgram buccal soluble film ---
r_associated #0: 26 -->
en:renal failure
n1=en:fentanyl 600microgram buccal soluble film | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:fibrocystic renal degeneration ---
r_associated #0: 26 -->
en:renal failure
n1=en:fibrocystic renal degeneration | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:focal medullary hypoplasia ---
r_associated #0: 26 -->
en:renal failure
n1=en:focal medullary hypoplasia | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:focal segmental glomerulosclerosis ---
r_associated #0: 26 -->
en:renal failure
n1=en:focal segmental glomerulosclerosis | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:fondaparinux ---
r_associated #0: 26 -->
en:renal failure
n1=en:fondaparinux | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:foot process effacement ---
r_associated #0: 26 -->
en:renal failure
n1=en:foot process effacement | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:foreign body in kidney ---
r_associated #0: 26 -->
en:renal failure
n1=en:foreign body in kidney | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:fused kidney ---
r_associated #0: 26 -->
en:renal failure
n1=en:fused kidney | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:galactose-deficient iga1 deposits in the glomerular mesangium, with or without igm and igg ---
r_associated #0: 26 -->
en:renal failure
n1=en:galactose-deficient iga1 deposits in the glomerular mesangium, with or without igm and igg | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:galantamine ---
r_associated #0: 26 -->
en:renal failure
n1=en:galantamine | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:glomerular tufts ---
r_associated #0: 26 -->
en:renal failure
n1=en:glomerular tufts | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:glomerulonephiitis ---
r_associated #0: 26 -->
en:renal failure
n1=en:glomerulonephiitis | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:glomerulonephritis and nephrotic syndrome ---
r_associated #0: 26 -->
en:renal failure
n1=en:glomerulonephritis and nephrotic syndrome | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:glomerulonephropathy ---
r_associated #0: 26 -->
en:renal failure
n1=en:glomerulonephropathy | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:glycosuria ---
r_associated #0: 26 -->
en:renal failure
n1=en:glycosuria | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:heavy chain deposition disease ---
r_associated #0: 26 -->
en:renal failure
n1=en:heavy chain deposition disease | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:hereditary nephropathy ---
r_associated #0: 26 -->
en:renal failure
n1=en:hereditary nephropathy | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:high fractional excretion of magnesium ---
r_associated #0: 26 -->
en:renal failure
n1=en:high fractional excretion of magnesium | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:histologically normal adrenal gland (in some patients) ---
r_associated #0: 26 -->
en:renal failure
n1=en:histologically normal adrenal gland (in some patients) | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:hydrochlorothiazide 12.5 mg oral tablet ---
r_associated #0: 26 -->
en:renal failure
n1=en:hydrochlorothiazide 12.5 mg oral tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:hydrochlorothiazide 50mg tablet ---
r_associated #0: 26 -->
en:renal failure
n1=en:hydrochlorothiazide 50mg tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:hyperplasia of zona fasciculata of adrenal gland ---
r_associated #0: 26 -->
en:renal failure
n1=en:hyperplasia of zona fasciculata of adrenal gland | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:immune complex nephritis ---
r_associated #0: 26 -->
en:renal failure
n1=en:immune complex nephritis | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:inability to concentrate urine ---
r_associated #0: 26 -->
en:renal failure
n1=en:inability to concentrate urine | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:increased risk for wilms tumor ---
r_associated #0: 26 -->
en:renal failure
n1=en:increased risk for wilms tumor | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:ketorolac tromethamine ---
r_associated #0: 26 -->
en:renal failure
n1=en:ketorolac tromethamine | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:magnesium 500mg tab ---
r_associated #0: 26 -->
en:renal failure
n1=en:magnesium 500mg tab | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:magnesium acetate tetrahydrate ---
r_associated #0: 26 -->
en:renal failure
n1=en:magnesium acetate tetrahydrate | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:magnesium sulfate 20 mg/ml injection ---
r_associated #0: 26 -->
en:renal failure
n1=en:magnesium sulfate 20 mg/ml injection | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:malignant bladder neoplasm ---
r_associated #0: 26 -->
en:renal failure
n1=en:malignant bladder neoplasm | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:membranoproliferative glomerulonephritis seen on biopsy ---
r_associated #0: 26 -->
en:renal failure
n1=en:membranoproliferative glomerulonephritis seen on biopsy | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:metformin hydrochloride ---
r_associated #0: 26 -->
en:renal failure
n1=en:metformin hydrochloride | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:methazolamide 25mg tablet ---
r_associated #0: 26 -->
en:renal failure
n1=en:methazolamide 25mg tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:methotrexate 15 mg oral tablet ---
r_associated #0: 26 -->
en:renal failure
n1=en:methotrexate 15 mg oral tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:metolazone ---
r_associated #0: 26 -->
en:renal failure
n1=en:metolazone | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:mild subclinical decrease in renal function ---
r_associated #0: 26 -->
en:renal failure
n1=en:mild subclinical decrease in renal function | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:multicystic dysplastic kidney ---
r_associated #0: 26 -->
en:renal failure
n1=en:multicystic dysplastic kidney | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:neonatal anuria ---
r_associated #0: 26 -->
en:renal failure
n1=en:neonatal anuria | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:nephrocalcinosis (in some patients) ---
r_associated #0: 26 -->
en:renal failure
n1=en:nephrocalcinosis (in some patients) | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:nephronophthisis ---
r_associated #0: 26 -->
en:renal failure
n1=en:nephronophthisis | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:nephronophthisis (1 of 2 patients) ---
r_associated #0: 26 -->
en:renal failure
n1=en:nephronophthisis (1 of 2 patients) | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:nephrovisceral fistula ---
r_associated #0: 26 -->
en:renal failure
n1=en:nephrovisceral fistula | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:no evidence of renal cysts ---
r_associated #0: 26 -->
en:renal failure
n1=en:no evidence of renal cysts | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:opium alkaloids hydrochloride ---
r_associated #0: 26 -->
en:renal failure
n1=en:opium alkaloids hydrochloride | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:other specified disorders resulting from impaired renal function ---
r_associated #0: 26 -->
en:renal failure
n1=en:other specified disorders resulting from impaired renal function | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:polythiazide 2mg tablet ---
r_associated #0: 26 -->
en:renal failure
n1=en:polythiazide 2mg tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:potassium bicarbonate ---
r_associated #0: 26 -->
en:renal failure
n1=en:potassium bicarbonate | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:potassium bicarbonate 6.5 meq oral tablet ---
r_associated #0: 26 -->
en:renal failure
n1=en:potassium bicarbonate 6.5 meq oral tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:potassium chloride 1.33 meq/ml oral solution ---
r_associated #0: 26 -->
en:renal failure
n1=en:potassium chloride 1.33 meq/ml oral solution | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:potassium chloride 1.5 meq/ml injectable solution ---
r_associated #0: 26 -->
en:renal failure
n1=en:potassium chloride 1.5 meq/ml injectable solution | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:potassium chloride 8 meq extended release oral tablet ---
r_associated #0: 26 -->
en:renal failure
n1=en:potassium chloride 8 meq extended release oral tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:potassium,chelated ---
r_associated #0: 26 -->
en:renal failure
n1=en:potassium,chelated | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:prominent epithelial luminal budding (1 of 2 patients) ---
r_associated #0: 26 -->
en:renal failure
n1=en:prominent epithelial luminal budding (1 of 2 patients) | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:pseudomembranous, calcified plaques in the renal collecting system (rare) ---
r_associated #0: 26 -->
en:renal failure
n1=en:pseudomembranous, calcified plaques in the renal collecting system (rare) | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:pyelonephritis (in some patients) ---
r_associated #0: 26 -->
en:renal failure
n1=en:pyelonephritis (in some patients) | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:pyuria ---
r_associated #0: 26 -->
en:renal failure
n1=en:pyuria | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:reduced fractional excretion of uric acid ---
r_associated #0: 26 -->
en:renal failure
n1=en:reduced fractional excretion of uric acid | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:renal amyloidosis (iowa type 107680.0010, systemic nonneuronopathic 107680.0016) ---
r_associated #0: 26 -->
en:renal failure
n1=en:renal amyloidosis (iowa type 107680.0010, systemic nonneuronopathic 107680.0016) | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:renal capsule ---
r_associated #0: 26 -->
en:renal failure
n1=en:renal capsule | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:renal colic (in some patients) ---
r_associated #0: 26 -->
en:renal failure
n1=en:renal colic (in some patients) | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:renal cortex calcification (in some patients) ---
r_associated #0: 26 -->
en:renal failure
n1=en:renal cortex calcification (in some patients) | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:renal failure adverse event ---
r_associated #0: 26 -->
en:renal failure
n1=en:renal failure adverse event | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:renal failure following abortion and ectopic and molar pregnancy ---
r_associated #0: 26 -->
en:renal failure
n1=en:renal failure following abortion and ectopic and molar pregnancy | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:renal failure may occur with myoglobinuria ---
r_associated #0: 26 -->
en:renal failure
n1=en:renal failure may occur with myoglobinuria | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:renal hypodysplasia (in some patients) ---
r_associated #0: 26 -->
en:renal failure
n1=en:renal hypodysplasia (in some patients) | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:renal medullary dysplasia ---
r_associated #0: 26 -->
en:renal failure
n1=en:renal medullary dysplasia | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:renal nutcracker syndrome ---
r_associated #0: 26 -->
en:renal failure
n1=en:renal nutcracker syndrome | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:renal pelvis ---
r_associated #0: 26 -->
en:renal failure
n1=en:renal pelvis | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:renal stone ---
r_associated #0: 26 -->
en:renal failure
n1=en:renal stone | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:ribavirin 600 mg oral tablet ---
r_associated #0: 26 -->
en:renal failure
n1=en:ribavirin 600 mg oral tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:scarred glomerular tufts ---
r_associated #0: 26 -->
en:renal failure
n1=en:scarred glomerular tufts | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:small kidneys (in some patients) ---
r_associated #0: 26 -->
en:renal failure
n1=en:small kidneys (in some patients) | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:some sclerotic glomeruli ---
r_associated #0: 26 -->
en:renal failure
n1=en:some sclerotic glomeruli | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:sotalol ---
r_associated #0: 26 -->
en:renal failure
n1=en:sotalol | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:stenosis of calyceal neck ---
r_associated #0: 26 -->
en:renal failure
n1=en:stenosis of calyceal neck | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:structure of inferior pole of kidney ---
r_associated #0: 26 -->
en:renal failure
n1=en:structure of inferior pole of kidney | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:swelling of endothelial cells ---
r_associated #0: 26 -->
en:renal failure
n1=en:swelling of endothelial cells | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:testosterone 30mg buccal system ---
r_associated #0: 26 -->
en:renal failure
n1=en:testosterone 30mg buccal system | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:testosterone 75mg pellet implant ---
r_associated #0: 26 -->
en:renal failure
n1=en:testosterone 75mg pellet implant | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:thickening of glomerular basement membrane ---
r_associated #0: 26 -->
en:renal failure
n1=en:thickening of glomerular basement membrane | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:thickening of the glomerular basement membrane on renal biopsy ---
r_associated #0: 26 -->
en:renal failure
n1=en:thickening of the glomerular basement membrane on renal biopsy | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:toxoplasma tubulointerstitial nephropathy ---
r_associated #0: 26 -->
en:renal failure
n1=en:toxoplasma tubulointerstitial nephropathy | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:transplanted kidney ---
r_associated #0: 26 -->
en:renal failure
n1=en:transplanted kidney | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:tubular calcification (in some patients) ---
r_associated #0: 26 -->
en:renal failure
n1=en:tubular calcification (in some patients) | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:tubulointerstitial atrophy ---
r_associated #0: 26 -->
en:renal failure
n1=en:tubulointerstitial atrophy | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:tubulopathy (patient a) ---
r_associated #0: 26 -->
en:renal failure
n1=en:tubulopathy (patient a) | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:urinary frequency ---
r_associated #0: 26 -->
en:renal failure
n1=en:urinary frequency | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:volume depletion, renal, due to output loss (renal deficit) ---
r_associated #0: 26 -->
en:renal failure
n1=en:volume depletion, renal, due to output loss (renal deficit) | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:volume excess, primary renal sodium retention ---
r_associated #0: 26 -->
en:renal failure
n1=en:volume excess, primary renal sodium retention | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- en:{7 (ribavirin 200 mg oral tablet) / 7 (ribavirin 400 mg oral tablet) } pack ---
r_associated #0: 26 -->
en:renal failure
n1=en:{7 (ribavirin 200 mg oral tablet) / 7 (ribavirin 400 mg oral tablet) } pack | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- infarctus du rein ---
r_associated #0: 26 -->
en:renal failure
n1=infarctus du rein | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- tubulopathies avec fuite phosphatée ---
r_associated #0: 26 -->
en:renal failure
n1=tubulopathies avec fuite phosphatée | n2=en:renal failure | rel=r_associated | relid=0 | w=26
- GNC ---
r_associated #0: 25 -->
en:renal failure
n1=GNC | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:0.6 ml fondaparinux sodium 12.5 mg/ml prefilled syringe ---
r_associated #0: 25 -->
en:renal failure
n1=en:0.6 ml fondaparinux sodium 12.5 mg/ml prefilled syringe | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:1 ml ketorolac tromethamine 30 mg/ml prefilled syringe ---
r_associated #0: 25 -->
en:renal failure
n1=en:1 ml ketorolac tromethamine 30 mg/ml prefilled syringe | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:1250 mg testosterone 0.0162 mg/mg topical gel [androgel] ---
r_associated #0: 25 -->
en:renal failure
n1=en:1250 mg testosterone 0.0162 mg/mg topical gel [androgel] | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:24 hr metformin hydrochloride 500 mg extended release oral tablet ---
r_associated #0: 25 -->
en:renal failure
n1=en:24 hr metformin hydrochloride 500 mg extended release oral tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:2500 mg testosterone 0.0162 mg/mg topical gel [androgel] ---
r_associated #0: 25 -->
en:renal failure
n1=en:2500 mg testosterone 0.0162 mg/mg topical gel [androgel] | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:50 ml magnesium sulfate 40 mg/ml injection ---
r_associated #0: 25 -->
en:renal failure
n1=en:50 ml magnesium sulfate 40 mg/ml injection | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:72 hr fentanyl 0.0625 mg/hr transdermal patch ---
r_associated #0: 25 -->
en:renal failure
n1=en:72 hr fentanyl 0.0625 mg/hr transdermal patch | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:abnormal mitochondria in podocytes ---
r_associated #0: 25 -->
en:renal failure
n1=en:abnormal mitochondria in podocytes | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:acute nephrotic syndrome (1 patient) ---
r_associated #0: 25 -->
en:renal failure
n1=en:acute nephrotic syndrome (1 patient) | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:amelogenesis imperfecta nephrocalcinosis ---
r_associated #0: 25 -->
en:renal failure
n1=en:amelogenesis imperfecta nephrocalcinosis | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:and hyperglycinuria ---
r_associated #0: 25 -->
en:renal failure
n1=en:and hyperglycinuria | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:arterionephrosclerosis ---
r_associated #0: 25 -->
en:renal failure
n1=en:arterionephrosclerosis | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:bilateral renal cortical necrosis ---
r_associated #0: 25 -->
en:renal failure
n1=en:bilateral renal cortical necrosis | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:blood urea nitrogen test device ---
r_associated #0: 25 -->
en:renal failure
n1=en:blood urea nitrogen test device | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:cakut ---
r_associated #0: 25 -->
en:renal failure
n1=en:cakut | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:calcification of renal arteries ---
r_associated #0: 25 -->
en:renal failure
n1=en:calcification of renal arteries | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:calcium nephrolithiasis ---
r_associated #0: 25 -->
en:renal failure
n1=en:calcium nephrolithiasis | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:chloral hydrate 250 mg oral capsule ---
r_associated #0: 25 -->
en:renal failure
n1=en:chloral hydrate 250 mg oral capsule | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:chlorothiazide 250mg/5ml oral suspension ---
r_associated #0: 25 -->
en:renal failure
n1=en:chlorothiazide 250mg/5ml oral suspension | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:chlorthalidone 50mg tablet ---
r_associated #0: 25 -->
en:renal failure
n1=en:chlorthalidone 50mg tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:cip-fenofibrate 150mg capsule ---
r_associated #0: 25 -->
en:renal failure
n1=en:cip-fenofibrate 150mg capsule | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:citric acid granules ---
r_associated #0: 25 -->
en:renal failure
n1=en:citric acid granules | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:cyclosporine 100 mg/ml oral solution [sandimmune] ---
r_associated #0: 25 -->
en:renal failure
n1=en:cyclosporine 100 mg/ml oral solution [sandimmune] | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:cyclosporine 50 mg oral capsule ---
r_associated #0: 25 -->
en:renal failure
n1=en:cyclosporine 50 mg oral capsule | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:cyclosporine, modified 25 mg oral capsule ---
r_associated #0: 25 -->
en:renal failure
n1=en:cyclosporine, modified 25 mg oral capsule | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:cyclothiazide 2 mg oral tablet ---
r_associated #0: 25 -->
en:renal failure
n1=en:cyclothiazide 2 mg oral tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:decreased tubular resorption of phosphate (in some patients) ---
r_associated #0: 25 -->
en:renal failure
n1=en:decreased tubular resorption of phosphate (in some patients) | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:deformities of the calyceal system ---
r_associated #0: 25 -->
en:renal failure
n1=en:deformities of the calyceal system | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:degenerative cysts ---
r_associated #0: 25 -->
en:renal failure
n1=en:degenerative cysts | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:dextrothyroxine 6 mg oral tablet ---
r_associated #0: 25 -->
en:renal failure
n1=en:dextrothyroxine 6 mg oral tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:diabetes mellitus ---
r_associated #0: 25 -->
en:renal failure
n1=en:diabetes mellitus | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:diatrizoate 76% injection solution 100ml vial ---
r_associated #0: 25 -->
en:renal failure
n1=en:diatrizoate 76% injection solution 100ml vial | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:diatrizoate meglumine 30%/edetate ca disodium 0.05mg/ml inj ---
r_associated #0: 25 -->
en:renal failure
n1=en:diatrizoate meglumine 30%/edetate ca disodium 0.05mg/ml inj | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:diatrizoate meglumine 66%/diatrizoate na 10% soln,oral ---
r_associated #0: 25 -->
en:renal failure
n1=en:diatrizoate meglumine 66%/diatrizoate na 10% soln,oral | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:diatrizoate na 20% inj ---
r_associated #0: 25 -->
en:renal failure
n1=en:diatrizoate na 20% inj | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:dilated calyces (in some patients) ---
r_associated #0: 25 -->
en:renal failure
n1=en:dilated calyces (in some patients) | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:duplicated collecting system (1 patient) ---
r_associated #0: 25 -->
en:renal failure
n1=en:duplicated collecting system (1 patient) | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:echodense kidneys on ultrasound ---
r_associated #0: 25 -->
en:renal failure
n1=en:echodense kidneys on ultrasound | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:echogenic kidneys with thick-walled pelvises (in some patients) ---
r_associated #0: 25 -->
en:renal failure
n1=en:echogenic kidneys with thick-walled pelvises (in some patients) | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:fenofibrate ---
r_associated #0: 25 -->
en:renal failure
n1=en:fenofibrate | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:fenofibrate micronized 134mg capsule ---
r_associated #0: 25 -->
en:renal failure
n1=en:fenofibrate micronized 134mg capsule | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:fentanyl 0.6 mg/actuat mucosal spray ---
r_associated #0: 25 -->
en:renal failure
n1=en:fentanyl 0.6 mg/actuat mucosal spray | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:fentanyl 400micrograms buccal tablet ---
r_associated #0: 25 -->
en:renal failure
n1=en:fentanyl 400micrograms buccal tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:fentanyl 800microgram buccal soluble film ---
r_associated #0: 25 -->
en:renal failure
n1=en:fentanyl 800microgram buccal soluble film | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:fentanyl citrate 20 ug in 1 ml intravenous injection, solution ---
r_associated #0: 25 -->
en:renal failure
n1=en:fentanyl citrate 20 ug in 1 ml intravenous injection, solution | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:fentanyl citrate pwdr ---
r_associated #0: 25 -->
en:renal failure
n1=en:fentanyl citrate pwdr | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:fetal pyelectasis ---
r_associated #0: 25 -->
en:renal failure
n1=en:fetal pyelectasis | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:fondaparinux sodium 2.5mg/0.5ml prefilled syringe ---
r_associated #0: 25 -->
en:renal failure
n1=en:fondaparinux sodium 2.5mg/0.5ml prefilled syringe | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:galantamine 12mg tablet ---
r_associated #0: 25 -->
en:renal failure
n1=en:galantamine 12mg tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:glomerular and renal tubular cysts ---
r_associated #0: 25 -->
en:renal failure
n1=en:glomerular and renal tubular cysts | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:glomerular c3 deposits, subendothelial and mesangial ---
r_associated #0: 25 -->
en:renal failure
n1=en:glomerular c3 deposits, subendothelial and mesangial | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:glomerulonephritis, postinfectious (1 patient) ---
r_associated #0: 25 -->
en:renal failure
n1=en:glomerulonephritis, postinfectious (1 patient) | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:glomerulosclerosis and fibrosis ---
r_associated #0: 25 -->
en:renal failure
n1=en:glomerulosclerosis and fibrosis | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:glycosuria, renal ---
r_associated #0: 25 -->
en:renal failure
n1=en:glycosuria, renal | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:granular material in cortical tubules ---
r_associated #0: 25 -->
en:renal failure
n1=en:granular material in cortical tubules | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:hematuria (in some patients) ---
r_associated #0: 25 -->
en:renal failure
n1=en:hematuria (in some patients) | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:hematuria, gross and microscopic ---
r_associated #0: 25 -->
en:renal failure
n1=en:hematuria, gross and microscopic | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:hydrochlorothiazide 100 mg oral tablet ---
r_associated #0: 25 -->
en:renal failure
n1=en:hydrochlorothiazide 100 mg oral tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:hydruria ---
r_associated #0: 25 -->
en:renal failure
n1=en:hydruria | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:hyperechogenic kidneys ---
r_associated #0: 25 -->
en:renal failure
n1=en:hyperechogenic kidneys | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:hyperplasia ---
r_associated #0: 25 -->
en:renal failure
n1=en:hyperplasia | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:hypoplastic kidneys (in some patients) ---
r_associated #0: 25 -->
en:renal failure
n1=en:hypoplastic kidneys (in some patients) | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:ketorolac tromethamine 0.45% ophthalmic solution ---
r_associated #0: 25 -->
en:renal failure
n1=en:ketorolac tromethamine 0.45% ophthalmic solution | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:kidneys and urinary system ---
r_associated #0: 25 -->
en:renal failure
n1=en:kidneys and urinary system | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:lecithin acyltransferase deficiency ---
r_associated #0: 25 -->
en:renal failure
n1=en:lecithin acyltransferase deficiency | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:magnesium chloride 535 mg delayed release oral tablet ---
r_associated #0: 25 -->
en:renal failure
n1=en:magnesium chloride 535 mg delayed release oral tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:magnesium oxide 200 mg oral tablet ---
r_associated #0: 25 -->
en:renal failure
n1=en:magnesium oxide 200 mg oral tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:membranous glomerulonephritis (in some patients) ---
r_associated #0: 25 -->
en:renal failure
n1=en:membranous glomerulonephritis (in some patients) | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:methazolamide ---
r_associated #0: 25 -->
en:renal failure
n1=en:methazolamide | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:methocarbamol ---
r_associated #0: 25 -->
en:renal failure
n1=en:methocarbamol | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:microcystic tubular dilatations ---
r_associated #0: 25 -->
en:renal failure
n1=en:microcystic tubular dilatations | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:nephritis, acute tubulointerstitial (mononuclear infiltrate) ---
r_associated #0: 25 -->
en:renal failure
n1=en:nephritis, acute tubulointerstitial (mononuclear infiltrate) | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:nephrosclerosis ---
r_associated #0: 25 -->
en:renal failure
n1=en:nephrosclerosis | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:nephrotic syndrome ---
r_associated #0: 25 -->
en:renal failure
n1=en:nephrotic syndrome | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:oligomeganephronia ---
r_associated #0: 25 -->
en:renal failure
n1=en:oligomeganephronia | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:opium ---
r_associated #0: 25 -->
en:renal failure
n1=en:opium | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:polythiazide ---
r_associated #0: 25 -->
en:renal failure
n1=en:polythiazide | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:potassium bicarbonate 20 meq effervescent oral tablet ---
r_associated #0: 25 -->
en:renal failure
n1=en:potassium bicarbonate 20 meq effervescent oral tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:potassium bicarbonate 99 mg oral capsule ---
r_associated #0: 25 -->
en:renal failure
n1=en:potassium bicarbonate 99 mg oral capsule | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:potassium bicarbonate pwdr ---
r_associated #0: 25 -->
en:renal failure
n1=en:potassium bicarbonate pwdr | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:potassium chloride 0.4 meq/ml injectable solution ---
r_associated #0: 25 -->
en:renal failure
n1=en:potassium chloride 0.4 meq/ml injectable solution | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:potassium gluconate 2.35 meq oral tablet ---
r_associated #0: 25 -->
en:renal failure
n1=en:potassium gluconate 2.35 meq oral tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:potassium gluconate 2.6 meq oral tablet ---
r_associated #0: 25 -->
en:renal failure
n1=en:potassium gluconate 2.6 meq oral tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:potassium phosphate ---
r_associated #0: 25 -->
en:renal failure
n1=en:potassium phosphate | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:proximal renal tubular defect ---
r_associated #0: 25 -->
en:renal failure
n1=en:proximal renal tubular defect | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:proximal tubulopathy (1 patient) ---
r_associated #0: 25 -->
en:renal failure
n1=en:proximal tubulopathy (1 patient) | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:renal cortex ---
r_associated #0: 25 -->
en:renal failure
n1=en:renal cortex | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:renal dysplasia (wws) ---
r_associated #0: 25 -->
en:renal failure
n1=en:renal dysplasia (wws) | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:renal glucose wasting ---
r_associated #0: 25 -->
en:renal failure
n1=en:renal glucose wasting | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:renal insufficiency (in some patients) ---
r_associated #0: 25 -->
en:renal failure
n1=en:renal insufficiency (in some patients) | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:renal malformation (in some patients) ---
r_associated #0: 25 -->
en:renal failure
n1=en:renal malformation (in some patients) | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:renal salt wasting ---
r_associated #0: 25 -->
en:renal failure
n1=en:renal salt wasting | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:ribavirin 600 mg oral tablet 7 day pack ---
r_associated #0: 25 -->
en:renal failure
n1=en:ribavirin 600 mg oral tablet 7 day pack | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:sodium diatrizoate 25% infusion solution 250 ml bottle ---
r_associated #0: 25 -->
en:renal failure
n1=en:sodium diatrizoate 25% infusion solution 250 ml bottle | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:sodium phosphate, dibasic, heptahydrate ---
r_associated #0: 25 -->
en:renal failure
n1=en:sodium phosphate, dibasic, heptahydrate | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:sodium phosphate, monobasic, monohydrate ---
r_associated #0: 25 -->
en:renal failure
n1=en:sodium phosphate, monobasic, monohydrate | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:sotalol hydrochloride 160mg tablet ---
r_associated #0: 25 -->
en:renal failure
n1=en:sotalol hydrochloride 160mg tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:sotalol hydrochloride 80mg tablet ---
r_associated #0: 25 -->
en:renal failure
n1=en:sotalol hydrochloride 80mg tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:stone in the kidney ---
r_associated #0: 25 -->
en:renal failure
n1=en:stone in the kidney | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:testosterone 15mg transdermal patch ---
r_associated #0: 25 -->
en:renal failure
n1=en:testosterone 15mg transdermal patch | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:testosterone 2.5mg/24hours transdermal patch ---
r_associated #0: 25 -->
en:renal failure
n1=en:testosterone 2.5mg/24hours transdermal patch | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:testosterone 30mg topical solution ---
r_associated #0: 25 -->
en:renal failure
n1=en:testosterone 30mg topical solution | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:testosterone enanthate 100mg/testosterone propionate 25mg/ml inj ---
r_associated #0: 25 -->
en:renal failure
n1=en:testosterone enanthate 100mg/testosterone propionate 25mg/ml inj | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:tubulointerstitial fibrosis ---
r_associated #0: 25 -->
en:renal failure
n1=en:tubulointerstitial fibrosis | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:urolithiasis ---
r_associated #0: 25 -->
en:renal failure
n1=en:urolithiasis | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:urorrhea ---
r_associated #0: 25 -->
en:renal failure
n1=en:urorrhea | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:water-losing nephritis ---
r_associated #0: 25 -->
en:renal failure
n1=en:water-losing nephritis | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- en:{7 (ribavirin 400 mg oral tablet) / 7 (ribavirin 600 mg oral tablet) } pack ---
r_associated #0: 25 -->
en:renal failure
n1=en:{7 (ribavirin 400 mg oral tablet) / 7 (ribavirin 600 mg oral tablet) } pack | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- néphron sain (théorie du) ---
r_associated #0: 25 -->
en:renal failure
n1=néphron sain (théorie du) | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- syndrome de Zellweger ---
r_associated #0: 25 -->
en:renal failure
n1=syndrome de Zellweger | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- tachycardie ---
r_associated #0: 25 -->
en:renal failure
n1=tachycardie | n2=en:renal failure | rel=r_associated | relid=0 | w=25
- Anurie ---
r_associated #0: 24 -->
en:renal failure
n1=Anurie | n2=en:renal failure | rel=r_associated | relid=0 | w=24
- Hypertension artérielle ---
r_associated #0: 24 -->
en:renal failure
n1=Hypertension artérielle | n2=en:renal failure | rel=r_associated | relid=0 | w=24
- en:0.4 ml methotrexate 18.8 mg/ml auto-injector ---
r_associated #0: 24 -->
en:renal failure
n1=en:0.4 ml methotrexate 18.8 mg/ml auto-injector | n2=en:renal failure | rel=r_associated | relid=0 | w=24
- en:0.5 ml methotrexate 50 mg/ml auto-injector ---
r_associated #0: 24 -->
en:renal failure
n1=en:0.5 ml methotrexate 50 mg/ml auto-injector | n2=en:renal failure | rel=r_associated | relid=0 | w=24
- en:allanson pantzar mcleod syndrome ---
r_associated #0: 24 -->
en:renal failure
n1=en:allanson pantzar mcleod syndrome | n2=en:renal failure | rel=r_associated | relid=0 | w=24
- en:brachymesomelia renal syndrome ---
r_associated #0: 24 -->
en:renal failure
n1=en:brachymesomelia renal syndrome | n2=en:renal failure | rel=r_associated | relid=0 | w=24
- en:calcifediol anhydrous ---
r_associated #0: 24 -->
en:renal failure
n1=en:calcifediol anhydrous | n2=en:renal failure | rel=r_associated | relid=0 | w=24
- en:calcifediol, anhydrous 20micrograms capsule ---
r_associated #0: 24 -->
en:renal failure
n1=en:calcifediol, anhydrous 20micrograms capsule | n2=en:renal failure | rel=r_associated | relid=0 | w=24
- en:caliectasis ---
r_associated #0: 24 -->
en:renal failure
n1=en:caliectasis | n2=en:renal failure | rel=r_associated | relid=0 | w=24
- en:cfhr5 deficiency ---
r_associated #0: 24 -->
en:renal failure
n1=en:cfhr5 deficiency | n2=en:renal failure | rel=r_associated | relid=0 | w=24
- en:chlorothiazide 250mg tablet ---
r_associated #0: 24 -->
en:renal failure
n1=en:chlorothiazide 250mg tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=24
- en:chlorthalidone 100 mg oral tablet ---
r_associated #0: 24 -->
en:renal failure
n1=en:chlorthalidone 100 mg oral tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=24
- en:cisplatin 1 mg/ml injectable solution ---
r_associated #0: 24 -->
en:renal failure
n1=en:cisplatin 1 mg/ml injectable solution | n2=en:renal failure | rel=r_associated | relid=0 | w=24
- en:citric acid monohydrate ---
r_associated #0: 24 -->
en:renal failure
n1=en:citric acid monohydrate | n2=en:renal failure | rel=r_associated | relid=0 | w=24
- en:citric acid,hydrous ---
r_associated #0: 24 -->
en:renal failure
n1=en:citric acid,hydrous | n2=en:renal failure | rel=r_associated | relid=0 | w=24
- en:cockayne syndrome, type ii ---
r_associated #0: 24 -->
en:renal failure
n1=en:cockayne syndrome, type ii | n2=en:renal failure | rel=r_associated | relid=0 | w=24
- en:cortical calcifications (in some patients) ---
r_associated #0: 24 -->
en:renal failure
n1=en:cortical calcifications (in some patients) | n2=en:renal failure | rel=r_associated | relid=0 | w=24
- en:corticomedullary cysts ---
r_associated #0: 24 -->
en:renal failure
n1=en:corticomedullary cysts | n2=en:renal failure | rel=r_associated | relid=0 | w=24
- en:cystinosis ---
r_associated #0: 24 -->
en:renal failure
n1=en:cystinosis | n2=en:renal failure | rel=r_associated | relid=0 | w=24
- en:decreased numbers of nephrons ---
r_associated #0: 24 -->
en:renal failure
n1=en:decreased numbers of nephrons | n2=en:renal failure | rel=r_associated | relid=0 | w=24
- en:dedifferentiated atrophic tubules with thick basement membrane seen on renal biopsy ---
r_associated #0: 24 -->
en:renal failure
n1=en:dedifferentiated atrophic tubules with thick basement membrane seen on renal biopsy | n2=en:renal failure | rel=r_associated | relid=0 | w=24
- en:dextrothyroxine 2 mg oral tablet ---
r_associated #0: 24 -->
en:renal failure
n1=en:dextrothyroxine 2 mg oral tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=24
- en:diatrizoate meglumine + diatrizoate sodium 520mg/80mg solution ---
r_associated #0: 24 -->
en:renal failure
n1=en:diatrizoate meglumine + diatrizoate sodium 520mg/80mg solution | n2=en:renal failure | rel=r_associated | relid=0 | w=24
- en:diatrizoate na 42% liquid,oral ---
r_associated #0: 24 -->
en:renal failure
n1=en:diatrizoate na 42% liquid,oral | n2=en:renal failure | rel=r_associated | relid=0 | w=24
- en:dofetilide ---
r_associated #0: 24 -->
en:renal failure
n1=en:dofetilide | n2=en:renal failure | rel=r_associated | relid=0 | w=24
- en:dorzolamide ---
r_associated #0: 24 -->
en:renal failure
n1=en:dorzolamide | n2=en:renal failure | rel=r_associated | relid=0 | w=24
- en:dorzolamide 2% ophthalmic solution ---
r_associated #0: 24 -->
en:renal failure
n1=en:dorzolamide 2% ophthalmic solution | n2=en:renal failure | rel=r_associated | relid=0 | w=24
- en:edetate disodium anhydrous 150mg/ml injection solution 20ml vial ---
r_associated #0: 24 -->
en:renal failure
n1=en:edetate disodium anhydrous 150mg/ml injection solution 20ml vial | n2=en:renal failure | rel=r_associated | relid=0 | w=24
- en:ergocalciferol 1.25mg capsule ---
r_associated #0: 24 -->
en:renal failure
n1=en:ergocalciferol 1.25mg capsule | n2=en:renal failure | rel=r_associated | relid=0 | w=24
- en:familial juvenile nephronophthisis ---
r_associated #0: 24 -->
en:renal failure
n1=en:familial juvenile nephronophthisis | n2=en:renal failure | rel=r_associated | relid=0 | w=24
- en:fenofibrate 40mg tablet ---
r_associated #0: 24 -->
en:renal failure
n1=en:fenofibrate 40mg tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=24
- en:fentanyl 100micrograms buccal tablet ---
r_associated #0: 24 -->
en:renal failure
n1=en:fentanyl 100micrograms buccal tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=24
- en:fentanyl 600micrograms lozenge ---
r_associated #0: 24 -->
en:renal failure
n1=en:fentanyl 600micrograms lozenge | n2=en:renal failure | rel=r_associated | relid=0 | w=24
- en:fentanyl citrate 600mg lozenge ---
r_associated #0: 24 -->
en:renal failure
n1=en:fentanyl citrate 600mg lozenge | n2=en:renal failure | rel=r_associated | relid=0 | w=24
- en:galantamine 8mg tablet ---
r_associated #0: 24 -->
en:renal failure
n1=en:galantamine 8mg tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=24
- en:gemfibrozil ---
r_associated #0: 24 -->
en:renal failure
n1=en:gemfibrozil | n2=en:renal failure | rel=r_associated | relid=0 | w=24
- en:hemorrhagic fever with renal syndrome ---
r_associated #0: 24 -->
en:renal failure
n1=en:hemorrhagic fever with renal syndrome | n2=en:renal failure | rel=r_associated | relid=0 | w=24
- en:hilar area of the kidney ---
r_associated #0: 24 -->
en:renal failure
n1=en:hilar area of the kidney | n2=en:renal failure | rel=r_associated | relid=0 | w=24
- en:horseshoe kidney ---
r_associated #0: 24 -->
en:renal failure
n1=en:horseshoe kidney | n2=en:renal failure | rel=r_associated | relid=0 | w=24
- en:hydrochlorothiazide 10 mg/ml oral solution ---
r_associated #0: 24 -->
en:renal failure
n1=en:hydrochlorothiazide 10 mg/ml oral solution | n2=en:renal failure | rel=r_associated | relid=0 | w=24
- en:hydrochlorothiazide 100 mg/ml oral solution ---
r_associated #0: 24 -->
en:renal failure
n1=en:hydrochlorothiazide 100 mg/ml oral solution | n2=en:renal failure | rel=r_associated | relid=0 | w=24
- en:hypercalciuria (in some patients) ---
r_associated #0: 24 -->
en:renal failure
n1=en:hypercalciuria (in some patients) | n2=en:renal failure | rel=r_associated | relid=0 | w=24
- en:hypoplastic glomerulocystic kidney disease ---
r_associated #0: 24 -->
en:renal failure
n1=en:hypoplastic glomerulocystic kidney disease | n2=en:renal failure | rel=r_associated | relid=0 | w=24
- en:impaired renal uric acid clearance ---
r_associated #0: 24 -->
en:renal failure
n1=en:impaired renal uric acid clearance | n2=en:renal failure | rel=r_associated | relid=0 | w=24
- en:interstitial fibrosis ---
r_associated #0: 24 -->
en:renal failure
n1=en:interstitial fibrosis | n2=en:renal failure | rel=r_associated | relid=0 | w=24
- en:kidney angiomyolipoma ---
r_associated #0: 24 -->
en:renal failure
n1=en:kidney angiomyolipoma | n2=en:renal failure | rel=r_associated | relid=0 | w=24
- en:kidney disease ---
r_associated #0: 24 -->
en:renal failure
n1=en:kidney disease | n2=en:renal failure | rel=r_associated | relid=0 | w=24
- en:magnesium aspartate ---
r_associated #0: 24 -->
en:renal failure
n1=en:magnesium aspartate | n2=en:renal failure | rel=r_associated | relid=0 | w=24
- en:magnesium chloride ---
r_associated #0: 24 -->
en:renal failure
n1=en:magnesium chloride | n2=en:renal failure | rel=r_associated | relid=0 | w=24
- en:magnesium citrate cap/tab ---
r_associated #0: 24 -->
en:renal failure
n1=en:magnesium citrate cap/tab | n2=en:renal failure | rel=r_associated | relid=0 | w=24
- en:magnesium gluconate ---
r_associated #0: 24 -->
en:renal failure
n1=en:magnesium gluconate | n2=en:renal failure | rel=r_associated | relid=0 | w=24
- en:magnesium oxide 420 mg oral tablet ---
r_associated #0: 24 -->
en:renal failure
n1=en:magnesium oxide 420 mg oral tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=24
- en:magnesium sulfate ---
r_associated #0: 24 -->
en:renal failure
n1=en:magnesium sulfate | n2=en:renal failure | rel=r_associated | relid=0 | w=24
- en:magnesium sulfate 10gm/1000ml intravenous ---
r_associated #0: 24 -->
en:renal failure
n1=en:magnesium sulfate 10gm/1000ml intravenous | n2=en:renal failure | rel=r_associated | relid=0 | w=24
- en:magnesium sulfate 12.5%(1meq/ml) injection 8ml vial ---
r_associated #0: 24 -->
en:renal failure
n1=en:magnesium sulfate 12.5%(1meq/ml) injection 8ml vial | n2=en:renal failure | rel=r_associated | relid=0 | w=24
- en:magnesium sulfate 40meq/5gm pwdr ---
r_associated #0: 24 -->
en:renal failure
n1=en:magnesium sulfate 40meq/5gm pwdr | n2=en:renal failure | rel=r_associated | relid=0 | w=24
- en:malrotation of kidney ---
r_associated #0: 24 -->
en:renal failure
n1=en:malrotation of kidney | n2=en:renal failure | rel=r_associated | relid=0 | w=24
- en:medullary cystic disease ---
r_associated #0: 24 -->
en:renal failure
n1=en:medullary cystic disease | n2=en:renal failure | rel=r_associated | relid=0 | w=24
- en:metformin hydrochloride 500 mg oral tablet ---
r_associated #0: 24 -->
en:renal failure
n1=en:metformin hydrochloride 500 mg oral tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=24
- en:methotrexate 10mg tablet ---
r_associated #0: 24 -->
en:renal failure
n1=en:methotrexate 10mg tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=24
- en:methotrexate 2.5mg/ml injection solution 2ml vial ---
r_associated #0: 24 -->
en:renal failure
n1=en:methotrexate 2.5mg/ml injection solution 2ml vial | n2=en:renal failure | rel=r_associated | relid=0 | w=24
- en:methylene blue 55 mg oral tablet ---
r_associated #0: 24 -->
en:renal failure
n1=en:methylene blue 55 mg oral tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=24
- en:metolazone 10mg tablet ---
r_associated #0: 24 -->
en:renal failure
n1=en:metolazone 10mg tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=24
- en:metolazone 2.5mg tablet ---
r_associated #0: 24 -->
en:renal failure
n1=en:metolazone 2.5mg tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=24
- en:nephronophthisis 16 ---
r_associated #0: 24 -->
en:renal failure
n1=en:nephronophthisis 16 | n2=en:renal failure | rel=r_associated | relid=0 | w=24
- en:perihilar mesangial deposition of proteinaceous material ---
r_associated #0: 24 -->
en:renal failure
n1=en:perihilar mesangial deposition of proteinaceous material | n2=en:renal failure | rel=r_associated | relid=0 | w=24
- en:potassium chloride 0.1 meq/ml injectable solution ---
r_associated #0: 24 -->
en:renal failure
n1=en:potassium chloride 0.1 meq/ml injectable solution | n2=en:renal failure | rel=r_associated | relid=0 | w=24
- en:potassium chloride 0.167 meq/ml oral solution ---
r_associated #0: 24 -->
en:renal failure
n1=en:potassium chloride 0.167 meq/ml oral solution | n2=en:renal failure | rel=r_associated | relid=0 | w=24
- en:potassium chloride 0.2 meq/ml injectable solution ---
r_associated #0: 24 -->
en:renal failure
n1=en:potassium chloride 0.2 meq/ml injectable solution | n2=en:renal failure | rel=r_associated | relid=0 | w=24
- en:potassium chloride 7.5% syrup ---
r_associated #0: 24 -->
en:renal failure
n1=en:potassium chloride 7.5% syrup | n2=en:renal failure | rel=r_associated | relid=0 | w=24
- en:potassium chloride 8 meq extended release oral capsule ---
r_associated #0: 24 -->
en:renal failure
n1=en:potassium chloride 8 meq extended release oral capsule | n2=en:renal failure | rel=r_associated | relid=0 | w=24
- en:potassium citrate ---
r_associated #0: 24 -->
en:renal failure
n1=en:potassium citrate | n2=en:renal failure | rel=r_associated | relid=0 | w=24
- en:potassium phosphate monobase 500mg tablet ---
r_associated #0: 24 -->
en:renal failure
n1=en:potassium phosphate monobase 500mg tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=24
- en:primary systemic amyloidosis ---
r_associated #0: 24 -->
en:renal failure
n1=en:primary systemic amyloidosis | n2=en:renal failure | rel=r_associated | relid=0 | w=24
- en:progressive renal failure ---
r_associated #0: 24 -->
en:renal failure
n1=en:progressive renal failure | n2=en:renal failure | rel=r_associated | relid=0 | w=24
- en:renal anomalies (in some patients) ---
r_associated #0: 24 -->
en:renal failure
n1=en:renal anomalies (in some patients) | n2=en:renal failure | rel=r_associated | relid=0 | w=24
- en:renal disease (in some patients) ---
r_associated #0: 24 -->
en:renal failure
n1=en:renal disease (in some patients) | n2=en:renal failure | rel=r_associated | relid=0 | w=24
- en:renal lobule ---
r_associated #0: 24 -->
en:renal failure
n1=en:renal lobule | n2=en:renal failure | rel=r_associated | relid=0 | w=24
- en:renal medulla ---
r_associated #0: 24 -->
en:renal failure
n1=en:renal medulla | n2=en:renal failure | rel=r_associated | relid=0 | w=24
- en:renal pyramid ---
r_associated #0: 24 -->
en:renal failure
n1=en:renal pyramid | n2=en:renal failure | rel=r_associated | relid=0 | w=24
- en:renal structural anomalies (reported in 1 family) ---
r_associated #0: 24 -->
en:renal failure
n1=en:renal structural anomalies (reported in 1 family) | n2=en:renal failure | rel=r_associated | relid=0 | w=24
- en:renal toxicity ---
r_associated #0: 24 -->
en:renal failure
n1=en:renal toxicity | n2=en:renal failure | rel=r_associated | relid=0 | w=24
- en:renal-hepatic-pancreatic dysplasia 1 ---
r_associated #0: 24 -->
en:renal failure
n1=en:renal-hepatic-pancreatic dysplasia 1 | n2=en:renal failure | rel=r_associated | relid=0 | w=24
- en:scleroderma renal crisis ---
r_associated #0: 24 -->
en:renal failure
n1=en:scleroderma renal crisis | n2=en:renal failure | rel=r_associated | relid=0 | w=24
- en:sepsis due to urinary tract infection ---
r_associated #0: 24 -->
en:renal failure
n1=en:sepsis due to urinary tract infection | n2=en:renal failure | rel=r_associated | relid=0 | w=24
- en:sodium phosphate, dibasic, anhydrous ---
r_associated #0: 24 -->
en:renal failure
n1=en:sodium phosphate, dibasic, anhydrous | n2=en:renal failure | rel=r_associated | relid=0 | w=24
- en:splitting of the glomerular basement membrane ---
r_associated #0: 24 -->
en:renal failure
n1=en:splitting of the glomerular basement membrane | n2=en:renal failure | rel=r_associated | relid=0 | w=24
- en:stroma of kidney ---
r_associated #0: 24 -->
en:renal failure
n1=en:stroma of kidney | n2=en:renal failure | rel=r_associated | relid=0 | w=24
- en:subendothelial deposits ---
r_associated #0: 24 -->
en:renal failure
n1=en:subendothelial deposits | n2=en:renal failure | rel=r_associated | relid=0 | w=24
- en:testicular hydrocele ---
r_associated #0: 24 -->
en:renal failure
n1=en:testicular hydrocele | n2=en:renal failure | rel=r_associated | relid=0 | w=24
- en:testosterone propionate 100 mg/ml injectable solution ---
r_associated #0: 24 -->
en:renal failure
n1=en:testosterone propionate 100 mg/ml injectable solution | n2=en:renal failure | rel=r_associated | relid=0 | w=24
- en:testosterone pwdr ---
r_associated #0: 24 -->
en:renal failure
n1=en:testosterone pwdr | n2=en:renal failure | rel=r_associated | relid=0 | w=24
- en:testosterone undecanoate ---
r_associated #0: 24 -->
en:renal failure
n1=en:testosterone undecanoate | n2=en:renal failure | rel=r_associated | relid=0 | w=24
- en:thickening of the glomerular basement membrane (later in the disease) ---
r_associated #0: 24 -->
en:renal failure
n1=en:thickening of the glomerular basement membrane (later in the disease) | n2=en:renal failure | rel=r_associated | relid=0 | w=24
- en:thrombotic microangiopathic nephropathy ---
r_associated #0: 24 -->
en:renal failure
n1=en:thrombotic microangiopathic nephropathy | n2=en:renal failure | rel=r_associated | relid=0 | w=24
- en:uromodulin reduced or absent in urine ---
r_associated #0: 24 -->
en:renal failure
n1=en:uromodulin reduced or absent in urine | n2=en:renal failure | rel=r_associated | relid=0 | w=24
- diabète sucré de type 2 avec surdité ---
r_associated #0: 23 -->
en:renal failure
n1=diabète sucré de type 2 avec surdité | n2=en:renal failure | rel=r_associated | relid=0 | w=23
- en:0.4 ml methotrexate 50 mg/ml auto-injector ---
r_associated #0: 23 -->
en:renal failure
n1=en:0.4 ml methotrexate 50 mg/ml auto-injector | n2=en:renal failure | rel=r_associated | relid=0 | w=23
- en:2 ml fentanyl 0.05 mg/ml cartridge ---
r_associated #0: 23 -->
en:renal failure
n1=en:2 ml fentanyl 0.05 mg/ml cartridge | n2=en:renal failure | rel=r_associated | relid=0 | w=23
- en:20 ml ammonium chloride 5 meq/ml injection ---
r_associated #0: 23 -->
en:renal failure
n1=en:20 ml ammonium chloride 5 meq/ml injection | n2=en:renal failure | rel=r_associated | relid=0 | w=23
- en:24 hr galantamine hydrobromide 24 mg extended release oral capsule ---
r_associated #0: 23 -->
en:renal failure
n1=en:24 hr galantamine hydrobromide 24 mg extended release oral capsule | n2=en:renal failure | rel=r_associated | relid=0 | w=23
- en:24 hr metformin hydrochloride 500 mg extended release oral tablet [fortamet] ---
r_associated #0: 23 -->
en:renal failure
n1=en:24 hr metformin hydrochloride 500 mg extended release oral tablet [fortamet] | n2=en:renal failure | rel=r_associated | relid=0 | w=23
- en:2500 mg testosterone 0.01 mg/mg topical gel ---
r_associated #0: 23 -->
en:renal failure
n1=en:2500 mg testosterone 0.01 mg/mg topical gel | n2=en:renal failure | rel=r_associated | relid=0 | w=23
- en:3 ml testosterone undecanoate 250 mg/ml injection ---
r_associated #0: 23 -->
en:renal failure
n1=en:3 ml testosterone undecanoate 250 mg/ml injection | n2=en:renal failure | rel=r_associated | relid=0 | w=23
- en:5000 mg testosterone 0.01 mg/mg topical gel [androgel] ---
r_associated #0: 23 -->
en:renal failure
n1=en:5000 mg testosterone 0.01 mg/mg topical gel [androgel] | n2=en:renal failure | rel=r_associated | relid=0 | w=23
- en:60 actuat testosterone 12.5 mg/actuat topical gel ---
r_associated #0: 23 -->
en:renal failure
n1=en:60 actuat testosterone 12.5 mg/actuat topical gel | n2=en:renal failure | rel=r_associated | relid=0 | w=23
- en:abnormal renal function ---
r_associated #0: 23 -->
en:renal failure
n1=en:abnormal renal function | n2=en:renal failure | rel=r_associated | relid=0 | w=23
- en:abnormality of the renal collecting system ---
r_associated #0: 23 -->
en:renal failure
n1=en:abnormality of the renal collecting system | n2=en:renal failure | rel=r_associated | relid=0 | w=23
- en:acitretin ---
r_associated #0: 23 -->
en:renal failure
n1=en:acitretin | n2=en:renal failure | rel=r_associated | relid=0 | w=23
- en:acitretin 10 mg oral capsule [soriatane] ---
r_associated #0: 23 -->
en:renal failure
n1=en:acitretin 10 mg oral capsule [soriatane] | n2=en:renal failure | rel=r_associated | relid=0 | w=23
- en:albinism with hemorrhagic diathesis and pigmented reticuloendothelial cells ---
r_associated #0: 23 -->
en:renal failure
n1=en:albinism with hemorrhagic diathesis and pigmented reticuloendothelial cells | n2=en:renal failure | rel=r_associated | relid=0 | w=23
- en:bendrofluazide 2.5mg tablet ---
r_associated #0: 23 -->
en:renal failure
n1=en:bendrofluazide 2.5mg tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=23
- en:calcium oxalate urolithiasis ---
r_associated #0: 23 -->
en:renal failure
n1=en:calcium oxalate urolithiasis | n2=en:renal failure | rel=r_associated | relid=0 | w=23
- en:capecitabine ---
r_associated #0: 23 -->
en:renal failure
n1=en:capecitabine | n2=en:renal failure | rel=r_associated | relid=0 | w=23
- en:chloral hydrate 500 mg oral capsule ---
r_associated #0: 23 -->
en:renal failure
n1=en:chloral hydrate 500 mg oral capsule | n2=en:renal failure | rel=r_associated | relid=0 | w=23
- en:chlorthalidone 25mg tablet ---
r_associated #0: 23 -->
en:renal failure
n1=en:chlorthalidone 25mg tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=23
- en:cisapride ---
r_associated #0: 23 -->
en:renal failure
n1=en:cisapride | n2=en:renal failure | rel=r_associated | relid=0 | w=23
- en:cisapride 10mg tablet ---
r_associated #0: 23 -->
en:renal failure
n1=en:cisapride 10mg tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=23
- en:congenital genitourinary abnormality ---
r_associated #0: 23 -->
en:renal failure
n1=en:congenital genitourinary abnormality | n2=en:renal failure | rel=r_associated | relid=0 | w=23
- en:crossed fused renal ectopia ---
r_associated #0: 23 -->
en:renal failure
n1=en:crossed fused renal ectopia | n2=en:renal failure | rel=r_associated | relid=0 | w=23
- en:cyclosporine, modified 100 mg/ml oral solution [gengraf] ---
r_associated #0: 23 -->
en:renal failure
n1=en:cyclosporine, modified 100 mg/ml oral solution [gengraf] | n2=en:renal failure | rel=r_associated | relid=0 | w=23
- en:cystic dysplasia, early (in some patients) ---
r_associated #0: 23 -->
en:renal failure
n1=en:cystic dysplasia, early (in some patients) | n2=en:renal failure | rel=r_associated | relid=0 | w=23
- en:cystic kidney disease with ventriculomegaly ---
r_associated #0: 23 -->
en:renal failure
n1=en:cystic kidney disease with ventriculomegaly | n2=en:renal failure | rel=r_associated | relid=0 | w=23
- en:cystic tubular dilatation in the cortex and medulla ---
r_associated #0: 23 -->
en:renal failure
n1=en:cystic tubular dilatation in the cortex and medulla | n2=en:renal failure | rel=r_associated | relid=0 | w=23
- en:cystinuria ---
r_associated #0: 23 -->
en:renal failure
n1=en:cystinuria | n2=en:renal failure | rel=r_associated | relid=0 | w=23
- en:death in first weeks of life without dialysis ---
r_associated #0: 23 -->
en:renal failure
n1=en:death in first weeks of life without dialysis | n2=en:renal failure | rel=r_associated | relid=0 | w=23
- en:dense deposit disease ---
r_associated #0: 23 -->
en:renal failure
n1=en:dense deposit disease | n2=en:renal failure | rel=r_associated | relid=0 | w=23
- en:dextrothyroxine 4 mg oral tablet ---
r_associated #0: 23 -->
en:renal failure
n1=en:dextrothyroxine 4 mg oral tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=23
- en:diatrizoate meglumine 85% inj ---
r_associated #0: 23 -->
en:renal failure
n1=en:diatrizoate meglumine 85% inj | n2=en:renal failure | rel=r_associated | relid=0 | w=23
- en:diatrizoic acid ---
r_associated #0: 23 -->
en:renal failure
n1=en:diatrizoic acid | n2=en:renal failure | rel=r_associated | relid=0 | w=23
- en:diphenidol ---
r_associated #0: 23 -->
en:renal failure
n1=en:diphenidol | n2=en:renal failure | rel=r_associated | relid=0 | w=23
- en:duplex kidney ---
r_associated #0: 23 -->
en:renal failure
n1=en:duplex kidney | n2=en:renal failure | rel=r_associated | relid=0 | w=23
- en:end stage renal disease (20-40 years)(28% of patients) ---
r_associated #0: 23 -->
en:renal failure
n1=en:end stage renal disease (20-40 years)(28% of patients) | n2=en:renal failure | rel=r_associated | relid=0 | w=23
- en:enlarged kidneys due to extramedullary hematopoiesis ---
r_associated #0: 23 -->
en:renal failure
n1=en:enlarged kidneys due to extramedullary hematopoiesis | n2=en:renal failure | rel=r_associated | relid=0 | w=23
- en:familial mediterranean fever ---
r_associated #0: 23 -->
en:renal failure
n1=en:familial mediterranean fever | n2=en:renal failure | rel=r_associated | relid=0 | w=23
- en:fenofibrate 145mg tablet ---
r_associated #0: 23 -->
en:renal failure
n1=en:fenofibrate 145mg tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=23
- en:fenofibrate 54 mg oral tablet ---
r_associated #0: 23 -->
en:renal failure
n1=en:fenofibrate 54 mg oral tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=23
- en:fentanyl 0.05 mg/ml injection ---
r_associated #0: 23 -->
en:renal failure
n1=en:fentanyl 0.05 mg/ml injection | n2=en:renal failure | rel=r_associated | relid=0 | w=23
- en:fentanyl 0.1 mg/actuat mucosal spray ---
r_associated #0: 23 -->
en:renal failure
n1=en:fentanyl 0.1 mg/actuat mucosal spray | n2=en:renal failure | rel=r_associated | relid=0 | w=23
- en:fentanyl 0.2 mg sublingual tablet ---
r_associated #0: 23 -->
en:renal failure
n1=en:fentanyl 0.2 mg sublingual tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=23
- en:fentanyl 0.8 mg sublingual tablet ---
r_associated #0: 23 -->
en:renal failure
n1=en:fentanyl 0.8 mg sublingual tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=23
- en:fentanyl 4mcg/ml nacl 0.9% inj,bag,250ml ---
r_associated #0: 23 -->
en:renal failure
n1=en:fentanyl 4mcg/ml nacl 0.9% inj,bag,250ml | n2=en:renal failure | rel=r_associated | relid=0 | w=23
- en:hemolytic uremic syndrome (in some patients) ---
r_associated #0: 23 -->
en:renal failure
n1=en:hemolytic uremic syndrome (in some patients) | n2=en:renal failure | rel=r_associated | relid=0 | w=23
- en:hyperoxaluria ---
r_associated #0: 23 -->
en:renal failure
n1=en:hyperoxaluria | n2=en:renal failure | rel=r_associated | relid=0 | w=23
- en:hypertension, moderate ---
r_associated #0: 23 -->
en:renal failure
n1=en:hypertension, moderate | n2=en:renal failure | rel=r_associated | relid=0 | w=23
- en:hypotonic urine (in some patients) ---
r_associated #0: 23 -->
en:renal failure
n1=en:hypotonic urine (in some patients) | n2=en:renal failure | rel=r_associated | relid=0 | w=23
- en:indapamide 1.25 mg oral tablet ---
r_associated #0: 23 -->
en:renal failure
n1=en:indapamide 1.25 mg oral tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=23
- en:iron deposition in renal tubular cells ---
r_associated #0: 23 -->
en:renal failure
n1=en:iron deposition in renal tubular cells | n2=en:renal failure | rel=r_associated | relid=0 | w=23
- en:juxtaglomerular hyperplasia due to activation of the renin-aldosterone axis ---
r_associated #0: 23 -->
en:renal failure
n1=en:juxtaglomerular hyperplasia due to activation of the renin-aldosterone axis | n2=en:renal failure | rel=r_associated | relid=0 | w=23
- en:large nuclei (karyomegaly) in renal tubules seen renal biopsy ---
r_associated #0: 23 -->
en:renal failure
n1=en:large nuclei (karyomegaly) in renal tubules seen renal biopsy | n2=en:renal failure | rel=r_associated | relid=0 | w=23
- en:magnesium 133mg plus protein tab ---
r_associated #0: 23 -->
en:renal failure
n1=en:magnesium 133mg plus protein tab | n2=en:renal failure | rel=r_associated | relid=0 | w=23
- en:magnesium aluminum silicate ---
r_associated #0: 23 -->
en:renal failure
n1=en:magnesium aluminum silicate | n2=en:renal failure | rel=r_associated | relid=0 | w=23
- en:magnesium chloride 200 mg/ml injectable solution ---
r_associated #0: 23 -->
en:renal failure
n1=en:magnesium chloride 200 mg/ml injectable solution | n2=en:renal failure | rel=r_associated | relid=0 | w=23
- en:magnesium citrate powder ---
r_associated #0: 23 -->
en:renal failure
n1=en:magnesium citrate powder | n2=en:renal failure | rel=r_associated | relid=0 | w=23
- en:magnesium glycinate ---
r_associated #0: 23 -->
en:renal failure
n1=en:magnesium glycinate | n2=en:renal failure | rel=r_associated | relid=0 | w=23
- en:magnesium hydroxide 78 mg/ml oral suspension ---
r_associated #0: 23 -->
en:renal failure
n1=en:magnesium hydroxide 78 mg/ml oral suspension | n2=en:renal failure | rel=r_associated | relid=0 | w=23
- en:magnesium stearate ---
r_associated #0: 23 -->
en:renal failure
n1=en:magnesium stearate | n2=en:renal failure | rel=r_associated | relid=0 | w=23
- en:metformin hydrochloride 100mg/ml oral solution ---
r_associated #0: 23 -->
en:renal failure
n1=en:metformin hydrochloride 100mg/ml oral solution | n2=en:renal failure | rel=r_associated | relid=0 | w=23
- en:methotrexate 12.5mg/ml infusion solution 30ml vial ---
r_associated #0: 23 -->
en:renal failure
n1=en:methotrexate 12.5mg/ml infusion solution 30ml vial | n2=en:renal failure | rel=r_associated | relid=0 | w=23
- en:methyclothiazide 2.5mg tablet ---
r_associated #0: 23 -->
en:renal failure
n1=en:methyclothiazide 2.5mg tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=23
- en:metolazone 500micrograms tablet ---
r_associated #0: 23 -->
en:renal failure
n1=en:metolazone 500micrograms tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=23
- en:monoclonal immunoglobulin deposition disease ---
r_associated #0: 23 -->
en:renal failure
n1=en:monoclonal immunoglobulin deposition disease | n2=en:renal failure | rel=r_associated | relid=0 | w=23
- en:multiple renal cysts ---
r_associated #0: 23 -->
en:renal failure
n1=en:multiple renal cysts | n2=en:renal failure | rel=r_associated | relid=0 | w=23
- en:nephrolithiasis (in some patients) ---
r_associated #0: 23 -->
en:renal failure
n1=en:nephrolithiasis (in some patients) | n2=en:renal failure | rel=r_associated | relid=0 | w=23
- en:podocyte effacement ---
r_associated #0: 23 -->
en:renal failure
n1=en:podocyte effacement | n2=en:renal failure | rel=r_associated | relid=0 | w=23
- en:polycystic kidney disease 1 ---
r_associated #0: 23 -->
en:renal failure
n1=en:polycystic kidney disease 1 | n2=en:renal failure | rel=r_associated | relid=0 | w=23
- en:potassium bitartrate ---
r_associated #0: 23 -->
en:renal failure
n1=en:potassium bitartrate | n2=en:renal failure | rel=r_associated | relid=0 | w=23
- en:potassium chloride 0.125 meq/ml oral solution ---
r_associated #0: 23 -->
en:renal failure
n1=en:potassium chloride 0.125 meq/ml oral solution | n2=en:renal failure | rel=r_associated | relid=0 | w=23
- en:potassium chloride 10 meq oral tablet ---
r_associated #0: 23 -->
en:renal failure
n1=en:potassium chloride 10 meq oral tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=23
- en:potassium chloride 4 meq/ml oral solution ---
r_associated #0: 23 -->
en:renal failure
n1=en:potassium chloride 4 meq/ml oral solution | n2=en:renal failure | rel=r_associated | relid=0 | w=23
- en:potassium chloride strong 15% injection solution 10ml ampule ---
r_associated #0: 23 -->
en:renal failure
n1=en:potassium chloride strong 15% injection solution 10ml ampule | n2=en:renal failure | rel=r_associated | relid=0 | w=23
- en:potassium citrate 260 mg oral tablet ---
r_associated #0: 23 -->
en:renal failure
n1=en:potassium citrate 260 mg oral tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=23
- en:potassium gluconate ---
r_associated #0: 23 -->
en:renal failure
n1=en:potassium gluconate | n2=en:renal failure | rel=r_associated | relid=0 | w=23
- en:potassium phosphate monobasic ---
r_associated #0: 23 -->
en:renal failure
n1=en:potassium phosphate monobasic | n2=en:renal failure | rel=r_associated | relid=0 | w=23
- en:pre-renal acute kidney injury ---
r_associated #0: 23 -->
en:renal failure
n1=en:pre-renal acute kidney injury | n2=en:renal failure | rel=r_associated | relid=0 | w=23
- en:probenecid ---
r_associated #0: 23 -->
en:renal failure
n1=en:probenecid | n2=en:renal failure | rel=r_associated | relid=0 | w=23
- en:propofol infusion syndrome ---
r_associated #0: 23 -->
en:renal failure
n1=en:propofol infusion syndrome | n2=en:renal failure | rel=r_associated | relid=0 | w=23
- en:renal abscess ---
r_associated #0: 23 -->
en:renal failure
n1=en:renal abscess | n2=en:renal failure | rel=r_associated | relid=0 | w=23
- en:renal biopsy shows focal tubular atrophy (in 33%) ---
r_associated #0: 23 -->
en:renal failure
n1=en:renal biopsy shows focal tubular atrophy (in 33%) | n2=en:renal failure | rel=r_associated | relid=0 | w=23
- en:renal cortical microcysts ---
r_associated #0: 23 -->
en:renal failure
n1=en:renal cortical microcysts | n2=en:renal failure | rel=r_associated | relid=0 | w=23
- en:renal ectopia (rare) ---
r_associated #0: 23 -->
en:renal failure
n1=en:renal ectopia (rare) | n2=en:renal failure | rel=r_associated | relid=0 | w=23
- en:renal hypoplasia (1 patient) ---
r_associated #0: 23 -->
en:renal failure
n1=en:renal hypoplasia (1 patient) | n2=en:renal failure | rel=r_associated | relid=0 | w=23
- en:renal hypoplasia (rare) ---
r_associated #0: 23 -->
en:renal failure
n1=en:renal hypoplasia (rare) | n2=en:renal failure | rel=r_associated | relid=0 | w=23
- en:renal malrotation (rare) ---
r_associated #0: 23 -->
en:renal failure
n1=en:renal malrotation (rare) | n2=en:renal failure | rel=r_associated | relid=0 | w=23
- en:renal stones (in one patient) ---
r_associated #0: 23 -->
en:renal failure
n1=en:renal stones (in one patient) | n2=en:renal failure | rel=r_associated | relid=0 | w=23
- en:reproductive system disorder ---
r_associated #0: 23 -->
en:renal failure
n1=en:reproductive system disorder | n2=en:renal failure | rel=r_associated | relid=0 | w=23
- en:sotalol hydrochloride ---
r_associated #0: 23 -->
en:renal failure
n1=en:sotalol hydrochloride | n2=en:renal failure | rel=r_associated | relid=0 | w=23
- en:sotalol hydrochloride 5 mg/ml oral solution ---
r_associated #0: 23 -->
en:renal failure
n1=en:sotalol hydrochloride 5 mg/ml oral solution | n2=en:renal failure | rel=r_associated | relid=0 | w=23
- en:testosterone 100 mg/ml injectable solution ---
r_associated #0: 23 -->
en:renal failure
n1=en:testosterone 100 mg/ml injectable solution | n2=en:renal failure | rel=r_associated | relid=0 | w=23
- en:tubulopathy (1 family) ---
r_associated #0: 23 -->
en:renal failure
n1=en:tubulopathy (1 family) | n2=en:renal failure | rel=r_associated | relid=0 | w=23
- en:urinary tract infection ---
r_associated #0: 23 -->
en:renal failure
n1=en:urinary tract infection | n2=en:renal failure | rel=r_associated | relid=0 | w=23
- en:5000 mg testosterone 0.01 mg/mg topical gel ---
r_associated #0: 22 -->
en:renal failure
n1=en:5000 mg testosterone 0.01 mg/mg topical gel | n2=en:renal failure | rel=r_associated | relid=0 | w=22
- en:5000 mg testosterone 0.01 mg/mg topical gel [testim] ---
r_associated #0: 22 -->
en:renal failure
n1=en:5000 mg testosterone 0.01 mg/mg topical gel [testim] | n2=en:renal failure | rel=r_associated | relid=0 | w=22
- en:72 hr fentanyl 0.0375 mg/hr transdermal patch ---
r_associated #0: 22 -->
en:renal failure
n1=en:72 hr fentanyl 0.0375 mg/hr transdermal patch | n2=en:renal failure | rel=r_associated | relid=0 | w=22
- en:72 hr fentanyl 0.05 mg/hr transdermal patch ---
r_associated #0: 22 -->
en:renal failure
n1=en:72 hr fentanyl 0.05 mg/hr transdermal patch | n2=en:renal failure | rel=r_associated | relid=0 | w=22
- en:acitretin 17.5 mg oral capsule ---
r_associated #0: 22 -->
en:renal failure
n1=en:acitretin 17.5 mg oral capsule | n2=en:renal failure | rel=r_associated | relid=0 | w=22
- en:acitretin 25mg capsule ---
r_associated #0: 22 -->
en:renal failure
n1=en:acitretin 25mg capsule | n2=en:renal failure | rel=r_associated | relid=0 | w=22
- en:adrenal hypoplasia ---
r_associated #0: 22 -->
en:renal failure
n1=en:adrenal hypoplasia | n2=en:renal failure | rel=r_associated | relid=0 | w=22
- en:amprenavir 15mg/ml oral solution ---
r_associated #0: 22 -->
en:renal failure
n1=en:amprenavir 15mg/ml oral solution | n2=en:renal failure | rel=r_associated | relid=0 | w=22
- en:atrophic zona glomerulosa of adrenal gland (rare) ---
r_associated #0: 22 -->
en:renal failure
n1=en:atrophic zona glomerulosa of adrenal gland (rare) | n2=en:renal failure | rel=r_associated | relid=0 | w=22
- en:capecitabine 500mg tablet ---
r_associated #0: 22 -->
en:renal failure
n1=en:capecitabine 500mg tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=22
- en:carnitine palmitoyltransferase ii deficiency, late-onset ---
r_associated #0: 22 -->
en:renal failure
n1=en:carnitine palmitoyltransferase ii deficiency, late-onset | n2=en:renal failure | rel=r_associated | relid=0 | w=22
- en:chloral hydrate 500 mg rectal suppository ---
r_associated #0: 22 -->
en:renal failure
n1=en:chloral hydrate 500 mg rectal suppository | n2=en:renal failure | rel=r_associated | relid=0 | w=22
- en:chloral hydrate 650 mg rectal suppository ---
r_associated #0: 22 -->
en:renal failure
n1=en:chloral hydrate 650 mg rectal suppository | n2=en:renal failure | rel=r_associated | relid=0 | w=22
- en:chronic inflammatory infiltrate, mild ---
r_associated #0: 22 -->
en:renal failure
n1=en:chronic inflammatory infiltrate, mild | n2=en:renal failure | rel=r_associated | relid=0 | w=22
- en:clofibrate 500 mg oral capsule ---
r_associated #0: 22 -->
en:renal failure
n1=en:clofibrate 500 mg oral capsule | n2=en:renal failure | rel=r_associated | relid=0 | w=22
- en:cyclosporine 100 mg/ml oral solution ---
r_associated #0: 22 -->
en:renal failure
n1=en:cyclosporine 100 mg/ml oral solution | n2=en:renal failure | rel=r_associated | relid=0 | w=22
- en:cyclosporine 50 mg/ml oral solution ---
r_associated #0: 22 -->
en:renal failure
n1=en:cyclosporine 50 mg/ml oral solution | n2=en:renal failure | rel=r_associated | relid=0 | w=22
- en:dahlberg borer newcomer syndrome ---
r_associated #0: 22 -->
en:renal failure
n1=en:dahlberg borer newcomer syndrome | n2=en:renal failure | rel=r_associated | relid=0 | w=22
- en:diatrizoate sodium ---
r_associated #0: 22 -->
en:renal failure
n1=en:diatrizoate sodium | n2=en:renal failure | rel=r_associated | relid=0 | w=22
- en:diseases of male genital organs (n40-n53) ---
r_associated #0: 22 -->
en:renal failure
n1=en:diseases of male genital organs (n40-n53) | n2=en:renal failure | rel=r_associated | relid=0 | w=22
- en:dofetilide 500micrograms capsule ---
r_associated #0: 22 -->
en:renal failure
n1=en:dofetilide 500micrograms capsule | n2=en:renal failure | rel=r_associated | relid=0 | w=22
- en:duplicated calyx ---
r_associated #0: 22 -->
en:renal failure
n1=en:duplicated calyx | n2=en:renal failure | rel=r_associated | relid=0 | w=22
- en:duplicated collecting system ---
r_associated #0: 22 -->
en:renal failure
n1=en:duplicated collecting system | n2=en:renal failure | rel=r_associated | relid=0 | w=22
- en:ergocalciferol 25000 unt oral capsule ---
r_associated #0: 22 -->
en:renal failure
n1=en:ergocalciferol 25000 unt oral capsule | n2=en:renal failure | rel=r_associated | relid=0 | w=22
- en:fenofibrate 43 mg oral capsule ---
r_associated #0: 22 -->
en:renal failure
n1=en:fenofibrate 43 mg oral capsule | n2=en:renal failure | rel=r_associated | relid=0 | w=22
- en:fenofibrate 48mg tablet ---
r_associated #0: 22 -->
en:renal failure
n1=en:fenofibrate 48mg tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=22
- en:fentanyl 100micrograms/2ml injection ---
r_associated #0: 22 -->
en:renal failure
n1=en:fentanyl 100micrograms/2ml injection | n2=en:renal failure | rel=r_associated | relid=0 | w=22
- en:fentanyl 12micrograms/hour patch ---
r_associated #0: 22 -->
en:renal failure
n1=en:fentanyl 12micrograms/hour patch | n2=en:renal failure | rel=r_associated | relid=0 | w=22
- en:fentanyl 800micrograms lozenge ---
r_associated #0: 22 -->
en:renal failure
n1=en:fentanyl 800micrograms lozenge | n2=en:renal failure | rel=r_associated | relid=0 | w=22
- en:focal segmental glomerulosclerosis (patient a) ---
r_associated #0: 22 -->
en:renal failure
n1=en:focal segmental glomerulosclerosis (patient a) | n2=en:renal failure | rel=r_associated | relid=0 | w=22
- en:galantamine 4mg/ml s/f oral solution ---
r_associated #0: 22 -->
en:renal failure
n1=en:galantamine 4mg/ml s/f oral solution | n2=en:renal failure | rel=r_associated | relid=0 | w=22
- en:gemfibrozil 300mg capsule ---
r_associated #0: 22 -->
en:renal failure
n1=en:gemfibrozil 300mg capsule | n2=en:renal failure | rel=r_associated | relid=0 | w=22
- en:hexahydrate, foscarnet sodium ---
r_associated #0: 22 -->
en:renal failure
n1=en:hexahydrate, foscarnet sodium | n2=en:renal failure | rel=r_associated | relid=0 | w=22
- en:hydrochlorothiazide ---
r_associated #0: 22 -->
en:renal failure
n1=en:hydrochlorothiazide | n2=en:renal failure | rel=r_associated | relid=0 | w=22
- en:hydroflumethiazide ---
r_associated #0: 22 -->
en:renal failure
n1=en:hydroflumethiazide | n2=en:renal failure | rel=r_associated | relid=0 | w=22
- en:hyperuricemic nephropathy, familial juvenile, 3 ---
r_associated #0: 22 -->
en:renal failure
n1=en:hyperuricemic nephropathy, familial juvenile, 3 | n2=en:renal failure | rel=r_associated | relid=0 | w=22
- en:left kidney ---
r_associated #0: 22 -->
en:renal failure
n1=en:left kidney | n2=en:renal failure | rel=r_associated | relid=0 | w=22
- en:magnesium carbonate 260 mg oral capsule ---
r_associated #0: 22 -->
en:renal failure
n1=en:magnesium carbonate 260 mg oral capsule | n2=en:renal failure | rel=r_associated | relid=0 | w=22
- en:magnesium carbonate blocks ---
r_associated #0: 22 -->
en:renal failure
n1=en:magnesium carbonate blocks | n2=en:renal failure | rel=r_associated | relid=0 | w=22
- en:magnesium citrate ---
r_associated #0: 22 -->
en:renal failure
n1=en:magnesium citrate | n2=en:renal failure | rel=r_associated | relid=0 | w=22
- en:magnesium citrate oral solution ---
r_associated #0: 22 -->
en:renal failure
n1=en:magnesium citrate oral solution | n2=en:renal failure | rel=r_associated | relid=0 | w=22
- en:magnesium oxide 500 mg oral tablet ---
r_associated #0: 22 -->
en:renal failure
n1=en:magnesium oxide 500 mg oral tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=22
- en:methazolamide 50mg tablet ---
r_associated #0: 22 -->
en:renal failure
n1=en:methazolamide 50mg tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=22
- en:methocarbamol 100mg/ml injection solution ampule ---
r_associated #0: 22 -->
en:renal failure
n1=en:methocarbamol 100mg/ml injection solution ampule | n2=en:renal failure | rel=r_associated | relid=0 | w=22
- en:methocarbamol 500mg tablet ---
r_associated #0: 22 -->
en:renal failure
n1=en:methocarbamol 500mg tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=22
- en:methylene blue 1% injection solution 10 ml vial ---
r_associated #0: 22 -->
en:renal failure
n1=en:methylene blue 1% injection solution 10 ml vial | n2=en:renal failure | rel=r_associated | relid=0 | w=22
- en:microphtalmia ---
r_associated #0: 22 -->
en:renal failure
n1=en:microphtalmia | n2=en:renal failure | rel=r_associated | relid=0 | w=22
- en:mitomycin 10mg powder for injection solution vial ---
r_associated #0: 22 -->
en:renal failure
n1=en:mitomycin 10mg powder for injection solution vial | n2=en:renal failure | rel=r_associated | relid=0 | w=22
- en:normal distal tubule acid excretion ---
r_associated #0: 22 -->
en:renal failure
n1=en:normal distal tubule acid excretion | n2=en:renal failure | rel=r_associated | relid=0 | w=22
- en:oculocerebrorenal syndrome ---
r_associated #0: 22 -->
en:renal failure
n1=en:oculocerebrorenal syndrome | n2=en:renal failure | rel=r_associated | relid=0 | w=22
- en:onychoosteodysostosis ---
r_associated #0: 22 -->
en:renal failure
n1=en:onychoosteodysostosis | n2=en:renal failure | rel=r_associated | relid=0 | w=22
- en:opium, powdered ---
r_associated #0: 22 -->
en:renal failure
n1=en:opium, powdered | n2=en:renal failure | rel=r_associated | relid=0 | w=22
- en:pancreatorenal syndrome ---
r_associated #0: 22 -->
en:renal failure
n1=en:pancreatorenal syndrome | n2=en:renal failure | rel=r_associated | relid=0 | w=22
- en:pelvicalyceal dilatation (in 1 of 6 patients) ---
r_associated #0: 22 -->
en:renal failure
n1=en:pelvicalyceal dilatation (in 1 of 6 patients) | n2=en:renal failure | rel=r_associated | relid=0 | w=22
- en:polyuria (in some patients) ---
r_associated #0: 22 -->
en:renal failure
n1=en:polyuria (in some patients) | n2=en:renal failure | rel=r_associated | relid=0 | w=22
- en:potassium chloride 2.4 meq/ml injectable solution ---
r_associated #0: 22 -->
en:renal failure
n1=en:potassium chloride 2.4 meq/ml injectable solution | n2=en:renal failure | rel=r_associated | relid=0 | w=22
- en:potassium chloride 4 meq delayed release oral tablet ---
r_associated #0: 22 -->
en:renal failure
n1=en:potassium chloride 4 meq delayed release oral tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=22
- en:potassium citrate 10 meq extended release oral tablet ---
r_associated #0: 22 -->
en:renal failure
n1=en:potassium citrate 10 meq extended release oral tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=22
- en:proteinuria (in 2 of 3 siblings) ---
r_associated #0: 22 -->
en:renal failure
n1=en:proteinuria (in 2 of 3 siblings) | n2=en:renal failure | rel=r_associated | relid=0 | w=22
- en:rare mesangial igm deposition ---
r_associated #0: 22 -->
en:renal failure
n1=en:rare mesangial igm deposition | n2=en:renal failure | rel=r_associated | relid=0 | w=22
- en:renal anasarca ---
r_associated #0: 22 -->
en:renal failure
n1=en:renal anasarca | n2=en:renal failure | rel=r_associated | relid=0 | w=22
- en:renal biopsy shows medullary cysts ---
r_associated #0: 22 -->
en:renal failure
n1=en:renal biopsy shows medullary cysts | n2=en:renal failure | rel=r_associated | relid=0 | w=22
- en:renal calcium wasting ---
r_associated #0: 22 -->
en:renal failure
n1=en:renal calcium wasting | n2=en:renal failure | rel=r_associated | relid=0 | w=22
- en:renal cysts (in some patients) ---
r_associated #0: 22 -->
en:renal failure
n1=en:renal cysts (in some patients) | n2=en:renal failure | rel=r_associated | relid=0 | w=22
- en:renal failure (in some patients) ---
r_associated #0: 22 -->
en:renal failure
n1=en:renal failure (in some patients) | n2=en:renal failure | rel=r_associated | relid=0 | w=22
- en:renal failure and impairment ---
r_associated #0: 22 -->
en:renal failure
n1=en:renal failure and impairment | n2=en:renal failure | rel=r_associated | relid=0 | w=22
- en:renal failure:find:pt:^patient:ord:mds ---
r_associated #0: 22 -->
en:renal failure
n1=en:renal failure:find:pt:^patient:ord:mds | n2=en:renal failure | rel=r_associated | relid=0 | w=22
- en:renal interstitial fibrosis ---
r_associated #0: 22 -->
en:renal failure
n1=en:renal interstitial fibrosis | n2=en:renal failure | rel=r_associated | relid=0 | w=22
- en:renal malposition (rare) ---
r_associated #0: 22 -->
en:renal failure
n1=en:renal malposition (rare) | n2=en:renal failure | rel=r_associated | relid=0 | w=22
- en:ribavirin 200mg capsule ---
r_associated #0: 22 -->
en:renal failure
n1=en:ribavirin 200mg capsule | n2=en:renal failure | rel=r_associated | relid=0 | w=22
- en:small kidney (rare) ---
r_associated #0: 22 -->
en:renal failure
n1=en:small kidney (rare) | n2=en:renal failure | rel=r_associated | relid=0 | w=22
- en:sodium phosphate ---
r_associated #0: 22 -->
en:renal failure
n1=en:sodium phosphate | n2=en:renal failure | rel=r_associated | relid=0 | w=22
- en:sodium phosphate, dibasic 398 mg / sodium phosphate,monobasic,monohydrate 1102 mg oral tablet [visicol] ---
r_associated #0: 22 -->
en:renal failure
n1=en:sodium phosphate, dibasic 398 mg / sodium phosphate,monobasic,monohydrate 1102 mg oral tablet [visicol] | n2=en:renal failure | rel=r_associated | relid=0 | w=22
- en:structural renal abnormalities ---
r_associated #0: 22 -->
en:renal failure
n1=en:structural renal abnormalities | n2=en:renal failure | rel=r_associated | relid=0 | w=22
- en:tegaserod ---
r_associated #0: 22 -->
en:renal failure
n1=en:tegaserod | n2=en:renal failure | rel=r_associated | relid=0 | w=22
- en:testosterone 0.02 mg/mg topical ointment ---
r_associated #0: 22 -->
en:renal failure
n1=en:testosterone 0.02 mg/mg topical ointment | n2=en:renal failure | rel=r_associated | relid=0 | w=22
- en:testosterone 20 mg/ml topical cream ---
r_associated #0: 22 -->
en:renal failure
n1=en:testosterone 20 mg/ml topical cream | n2=en:renal failure | rel=r_associated | relid=0 | w=22
- en:testosterone 20.25 mg/actuat topical gel ---
r_associated #0: 22 -->
en:renal failure
n1=en:testosterone 20.25 mg/actuat topical gel | n2=en:renal failure | rel=r_associated | relid=0 | w=22
- en:testosterone 50mg/ml suspension ---
r_associated #0: 22 -->
en:renal failure
n1=en:testosterone 50mg/ml suspension | n2=en:renal failure | rel=r_associated | relid=0 | w=22
- en:testosterone propionate 50mg/ml injection solution 2ml ampule ---
r_associated #0: 22 -->
en:renal failure
n1=en:testosterone propionate 50mg/ml injection solution 2ml ampule | n2=en:renal failure | rel=r_associated | relid=0 | w=22
- en:testosterone propionate pwdr ---
r_associated #0: 22 -->
en:renal failure
n1=en:testosterone propionate pwdr | n2=en:renal failure | rel=r_associated | relid=0 | w=22
- en:thickened tubular basement membrane ---
r_associated #0: 22 -->
en:renal failure
n1=en:thickened tubular basement membrane | n2=en:renal failure | rel=r_associated | relid=0 | w=22
- en:unilateral renal aplasia (rare) ---
r_associated #0: 22 -->
en:renal failure
n1=en:unilateral renal aplasia (rare) | n2=en:renal failure | rel=r_associated | relid=0 | w=22
- en:unintentional voiding of urine ---
r_associated #0: 22 -->
en:renal failure
n1=en:unintentional voiding of urine | n2=en:renal failure | rel=r_associated | relid=0 | w=22
- en:urinary tract toxicity ---
r_associated #0: 22 -->
en:renal failure
n1=en:urinary tract toxicity | n2=en:renal failure | rel=r_associated | relid=0 | w=22
- en:urination ---
r_associated #0: 22 -->
en:renal failure
n1=en:urination | n2=en:renal failure | rel=r_associated | relid=0 | w=22
- insuffisance rénale (neuropathie et) ---
r_associated #0: 22 -->
en:renal failure
n1=insuffisance rénale (neuropathie et) | n2=en:renal failure | rel=r_associated | relid=0 | w=22
- BWAV ---
r_associated #0: 21 -->
en:renal failure
n1=BWAV | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- défaillance respiratoire chronique ---
r_associated #0: 21 -->
en:renal failure
n1=défaillance respiratoire chronique | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:0.15 ml methotrexate 50 mg/ml auto-injector ---
r_associated #0: 21 -->
en:renal failure
n1=en:0.15 ml methotrexate 50 mg/ml auto-injector | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:0.45 ml methotrexate 50 mg/ml auto-injector ---
r_associated #0: 21 -->
en:renal failure
n1=en:0.45 ml methotrexate 50 mg/ml auto-injector | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:1 ml ketorolac tromethamine 15 mg/ml injection ---
r_associated #0: 21 -->
en:renal failure
n1=en:1 ml ketorolac tromethamine 15 mg/ml injection | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:24 hr galantamine hydrobromide 16 mg extended release oral capsule ---
r_associated #0: 21 -->
en:renal failure
n1=en:24 hr galantamine hydrobromide 16 mg extended release oral capsule | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:24 hr testosterone 0.0833 mg/hr transdermal patch ---
r_associated #0: 21 -->
en:renal failure
n1=en:24 hr testosterone 0.0833 mg/hr transdermal patch | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:24 hr testosterone 0.167 mg/hr transdermal patch ---
r_associated #0: 21 -->
en:renal failure
n1=en:24 hr testosterone 0.167 mg/hr transdermal patch | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:24 hr testosterone 0.208 mg/hr transdermal patch [androderm] ---
r_associated #0: 21 -->
en:renal failure
n1=en:24 hr testosterone 0.208 mg/hr transdermal patch [androderm] | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:72 hr fentanyl 0.0875 mg/hr transdermal patch ---
r_associated #0: 21 -->
en:renal failure
n1=en:72 hr fentanyl 0.0875 mg/hr transdermal patch | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:Frasier syndrome ---
r_associated #0: 21 -->
en:renal failure
n1=en:Frasier syndrome | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:acitretin 10mg capsule ---
r_associated #0: 21 -->
en:renal failure
n1=en:acitretin 10mg capsule | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:acitretin 25 mg oral capsule [soriatane] ---
r_associated #0: 21 -->
en:renal failure
n1=en:acitretin 25 mg oral capsule [soriatane] | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:ammonium chloride ---
r_associated #0: 21 -->
en:renal failure
n1=en:ammonium chloride | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:ammonium chloride 0.4 meq/ml injectable solution ---
r_associated #0: 21 -->
en:renal failure
n1=en:ammonium chloride 0.4 meq/ml injectable solution | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:ammonium chloride 500 mg delayed release oral tablet ---
r_associated #0: 21 -->
en:renal failure
n1=en:ammonium chloride 500 mg delayed release oral tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:anhydrous citric acid ---
r_associated #0: 21 -->
en:renal failure
n1=en:anhydrous citric acid | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:atrophic tubules ---
r_associated #0: 21 -->
en:renal failure
n1=en:atrophic tubules | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:bendroflumethiazide 10 mg oral tablet ---
r_associated #0: 21 -->
en:renal failure
n1=en:bendroflumethiazide 10 mg oral tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:benzthiazide 25 mg oral tablet ---
r_associated #0: 21 -->
en:renal failure
n1=en:benzthiazide 25 mg oral tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:brinzolamide 10mg/ml eye drops ---
r_associated #0: 21 -->
en:renal failure
n1=en:brinzolamide 10mg/ml eye drops | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:chloral hydrate ---
r_associated #0: 21 -->
en:renal failure
n1=en:chloral hydrate | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:chloral hydrate 250mg/5ml syrup ---
r_associated #0: 21 -->
en:renal failure
n1=en:chloral hydrate 250mg/5ml syrup | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:chloral hydrate 325 mg rectal suppository ---
r_associated #0: 21 -->
en:renal failure
n1=en:chloral hydrate 325 mg rectal suppository | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:chlorothiazide 500mg powder for injection solution vial ---
r_associated #0: 21 -->
en:renal failure
n1=en:chlorothiazide 500mg powder for injection solution vial | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:chlorothiazide 500mg tablet ---
r_associated #0: 21 -->
en:renal failure
n1=en:chlorothiazide 500mg tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:chronic respiratory failure ---
r_associated #0: 21 -->
en:renal failure
n1=en:chronic respiratory failure | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:cockayne syndrome, type i ---
r_associated #0: 21 -->
en:renal failure
n1=en:cockayne syndrome, type i | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:complement component 3 deficiency, autosomal recessive ---
r_associated #0: 21 -->
en:renal failure
n1=en:complement component 3 deficiency, autosomal recessive | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:congenital absence of kidney ---
r_associated #0: 21 -->
en:renal failure
n1=en:congenital absence of kidney | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:cyclosporine, modified 100 mg oral capsule ---
r_associated #0: 21 -->
en:renal failure
n1=en:cyclosporine, modified 100 mg oral capsule | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:cyclosporine, modified 100 mg oral capsule [neoral] ---
r_associated #0: 21 -->
en:renal failure
n1=en:cyclosporine, modified 100 mg oral capsule [neoral] | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:cyclosporine, modified 100 mg/ml oral solution ---
r_associated #0: 21 -->
en:renal failure
n1=en:cyclosporine, modified 100 mg/ml oral solution | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:cyclosporine, modified 25 mg oral capsule [gengraf] ---
r_associated #0: 21 -->
en:renal failure
n1=en:cyclosporine, modified 25 mg oral capsule [gengraf] | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:cystic kidneys (in some patients) ---
r_associated #0: 21 -->
en:renal failure
n1=en:cystic kidneys (in some patients) | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:defect in renal tubular reabsorption of mg(2+) ---
r_associated #0: 21 -->
en:renal failure
n1=en:defect in renal tubular reabsorption of mg(2+) | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:dextrothyroxine ---
r_associated #0: 21 -->
en:renal failure
n1=en:dextrothyroxine | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:dextrothyroxine sodium ---
r_associated #0: 21 -->
en:renal failure
n1=en:dextrothyroxine sodium | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:diatrizoate sodium 50% injection solution vial ---
r_associated #0: 21 -->
en:renal failure
n1=en:diatrizoate sodium 50% injection solution vial | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:dilated collecting tubules ---
r_associated #0: 21 -->
en:renal failure
n1=en:dilated collecting tubules | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:dofetilide 250micrograms capsule ---
r_associated #0: 21 -->
en:renal failure
n1=en:dofetilide 250micrograms capsule | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:double right kidney ---
r_associated #0: 21 -->
en:renal failure
n1=en:double right kidney | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:duplication of the renal pelvis (1 patient) ---
r_associated #0: 21 -->
en:renal failure
n1=en:duplication of the renal pelvis (1 patient) | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:end-stage renal disease (1 of 2 patients) ---
r_associated #0: 21 -->
en:renal failure
n1=en:end-stage renal disease (1 of 2 patients) | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:enlarged polycystic kidneys (detectable prenatally) ---
r_associated #0: 21 -->
en:renal failure
n1=en:enlarged polycystic kidneys (detectable prenatally) | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:familial mediterranean fever, autosomal dominant ---
r_associated #0: 21 -->
en:renal failure
n1=en:familial mediterranean fever, autosomal dominant | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:family history of renal failure syndrome ---
r_associated #0: 21 -->
en:renal failure
n1=en:family history of renal failure syndrome | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:fanconi syndrome ---
r_associated #0: 21 -->
en:renal failure
n1=en:fanconi syndrome | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:fentanyl 0.1 mg oral lozenge ---
r_associated #0: 21 -->
en:renal failure
n1=en:fentanyl 0.1 mg oral lozenge | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:fentanyl 200microgram buccal soluble film ---
r_associated #0: 21 -->
en:renal failure
n1=en:fentanyl 200microgram buccal soluble film | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:fentanyl 600micrograms buccal tablet ---
r_associated #0: 21 -->
en:renal failure
n1=en:fentanyl 600micrograms buccal tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:hydronephrosis (rare) ---
r_associated #0: 21 -->
en:renal failure
n1=en:hydronephrosis (rare) | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:hyperuricemia ---
r_associated #0: 21 -->
en:renal failure
n1=en:hyperuricemia | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:hypoplastic kidneys (in 2 of 3 siblings) ---
r_associated #0: 21 -->
en:renal failure
n1=en:hypoplastic kidneys (in 2 of 3 siblings) | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:iga nephropathy ---
r_associated #0: 21 -->
en:renal failure
n1=en:iga nephropathy | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:immature podocytes ---
r_associated #0: 21 -->
en:renal failure
n1=en:immature podocytes | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:incontinentia urinae ---
r_associated #0: 21 -->
en:renal failure
n1=en:incontinentia urinae | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:increased mesangial matrix ---
r_associated #0: 21 -->
en:renal failure
n1=en:increased mesangial matrix | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:kidney neoplasm ---
r_associated #0: 21 -->
en:renal failure
n1=en:kidney neoplasm | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:magaldrate 480 mg chewable tablet ---
r_associated #0: 21 -->
en:renal failure
n1=en:magaldrate 480 mg chewable tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:magnesium 84mg tab,sa ---
r_associated #0: 21 -->
en:renal failure
n1=en:magnesium 84mg tab,sa | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:magnesium hydroxide 240 mg/ml oral suspension ---
r_associated #0: 21 -->
en:renal failure
n1=en:magnesium hydroxide 240 mg/ml oral suspension | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:magnesium hydroxide 81 mg/ml oral suspension ---
r_associated #0: 21 -->
en:renal failure
n1=en:magnesium hydroxide 81 mg/ml oral suspension | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:magnesium sulfate 1000 mg oral granules ---
r_associated #0: 21 -->
en:renal failure
n1=en:magnesium sulfate 1000 mg oral granules | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:magnesium sulfate 500 mg/ml injection ---
r_associated #0: 21 -->
en:renal failure
n1=en:magnesium sulfate 500 mg/ml injection | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:magnesium trisilicate ---
r_associated #0: 21 -->
en:renal failure
n1=en:magnesium trisilicate | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:malignant neoplasm of genitourinary organ ---
r_associated #0: 21 -->
en:renal failure
n1=en:malignant neoplasm of genitourinary organ | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:metaxalone 400mg tablet ---
r_associated #0: 21 -->
en:renal failure
n1=en:metaxalone 400mg tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:metformin ---
r_associated #0: 21 -->
en:renal failure
n1=en:metformin | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:methotrexate ---
r_associated #0: 21 -->
en:renal failure
n1=en:methotrexate | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:methotrexate 2.5mg tablet ---
r_associated #0: 21 -->
en:renal failure
n1=en:methotrexate 2.5mg tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:methotrexate sodium ---
r_associated #0: 21 -->
en:renal failure
n1=en:methotrexate sodium | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:methyclothiazide 5mg tablet ---
r_associated #0: 21 -->
en:renal failure
n1=en:methyclothiazide 5mg tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:multiple organ dysfunction syndrome ---
r_associated #0: 21 -->
en:renal failure
n1=en:multiple organ dysfunction syndrome | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:nephrotic syndrome (1 patient) ---
r_associated #0: 21 -->
en:renal failure
n1=en:nephrotic syndrome (1 patient) | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:nephrotic syndrome, type 4 ---
r_associated #0: 21 -->
en:renal failure
n1=en:nephrotic syndrome, type 4 | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:opium 10mg/ml tincture ---
r_associated #0: 21 -->
en:renal failure
n1=en:opium 10mg/ml tincture | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:paromomycin sulfate ---
r_associated #0: 21 -->
en:renal failure
n1=en:paromomycin sulfate | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:pelvic dilation (some patients) ---
r_associated #0: 21 -->
en:renal failure
n1=en:pelvic dilation (some patients) | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:phosphorus 3mmol/sodium 4meq/ml inj ---
r_associated #0: 21 -->
en:renal failure
n1=en:phosphorus 3mmol/sodium 4meq/ml inj | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:potassium acetate 2 meq/ml injectable solution ---
r_associated #0: 21 -->
en:renal failure
n1=en:potassium acetate 2 meq/ml injectable solution | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:potassium chloride 10 meq extended release oral capsule ---
r_associated #0: 21 -->
en:renal failure
n1=en:potassium chloride 10 meq extended release oral capsule | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:potassium chloride 2.67 meq/ml oral solution ---
r_associated #0: 21 -->
en:renal failure
n1=en:potassium chloride 2.67 meq/ml oral solution | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:potassium chloride 20 meq extended release oral tablet [k-dur] ---
r_associated #0: 21 -->
en:renal failure
n1=en:potassium chloride 20 meq extended release oral tablet [k-dur] | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:potassium chloride 3 meq/ml injectable solution ---
r_associated #0: 21 -->
en:renal failure
n1=en:potassium chloride 3 meq/ml injectable solution | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:potassium citrate 15 meq extended release oral tablet ---
r_associated #0: 21 -->
en:renal failure
n1=en:potassium citrate 15 meq extended release oral tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:potassium phosphate 1450 mg oral capsule ---
r_associated #0: 21 -->
en:renal failure
n1=en:potassium phosphate 1450 mg oral capsule | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:potassium phosphate, dibasic ---
r_associated #0: 21 -->
en:renal failure
n1=en:potassium phosphate, dibasic | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:potassium tripolyphosphate ---
r_associated #0: 21 -->
en:renal failure
n1=en:potassium tripolyphosphate | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:renal abnormalities (in some patients) ---
r_associated #0: 21 -->
en:renal failure
n1=en:renal abnormalities (in some patients) | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:renal amyloidosis, late-onset ---
r_associated #0: 21 -->
en:renal failure
n1=en:renal amyloidosis, late-onset | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:renal cysts (33%) ---
r_associated #0: 21 -->
en:renal failure
n1=en:renal cysts (33%) | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:renal failure by age 3 ---
r_associated #0: 21 -->
en:renal failure
n1=en:renal failure by age 3 | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:renal hypoplasia (less common) ---
r_associated #0: 21 -->
en:renal failure
n1=en:renal hypoplasia (less common) | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:renal juxtaglomerular cell hypertrophy/hyperplasia ---
r_associated #0: 21 -->
en:renal failure
n1=en:renal juxtaglomerular cell hypertrophy/hyperplasia | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:renal pelvis fibroepithelial polyp ---
r_associated #0: 21 -->
en:renal failure
n1=en:renal pelvis fibroepithelial polyp | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:renal stones, bilateral ---
r_associated #0: 21 -->
en:renal failure
n1=en:renal stones, bilateral | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:sclerotic glomeruli, 50% to 75% ---
r_associated #0: 21 -->
en:renal failure
n1=en:sclerotic glomeruli, 50% to 75% | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:small renal cysts ---
r_associated #0: 21 -->
en:renal failure
n1=en:small renal cysts | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:sodium phosphate, dibasic 142 mg/ml / sodium phosphate, monobasic 276 mg/ml injectable solution ---
r_associated #0: 21 -->
en:renal failure
n1=en:sodium phosphate, dibasic 142 mg/ml / sodium phosphate, monobasic 276 mg/ml injectable solution | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:sodium phosphate, monobasic ---
r_associated #0: 21 -->
en:renal failure
n1=en:sodium phosphate, monobasic | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:sotalol hydrochloride 120mg tablet ---
r_associated #0: 21 -->
en:renal failure
n1=en:sotalol hydrochloride 120mg tablet | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:structural abnormalities, mild ---
r_associated #0: 21 -->
en:renal failure
n1=en:structural abnormalities, mild | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:structural urinary tract ---
r_associated #0: 21 -->
en:renal failure
n1=en:structural urinary tract | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:testosterone propionate 25 mg/ml injectable solution ---
r_associated #0: 21 -->
en:renal failure
n1=en:testosterone propionate 25 mg/ml injectable solution | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:townes-brocks syndrome ---
r_associated #0: 21 -->
en:renal failure
n1=en:townes-brocks syndrome | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:unilateral renal pelviectasis (rare) ---
r_associated #0: 21 -->
en:renal failure
n1=en:unilateral renal pelviectasis (rare) | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:uremia syndrome ---
r_associated #0: 21 -->
en:renal failure
n1=en:uremia syndrome | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:uroclepsia ---
r_associated #0: 21 -->
en:renal failure
n1=en:uroclepsia | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:urofacial syndrome 2 ---
r_associated #0: 21 -->
en:renal failure
n1=en:urofacial syndrome 2 | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:vacuolization of glomerular and tubular epithelial cells ---
r_associated #0: 21 -->
en:renal failure
n1=en:vacuolization of glomerular and tubular epithelial cells | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:vesicoureteral reflux ---
r_associated #0: 21 -->
en:renal failure
n1=en:vesicoureteral reflux | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- en:{14 (ribavirin 400 mg oral tablet) } pack ---
r_associated #0: 21 -->
en:renal failure
n1=en:{14 (ribavirin 400 mg oral tablet) } pack | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- insuffisance du rein ---
r_associated #0: 21 -->
en:renal failure
n1=insuffisance du rein | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- insuffisance respiratoire chronique ---
r_associated #0: 21 -->
en:renal failure
n1=insuffisance respiratoire chronique | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- maladie de l'appareil urinaire ---
r_associated #0: 21 -->
en:renal failure
n1=maladie de l'appareil urinaire | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- néphropathie tubulo-interstitielle aigüe ---
r_associated #0: 21 -->
en:renal failure
n1=néphropathie tubulo-interstitielle aigüe | n2=en:renal failure | rel=r_associated | relid=0 | w=21
- HIVAN (syndrome) ---
r_associated #0: 20 -->
en:renal failure
n1=HIVAN (syndrome) | n2=en:renal failure | rel=r_associated | relid=0 | w=20
- Tachycardie ---
r_associated #0: 20 -->
en:renal failure
n1=Tachycardie | n2=en:renal failure | rel=r_associated | relid=0 | w=20
- cristaux d'oxalate de calcium ---
r_associated #0: 20 -->
en:renal failure
n1=cristaux d'oxalate de calcium | n2=en:renal failure | rel=r_associated | relid=0 | w=20
- dialyse ---
r_associated #0: 20 -->
en:renal failure
n1=dialyse | n2=en:renal failure | rel=r_associated | relid=0 | w=20
- défaillance ---
r_associated #0: 20 -->
en:renal failure
n1=défaillance | n2=en:renal failure | rel=r_associated | relid=0 | w=20
- en:abnormal glomerular filtration rate ---
r_associated #0: 20 -->
en:renal failure
n1=en:abnormal glomerular filtration rate | n2=en:renal failure | rel=r_associated | relid=0 | w=20
- en:abnormality of renal excretion ---
r_associated #0: 20 -->
en:renal failure
n1=en:abnormality of renal excretion | n2=en:renal failure | rel=r_associated | relid=0 | w=20
- en:hyperuricemic nephropathy, familial juvenile 2 ---
r_associated #0: 20 -->
en:renal failure
n1=en:hyperuricemic nephropathy, familial juvenile 2 | n2=en:renal failure | rel=r_associated | relid=0 | w=20
- en:isothenuria ---
r_associated #0: 20 -->
en:renal failure
n1=en:isothenuria | n2=en:renal failure | rel=r_associated | relid=0 | w=20
- en:low alkaline phosphatase of renal origin ---
r_associated #0: 20 -->
en:renal failure
n1=en:low alkaline phosphatase of renal origin | n2=en:renal failure | rel=r_associated | relid=0 | w=20
- en:medicine ---
r_associated #0: 20 -->
en:renal failure
n1=en:medicine | n2=en:renal failure | rel=r_associated | relid=0 | w=20
- en:renal coloboma syndrome ---
r_associated #0: 20 -->
en:renal failure
n1=en:renal coloboma syndrome | n2=en:renal failure | rel=r_associated | relid=0 | w=20
- en:renovascular hypertension ---
r_associated #0: 20 -->
en:renal failure
n1=en:renovascular hypertension | n2=en:renal failure | rel=r_associated | relid=0 | w=20
- en:x-linked recessive nephrolithiasis with renal failure ---
r_associated #0: 20 -->
en:renal failure
n1=en:x-linked recessive nephrolithiasis with renal failure | n2=en:renal failure | rel=r_associated | relid=0 | w=20
- encéphalopathie pancréatique ---
r_associated #0: 20 -->
en:renal failure
n1=encéphalopathie pancréatique | n2=en:renal failure | rel=r_associated | relid=0 | w=20
- gastrinémie ---
r_associated #0: 20 -->
en:renal failure
n1=gastrinémie | n2=en:renal failure | rel=r_associated | relid=0 | w=20
- hyperkaliémie ---
r_associated #0: 20 -->
en:renal failure
n1=hyperkaliémie | n2=en:renal failure | rel=r_associated | relid=0 | w=20
- hyperuricémie ---
r_associated #0: 20 -->
en:renal failure
n1=hyperuricémie | n2=en:renal failure | rel=r_associated | relid=0 | w=20
- hypocalcémie ---
r_associated #0: 20 -->
en:renal failure
n1=hypocalcémie | n2=en:renal failure | rel=r_associated | relid=0 | w=20
- insuffisance ---
r_associated #0: 20 -->
en:renal failure
n1=insuffisance | n2=en:renal failure | rel=r_associated | relid=0 | w=20
- maladie ---
r_associated #0: 20 -->
en:renal failure
n1=maladie | n2=en:renal failure | rel=r_associated | relid=0 | w=20
- maladie des reins ---
r_associated #0: 20 -->
en:renal failure
n1=maladie des reins | n2=en:renal failure | rel=r_associated | relid=0 | w=20
- maladie
(médecine) ---
r_associated #0: 20 -->
en:renal failure
n1=maladie (médecine) | n2=en:renal failure | rel=r_associated | relid=0 | w=20
- maladies ---
r_associated #0: 20 -->
en:renal failure
n1=maladies | n2=en:renal failure | rel=r_associated | relid=0 | w=20
- oxalose osseuse ---
r_associated #0: 20 -->
en:renal failure
n1=oxalose osseuse | n2=en:renal failure | rel=r_associated | relid=0 | w=20
- processus pathologique ---
r_associated #0: 20 -->
en:renal failure
n1=processus pathologique | n2=en:renal failure | rel=r_associated | relid=0 | w=20
- rein ---
r_associated #0: 20 -->
en:renal failure
n1=rein | n2=en:renal failure | rel=r_associated | relid=0 | w=20
- reins ---
r_associated #0: 20 -->
en:renal failure
n1=reins | n2=en:renal failure | rel=r_associated | relid=0 | w=20
- réduction néphronique ---
r_associated #0: 20 -->
en:renal failure
n1=réduction néphronique | n2=en:renal failure | rel=r_associated | relid=0 | w=20
- rénale ---
r_associated #0: 20 -->
en:renal failure
n1=rénale | n2=en:renal failure | rel=r_associated | relid=0 | w=20
- syndrome HIVAN ---
r_associated #0: 20 -->
en:renal failure
n1=syndrome HIVAN | n2=en:renal failure | rel=r_associated | relid=0 | w=20
- syndrome émail-rein ---
r_associated #0: 20 -->
en:renal failure
n1=syndrome émail-rein | n2=en:renal failure | rel=r_associated | relid=0 | w=20
- transplantation rénale ---
r_associated #0: 20 -->
en:renal failure
n1=transplantation rénale | n2=en:renal failure | rel=r_associated | relid=0 | w=20
- uricémie ---
r_associated #0: 20 -->
en:renal failure
n1=uricémie | n2=en:renal failure | rel=r_associated | relid=0 | w=20
- urémigène ---
r_associated #0: 20 -->
en:renal failure
n1=urémigène | n2=en:renal failure | rel=r_associated | relid=0 | w=20
- urémique ---
r_associated #0: 20 -->
en:renal failure
n1=urémique | n2=en:renal failure | rel=r_associated | relid=0 | w=20
- épuration extrarénale (méthodes de) ---
r_associated #0: 20 -->
en:renal failure
n1=épuration extrarénale (méthodes de) | n2=en:renal failure | rel=r_associated | relid=0 | w=20
- érythropoïétine et insuffisance rénale chronique ---
r_associated #0: 20 -->
en:renal failure
n1=érythropoïétine et insuffisance rénale chronique | n2=en:renal failure | rel=r_associated | relid=0 | w=20
- Ca CO2 ---
r_associated #0: 15 -->
en:renal failure
n1=Ca CO2 | n2=en:renal failure | rel=r_associated | relid=0 | w=15
- Calcul rénal ---
r_associated #0: 15 -->
en:renal failure
n1=Calcul rénal | n2=en:renal failure | rel=r_associated | relid=0 | w=15
- Dysfonction sexuelle ---
r_associated #0: 15 -->
en:renal failure
n1=Dysfonction sexuelle | n2=en:renal failure | rel=r_associated | relid=0 | w=15
- HyperTension ---
r_associated #0: 15 -->
en:renal failure
n1=HyperTension | n2=en:renal failure | rel=r_associated | relid=0 | w=15
- Infarctus rénal ---
r_associated #0: 15 -->
en:renal failure
n1=Infarctus rénal | n2=en:renal failure | rel=r_associated | relid=0 | w=15
- TCT ---
r_associated #0: 15 -->
en:renal failure
n1=TCT | n2=en:renal failure | rel=r_associated | relid=0 | w=15
- c-Myc gene ---
r_associated #0: 15 -->
en:renal failure
n1=c-Myc gene | n2=en:renal failure | rel=r_associated | relid=0 | w=15
- déefférentation motrice (syndrome de) ---
r_associated #0: 15 -->
en:renal failure
n1=déefférentation motrice (syndrome de) | n2=en:renal failure | rel=r_associated | relid=0 | w=15
- glomerulo-néphrite ---
r_associated #0: 15 -->
en:renal failure
n1=glomerulo-néphrite | n2=en:renal failure | rel=r_associated | relid=0 | w=15
- glucosurie rénale ---
r_associated #0: 15 -->
en:renal failure
n1=glucosurie rénale | n2=en:renal failure | rel=r_associated | relid=0 | w=15
- néphritique (syndrome) ---
r_associated #0: 15 -->
en:renal failure
n1=néphritique (syndrome) | n2=en:renal failure | rel=r_associated | relid=0 | w=15
- oligoanurie ---
r_associated #0: 15 -->
en:renal failure
n1=oligoanurie | n2=en:renal failure | rel=r_associated | relid=0 | w=15
- Énurésie ---
r_associated #0: 15 -->
en:renal failure
n1=Énurésie | n2=en:renal failure | rel=r_associated | relid=0 | w=15
- néphropathie tubulo-interstitielle aiguë ---
r_associated #0: 11 -->
en:renal failure
n1=néphropathie tubulo-interstitielle aiguë | n2=en:renal failure | rel=r_associated | relid=0 | w=11
- néphropathies ---
r_associated #0: 11 -->
en:renal failure
n1=néphropathies | n2=en:renal failure | rel=r_associated | relid=0 | w=11
- syndrome de Frasier ---
r_associated #0: 11 -->
en:renal failure
n1=syndrome de Frasier | n2=en:renal failure | rel=r_associated | relid=0 | w=11
- troubles rénaux ---
r_associated #0: 11 -->
en:renal failure
n1=troubles rénaux | n2=en:renal failure | rel=r_associated | relid=0 | w=11
- urticaire-surdité-amylose rénale ---
r_associated #0: 11 -->
en:renal failure
n1=urticaire-surdité-amylose rénale | n2=en:renal failure | rel=r_associated | relid=0 | w=11
- Anton-Babinski (syndrome d') ---
r_associated #0: 10 -->
en:renal failure
n1=Anton-Babinski (syndrome d') | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- Bwamba (virus) ---
r_associated #0: 10 -->
en:renal failure
n1=Bwamba (virus) | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- Bywaters (syndrome de) ---
r_associated #0: 10 -->
en:renal failure
n1=Bywaters (syndrome de) | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- C peptide ---
r_associated #0: 10 -->
en:renal failure
n1=C peptide | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- C1 inhibiteur ---
r_associated #0: 10 -->
en:renal failure
n1=C1 inhibiteur | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- C3 Nef ---
r_associated #0: 10 -->
en:renal failure
n1=C3 Nef | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- CA 15-3 ---
r_associated #0: 10 -->
en:renal failure
n1=CA 15-3 | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- Diabète insipide ---
r_associated #0: 10 -->
en:renal failure
n1=Diabète insipide | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- Dysfonctionnement sexuel ---
r_associated #0: 10 -->
en:renal failure
n1=Dysfonctionnement sexuel | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- Glomérulonéphrite ---
r_associated #0: 10 -->
en:renal failure
n1=Glomérulonéphrite | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- Grönblad-Strandberg-Touraine (syndrome de) ---
r_associated #0: 10 -->
en:renal failure
n1=Grönblad-Strandberg-Touraine (syndrome de) | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- Hta ---
r_associated #0: 10 -->
en:renal failure
n1=Hta | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- Hyperkaliémie ---
r_associated #0: 10 -->
en:renal failure
n1=Hyperkaliémie | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- Hypertension ---
r_associated #0: 10 -->
en:renal failure
n1=Hypertension | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- Hypocalcémie ---
r_associated #0: 10 -->
en:renal failure
n1=Hypocalcémie | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- Incontinence urinaire ---
r_associated #0: 10 -->
en:renal failure
n1=Incontinence urinaire | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- Insuffisance respiratoire chronique ---
r_associated #0: 10 -->
en:renal failure
n1=Insuffisance respiratoire chronique | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- Lithiase rénale ---
r_associated #0: 10 -->
en:renal failure
n1=Lithiase rénale | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- Néphron ---
r_associated #0: 10 -->
en:renal failure
n1=Néphron | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- Néphropathie ---
r_associated #0: 10 -->
en:renal failure
n1=Néphropathie | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- Néphropathie diabétique ---
r_associated #0: 10 -->
en:renal failure
n1=Néphropathie diabétique | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- Néphropathie obstructive ---
r_associated #0: 10 -->
en:renal failure
n1=Néphropathie obstructive | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- Polyurie ---
r_associated #0: 10 -->
en:renal failure
n1=Polyurie | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- Puumala (virus) ---
r_associated #0: 10 -->
en:renal failure
n1=Puumala (virus) | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- Randall (syndrome de) ---
r_associated #0: 10 -->
en:renal failure
n1=Randall (syndrome de) | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- Syndrome de défaillance multiviscérale ---
r_associated #0: 10 -->
en:renal failure
n1=Syndrome de défaillance multiviscérale | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- Système urinaire ---
r_associated #0: 10 -->
en:renal failure
n1=Système urinaire | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- Tübingen (périmètre de) ---
r_associated #0: 10 -->
en:renal failure
n1=Tübingen (périmètre de) | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- Wegener (granulomatose de) ---
r_associated #0: 10 -->
en:renal failure
n1=Wegener (granulomatose de) | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- abcès du rein ---
r_associated #0: 10 -->
en:renal failure
n1=abcès du rein | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- abcès rénal ---
r_associated #0: 10 -->
en:renal failure
n1=abcès rénal | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- acidose rénale hyperchlorémique ---
r_associated #0: 10 -->
en:renal failure
n1=acidose rénale hyperchlorémique | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- acitrétine ---
r_associated #0: 10 -->
en:renal failure
n1=acitrétine | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- acrivastine ---
r_associated #0: 10 -->
en:renal failure
n1=acrivastine | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- acétate de potassium ---
r_associated #0: 10 -->
en:renal failure
n1=acétate de potassium | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- amylose portugaise (manifestations articulaires de l') ---
r_associated #0: 10 -->
en:renal failure
n1=amylose portugaise (manifestations articulaires de l') | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- angl. NSE ---
r_associated #0: 10 -->
en:renal failure
n1=angl. NSE | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- battement rapide du coeur ---
r_associated #0: 10 -->
en:renal failure
n1=battement rapide du coeur | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- c-Mpl ---
r_associated #0: 10 -->
en:renal failure
n1=c-Mpl | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- calcul urinaire ---
r_associated #0: 10 -->
en:renal failure
n1=calcul urinaire | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- chloral hydraté ---
r_associated #0: 10 -->
en:renal failure
n1=chloral hydraté | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- chlorothiazide ---
r_associated #0: 10 -->
en:renal failure
n1=chlorothiazide | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- chlorthalidone ---
r_associated #0: 10 -->
en:renal failure
n1=chlorthalidone | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- chlorure d'ammonium ---
r_associated #0: 10 -->
en:renal failure
n1=chlorure d'ammonium | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- cis-diaminedichloroplatine ---
r_associated #0: 10 -->
en:renal failure
n1=cis-diaminedichloroplatine | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- cisapride ---
r_associated #0: 10 -->
en:renal failure
n1=cisapride | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- cisplatine ---
r_associated #0: 10 -->
en:renal failure
n1=cisplatine | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- clofibrate ---
r_associated #0: 10 -->
en:renal failure
n1=clofibrate | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- créatinine ---
r_associated #0: 10 -->
en:renal failure
n1=créatinine | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- cyclopentylpropionate de testostérone ---
r_associated #0: 10 -->
en:renal failure
n1=cyclopentylpropionate de testostérone | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- cyclosporine ---
r_associated #0: 10 -->
en:renal failure
n1=cyclosporine | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- cyclothiazide ---
r_associated #0: 10 -->
en:renal failure
n1=cyclothiazide | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- dextrothyroxine ---
r_associated #0: 10 -->
en:renal failure
n1=dextrothyroxine | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- diabète bronzé ---
r_associated #0: 10 -->
en:renal failure
n1=diabète bronzé | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- diabète de type 1 ---
r_associated #0: 10 -->
en:renal failure
n1=diabète de type 1 | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- diabète de type 2 ---
r_associated #0: 10 -->
en:renal failure
n1=diabète de type 2 | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- diabète et psychisme ---
r_associated #0: 10 -->
en:renal failure
n1=diabète et psychisme | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- diabète et surdité d'origine mitochondriale ---
r_associated #0: 10 -->
en:renal failure
n1=diabète et surdité d'origine mitochondriale | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- diabète gestationnel ---
r_associated #0: 10 -->
en:renal failure
n1=diabète gestationnel | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- diabète gras ---
r_associated #0: 10 -->
en:renal failure
n1=diabète gras | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- diabète insulinodépendant ---
r_associated #0: 10 -->
en:renal failure
n1=diabète insulinodépendant | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- diabète lipoatrophique congénital ---
r_associated #0: 10 -->
en:renal failure
n1=diabète lipoatrophique congénital | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- diabète non-insulinodépendant ---
r_associated #0: 10 -->
en:renal failure
n1=diabète non-insulinodépendant | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- diabète phosphaté ---
r_associated #0: 10 -->
en:renal failure
n1=diabète phosphaté | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- diabète post-transplantation ---
r_associated #0: 10 -->
en:renal failure
n1=diabète post-transplantation | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- diabète rénal ---
r_associated #0: 10 -->
en:renal failure
n1=diabète rénal | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- diabète sucré ---
r_associated #0: 10 -->
en:renal failure
n1=diabète sucré | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- diabète sucré et complications rénales ---
r_associated #0: 10 -->
en:renal failure
n1=diabète sucré et complications rénales | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- diabètes monogéniques ---
r_associated #0: 10 -->
en:renal failure
n1=diabètes monogéniques | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- diabètes sucrés et insipides avec atrophie optique et surdité ---
r_associated #0: 10 -->
en:renal failure
n1=diabètes sucrés et insipides avec atrophie optique et surdité | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- diabétide génitale ---
r_associated #0: 10 -->
en:renal failure
n1=diabétide génitale | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- diverticulaire (maladie) ---
r_associated #0: 10 -->
en:renal failure
n1=diverticulaire (maladie) | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- en:acute kidney failure ---
r_associated #0: 10 -->
en:renal failure
n1=en:acute kidney failure | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- en:and cerebral dysfonction ---
r_associated #0: 10 -->
en:renal failure
n1=en:and cerebral dysfonction | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- en:bed wetting ---
r_associated #0: 10 -->
en:renal failure
n1=en:bed wetting | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- en:bloody urine ---
r_associated #0: 10 -->
en:renal failure
n1=en:bloody urine | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- en:diabetic strokes ---
r_associated #0: 10 -->
en:renal failure
n1=en:diabetic strokes | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- en:enuresis ---
r_associated #0: 10 -->
en:renal failure
n1=en:enuresis | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- en:excretory system ---
r_associated #0: 10 -->
en:renal failure
n1=en:excretory system | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- en:extrarenal dialysis ---
r_associated #0: 10 -->
en:renal failure
n1=en:extrarenal dialysis | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- en:gross hematuria ---
r_associated #0: 10 -->
en:renal failure
n1=en:gross hematuria | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- en:hypertelorism ---
r_associated #0: 10 -->
en:renal failure
n1=en:hypertelorism | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- en:hypospadias ---
r_associated #0: 10 -->
en:renal failure
n1=en:hypospadias | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- en:kidney cortex necrosis. ---
r_associated #0: 10 -->
en:renal failure
n1=en:kidney cortex necrosis. | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- en:loss of bladder control ---
r_associated #0: 10 -->
en:renal failure
n1=en:loss of bladder control | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- en:monoclonal immunoglobulin deposition disease (MIDD) ---
r_associated #0: 10 -->
en:renal failure
n1=en:monoclonal immunoglobulin deposition disease (MIDD) | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- en:nephredema ---
r_associated #0: 10 -->
en:renal failure
n1=en:nephredema | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- en:nephritic syndrom ---
r_associated #0: 10 -->
en:renal failure
n1=en:nephritic syndrom | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- en:nephrohydrosis ---
r_associated #0: 10 -->
en:renal failure
n1=en:nephrohydrosis | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- en:nephrydrosis ---
r_associated #0: 10 -->
en:renal failure
n1=en:nephrydrosis | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- en:neuropathy and renal insufficiency ---
r_associated #0: 10 -->
en:renal failure
n1=en:neuropathy and renal insufficiency | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- en:organa urinaria ---
r_associated #0: 10 -->
en:renal failure
n1=en:organa urinaria | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- en:polysyndactyly syndrome ---
r_associated #0: 10 -->
en:renal failure
n1=en:polysyndactyly syndrome | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- en:primary hyperoxaluria, type i ---
r_associated #0: 10 -->
en:renal failure
n1=en:primary hyperoxaluria, type i | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- en:renal calculus ---
r_associated #0: 10 -->
en:renal failure
n1=en:renal calculus | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- en:renal disease ---
r_associated #0: 10 -->
en:renal failure
n1=en:renal disease | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- en:respiratory failure ---
r_associated #0: 10 -->
en:renal failure
n1=en:respiratory failure | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- en:respiratory insufficiency ---
r_associated #0: 10 -->
en:renal failure
n1=en:respiratory insufficiency | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- en:synchopexia ---
r_associated #0: 10 -->
en:renal failure
n1=en:synchopexia | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- en:tachyrhythmia ---
r_associated #0: 10 -->
en:renal failure
n1=en:tachyrhythmia | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- en:tachysystole ---
r_associated #0: 10 -->
en:renal failure
n1=en:tachysystole | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- en:urinary lithiasis ---
r_associated #0: 10 -->
en:renal failure
n1=en:urinary lithiasis | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- en:urinary organs ---
r_associated #0: 10 -->
en:renal failure
n1=en:urinary organs | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- en:urinary tract ---
r_associated #0: 10 -->
en:renal failure
n1=en:urinary tract | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- en:uronephrosis ---
r_associated #0: 10 -->
en:renal failure
n1=en:uronephrosis | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- ergocalciférol ---
r_associated #0: 10 -->
en:renal failure
n1=ergocalciférol | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- fentanyl ---
r_associated #0: 10 -->
en:renal failure
n1=fentanyl | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- foscarnet ---
r_associated #0: 10 -->
en:renal failure
n1=foscarnet | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- fréquence cardiaque élevée ---
r_associated #0: 10 -->
en:renal failure
n1=fréquence cardiaque élevée | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- fénofibrate ---
r_associated #0: 10 -->
en:renal failure
n1=fénofibrate | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- glomérulonéphropathie ---
r_associated #0: 10 -->
en:renal failure
n1=glomérulonéphropathie | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- glycosurie rénale ---
r_associated #0: 10 -->
en:renal failure
n1=glycosurie rénale | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- hydrochlorothiazide ---
r_associated #0: 10 -->
en:renal failure
n1=hydrochlorothiazide | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- hydrocèle ---
r_associated #0: 10 -->
en:renal failure
n1=hydrocèle | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- hydrocèle testiculaire ---
r_associated #0: 10 -->
en:renal failure
n1=hydrocèle testiculaire | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- hydrocèle vaginal ---
r_associated #0: 10 -->
en:renal failure
n1=hydrocèle vaginal | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- hyperoxalurie primitive de type i ---
r_associated #0: 10 -->
en:renal failure
n1=hyperoxalurie primitive de type i | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- hyperplasie ---
r_associated #0: 10 -->
en:renal failure
n1=hyperplasie | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- hypertensinase ---
r_associated #0: 10 -->
en:renal failure
n1=hypertensinase | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- hypertensine ---
r_associated #0: 10 -->
en:renal failure
n1=hypertensine | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- hypertensinogène ---
r_associated #0: 10 -->
en:renal failure
n1=hypertensinogène | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- hypertension abdominale ---
r_associated #0: 10 -->
en:renal failure
n1=hypertension abdominale | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- hypertélorisme-microtie-fente faciale ---
r_associated #0: 10 -->
en:renal failure
n1=hypertélorisme-microtie-fente faciale | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- hépatorraphie ---
r_associated #0: 10 -->
en:renal failure
n1=hépatorraphie | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- hépatosidérose ---
r_associated #0: 10 -->
en:renal failure
n1=hépatosidérose | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- incontinence (cure endoscopique de l') ---
r_associated #0: 10 -->
en:renal failure
n1=incontinence (cure endoscopique de l') | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- indapamide ---
r_associated #0: 10 -->
en:renal failure
n1=indapamide | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- insuffisance d'adhérence leucocytaire (syndrome d') ---
r_associated #0: 10 -->
en:renal failure
n1=insuffisance d'adhérence leucocytaire (syndrome d') | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- maladie de Byler ---
r_associated #0: 10 -->
en:renal failure
n1=maladie de Byler | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- metformine ---
r_associated #0: 10 -->
en:renal failure
n1=metformine | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- miction ---
r_associated #0: 10 -->
en:renal failure
n1=miction | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- méthotrexate ---
r_associated #0: 10 -->
en:renal failure
n1=méthotrexate | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- non précisée, hydrocèle ---
r_associated #0: 10 -->
en:renal failure
n1=non précisée, hydrocèle | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- paromomycine ---
r_associated #0: 10 -->
en:renal failure
n1=paromomycine | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- probénécide ---
r_associated #0: 10 -->
en:renal failure
n1=probénécide | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- pyélonéphrite ---
r_associated #0: 10 -->
en:renal failure
n1=pyélonéphrite | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- périnée descendant (syndrome du) ---
r_associated #0: 10 -->
en:renal failure
n1=périnée descendant (syndrome du) | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- retard mental avec atrophie optique, surdité et épilepsie ---
r_associated #0: 10 -->
en:renal failure
n1=retard mental avec atrophie optique, surdité et épilepsie | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- retard mental, retard de croissance, surdité, microgénitalisme lié au sexe ---
r_associated #0: 10 -->
en:renal failure
n1=retard mental, retard de croissance, surdité, microgénitalisme lié au sexe | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- rétinite pigmentaire, surdité, retard mental, et hypogonadisme ---
r_associated #0: 10 -->
en:renal failure
n1=rétinite pigmentaire, surdité, retard mental, et hypogonadisme | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- sel d'Epsom ---
r_associated #0: 10 -->
en:renal failure
n1=sel d'Epsom | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- sotalol ---
r_associated #0: 10 -->
en:renal failure
n1=sotalol | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- sulfadoxine ---
r_associated #0: 10 -->
en:renal failure
n1=sulfadoxine | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- surdité ---
r_associated #0: 10 -->
en:renal failure
n1=surdité | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- syndrome cataracte-ataxie-surdité et retard mental ---
r_associated #0: 10 -->
en:renal failure
n1=syndrome cataracte-ataxie-surdité et retard mental | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- syndrome de Treft-Sanborn-Carey ---
r_associated #0: 10 -->
en:renal failure
n1=syndrome de Treft-Sanborn-Carey | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- syndrome de résection transuréthrale de la prostate ---
r_associated #0: 10 -->
en:renal failure
n1=syndrome de résection transuréthrale de la prostate | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- syndrome de résection transurétrale de la prostate ---
r_associated #0: 10 -->
en:renal failure
n1=syndrome de résection transurétrale de la prostate | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- syndrome de zellweger ---
r_associated #0: 10 -->
en:renal failure
n1=syndrome de zellweger | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- tuberculose pulmonaire chez les sujets infectés par le VIH (traitement de la) ---
r_associated #0: 10 -->
en:renal failure
n1=tuberculose pulmonaire chez les sujets infectés par le VIH (traitement de la) | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- tubulopathie rénale, diabète sucré, ataxie cérébelleuse secondaire à une duplication de l'ADN mitochondrial ---
r_associated #0: 10 -->
en:renal failure
n1=tubulopathie rénale, diabète sucré, ataxie cérébelleuse secondaire à une duplication de l'ADN mitochondrial | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- urination ---
r_associated #0: 10 -->
en:renal failure
n1=urination | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- Épuration extrarénale ---
r_associated #0: 10 -->
en:renal failure
n1=Épuration extrarénale | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- équateur de l'oeil ---
r_associated #0: 10 -->
en:renal failure
n1=équateur de l'oeil | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- équateur du cristallin ---
r_associated #0: 10 -->
en:renal failure
n1=équateur du cristallin | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- équation colorée métamérique ---
r_associated #0: 10 -->
en:renal failure
n1=équation colorée métamérique | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- équationnel ---
r_associated #0: 10 -->
en:renal failure
n1=équationnel | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- équilibre acido-basique ---
r_associated #0: 10 -->
en:renal failure
n1=équilibre acido-basique | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- équilibre acidobasique ---
r_associated #0: 10 -->
en:renal failure
n1=équilibre acidobasique | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- équilibre glomérulotubulaire ---
r_associated #0: 10 -->
en:renal failure
n1=équilibre glomérulotubulaire | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- équilibre génique ---
r_associated #0: 10 -->
en:renal failure
n1=équilibre génique | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- équilibre électronique ---
r_associated #0: 10 -->
en:renal failure
n1=équilibre électronique | n2=en:renal failure | rel=r_associated | relid=0 | w=10
- Appareil urinaire ---
r_associated #0: 5 -->
en:renal failure
n1=Appareil urinaire | n2=en:renal failure | rel=r_associated | relid=0 | w=5
- C3 nef ---
r_associated #0: 5 -->
en:renal failure
n1=C3 nef | n2=en:renal failure | rel=r_associated | relid=0 | w=5
- CA 125 ---
r_associated #0: 5 -->
en:renal failure
n1=CA 125 | n2=en:renal failure | rel=r_associated | relid=0 | w=5
- CA1 ---
r_associated #0: 5 -->
en:renal failure
n1=CA1 | n2=en:renal failure | rel=r_associated | relid=0 | w=5
- CA2 ---
r_associated #0: 5 -->
en:renal failure
n1=CA2 | n2=en:renal failure | rel=r_associated | relid=0 | w=5
- Cystite interstitielle ---
r_associated #0: 5 -->
en:renal failure
n1=Cystite interstitielle | n2=en:renal failure | rel=r_associated | relid=0 | w=5
- Hyperuricémie ---
r_associated #0: 5 -->
en:renal failure
n1=Hyperuricémie | n2=en:renal failure | rel=r_associated | relid=0 | w=5
- Hématurie ---
r_associated #0: 5 -->
en:renal failure
n1=Hématurie | n2=en:renal failure | rel=r_associated | relid=0 | w=5
- Lithiase urinaire ---
r_associated #0: 5 -->
en:renal failure
n1=Lithiase urinaire | n2=en:renal failure | rel=r_associated | relid=0 | w=5
- Navratil (opération de) ---
r_associated #0: 5 -->
en:renal failure
n1=Navratil (opération de) | n2=en:renal failure | rel=r_associated | relid=0 | w=5
- Onsager (relation d') ---
r_associated #0: 5 -->
en:renal failure
n1=Onsager (relation d') | n2=en:renal failure | rel=r_associated | relid=0 | w=5
- Transplantation rénale ---
r_associated #0: 5 -->
en:renal failure
n1=Transplantation rénale | n2=en:renal failure | rel=r_associated | relid=0 | w=5
- Tubule rénal ---
r_associated #0: 5 -->
en:renal failure
n1=Tubule rénal | n2=en:renal failure | rel=r_associated | relid=0 | w=5
- amidotrizoate de méglumine ---
r_associated #0: 5 -->
en:renal failure
n1=amidotrizoate de méglumine | n2=en:renal failure | rel=r_associated | relid=0 | w=5
- byssinose ---
r_associated #0: 5 -->
en:renal failure
n1=byssinose | n2=en:renal failure | rel=r_associated | relid=0 | w=5
- diabète insulino-requérant ---
r_associated #0: 5 -->
en:renal failure
n1=diabète insulino-requérant | n2=en:renal failure | rel=r_associated | relid=0 | w=5
- défaillance autonomique progressive ---
r_associated #0: 5 -->
en:renal failure
n1=défaillance autonomique progressive | n2=en:renal failure | rel=r_associated | relid=0 | w=5
- défaillance cardiaque ---
r_associated #0: 5 -->
en:renal failure
n1=défaillance cardiaque | n2=en:renal failure | rel=r_associated | relid=0 | w=5
- défaillance psychique sénile ---
r_associated #0: 5 -->
en:renal failure
n1=défaillance psychique sénile | n2=en:renal failure | rel=r_associated | relid=0 | w=5
- défaillance viscérale ---
r_associated #0: 5 -->
en:renal failure
n1=défaillance viscérale | n2=en:renal failure | rel=r_associated | relid=0 | w=5
- fondaparinux ---
r_associated #0: 5 -->
en:renal failure
n1=fondaparinux | n2=en:renal failure | rel=r_associated | relid=0 | w=5
- galantamine ---
r_associated #0: 5 -->
en:renal failure
n1=galantamine | n2=en:renal failure | rel=r_associated | relid=0 | w=5
- mitomycine ---
r_associated #0: 5 -->
en:renal failure
n1=mitomycine | n2=en:renal failure | rel=r_associated | relid=0 | w=5
- nephropathia epidemica ---
r_associated #0: 5 -->
en:renal failure
n1=nephropathia epidemica | n2=en:renal failure | rel=r_associated | relid=0 | w=5
- néphronique ---
r_associated #0: 5 -->
en:renal failure
n1=néphronique | n2=en:renal failure | rel=r_associated | relid=0 | w=5
- néphronophthise ---
r_associated #0: 5 -->
en:renal failure
n1=néphronophthise | n2=en:renal failure | rel=r_associated | relid=0 | w=5
- néphronophtise ---
r_associated #0: 5 -->
en:renal failure
n1=néphronophtise | n2=en:renal failure | rel=r_associated | relid=0 | w=5
- néphronophtise familiale juvénile ---
r_associated #0: 5 -->
en:renal failure
n1=néphronophtise familiale juvénile | n2=en:renal failure | rel=r_associated | relid=0 | w=5
- néphronophtise juvénile avec amaurose de Leber ---
r_associated #0: 5 -->
en:renal failure
n1=néphronophtise juvénile avec amaurose de Leber | n2=en:renal failure | rel=r_associated | relid=0 | w=5
- néphropathie aiguë à oxalate ---
r_associated #0: 5 -->
en:renal failure
n1=néphropathie aiguë à oxalate | n2=en:renal failure | rel=r_associated | relid=0 | w=5
- néphropathie avec perte de sel ---
r_associated #0: 5 -->
en:renal failure
n1=néphropathie avec perte de sel | n2=en:renal failure | rel=r_associated | relid=0 | w=5
- néphropathie bilharzienne ---
r_associated #0: 5 -->
en:renal failure
n1=néphropathie bilharzienne | n2=en:renal failure | rel=r_associated | relid=0 | w=5
- néphropathie de choc ---
r_associated #0: 5 -->
en:renal failure
n1=néphropathie de choc | n2=en:renal failure | rel=r_associated | relid=0 | w=5
- néphropathie des Balkans ---
r_associated #0: 5 -->
en:renal failure
n1=néphropathie des Balkans | n2=en:renal failure | rel=r_associated | relid=0 | w=5
- néphropathie des analgésiques ---
r_associated #0: 5 -->
en:renal failure
n1=néphropathie des analgésiques | n2=en:renal failure | rel=r_associated | relid=0 | w=5
- néphropathie des antalgiques ---
r_associated #0: 5 -->
en:renal failure
n1=néphropathie des antalgiques | n2=en:renal failure | rel=r_associated | relid=0 | w=5
- onychodysplasie ---
r_associated #0: 5 -->
en:renal failure
n1=onychodysplasie | n2=en:renal failure | rel=r_associated | relid=0 | w=5
- onychogryphose ---
r_associated #0: 5 -->
en:renal failure
n1=onychogryphose | n2=en:renal failure | rel=r_associated | relid=0 | w=5
- onycholyse ---
r_associated #0: 5 -->
en:renal failure
n1=onycholyse | n2=en:renal failure | rel=r_associated | relid=0 | w=5
- onycholyse candidosique ---
r_associated #0: 5 -->
en:renal failure
n1=onycholyse candidosique | n2=en:renal failure | rel=r_associated | relid=0 | w=5
- onycholyse semi-lunaire partielle ---
r_associated #0: 5 -->
en:renal failure
n1=onycholyse semi-lunaire partielle | n2=en:renal failure | rel=r_associated | relid=0 | w=5
- onychomadèse ---
r_associated #0: 5 -->
en:renal failure
n1=onychomadèse | n2=en:renal failure | rel=r_associated | relid=0 | w=5
- onychomatricome ---
r_associated #0: 5 -->
en:renal failure
n1=onychomatricome | n2=en:renal failure | rel=r_associated | relid=0 | w=5
- syndrome de déefférentation motrice ---
r_associated #0: 5 -->
en:renal failure
n1=syndrome de déefférentation motrice | n2=en:renal failure | rel=r_associated | relid=0 | w=5
- syndrome tumeur de Wilms-aniridie-anomalies génito-urinaires-retard mental ---
r_associated #0: 5 -->
en:renal failure
n1=syndrome tumeur de Wilms-aniridie-anomalies génito-urinaires-retard mental | n2=en:renal failure | rel=r_associated | relid=0 | w=5
- taches blanches évanescentes (syndrome des) ---
r_associated #0: 5 -->
en:renal failure
n1=taches blanches évanescentes (syndrome des) | n2=en:renal failure | rel=r_associated | relid=0 | w=5
- édétate disodique ---
r_associated #0: 5 -->
en:renal failure
n1=édétate disodique | n2=en:renal failure | rel=r_associated | relid=0 | w=5
- insuffisance rénale aigu ---
r_associated #0: 1 -->
en:renal failure
n1=insuffisance rénale aigu | n2=en:renal failure | rel=r_associated | relid=0 | w=1
- insuffisance rénale aiguë avec lésion de nécrose rénale corticale ---
r_associated #0: 1 -->
en:renal failure
n1=insuffisance rénale aiguë avec lésion de nécrose rénale corticale | n2=en:renal failure | rel=r_associated | relid=0 | w=1
- insuffisance rénale aiguë non précisée ---
r_associated #0: 1 -->
en:renal failure
n1=insuffisance rénale aiguë non précisée | n2=en:renal failure | rel=r_associated | relid=0 | w=1
- insuffisance rénale aiguë sur insuffisance rénale chronique ---
r_associated #0: 1 -->
en:renal failure
n1=insuffisance rénale aiguë sur insuffisance rénale chronique | n2=en:renal failure | rel=r_associated | relid=0 | w=1
- insuffisance rénale aiguë survenant après le travail et l'accouchement ---
r_associated #0: 1 -->
en:renal failure
n1=insuffisance rénale aiguë survenant après le travail et l'accouchement | n2=en:renal failure | rel=r_associated | relid=0 | w=1
- insuffisance rénale chronique avancée ---
r_associated #0: 1 -->
en:renal failure
n1=insuffisance rénale chronique avancée | n2=en:renal failure | rel=r_associated | relid=0 | w=1
- insuffisance rénale chronique du chat ---
r_associated #0: 1 -->
en:renal failure
n1=insuffisance rénale chronique du chat | n2=en:renal failure | rel=r_associated | relid=0 | w=1
- insuffisance rénale chronique terminale ---
r_associated #0: 1 -->
en:renal failure
n1=insuffisance rénale chronique terminale | n2=en:renal failure | rel=r_associated | relid=0 | w=1
- insuffisance rénale congénitale ---
r_associated #0: 1 -->
en:renal failure
n1=insuffisance rénale congénitale | n2=en:renal failure | rel=r_associated | relid=0 | w=1
- insuffisance rénale et médicaments ---
r_associated #0: 1 -->
en:renal failure
n1=insuffisance rénale et médicaments | n2=en:renal failure | rel=r_associated | relid=0 | w=1
- insuffisance rénale par réaction corticale ---
r_associated #0: 1 -->
en:renal failure
n1=insuffisance rénale par réaction corticale | n2=en:renal failure | rel=r_associated | relid=0 | w=1
|